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Dolabriferol C is a member of a small family of marine natural products known as non-
contiguous polypropionates that are esters of a polypropionate carboxylic acid with a 
polypropionate alcohol. The origin of these so-called ‘natural products’ is uncertain, but they are 
often hypothesized to arise from a retro-Claisen fragmentation of a hemiacetal formed from a 5-
hydroxy-1,3-dione embedded in a contiguous polypropionate chain (e.g., S1 and S2). To test that 
conjecture, these putative precursors have been targeted for total synthesis to allow exploration of 
their properties, especially the tendency to rearrange into the non-contiguous ‘natural products’. 
In previous work, the Ward group produced experimental evidence for the proposed origin of non-
contiguous polypropionates baconipyrone A, baconipyrone C, and dolabriferol by total synthesis 
from their putative contiguous precursors via a retro-Claisen approach. 
Towards the synthesis of S2, the putative contiguous precursor of dolabriferol C, a new 
strategy was contemplated and examined the potential of bisenolates of meso 1,5-diketones S5 and 
S8, previously unknown entities. The research presented herein describes the development and 
application of one-pot sequential enantiotopic group selective (SEGS) aldol reactions as a 
powerful strategy for highly convergent polypropionate synthesis. Both (E,E)- and (Z,Z)-bisenol 
borinates (e.g., S5-E, S5-Z, S8-E) were prepared stereoselectively from meso 1,5-diketones S5 
and S8, and were successfully used in enantioselective desymmetrization and SEGS bisaldol 
reactions to synthesize several meso, racemic, and enantiopure polypropionate motifs with high 
diastereoselectivities. 
The putative contiguous precursor S2 was prepared via a highly stereoselective bisaldol 
reaction of a meso 1,5-diketone S5 with two different chiral aldehydes S6 (enantiopure) and S7 
(racemic or enantiopure) that generates the full carbon skeleton S4 (enantiopure) and sets the 
 ix 
absolute configuration of eight stereocenters in a one-pot process. Brief exposure of the precursor 
S2 to neutral alumina cleanly produced dolabriferol C via a remarkably chemoselective retro-
Claisen reaction thereby establishing this natural product as a plausible isolation artifact. This is 
the first total synthesis of dolabriferol C (and its contiguous precursor S2) and was achieved in 7 
steps with 13.6% overall yield from the known aldehyde S6. Using this strategy, an improved 
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Polypropionates are one of the most important classes of secondary metabolites isolated 
from plants, fungi, bacteria and sponges.1 The characteristic structural motif of polypropionates is 
a hydrocarbon chain with alternating methyl and hydroxy (or oxo) substituents (Figure 1-1). 
 
Figure 1-1: Structure of polypropionate. 
Several polypropionate natural products exhibit various biological activities and are widely 
used in drug development for human health (Figure 1-2). Because of their wide range of biological 
activities and structural complexity, polypropionates have attracted the attention of many synthetic 
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1.1.1. Biosynthesis of polypropionates 
The biosynthesis of polypropionates proceeds via iterative coupling of propionate units by 
polyketide synthase (PKS) enzymes. These multi-modular enzymes complete multistep 
biosynthetic sequences by passing the substrate from the active site of one module to that of the 
next module in a coordinated fashion. In general, the process begins with a stereoselective 
decarboxylative addition of methyl malonyl CoA catalyzed by the first ketosynthase (KS) module 
to give the corresponding β-ketoester intermediate (Scheme 1-1); however, the next module often 
is a ketoreductase (KR) that effects stereoselective reduction of the ketoester intermediate to give 
β-hydroxy ester before the next homologation of the chain. This process repeats with each 
homologation of the chain and the process is terminated by thioesterase (TE) module to provide 
polypropionate that have alternating methyl and hydroxy subunits.1–3 However, these linear 
polypropionates may not be the final products and can undergo further modification by enzyme 




Scheme 1-1: Biosynthetic pathway for polypropionate synthesis (adapted from ref. 1). 
 
1.2. Non-Contiguous Polypropionates  
1.2.1. Structure and isolation 
Non-contiguous polypropionates are esters of a polypropionate carboxylic acid with a 
polypropionate alcohol and consequently have a non-contiguous carbon chain. To date, all 
members of this small family of polypropionates have been isolated from marine mollusks (Figure 
1-3). 
  
















































CoA = coenzyme A
PKS = polyketide synthase
AT = acyltransferase









Figure 1-3: Isolated non-contiguous polypropionates. 
The first non-contiguous polypropionate 8 was isolated along with the hemiacetal isomer 
8a from Siphonaria australis collected near Auckland, New Zealand (Figure 1-4).4 Spectral data 
analysis allowed assignment of the relative configuration at C-7, C-8, C-10 and C-11 in 8a; 
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Figure 1-4: Structures of 8 and 8a. 
Faulkner et al. isolated baconipyrones A-D (9-12) along with the known5 siphonarin A (21) 
from Siphonaria baconi collected near Melbourne, Australia (Scheme 1-2). The structure of 
baconipyrone B (10) was established by X-ray crystallography, while the structures of other 
baconipyrones were established by comparing their spectral data with the known 10. The spectral 
data of baconipyrone A (9) were quite similar to those of 10 and differed only by the signals due 
to the presence of a methyl vs. an ethyl group at C-28. The relative configuration at C-4, C-6, C-
10, C-11, C-12 and C-14 in 10 are identical to those of siphonarin A (21). Baconipyrones A-D (9-
12) all contain a polypropionate ester chain and highly substituted γ-pyrone ring system. In the 
structures of 9 and 10, the polypropionate carboxylic acid fragment was connected through an ester 
link to a highly substituted β-hydroxy cyclohexanone, whereas in 11 and 12, the same fragment 
was connected to an acyclic 1,5-diketone. Baconipyrones 9 and 10 are interrelated with 11 and 12, 
respectively, by means of an aldol-retro aldol pathway (Scheme 1-2). 
O O
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Scheme 1-2: Relationship of baconipyrones (A-D) with siphonarins A and B. 
Membrenones A-C (13, 14 and 24) (Figure 1-5) were isolated from the skin of 
Pleurobranchus membranaceus, a Mediterranean mollusc species collected by SCUBA divers in 
the bay of Pozzuoli, and the structures were reported by Ciavatta et al. in 1993.6 The three 
structures have a common polysubstituted γ-dihydropyrone core. Membrenone A (13) and 
membrenone B (14) have non-contiguous carbon-chains (esters of simple carboxylic acids), 
whereas, membrenone C (24) has a contiguous carbon-chain. The relative configuration at C-6 and 
C-7 of membrenones was established on the basis of the 3JH6-H7 coupling constant values and by 
comparison with model compounds. The C-8, C-9 and C-10 relative configuration and the absolute 
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Figure 1-5: Structures of membrenones A-C. 
Dolabriferol (15) was isolated from the anaspidean mollusc Dolabrifera dolabrifera 
collected in Cuba by SCUBA divers, and its structure was reported by Gavagnin and co-workers 
in 1996.7 Dolabriferol (15) consists of a highly substituted 4-hydroxyoxane connected to a β-
hydroxy-5-oxo carboxylic acid via an ester linkage (Figure 1-6). The structure of 15 was elucidated 
by NMR studies and the relative configuration was confirmed by X-ray crystallography. In 2012, 
Rodríguez et al. reported dolabriferol B (16) and dolabriferol C (17) along with the known 15 
isolated from Dolabrifera dolabrifera collected in Puerto Rico.8 The structure of 16 differs from 
15 by having an ethyl group at C-18 instead of isopropyl group. The relative configuration of the 
cyclic hemiacetal in 16 was established by 1H NMR coupling constant values and by NOE 
correlations. Because the spectral data and optical rotation values of 16 are in close agreement with 
those of 15, all the relative configuration of 16 were assumed to be same as in 15. This assumption 
was further supported by obtaining the common acid fragment 25 from degradation of 15 and 16. 
The spectral data of dolabriferol C (17) were quite similar to those of 15. The relative configuration 
of 17 was determined unambiguously from X-ray crystallographic analysis. The absolute 
configuration of 17 was assumed to be same as in 15 based on their similar spectral data and similar 
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Figure 1-6: Structures of dolabriferols; degradation of 15 and 16 to the common acid fragment 
25. 
Siserrone A (18) was isolated along with the known5 dihydrosiphonarins A and B from 
Siphonaria serrata and its structure was reported by Davies-Coleman in 2000 (Figure 1-7).9 The 
structure of 18 is comprised of a γ-pyrone polypropionate carboxylic acid connected to a hydroxy-
substituted cyclic hemiacetal via an ester link. With the exception of C-7, the relative configuration 
of cyclic hemiacetal in 18 was determined by 1H NMR coupling constant values and by ROESY 
correlations, while the relative configuration of the acyclic chain was established by chemical 
degradation studies. A 4:1 diastereomeric mixture of carboxylic acids was obtained from 
degradation of 18. After esterification of the acid mixture, the major ester 26 was isolated, and its 
spectral data was consistent with those of the known acid 2710 suggesting the relative configuration 









dolabriferol (15); R = Me


































Figure 1-7: Degradation of siserrone A followed by esterification to ester 26. 
Micromelones A (19) and B (20) were isolated from Micromelo undata collected from the 
intertidal zone along the north coast of Tenerife (Figure 1-8). Structures of 19 and 20 were 
determined by NMR data analysis and MS fragmentation. However, the relative and absolute 
configurations of either 19 or 20 were not established due to their rapid decomposition. 
 
Figure 1-8: Structures of micromelones A and B. 
 
1.2.2. Biosynthetic hypothesis on the origin of non-contiguous polypropionates 
Compounds 8 and 8a have the same chemical formula and are related by a rearrangement 
pathway (Scheme 1-3). Indeed, it was hypothesized that the ester link in non-contiguous 8 was 
formed from a retro-Claisen rearrangement of the contiguous 8a generated by ring-chain 
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 11 
rearrangement of 8a to 8 in presence of DBU4,11 or basic alumina.12 Although the in vitro 
transformation of 8a to 8 is evidence for the proposed retro-Claisen rearrangement, an enzymatic 
propionylation of β-hydroxy ketone 8c to 8 cannot be ruled out. 
 
Scheme 1-3: Transformation of contiguous 8a to non-contiguous 8 via a retro-Claisen 
rearrangement. 
Faulkner et al. proposed a biosynthetic hypothesis that links baconipyrones A-D (9-12) 
with siphonarins A-B (21, 22) as shown in Scheme 1-2. The proposed mechanism suggests 
baconipyrones 9, 11 could be derived from siphonarin A (21), whereas 10, 12 could be derived 
from siphonarin B (22) (Scheme 1-4).13 Furthermore, baconipyrones and siphonarins have 
identical absolute configurations at related centers. A careful extraction of the same mollusk 
Siphonaria baconi by Davies-Coleman revealed the presence of siphonarins but no baconipyrones 
were detected.9 Similarly, preliminary extraction of Siphonaria serrata yielded the known5 
dihydrosiphonarin A (28) and dihydrosiphonarin B (29) as major components along with minor 
siserrone A (18). Surprisingly, latter extractions from the same species collected from the same 
collection site produced 18, but no dihydrosiphonarins were observed. Because the appearance of 
O O
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baconipyrones and siserrone varied with extraction procedures, the natural product status of these 
polypropionate esters was viewed with suspicion. Furthermore, it was hypothesized that the non-
contiguous polypropionate 18 could be formed from contiguous precursor 28 during isolation via 
a plausible rearrangement pathway as shown in Scheme 1-4. 
 
Scheme 1-4: A plausible rearrangement pathway of dihydrosiphonarin A (28) to siserrone A 
(18). 
Gavagnin also hypothesized that the non-contiguous natural product 15 could be obtained 
from its isomeric hemiacetal precursor 32 (C5-OH➔C9-carbonyl) via a retro-Claisen 
rearrangement pathway (Scheme 1-5).7 Towards the synthesis of dolabriferol (15), Perkins14 and 
Goodman15 independently generated non-contiguous polypropionates (hydroxy protected) from 
their isomeric C13-hydroxy protected contiguous polypropionates (e.g., 32) via a DBU induced 
retro-Claisen rearrangement. Although, these approaches support the proposed retro-Claisen 
rearrangement pathway to form a non-contiguous carbon chain, the presence of protecting groups 
prevents other competitive cyclizations or rearrangements. Ward et al. successfully synthesized 
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non-contiguous polypropionate “natural products” (e.g., 15, 9 and 11, respectively) via a 
regioselective retro-Claisen rearrangement under mild conditions (Scheme 1-5).16,17 Ward’s 
synthetic approaches provide the first experimental evidence that supports the proposed hypothesis 
on the origin of non-contiguous polypropionates 9, 11 and 15. Based on all the above observations 
and experimental evidence, it can be concluded that non-contiguous polypropionates are most 
likely generated from their isomeric contiguous polypropionates during isolation, but not from 
enzymatic reactions in biological systems. 
 
Scheme 1-5: Proposed retro-Claisen rearrangement of putative contiguous precursors to non-
contiguous natural products. 
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1.2.3. Total synthesis and synthetic studies on non-contiguous polypropionates (by other 
groups) 
Several research groups have published synthetic studies on non-contiguous 
polypropionates; however, only a few of these so-called natural products have been synthesized to 
date. 
1.2.3.1.Total synthesis of polypropionate ester 8 
In 1992, Albizati et.al., reported the relative and absolute configuration of polypropionate 
ester 8 by achieving its synthesis (Scheme 1-6).12 Aldol reaction of dione 34 with enantiopure 
aldehyde 35 produced the hydroxy dione 36 as a mixture of stereoisomers (major adduct has 7,8-
syn relative configuration) (Scheme 1-6a). The adduct 36 was readily dehydrated (under basic or 
acidic or buffered conditions) to give 37 as a mixture of diastereomers. Interestingly, flash 
chromatography of 36 produced the ester 38 via retro-Claisen rearrangement of the corresponding 
hemiacetal. However, the relative configuration at C7-C8 in 38 was determined as syn, which is 
not identical to the natural product 8 (7,8-anti). Alternatively, an aldol reaction of Li-enolate of 3-
pentanone with aldehyde 35 produced the adduct 39 that was converted to the corresponding esters 
8 and 40 (Scheme 1-6b). The absolute configuration of natural and synthetic products was assigned 
as shown in 8 by using the exciton chirality method on 40. Because 8 was obtained from 8a, the 
absolute configuration of 8a was assigned on the basis of 8. 
 15 
 
Scheme 1-6: Albizati’s synthesis of ester polypropionate 8. 
Lister and Perkins reported a stereocontrolled synthesis of hemiacetal 8a and its 
transformation to polypropionate ester 8 via retro-Claisen rearrangement, thereby establishing the 
absolute and relative configurations of both natural products (Scheme 1-7).11 A substrate-
controlled aldol reaction of Paterson’s ketone 41 (enantiopure) with aldehyde 35 (enantiopure) 
generated the adduct 42 (enantiopure) with the desired 7,8-anti relative configuration. Subsequent 
functional group manipulations and chain elongation produced the adduct 43 with an epimerizable 
stereocenter at C-10 as a mixture of keto-enol tautomers. Treatment of 43 with buffered pyridinium 
hydrofluoride and catalytic amount of water for six days produced the thermodynamically stable 
hemiacetal 8a. Applying the known4 DBU conditions on 8a generated the ester 8 via retro-Claisen 
rearrangement. 
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Scheme 1-7: Perkins’ synthesis of ester polypropionate 8. 
1.2.3.2.Total synthesis of membrenone A and B 
Several research groups accomplished the total syntheses of (−)-membrenones A and B 
(unnatural enantiomers). Perkins et al. achieved the total syntheses of (−)-membrenones A and B 
via an esterification approach. Using Paterson’s ketone 44 and aldehyde 45, trione 46 was prepared 
as a 3:2 mixture (C4-epimers) of diastereomers (Scheme 1-8).18 Treatment of this trione mixture 
46 with HF·pyridine and pyridine, and then with p-TsOH accomplished desilylation, cyclization 
and dehydration to give the γ-dihydropyrone 47. Final acylations of the hydroxy group in γ-
dihydropyrone 47 with (S)-(+)-2-methyl butyric acid (using modified Yonemitsu-Yamaguchi 
esterification conditions19,20) and propionyl chloride furnished (−)-membrenone A and (−)-


































Scheme 1-8: Perkins’ synthesis of (−)-membrenones A and B. 
Shibasaki et al. synthesized (−)-membrenones A and B via an esterification approach 
starting from thiopropionamide 48 using an iterative aldol coupling strategy (Scheme 1-9).21 
Thiopropionamide 48 was converted to hydroxy-thiopropionamide 49 that was further transformed 
to γ-dihydropyrone 50 with the desired stereochemical configurations. The γ-dihydropyrone 50 
upon silyl removal and oxidation produced the keto-pyrone 51. Final TBDPS removal with TASF, 
followed by acylations with (S)-2-methylbutyric anhydride and propionyl chloride afforded (−)-
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Scheme 1-9: Shibasaki’s synthesis of (−)-membrenones A and B. 
1.2.3.3.Total synthesis of baconipyrone C 
Among the four total syntheses of baconipyrone C, three of them (Paterson, Hoveyda and 
Yadav) followed an identical approach to make the key ester link in the natural product by coupling 
the corresponding carboxylic acid with alcohol. Ward et al. established a retro-Claisen approach 
towards the synthesis of baconipyrone C from its putative contiguous precursor (for detailed 
discussion refer to the section 1.2.4) 
The first total synthesis of (−)-baconipyrone C (11) was achieved by Paterson et al. via 
coupling of  alcohol fragment 54 with acid fragment 53 (Scheme 1-10).22 The acid fragment 53 
was prepared from 52 via iterative aldol couplings. The alcohol fragment 54 was prepared from 
enantiopure ketone ent-41 or from 3-pentanone. After several attempts at the challenging 
esterification between alcohol 54 and acid 53, the corresponding ester was generated as an 
inseparable mixture of diastereomers resulting from epimerization of the acid fragment 53. 
However, after modifications of Yonemitsu-Yamaguchi protocol,19,20 the epimerization was 
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 19 
deprotection with DDQ to give (−)-baconipyrone C (11) (67%). This total synthesis was achieved 
in 17 steps with 13.9% overall yield from 52.  
 
Scheme 1-10: Paterson’s synthesis of (−)-baconipyrone C. 
Hoveyda et al. used an NHC-catalyzed asymmetric ring opening metathesis (AROM) and 
asymmetric allylic alkylation (AAA) to achieve the total synthesis of ent-baconipyrone C (the 
unnatural enantiomer) via coupling of alcohol fragment 57 with acid fragment 60 (Scheme 1-11).23 
The desired hydroxy diketone 57 was prepared from aldehyde 56. The acid fragment 60 was 
synthesized starting from the oxabicycle 58 via Ru-catalyzed asymmetric ring opening metathesis 
(AROM) to give highly substituted pyran 59 with 88% ee. The pyran 59 was converted to acid 60 
that was treated with alcohol 57 under modified Yonemitsu-Yamaguchi esterification conditions 


































Scheme 1-11: Hoveyda’s synthesis of (+)-baconipyrone C. 
In 2009, Yadav et al. reported a total synthesis of (−)-baconipyrone C by coupling alcohol 
54 with acid 65 (Scheme 1-12).24 Using an enzymatic strategy, the racemic monobenzyl ether of 
diol 61 was resolved to give the single enantiomer 62 (35%). After chain elongation and functional 
group manipulations, alcohol 62 was converted to hydroxy diketone 54. The γ-pyrone acid 65 was 
prepared from lactone 63. Final esterification was achieved by treating acid 65 with alcohol 54 
under the modified Yonemitsu-Yamaguchi protocol as previously reported by Paterson et al.,22 
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    PhMe, 22 oC, 
    30 min, 68%
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Scheme 1-12: Yadav’s synthesis of (−)-baconipyrone C. 
1.2.3.4.Towards the total synthesis of dolabriferol 
Several research groups worked towards the total synthesis of dolabriferol. Dias et al.25 and 
Chênevert et al.26,27 prepared the corresponding carboxylic acid and alcohol coupling fragments to 
make the ester link in 15; however, no coupling of these fragments was reported. Perkins et al.14 
and Toste et al.28 were able to generate an ester precursor (a non-contiguous carbon chain) to 15; 
however, they were unsuccessful in final deprotection to obtain the natural product 15. The first 
total synthesis of 15 was achieved by Vogel et al. in 2010 by coupling of the corresponding acid 
and alcohol.29 Later, Goodman et al.15 and Ward et al.17 accomplished the total synthesis of 15 via 
a retro-Claisen approach. Very recently, Pabbaraja et al.30 synthesized 15 via an esterification 
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Dias et al. proposed a convergent synthesis of dolabriferol (15) via the coupling of the two 
fragments: keto acid 69 and hemiacetal 68 (Scheme 1-13).25 Both of these fragments were 
synthesized from a common enantiopure Weinreb amide 67 that was prepared from the known 
Evans acyloxazolidinone 66. Although the two coupling fragments 68 and 69 were synthesized, 
no esterification to obtain 15 was reported. 
 
Scheme 1-13: Dias synthetic route to alcohol 68 and acid 69. 
Chênevert approach:  
Towards the synthesis of dolabriferol (15), Chênevert synthesized the two coupling 
fragments: alcohol 68 and acid 72, starting from an enzyme mediated desymmetrization of meso 
diol 70 to give the corresponding monoester 71 in excellent yield (94%) with high enantiopurity 
(97% ee) (Scheme 1-14).26,27 To achieve high enantiopurity, addition of molecular sieves to the 
medium was essential to trap the byproduct acetaldehyde. The monoester 71 was converted to the 
desired acid and alcohol fragments 72 and 68, respectively. However, Chênevert et al. never 



















Scheme 1-14: Chênevert synthetic route to alcohol 68 and acid 72. 
Perkins approach: 
Lister and Perkins synthesized the desired ester 78 (a non-contiguous carbon chain), a 
precursor to dolabriferol (15), using a retro-Claisen approach; however, they were unsuccessful in 
transforming 78 to 15 under variety of conditions (Scheme 1-15). Both coupling fragments 
aldehyde 73 and ketone 74 were synthesized from a common enantioenriched ketone 41. Having 
these coupling fragments, the Li-enolate of 74 was generated and treated with aldehyde 73 to give 
the adduct 75 as a separable mixture of diastereomers (6:1 dr). PMB deprotection of 75, followed 
by oxidation of the free hydroxy groups gave the trione 76. Desilylation of 76 using HFᐧpyridine 
and pyridine in THF led to a trioxaadamantane 77 that was acid sensitive and decomposed upon 
exposure to CDCl3. Alternatively, a reaction of 77 with DBU facilitated a retro-Claisen 
rearrangement to give the desired ester 78. The final steps to obtain 15 require removal of TBS 
group from 78 and formation of a cyclic hemiacetal. Attempted removal of TBS group, led to 
elimination of a hydroxy group (to form an enone) under a variety of desilylation conditions, 




















15. Despite the challenges to obtain 15 from 78, this approach demonstrated a base induced retro-
Claisen rearrangement of the linear precursor 77 to form the desired ester link in 78. 
 
Scheme 1-15: Perkins approach to dolabriferol. 
Vogel approach: 
Vogel and co-workers achieved the first total synthesis of dolabriferol (15) and established 
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esterification of acid 82 with acyclic alcohol 85.i Both these coupling partners 82 and 85 were 
synthesized from a common SO2-induced oxyallylation cascade reaction. Esterification of acid 82 
with alcohol 85 (less hindered than the cyclic alcohol 68) using modified Yonemitsu-Yamaguchi 
esterification protocol22 provided 86 as a 9:1 mixture of diastereomers. Selective removal of acetyl 
group in 86, followed by cleavage of phenylethyl ether resulted in the formation of the precursor 
87. Final alloc deprotection (easier than the silyl deprotection as in Perkins approach) generated 
the free alcohol that underwent hemiacetal formation to give 15. Using an identical approach, a 
stereoisomer of 15 was also synthesized. 
 
Scheme 1-16: Vogel approach to dolabriferol. 
 
                                                        











































    -78 oC, 0.1 torr
2. KF, H2O, rt
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Goodman et al. achieved the total synthesis of dolabriferol (15) via a retro-Claisen 
approach from the PMB-protected contiguous precursor 95 (Scheme 1-17).15 The full carbon 
skeleton 92 required for 15 was prepared by a stereoselective aldol coupling of ketone 91 with 
aldehyde 89. The aldehyde 89 was prepared from Evans oxazolidinone 88 and the ketone 91 was 
prepared from the diol 90 that was generated from a one-pot L-proline catalyzed aldol reaction of 
propanal with isobutyraldehyde and NaBH4 reduction as reported by MacMillan31. 
Coupling aldehyde 89 with the Sn-enolate of ketone 91 afforded the adduct 92 with good 
diastereoselectivity (12.6:1, dr) (Scheme 1-17). Oxidation of the free hydroxy group in 92 
produced the stable diastereomer 93 with no evidence of epimerization at C-10. Removal of the 
silyl ether in 93 with HF·pyridine and pyridine in THF, followed by DBU induced retro-Claisen 
rearrangement furnished the adduct 94 (a non-contiguous carbon chain) with the desired ester link. 
Removal of the PMP acetal in 94, followed by oxidation of the terminal hydroxy group with DMP 
afforded 95. The final oxidative removal of PMB protecting group in 95 with DDQ allowed 
hemiacetal formation to give 15. This total synthesis was accomplished in 15 steps with 4% overall 
yield from propanal. Although this synthesis demonstrated a retro-Claisen rearrangement of the 
precursor 93 to form dolabriferol (15), the PMB and PMP-acetal protection groups in 93 blocked 
possible competing retro-Claisen reactions. 
 27 
 
Scheme 1-17: Goodman approach to dolabriferol. 
Toste approach: 
Toste et al. used a novel Kornblum-DeLaMare enantiomeric resolution to generate the two 
coupling fragments 99 and 100 for dolabriferol (15) from a common precursor (±)-96 (Scheme 1-
18).28 Although, Toste and co-workers achieved the synthesis of the non-contiguous precursor 102, 
final deprotection was unsuccessful to obtain the natural product 15. Towards the synthesis of 15, 
Toste et al. chose racemic peroxide (±)-97 as a precursor that originated from a [4+2] addition of 
singlet oxygen to the PMB derivative of diene (±)-96. Under optimized Kornblum-DeLaMare 
enantiomeric resolution the racemic peroxide (±)-97 provided the enone 98 (93% ee) that was 
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     rt (76%, 2 steps)
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    THF, rt
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Enantiomer (+)-97 was converted to the desired alcohol 100 (Scheme 1-18). Coupling of 
acid 99 with alcohol 100 was attempted using Yamaguchi esterification conditions;19 however, 
during esterification, racemization at C-4 stereocenter was observed resulting an inseparable 
mixture of diastereomers 101 (10:1). This 10:1 mixture was separated after removal of the PMB 
group from 101 to obtain alcohol 102 as a single diastereomer. Final removal of SEM-ether from 
102 led to either elimination or no reaction under variety of conditions. Alternatively, TES, TBS 
and BOM variants were synthesized, but none of them afforded the natural product 15. Although 
Toste et al. were unsuccessful to obtain 15, their method generated enantiopure non-contiguous 
precursor 102. 
 
Scheme 1-18: Toste approach to dolabriferol. 
Pabbaraja approach: 
Pabbaraja et al. reported the total synthesis of dolabriferol (15) in 2018 via esterification 
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from propanal and isobutyraldehyde, respectively.ii After several attempts, coupling of acid 103 
with alcohol 104 was achieved under Yamaguchi esterification conditions19 affording the ester 105 
as an inseparable mixture of diastereomers (9:1, dr). The pivaloyl group was removed by treating 
105 with DIBALH to give alcohol 106. Subjecting alcohol 106 to a series of oxidation-Grignard-
oxidation reactions produced ketone 107. Silyl ether removal in 107 followed by selective 
oxidation of the least hindered alcohol with DMP afforded the known15 precursor 108. Oxidative 
removal of PMB group in 108 with DDQ facilitated the hemiacetal formation to give 15. This total 
synthesis was accomplished in 17 steps (LLS) from commercially available propanal with 3% 
overall yield. 
 
Scheme 1-19: Pabbaraja approach to dolabriferol. 
From all the above synthetic approaches towards dolabriferol (15), it is clear that coupling 
of the corresponding carboxylic acid with alcohol and the choice of protecting group (and 
                                                        
ii Initially, an analogous alcohol was prepared as TBS-ether, but this alcohol with TBS group did not couple with 
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deprotection conditions) at the late stage of the synthesis were crucial to achieve the natural 
product 15. 
 
1.2.4. Total synthesis of non-contiguous polypropionates (by Ward group) 
The Ward group has synthesized several polypropionates by developing the thiopyran route 
to polypropionates (TR2P) and the acyclic thiopyran route to polypropionates (ATR2P) strategies. 
Among thirteen non-contiguous polypropionates, Ward and co-workers have synthesized (−)-
membrenone B, baconipyrone A, baconipyrone C, dolabriferol, and dolabriferol C, to date.iii The 
TR2P and the ATR2P are attractive strategies for the rapid assembly of hexapropionate synthons 
from simple and readily available precursors (for detailed discussion of these strategies, please 
refer to section 1.3). 
1.2.4.1.Total synthesis of (−)-membrenone B 
Ward et al.  synthesized (−)-membrenone B, the unnatural enantiomer, using dynamic 
kinetic resolution (DKR) and kinetic resolution (KR) strategy to access enantiopure 
hexapropionates 114a and 114b from racemic and achiral materials (Scheme 1-20).32 In a previous 
study, the tetrapropionate (−)-112as was prepared in good yield (75%)iv with high enantiopurity 
(>98% ee) via a tetrazole derivative 111 catalyzed aldol reaction of (±)-109 with 110, which 
proceeds with dynamic kinetic resolution (DKR).33 The anti,syn-diastereomer 112as was 
isomerized to the desired syn,syn-diastereomer 112ss using the known34 isomerization conditions. 
A reaction of the Ti-enolate of enantiopure ketone (+)-112ss with racemic aldehyde (±)-109 that 
                                                        
iii The synthetic route to (−)-membrenone B also constitutes a formal synthesis of (−)-membrenone A. 
iv Although yields were improved further (up to 85%) at lower reaction concentrations, a large excess of 110 (6-12 
equiv) was required. 
 31 
proceeds with kinetic resolution gave the enantiopure adducts 113a, 113b, 113c as 11:6:1 mixture 
of diastereomers, respectively. This mixture was converted to 114a, 114b as a 2.8:1 mixture of 
diastereomers, respectively. Brief exposure of the mixture 114a:114b (2.8:1) to p-TsOH in CH2Cl2 
gave the known18 γ-dihydropyrone 115 via cyclization and elimination. The γ-dihydropyrone 115 
serves as a common precursor for the synthesis of (−)-membrenones A and B. Thus, final acylation 
of 115 with propanoyl chloride in the presence of pyridine gave (−)-membrenone B. Because the 
synthesis of (−)-membrenone A is known from the common precursor 115, this route also 
constitutes a formal synthesis of (−)-membrenone A. 
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1.2.4.2. Total synthesis of baconipyrone A and baconipyrone C via their putative common 
precursor (a retro-Claisen approach) 
Ward et al. accomplished a “biomimetic” synthesis of complex non-contiguous 
polypropionates baconipyrone A (9) and baconipyrone C (11) from their common putative 
contiguous precursor 123 via a retro-Claisen rearrangement (Scheme 1-21). The known 
tetrapropionate 117 was prepared from a proline catalyzed aldol reaction of 110 with a mixture of 
meso and racemic aldehyde 116 that proceeds with enantiotopic group selectivity with dynamic 
kinetic and thermodynamic resolution.35 Tetrapropionate 117 was converted to aldehyde 118 that 
was used in aldol reaction with the Ti-enolate of the known ketone 11933,35 to give the adduct 120 
as a single diastereomer. The high stereoselectivity under these conditions was governed and 
predicted by the known diastereoface selectivities of ketone 119 (reaction occurs selectively from 
the trans face of the C-3 substituent)36,37 and aldehyde 118 (addition is highly Felkin-selective)38. 
Desulfurization of 120 with Raney nickel, followed by a simultaneous FeCl3-mediated acetal 
hydrolysis39,40 and MOM-deprotection resulted the triol 121. Selective protection of the C-5 
hydroxy group in 121 as triethylsilyl (TES) ether,v  followed by IBX oxidation produced the 
tetraone 122 as a mixture of keto-enol tautomers. Sequential removal of benzyl and silyl ethers in 
122 afforded the desired precursor 33 as a complex mixture of ring-chain and keto-enol tautomers. 
                                                        
v The triol 121 was regenerated from the corresponding undesired bis TES-protected adduct by deprotection and was 
recycled to 122. 
 33 
 
Scheme 1-21: Ward retro-Claisen approach to baconipyrones A and C (adapted from ref. 16). 
The isomerization or rearrangement of 33 was examined under various conditions (Scheme 
1-21). On treatment with imidazole in CDCl3 for 24 h, 33 isomerized to the thermodynamically 
more stable siphonarin B (22) (ca. 70%); while treatment of 33 with DBU in C6D6 for 1 h induced 
a retro-Claisen rearrangement (via a hemiacetal generated from C5-OH to C9-C=O) to give a 2:1 
mixture of baconipyrone C (11) and 14-epi-11, respectively. Alternatively, subjecting the 
precursor 33 to neutral alumina in refluxing ethanol for 1 h (a similar condition for retro-Claisen 
rearrangement was reported by Albizati12) provided a 10:7:5:3 mixture of 124 (undesired retro-
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 34 
respectively. Under the same neutral alumina conditions, 22 produced 3:2.3:1:1 mixture of 11, 22, 
9 and 33, respectively. Surprisingly, 123 (obtained from TES-ether removal of 122) was stable 
under the identical neutral alumina conditions; however, using basic alumina produced a 4:1 
mixture of retro-Claisen adducts that, after hydrogenolysis of the benzyl ether, gave 9 (18%) and 
11 (70%). These results suggest that the in situ generated enolate of 11 or its benzyl ether 
(generated by retro-Claisen rearrangement of precursor 33 or 123) underwent a stereoselective 
intramolecular aldol coupling with the proximal ketone to give 9 or its benzyl ether. These results 
demonstrate that baconipyrones A (9) and C (11) are plausible isolation artifacts and suggest that 
they were more likely generated from 22 than directly from 33, a plausible biosynthetic product. 
 
1.2.4.3. Total synthesis of dolabriferol from the putative contiguous precursor (a retro-Claisen 
approach) 
Similar to the baconipyrone syntheses,16 Ward et al. intended to synthesize the putative 
contiguous precursor 32 and examine its propensity to undergo a selective retro-Claisen 
rearrangement to give dolabriferol (15) (Scheme 1-22). According to Goodman’s calculations,41 
the formation of 13→9 hemiacetal is more favorable among the three possible hemiacetals in 
precursor 32; however, only the 11→7 hemiacetal can lead to 15.  
 35 
 
Scheme 1-22: Regioselective retro-Claisen rearrangement of 32 to 15. 
The synthesis was initiated from a proline catalyzed enantioselective aldol reaction of 110 
with isobutyraldehyde to produce 125 as the only product with good enantioselectivity (92% ee) 
(Scheme 1-23). Silyl protection of the hydroxy group in 125, followed by reaction of the 
corresponding Li enolate with BnO2CCN provided the β-ketoester 126. Hydroxy-directed 
stereoselective reduction of 126, generated a 1:1 mixture of 1,3-syn diols 127 and 3-epi-127. 
However, the mixture was successfully isomerized to the single diastereomer (3S)-127 in presence 
of tert-BuOK and CuI. Protection of the diol (3S)-127 as benzylidene acetal followed by reduction 
of ester gave the corresponding alcohol that was oxidized to the desired aldehyde (+)-128. 
Mukaiyama aldol reaction of (±)-109 with 129 (4:1 dr), followed by desulfurization gave the 
hydroxy ketone (±)-130 that was converted to the corresponding BOM derivative (±)-131. Aldol 
reaction of Ti-enolate of (±)-131 with aldehyde (+)-128 (7:1 dr) that proceeds with kinetic 
dolabriferol (15)


































resolution gave the adduct 132 along with (+)-131.vi The 8,9-syn-9,10-syn relative configuration 
in 132 was expected based on known diastereoselectivities from similar substrates and reaction 
conditions.42,43 FeCl3 catalyzed acetal hydrolysis of 132, oxidation of the C9-hydroxy group with 
IBX, and simultaneous desulfurization and hydrogenolysis of BOM group gave 133 as a 10:10:1 
mixture of two keto and enol tautomeric forms, respectively. Hydrogenolysis of the benzylidene 
acetal in 133 with freshly prepared Pd black (excess) in iPrOH under H2 atmosphere (4 bar) cleanly 
produced the precursor 32 that exists predominantly as a 1.5:1 mixture of hemiacetals 32 ((9S), 
13→9; epimeric at C-8) consistent with Goodman’s calculations. Treatment of 32 with DBU in 
benzene produced a 3:6:1 mixture of 15 and two unidentified diastereomers, respectively (38%), 
and the known lactone 134 (ca. 44%), among others. The formation of 15 and 134 indicates that 
the retro-Claisen fragmentation occurred at C7-C8 bond in 11→7 hemiacetal and at C8-C9 bond 
in 13→9 or 5→9 hemiacetal, respectively. Treatment of 32 with neutral alumina in benzene 
(known conditions12,16) furnished 15 in good yield. Formation of 15 and absence of 134 indicates 
a regioselective retro-Claisen rearrangement occurred at C7-C8 bond in the 11→7 hemiacetal of 
the precursor, where the hemiacetal equilibration (between 11→7 and 13→9 hemiacetals) is rapid. 
                                                        




Scheme 1-23: Ward’s retro-Claisen approach to dolabriferol (adapted from ref. 17). 
The Ward group established synthetic routes to obtain the putative contiguous precursors 
(plausible biosynthetic products) and showed their rearrangements to produce the ‘non-contiguous 
natural products’ baconipyrone A, baconipyrone C and dolabriferol. These results provided 
experimental evidence in support of the earlier hypothesis on the origin of non-contiguous 
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1.3. Ward Group Synthetic Strategy Towards Polypropionates 
The Ward group has developed efficient strategies (e.g., the thiopyran route to 
polypropionates-TR2P and the acyclic thiopyran route to polypropionates-ATR2P) using 
stereoselective aldol reactions to access racemic and enantiopure polypropionates from simple 
chiral or achiral substrates.42,44 The TR2P is well-established and has been an active research theme 
in the Ward group to access tetrapropionate motifs 137 and hexapropionate motifs 138 selectively 
from readily available starting materials (Scheme 1-24). Tetrahydro-4H-thiopyran-4-one (110) and 
β-ketoester 136 are the most common starting materials for the preparation of the thiopyran motifs. 
Ward et al. developed an efficient method to prepare 110 and 136 conveniently on large scales 
(50-700 g) without chromatography.45 The TR2P strategy has several advantages including simple 
preparation methods, versatile reaction chemistry and relative ease of removal of sulphur from the 
products. 
 
Scheme 1-24: The thiopyran route to polypropionates (TR2P). 
The four possible monoaldol diastereomers (tetrapropionate synthons) 137 (Scheme 1-24) 
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the reaction conditions.43,46 The diastereomers 137 can be prepared in enantiopure form by using 
proline (or a derivative) to achieve enantioselective aldol or retro-aldol reactions.33,35 Aldol 
reactions of 137 with aldehyde (±)-109 give the bisaldol adducts 138 (20 possible diastereomers 
with R = H).36,37 The hexapropionate synthons 138 can be transformed into various polypropionate 
motifs using a variety of reactions (e.g., desulfurization, reductions, desymmetrization).  
The diastereoselectivities in a kinetically controlled aldol reaction of two chiral coupling 
partners (ketone and aldehyde) can be qualitatively predicted and rationalized by application of 
the multiplicativity rule.37,47–49 In this approach, the stereoselectivity is factorized into three 
stereocontrol elements:32,44,50 (1) The relative topicity (R, also known as simple 
diastereoselectivity); (2) The diastereoface selectivity for the chiral ketone enol(ate) (E); and (3) 
The diastereoface selectivity for the chiral aldehyde (A).  In general, an aldol reaction of a simple 
ethyl ketone with an aldehyde can produce adducts with up to two new stereogenic centers (i.e., 
up to four stereoisomers can be formed) (Scheme 1-25a). For any given adduct diastereomer 
resulting from a kinetically controlled aldol reaction of an enolate derivative with an aldehyde, 
inspection of the adduct’s structure reveals which face of the enolate (re or si) has added to which 
face of the aldehyde (re or si) and thereby the senses of the three stereocontrol elements involved. 
(1) The relative topicity (R, also known as simple diastereoselectivity): The relative topicity of 
a reaction leading to a specific adduct is assigned according to whether that adduct was 
formed by addition of “like” (re-re and si-si) verses “unlike” (re-si and si-re) faces51 
(Scheme 1-25a). vii  More commonly, the relative topicity is designated by the relative 
configuration of the newly formed two stereocenters (i.e., syn or anti). When a reaction 
                                                        
vii “The like and unlike descriptors specify the relationship between the absolute configurations of the reactant 
enantiomers” (see ref. 30). 
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leads to more than one diastereomer, the preferred relative topicity (and the extent of 
preference) of the reaction is the greater of the mole fractions (ratio of the mole fractions) 
of products formed with “like” verses “unlike” relative topicity. In most aldol reactions, the 
preferred relative topicity is strongly correlated to the geometry of the enolate; i.e., (E) and 
(Z)- enolates produce 1,1′-anti (e.g., 143a, 144a) and 1,1′-syn (e.g., 143s, 144s) adducts, 
respectively. This outcome can be explained via “closed” (a six-membered chair-like 
conformation) transition-states. 
(2) The diastereoface selectivity for the chiral ketone enol(ate) (E): A chiral enolate will have 
two diastereotopic faces (re and si), and these faces can be differentiated by their 
relationship with an existing stereocenter in the enolate- “like” (R-re, S-si) versus “unlike” 
(S-re, R-si). The two faces will have different reactivity and, for any adduct, the reacting 
face is revealed by the structure of that adduct. The diastereoface selectivity (and the extent 
of the selectivity) of the reaction is the greater of the mole fractions (ratio of the mole 
fractions) of adducts formed by addition to the “like” verses “unlike” diastereofaces. More 
commonly, the diastereoface selectivity for addition to the enolate is designated by relative 
configuration of the newly formed stereocenter in the adduct to a preexisting stereocenter 
in the starting ketone (i.e., syn or anti) (Scheme 1-25b). An important factor that contributes 
to this diastereoselectivity is the preferred torsion angle of the C-C bond between an α-
stereocenter and the enolate (i.e., H−C*−C=C torsion) and this torsion angle will be 
strongly influenced by allylic 1,3-strain. 
(3) The diastereoface selectivity for the chiral aldehyde (A): The chiral aldehyde will have two 
diastereotopic faces (re and si), and these faces can be differentiated by their relationship 
with an existing stereocenter in the aldehyde- “like” (R-re, S-si) versus “unlike” (S-re, R-
 41 
si). The two faces will have different reactivity and, for any adduct, the reacting face is 
revealed by the structure of that adduct. The diastereoface selectivity (and the extent of the 
selectivity) of the reaction is the greater of the mole fractions (ratio of the mole fractions) 
of adduct formed by addition to the “like” verses “unlike” diastereofaces. More commonly, 
the diastereoface selectivity for addition to the aldehyde is designated by relative 
configuration of the newly formed stereocenter in the adduct to the preexisting stereocenter 
in the starting aldehyde (i.e., syn or anti) (Scheme 1-25c). The diastereoselectivities are 
usually predicted (depending on the nature of the C-2 substituent) using the Felkin-Anh52–
54 (in absence of chelating effects), Cram-Chelate55–57 (in presence of chelating effects) or 
Cornforth-Evans58–60 (in presence of polar substituent at C-2) transition-state models. 
 42 
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1.3.1. Enantiotopic group selective (EGS) aldol reactions  
In enantiotopic group selective (EGS) aldol reactions, enantiotopic groups are 
differentiated in a chiral environment (i.e., with a chiral reagent or catalyst or reactant). The 
enantiotopic groups must have substantially different reactivities (e.g., >10:1) in this chiral 
environment for an EGS reaction to have synthetic utility. Enantiotopic group selective aldol 
reactions are categorized into two types: i) external enantiotopic group selective aldol reactions 
(e.g., mutual kinetic enantioselection (MKE) and kinetic resolution (KR)); ii) internal enantiotopic 
group selective aldol reactions (e.g., enantioselective desymmetrization) (Scheme 1-26). 
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1.3.1.1.External enantiotopic group selective (external EGS) aldol reactions 
In external EGS aldol reactions, the enantiotopic groups are associated with different 
molecules (i.e., enantiomers) and have different reactivity in a chiral environment. 
Aldol reactions proceeding with mutual kinetic enantioselection (MKE): 
In a kinetically controlled aldol coupling of racemic reactants, there are four possible 
reactions, two each from like and unlike combinations of reactant enantiomers. The ratio of like 
and unlike adducts is equal to the ratio of rate constants for the like and unlike reactions (klike/kunlike) 
and a measure of mutual kinetic enantioselection (MKE);61,62 i.e., the kinetic preference of one 
enantiomer of racemic reactant to react with one enantiomer of the other racemic reactant. Aldol 
reactions of each diastereomer of (±)-154 with (±)-109 can produce up to eight diastereomeric 
adducts (racemic), four each from the “like” and the “unlike” combinations51 of the reactant 
enantiomers (Scheme 1-27). Under established reaction conditions, the boron enolate (±)-155a 
favored the “like” reaction to give (±)-156aas (i.e., 3S,6ʹʹS and 3R,6ʹʹR), whereas the titanium “ate” 
enolate (±)-155b favored the “unlike” reaction to give (±)-156ass (i.e., 3S,6ʹʹR and 3R,6ʹʹS).37 MKE 
for each of these reactions was determined by the ratio of like and unlike adducts (observed MKE 
for reactions with boron enolate (±)-155a is 15-20:1 and for reactions with titanium “ate” enolate 
(±)-155b is 10-20:1). 
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Scheme 1-27: Aldol reactions proceeding with MKE (NOTE: only one enantiomer is depicted 
for each racemic compound). 
Aldol reactions proceeding with kinetic resolution (KR): 
Synthesis of polypropionate natural products typically demands non-racemic (or 
enantiopure) intermediates. Synthesis of enantiomerically pure compounds is generally achieved 
by: (i) diastereoselective transformation of enantiomerically pure reactants (chiral pool), (ii) 
separation of enantiomers by chemical or physical methods (resolution), (iii) enantioselective 
transformation of achiral compounds (asymmetric synthesis). Coupling of two enantioenriched 
reactants is a well-known strategy to obtain non-racemic products; however, it requires preparation 
of both reactants in enantiomerically pure form. Alternatively, enantioselective transformation of 
racemic reactants to non-racemic (enantioenriched) adducts requires a method where enantiotopic 
faces or groups in the reactants are differentiated. For instance, an aldol reaction that proceeds with 
kinetic resolution (KR)63 can discriminate the enantiomers of a racemic reactant with an 
enantiopure reactant. In an aldol coupling of an enantiopure reactant with a racemic reactant, there 
are two possible reactions, the coupling of like or unlike enantiomers. Under these conditions, the 
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(KR); i.e., kinetic preference of the enantiopure reactant to preferentially react with one enantiomer 
of racemic reactant. This strategy is convenient because it requires preparation of only one reactant 
in enantiomerically pure form. 
Aldol reactions of each diastereomer of enantiopure ketone (−)-154 with racemic aldehyde 
(±)-109 can produce up to eight diastereomeric adducts (enantiopure), four each from the “like” 
and the “unlike” combinations of the reactant enantiomers (Scheme 1-28). Aldol reactions of (−)-
154 with (±)-109 proceeded with KR to give the corresponding enantiopure adducts 156aas and 
156ass in good yields with high enantio- and diastereo selectivities (Scheme 1-28).37 In these 
reactions, the boron enolate 155a favored the “like” reaction to give the adduct 156aas (i.e., 
3R,6ʺR); whereas, titanium “ate” enolate 155b favored the “unlike” reaction to give the adduct 
156ass (i.e., 3R,6ʺS). The kinetic resolution selectivity (s) for each of these reactions should be 
identical to the MKE in analogous reactions with (±)-154 (i.e., 15-20:1 for reactions of the boron 
enolate and 10-20:1 for reactions with titanium “ate” enolate). 
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Ward et al. reported a (S)-proline or the tetrazole derivative 111 catalyzed aldol reaction of 
(±)-109 with 110 that proceeded with dynamic kinetic resolution (DKR)64 to give the adduct (−)-
112as with high enantio- and diastereoselectivities (Scheme 1-29).33,35  
 
Scheme 1-29: (S)-proline catalyzed dynamic kinetic resolution (DKR) of (±)-109 with 110. 
As shown in the TS-II, this result is explained by the preferential addition of the more 
accessible re-face of the β-carbon in the anti-oriented enamine to the re-face of the aldehyde (S)-
109 (Felkin addition) with like relative topicity preferred by the “closed” transition state (Scheme 
1-29). The absolute configuration of the proline catalyst, the strong preference for Felkin 
diastereoface selectivity in addition to the aldehyde (±)-109, and the “closed” transition state are 
the key factors that govern the stereoselectivity of the reaction. It was concluded that the reaction 
proceeds with dynamic kinetic resolution based on the following observations: (i) (−)-112as was 
re-isolated in >85% yield with >90% ee after subjecting it to the identical reaction conditions (i.e., 

















































was shown65 to racemize under the reaction conditions. These results indicate that the 
isomerization of the aldehyde (±)-109 is much faster than the aldol reaction. 
Acyclic thiopyran route to polypropionates (ATR2P): 
Similar to the thiopyran route to polypropionates (TR2P), extensive research on 
stereoselective aldol reactions for the acyclic thiopyran route to polypropionates (ATR2P) has 
been done in the Ward group.66 Aldol reactions of each diastereomer of ketone (±)-157 with 
aldehydes (±)-109, (±)-159 proceeded with moderate to good MKE to give the adducts (±)-160sas, 
(±)-160sss and (±)-16-ssa (Scheme 1-30). Reactions of (E)-boron enolate (±)-158a with aldehydes 
(±)-109, (±)-159 are more selective (MKE = 15-20; dr >20) than the corresponding (Z)-titanium 
“ate” and (Z)-boron enolates (±)-158b, (±)-158c (MKE = 6-15; dr >9), respectively. However, 
much lower stereoselectivities were obtained in reactions of (Z)-enolates (±)-158b, (±)-158c with 
acyclic aldehyde (±)-159 compare to reactions with cyclic aldehyde (±)-109. The obtained results 
indicate that the minor adduct (±)-160ssa (1ʹʹ,6ʹʹ-anti) results from non-Felkin addition of the (Z)-
enolates (±)-158b, (±)-158c to aldehyde (±)-159. By adapting these established conditions, KR 
was achieved using the corresponding enantiopure ketones in the ATR2P. 
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Scheme 1-30: External EGS aldol reactions in ATR2P (NOTE: only one enantiomer is depicted 
for each racemic compound). 
1.3.1.2. Internal enantiotopic group selective (internal EGS) aldol reactions 
Enantioselective desymmetrization: 
The desymmetrization of meso-bifunctional compounds by an enantiotopic group selective 
reaction is a powerful strategy for asymmetric synthesis (“meso trick”67).68–70 In enantioselective 
desymmetrization, enantiotopic groups in a meso substrate have different reactivities in a chiral 
environment. For instance, the meso substrate A has two enantiotopic groups that can react with 
different rate constants in a chiral environment to produce chiral products M1 and M2 in unequal 
amounts (i.e., M1/M2 = k1/k2) (Scheme 1-31). 
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Scheme 1-31: Enantioselective desymmetrization (internal EGS) of meso substrate A where 
ligand “a” is replaced by ligand “d” and the R group react faster than the S group 
(i.e., kR>kS). 
The (S)-proline catalyzed enantioselective desymmetrization (internal EGS aldol) of meso 
dialdehyde 116 with 110 gave the mono-aldol adduct 117 with high enantio- and 
diastereoselectivities (Scheme 1-32).35 The selective formation of 117 (92% ee) from meso-116 
confirms that preferential aldol reaction of 110 (re-face of the corresponding enamine) occurred 
with the re-face of the (αS)-aldehyde group of meso-116. The high enantiotopic group selectivity 
results from the strong preference for Felkin additions to the aldehyde combined with the high 
propensity for addition to the aldehyde re-face imposed by the (S) proline catalyst. This remarkable 
process simultaneously sets the absolute configurations of four stereogenic centers in 117 with 
excellent enantio- and diastereo selectivities. 
























(S) and (R) are arbitrary
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Scheme 1-32: (S)-proline catalyzed enantioselective desymmetrization (internal EGS aldol) of 
meso-dialdehyde 116. 
 
1.3.2. Sequential enantiotopic group selective (SEGS) reactions 
The use of EGS reactions to achieve asymmetric synthesis is particularly effective if the 
enantiotopic groups can react sequentially, thereby coupling an asymmetric synthesis with a 
kinetic resolution and producing products with high enantio- and diastereomeric purity, even from 
reactions of moderate group selectivity (Scheme 1-33).69–72 In a sequential enantiotopic group 
selective (SEGS) reaction, the products of the initial EGS reaction (M1, M2) are enantiomers that 
have reactive enantiotopic groups (external comparison) capable of a second EGS reaction, in this 
case a kinetic resolution. If the enantiotopic group selectivity of the 1st (enantioselective 
desymmetrization) and 2nd (kinetic resolution) EGS reactions favors the same enantiotopic group, 
the kinetic resolution increases the enantiopurity of M (i.e., [M1]/[ M2]), but reduces the yield 
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Scheme 1-33: Sequential enantiotopic group selective (SEGS) reactions of meso substrate A 
(“meso” trick). 
1.3.2.1. Preparation of meso 1,9-diketones from one-pot bisaldol reactions 
The ease of access to Cs (or Ci) symmetric starting materials is one of the primary 
challenges to the use of sequential enantiotopic group selective (SEGS) reactions. Ward et al. 
established synthetic routes to meso 1,9-diketones 163, 164 and 166 (Scheme 1-34).73,74 A highly 
stereoselective synthesis of the meso bisaldol 162 was achieved in two steps from readily available 
starting materials (±)-109 and 161; alternatively, the same meso bisaldol 162 was obtained from a 
Ti(IV)-mediated one-pot sequential bisaldol reactions of 110 with (±)-109, albeit with much lower 
diastereoselectivity.73 Similarly, a one-pot two directional aldol reaction of meso 116 with 110 via 
the boron enolate gave the meso bisaldol adduct 165 (50%). The adducts 162 and 165 were 
converted to the corresponding meso 1,9-diketones 163, 164 and 166 to investigate 
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Scheme 1-34: Preparation of meso 1,9-diketones from one-pot bisaldol reactions. 
1.3.2.2. Sequential enantiotopic group selective (SEGS) enolizations of meso 1,9-diketones 
Having the meso diketones 163, 164 and 166 in hand, Ward et al. investigated their 
enantioselective desymmetrization and SEGS enolizations towards the synthesis of non-racemic 
(−)-denticulatin A.74,75 Enantioselective enolborination of meso 163 under the known76 conditions 
((−)-Ipc2BCl and sparteine conditions used for kinetic resolution of 2-methylcyclohexanone) gave 
the unreacted 163 (Scheme 1-35). Alternatively, enantioselective enolization of meso 1,9-
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167, followed by trapping the corresponding enolate with TMSCl. As expected,72 the enantiopurity 
of mono-enol ethers (168, 169 and 172) increased with increasing conversion due to kinetic 
resolution (ee enhancement feature) of these mono-enol ethers to form meso bis-enol ethers (170, 
171 and 173) in the second reaction. This method is very efficient to obtain products with high 
enantiopurity and high yields (>90%), because the starting diketones 163, 164 and 166 were easily 
obtained from the bis-enol ethers 170, 171 and 173, respectively, upon treatment with aqueous HF. 
 
Scheme 1-35: Enantioselective (SEGS) enolization of meso 1,9-diketones. 
 
1.4. Conclusions 
In most synthetic approaches to obtain non-contiguous polypropionates, the key ester link 
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polypropionate alcohol. In those approaches, several research groups were unsuccessful to achieve 
non-contiguous natural products due to difficulties in coupling of hindered alcohol with carboxylic 
acid or removing protecting groups at late stages of the synthesis. In a few approaches (Perkin, 
Goodman and Ward), non-contiguous polypropionates were synthesized via a retro-Claisen 
rearrangement of the corresponding contiguous precursors (with or without protecting groups); in 
particular, Ward et al. successfully synthesized the putative contiguous precursors 33 and 133 
(without protecting groups) and transformed them into the non-contiguous natural products 9, 11 
and 15, respectively, via retro-Claisen rearrangement, thereby providing experimental evidence 
for the proposed origin of non-contiguous natural products and demonstrating that these so-called 
natural products are plausible isolation artifacts. 
Ward et al. established enantiotopic group selective (EGS) aldol reactions (proceeding with 
MKE or KR or enantioselective desymmetrization) using the thiopyran route to polypropionates 
(TR2P) and the acyclic thiopyran route to polypropionates (ATR2P) themes to access various 





2. RESULTS AND DISCUSSION 
 
2.1. Research Objectives 
Dolabriferol C (17) (Scheme 2-1) is a “non-contiguous polypropionate”. The ‘natural 
product’ status of 17 and other non-contiguous polypropionates are viewed with suspicion because 
they are speculated to arise from retro-Claisen fragmentation of a contiguous biosynthetically 
derived polypropionate, possibly as isolation artifacts.1,8,9 Similar to Ward’s syntheses of 
baconipyrone C (11) and dolabriferol (15), this research project was designed to test this 
hypothesis on the origin of dolabriferol C. The main research objectives were: 
1. To test whether the putative contiguous precursor 174 can be transformed in vitro into the 
“natural product” 17 via the proposed chemoselective retro-Claisen rearrangement 
(Scheme 2-1). 
2. To develop a new synthetic strategy (one-pot sequential enantiotopic group selective 
(SEGS) bisaldol reactions of meso bisenolates) for convergent enantioselective synthesis 
of the contiguous precursor 174 (Scheme 2-2). 
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Scheme 2-1: Proposed retro-Claisen rearrangement of precursor 174 to the natural product 17. 
 
2.2. Retrosynthetic Analysis 
The synthesis of 174 presents a significant challenge, as this molecule has eleven 
stereocenters on a nineteen-carbon chain. Because the natural product 17 exists as a single 
enantiomer, all the relative and absolute configurations must be controlled in synthesis of 
precursor 174. Retrosynthetic analysis of precursor 174 suggested the well-established TR2P and 
ATR2P could be used to develop a highly convergent approach to this target molecule from 
readily available starting materials (Scheme 2-2). 






































Scheme 2-2: Retrosynthesis of the putative precursor 174. 
Disconnection of the C5-C6 and C12-C13 bonds of the target molecule 174 leads to two 
aldehydes (159a, 128a) and a diketone (178aa) (Scheme 2-2). These fragments can be coupled 
together to construct the full carbon skeleton of precursor 174 via two consecutive stereoselective 
aldol reactions. However, these synthons can’t be used directly in aldol reactions because they 
have free hydroxy groups. Equivalent reagents for 159a, and 128a are the proposed chiral 
aldehydes (±)-15942 and (+)-128,17 respectively, both known in the Ward group; whereas 
bisenolate 179aa can be generated from the meso diketone 180aa77.  
In considering the coupling of fragments (±)-159, (+)-128, and 180aa, a one-pot 
stereoselective bisaldol strategy was contemplated (Scheme 2-3). In this proposed strategy, the 
meso bisenolate 179aa would undergo sequential directed aldol reactions with two different 
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then with racemic aldehyde (±)-159 via kinetic resolution to obtain the enantioenriched bisaldol 
product 177 in a one-pot process.  
 
Scheme 2-3: One-pot sequential enantiotopic group selective (SEGS) bisaldol reactions of meso 
180aa with (+)-128 and (±)-159. 
The proposed one-pot SEGS bisaldol strategy (Scheme 2-3) to couple 180aa, (+)-128 and 
(±)-159 is clearly not trivial; to achieve this strategy there are three major problems to resolve: i) 
how to generate bisenolates of 1,5-diketones 180aa? ii) how to control stereoselectivity in the 
formation of meso bisenolates 179aa? iii) how to control stereoselectivity in the sequential aldol 
reactions? Although suitable ways to handle these challenges were unknown, the extensive 
research from the Ward group provided some guidance to solve these problems. 
The Ward group has developed a powerful strategy for stereoselective synthesis of 
complex polypropionates which involves the iterative aldol coupling of dipropionate fragments 
with kinetic resolution63 (in TR2P and ATR2P) thereby generating three stereocenters in each 
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stereoselectivities for the proposed one-pot bisaldol strategy were feasible. Because the two 
enolates in meso 179aa have an enantiotopic relationship, they can be differentiated in an aldol 
reaction with (+)-128 via enantioselective desymmetrization68 (or internal enantiotopic group 
selectivity; internal EGS) (Scheme 2-3). Coupling of the resulting enantioenriched aldolate-
enolate 181 with racemic aldehyde (±)-159 is expected to proceed with kinetic resolution (or 
external enantiotopic group selectivity; external EGS) to obtain enantioenriched bisaldol product 
177 in a one-pot process. Chemoselective oxidation of the C13-hydroxy group in 177 followed 
by global deprotection would lead to the desired putative contiguous precursor 174 as shown 
Scheme 2-2. The proposed starting materials meso diketone 180aa and chiral aldehydes (+)-128 
and (±)-159 were prepared from readily available inexpensive starting materials. 
 
2.3. Preparation of the Starting Materials 
2.3.1. Preparation of the ‘eastern’ aldehyde (+)-128 
Preparation of enantioenriched aldehyde (+)-128 was initiated with the known81 L-proline 
catalyzed aldol reaction of 110 with isobutyraldehyde that provided adduct 125 with high enantio- 
and diastereoselectivities (Scheme 2-4). Treatment of the adduct 125 with Et3SiCl and Et3N gave 
182 in excellent yield. Reaction of 182 with tert-BuLi gave the corresponding Li-enolate that was 
trapped with Mander’s reagent which, after an aqueous HF workup (to remove the triethylsilyl 




Scheme 2-4: Towards the synthesis of aldehyde (+)-128. 
Hydroxy directed 1,3-syn-selective reduction82 of  β-hydroxyketone 183 (keto-enol 
mixture) generated a separable 1.2:1 mixture of syn diols (3S)-184 (3,5-cis) and (3R)-184 (3,5-
trans), respectively (Scheme 2-4). Among these two diols, diastereomer (3S)-184 (3,5-cis) has the 
relative and absolute configuration corresponding to the desired aldehyde (+)-128. Rather than 
discarding (3R)-184 (3,5-trans) and losing half of the material in the process, isomerization at C-
3 of (3R)-184 (or a derivative thereof) was considered. Toward that end, Pramod Jadhav (a 
previous member of the Ward group) attempted alkylation of the hydroxy groups of (3R)-184 by 
treatment with benzyl bromide in presence of KH. Surprisingly, a clean isomerization of (3R)-184 
to (3S)-184 occurred, instead of the anticipated alkylation. This serendipitous observation 
provided a great opportunity to improve the yield of the desired (3S)-184. Thano Karagiannis 
(another former Ward group member) studied the isomerization reaction extensively. Although 
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incomplete isomerization and lower material recovery. Despite examining numerous variations in 
the reaction conditions, a reliable and scalable procedure was not identified. 
2.3.1.1. Isomerization study 
I investigated the isomerization reaction of (3R)-184 to (3S)-184 using KOtBu that initially 
provided poor and non-reproducible yields of the desired product (<50%) (Scheme 2-5). After 
extensive experimentation, formation of the corresponding carboxylic acid 185 (in variable 
amounts) was identified as an important side reaction. 
 
Scheme 2-5: Isomerization of (3R)-184 to (3S)-184 with KOtBu. 
Presumably, the isomerization occurs via a retro-aldol pathway (A) as proposed in Scheme 
2-6. Deprotonation of (3R)-184 at the C3 hydroxy group leads to alkoxide 186, which upon retro-
aldol generates enolate 187, which then can undergo a stereoselective (or reversible) aldol reaction 
to give the thermodynamically more stable 188. A similar deprotonation of (3S)-184 would also 
lead to 188; however, it is also possible that deprotonation is diastereomer selective in favor of 
(3R)-184. Proton transfer from (3R)-184 to 188 would make the process catalytic in base. 
On the other hand, alkoxide 189 can be formed by an intramolecular proton transfer in 188 
or direct deprotonation of (3S)-184. Alkoxide 189 can lactonize to generate 190. This lactonization 
reaction would be reversible; however, in presence of hydroxide ions lactone 190 would be 
irreversibly transformed to the carboxylate 191. Apparently, the presence of carboxylate ion 191 























Scheme 2-6: Plausible mechanism for the isomerization of (3R)-184 to (3S)-184 and hydrolysis 
to carboxylic acid 185. 
In order to improve the isomerization reaction, it was essential to prevent the formation of 
lactone 190 or the hydrolysis pathway to the carboxylate ion 191. After examination of various 

















































































yields (Table 2-1, entries 2, 4 and 5). Using 2 equivalents of KOtBu and 20 mol% of CuI, the 
isomerization reaction yields were reproducible even on larger scales. These results suggest that 
CuI has an important role in suppressing the formation of 190 or its hydrolysis. Interestingly, 
addition of excess CuI (1 equiv) diminished the isomerization yields (entry 6). Presumably, CuI 
traps hydroxide ions as CuOH that impedes the hydrolysis of lactone 190 to carboxylate 191, and 
(or) produced the Cu (I) alkoxide from 189 that is less prone to lactonize. In any event, the 
presence of the optimal amount of CuI is highly beneficial to the reaction. 
Table 2-1: Isomerization of (3R)-184 to (3S)-184 with KOtBu in presence of CuI. 
 
entry KOtBu (equiv) CuI (equiv) (3S)-184 
(% yield)a 
1  1 0 31 
2 1 0.1 38 
3 2 0 42 
4 2 0.1 66 
5 2 0.2 75 
6 2 1 39 
                                   a Isolated yields. 
To improve synthetic efficiency, the crude mixture of (3R)-184 and (3S)-184 (obtained 
from reduction of 183; Scheme 2-4) was subjected to the established isomerization conditions (2 
equiv of KOtBu and 20 mol% of CuI). Interestingly, isomerization of the mixture gave the desired 
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It was hypothesized that replacing the methyl ester in compound 183 (Scheme 2-4) with a 
more hindered benzyl ester would further impede the lactonization pathway. Accordingly, the 
benzyl analogue of Mander’s reagent (benzyl cyanoformate83) was prepared and used for the 
carboxylation of 182 to obtain benzyl ester 193 in 88% yield as a 2:3:3 mixture of enol and two 
keto tautomers, respectively (Scheme 2-7). Hydroxy-directed syn-selective reduction of ketone 
193 (keto-enol mixture) generated a separable 1:1 mixture of diols (3R)-194 (3,5-trans) and (3S)-
194 (3,5-cis). After extensive experimentation, the mixture of diols (3R)-194 and (3S)-194 was 
successfully isomerized to the desired diol (3S)-194 (85%) by treatment with KOtBu (2 equiv) 
and CuI (20 mol%). The isomerization yield was further improved (97%) by changing the reaction 
solvent from THF to Et2O. This method allowed direct isomerization of the crude mixture of (3R)-
194 and (3S)-194 (i.e., the crude product obtained from syn-selective reduction of 193) to the 
desired product (3S)-194 on large scale (14 g) in excellent yield (80% over two steps). 
Remarkably, under these optimized conditions, isomerization was completed in 10 minutes at 0 
oC even on large scale. Hence, these reaction conditions are reliable, scalable, and reproducible to 
prepare the desired 3,5-cis diastereomer (3S)-194. 
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Scheme 2-7: Preparation of aldehyde (+)-128 via an improved isomerization to (3S)-194. 
The diol (3S)-194, without purification, upon treatment with PhCH(OMe)2 in presence of 
a catalytic amount of pTsOH･H2O gave the corresponding benzylidene acetal which was 
subjected to LiAlH4 reduction to give the desired alcohol 195 in 70% yield over 4 steps (from 
193) (Scheme 2-7). Oxidation of 195 with DMP84–87 gave the desired aldehyde (+)-128 in high 
yield (91%). It is noteworthy that only two chromatographic purifications were required to prepare 
aldehyde (+)-128 from 110 (over 8 steps). 
 
2.3.2. Preparation of meso-1,5-diketones 
The two meso 1,5-diketones 180aa (4,5-anti-5,6-anti) and 180ss (4,5-syn-5,6-syn) were 
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FeCl3 catalyzed removal of the ketal protecting group in the known ketones 130aa42 and 130ss42 
produced meso 1,5-diketones 178aa and 178ss, respectively, in excellent yields.  
 
Scheme 2-8: Preparation of meso 1,5-diketones 178aa and 178ss. 
 
2.4. Preparation of Meso Bisenolates 
The hydroxy groups in diketones 178aa and 178ss (Scheme 2-8) require protection before 
proceeding to the stereoselective synthesis of meso bisenolates. Although, various protecting 
groups are available to install on 178aa and 178ss, the choice of protecting group was mainly 
guided by the Ward group study on ‘the effect of the protecting group on the diastereoselectivities 
of aldol reactions of chiral ethyl ketones’.42 In this study, the CH3OCH2- (MOM) and Et3Si- (TES) 
protected ketones (196 and 197) were used to generate Li and B-enolates (both E- and Z) and (Z)-
Ti(IV) enolates that were treated with isobutyraldehyde to obtain aldol adducts (diastereomers) in 
different ratios (Scheme 2-9). The diastereoselectivities of these reactions were greatly influenced 
by the enolate geometry, the nature of the metal, the protecting group, and the relative 
configuration of the ketone. 
FeCl3, acetone
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Scheme 2-9: Known aldol reactions of ketones 196 and 197 with isobutyraldehyde. 
Ketones 196ss or 197ss (syn,syn) and 196aa or 197aa (anti,anti) were of particular interest 
because they share the same relative configurations as 180ss (syn,syn) and 180aa (anti,anti), 
respectively. The results for reactions of Li and B-enolates of 196aa and 197aa with 
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According to the above study, aldol diastereoselectivities from the (Z)-Li and (Z)-B-
enolates of the methoxymethyl (MOM) protected ketone 196aa were much higher than those from 
the Et3Si-protected ketone 197aa; conversely, the (E)-B-enolate of 197aa (Et3Si) gave higher 
diastereoselectivites than the MOM analogue 196aa (Table 2-2). Thus, the benzyloxymethyl 
(BOM; a synthetically more versatile analogue of MOM) and Et3Si-derivatives of 178aa were 
prepared to generate meso bisenolates (Scheme 2-10). 
 
Scheme 2-10: Preparation of BOM and Et3Si-protected meso 1,5-diketones (201aa, 202aa). 
As indicated, stereoselective preparation of meso bisenolate 179aa from 180aa is an 
essential requirement to achieve the proposed SEGS bisaldol strategy (Scheme 2-3). Nevertheless, 
no literature method was available to prepare bisenolates until this work. Hence, to explore the 
proposed strategy, the initial goal was to develop a method to prepare meso bisenolates 
stereoselectively. Because the two keto groups in meso diketone 180aa are at 1,5 relationship, a 
challenge in achieving bisenolate formation is overcoming the potentially facile cyclization of the 























Scheme 2-11: Potential competitive reactions (enolization vs. cyclization) from monoenolate 
203. 
 
2.4.1. Attempts to generate meso-(Z,Z)-bisenolate from 201aa 
Reaction of meso diketone 201aa with LiHMDS and TMSCl/Et3N88 (with both internal 
and external quenching) was attempted in an effort to produce the corresponding disilyl (Z,Z)-
bisenol ether derivative 207 (Scheme 2-12). Interestingly, only the cyclization-elimination 
product 206 was observed. The formation of 206 is presumably due to an intramolecular aldol 
addition of the mono Li-enolate of 201aa to the proximal ketone as previously shown for 203 
(Scheme 2-11). This result suggests that the cyclization pathway is faster than the silyl enol 
formation under these conditions.  
 







































Collum et al. developed a rapid enolization of acyclic ketones using LiHMDS or LDA in 
Et3N-toluene.89 In this research, it was observed that formation of enolate from 2-
methylcyclohexanone was >100 times faster in Et3N-toluene than in THF. The use of Et3N-
toluene system not only enhanced the rate of enolization, but also influenced the E/Z 
diastereoselectivities and enolate reactivity. Inspired by this work, it was anticipated that using 
LiHMDS or LDA in Et3N-toluene might generate the desired bisenolate from 201aa if the rate of 
enolization of the corresponding intermediate enolate-ketone was faster than the rate of its 
cyclization. Accordingly, meso diketone 201aa was subjected to enolization conditions using 
Collum’s procedure both with LiHMDS and LDA in presence of TMSCl and Et3N (internal and 
external quenching). Disappointingly, only the cyclized product 206 was observed. Using an 
alternative silyl enol ether preparation method via soft enolization with TMSOTf and Et3N90 did 
not yield fruitful results. 
Next, generation of the (Z,Z)-bisenol borinate of 201aa by soft enolization was attempted 
adapting the reaction conditions from a previous study in the Ward group.42 Accordingly, 201aa 
was treated with 9-BBNOTf and Et3N under the conditions previously established for 196aa, 
followed by addition of  isobutyraldehyde (10 equiv) to give a 41:19:17:13:1 mixture (by 1H 
NMR) of bisaldol diastereomers 208 (90%) (Scheme 2-13).viii After careful analysis of the 13C 
NMR spectrum of the mixture 208 (particularly the diagnostic signals for the iPr methyl groups;42 
ca. 15 and 20 ppm = anti, two at ca. 20 ppm = syn), it was concluded that both syn and anti-aldols 
were present suggesting that both (E) and (Z)-enolates were generated.ix Although this reaction 
afforded poor diastereoselectivity, formation of the bisaldol adducts in excellent yield confirmed 
                                                        
viii 1H NMR of the mixture 208 confirmed the presence of five bisaldols; however, it was difficult to interpret the 
bisaldols as chiral or achiral diastereomers. 
ix Detailed analysis of the data obtained from various syn and anti-aldol adducts are discussed in the structure 
determination section. 
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that the bisenolate was generated efficiently. Remarkably, no cyclization product was detected 
under these soft enolization conditions.  
 
Scheme 2-13: Preparation of (Z,Z)-bisenolates and bisaldols from meso 201aa. 
Alternatively, attempting to generate the (E,E)-bisenol borinate, 201aa was treated with 
c-Hex2BCl and Et3N followed by addition of isobutyraldehyde to give a 1.8:1 mixture of bisaldol 
adducts 209 (meso) and 210 (chiral), respectively (Scheme 2-14). Both adducts were found to 
have 3,4-anti-10,11-anti relative configuration with the meso bisaldol 209 having 4,6-syn-8,10-
syn and the chiral-bisaldol 210 having 4,6-syn-8,10-anti relative configurations by analysis of 
their 13C NMR data.x In keeping with the convention that has been used previously for the minor 
aldol products, the 3,4,6 relative configuration should be ‘normal’ and the 8,10,11 configuration 
‘abnormal’. That is, the minor isomer should be 8,10-anti-10,11-anti. This result confirms that the 
(E,E)-bisenol borinate 211 was formed stereoselectively under these conditions. The 8,10-anti 
relative configuration in chiral-bisaldol 210 (as opposed to 8,10-syn in 209) presumably results 
from poor diastereoface selectivity in aldol addition to the enolate. Notably, low 
diastereoselectivity was observed in the known reaction of the (E)-enol borinate of ketone 196aa 
(MOM) with isobutyraldehyde (Table 2-2, entry 5).  
                                                        










2. iPrCHO, −78 oC, 90%,
dr 41:19:17:13:1 208
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Scheme 2-14: Preparation of (E,E)-bisenolates and bisaldols from meso 201aa. 
Because, the (E,E)-bisenol borinate 211 was formed stereoselectively (confirmed by the 
anti aldol products) from 201aa and the adducts were obtained with 1.8:1 diastereoselectivity 
(Scheme 2-14), further exploration of this chemistry was initiated. In an effort to improve 
diastereoselectivities in reactions with the (E,E)-bisenol borinate (e.g., 211), the Et3Si-protected 
analogue 202aa was prepared (Scheme 2-10) in excellent yields using the known42 procedure. 
The choice of silyl protecting group (TES) was based on the observation that the (E)-enol borinate 
of Et3Si (TES) protected ketone 197aa gives much higher diastereoselectivity (dr >19:1; Table 2-
2, entry 6) in aldol reaction with isobutyraldehyde than the corresponding methoxymethyl (MOM) 
protected analogue 196aa (dr = 6:1; Table 2-2, entry 5). 
 
2.5. Preparation of Meso Bis-Anti-Aldol Adducts 
2.5.1. Preparation of meso bis-anti-aldols from diketone 202aa (4,5-anti-5,6-anti) 
Compared to methoxymethyl (MOM) protected β-hydroxy ketones, the Et3Si protected 
analogues require higher temperatures, longer reaction times and higher concentrations to 
generate enol borinates by soft enolization.42 The reaction of meso diketone 202aa with c-
Hex2BCl and Et3N at 0 oC followed by addition of isobutyraldehyde was studied extensively 
1. c-Hex2BCl, Et3N,
    CH2Cl2, −42 oC
2. iPrCHO, −78 oC, 91%,





































(Table 2-3). As the enolization time and concentration were increased, conversion to bisaldol 212 
was improved significantly (entries 1-3). After 3 h of enolization at higher concentration (0.18 
M), 3 h of aldol reaction at −78 oC produced 63% of 212 as the only bisaldol detected (by 1H 
NMR) (entry 3). At this stage, it was not clear whether enolization was incomplete or the aldol 
reaction was not proceeding to completion at lower temperatures (−78 oC). By increasing the aldol 
reaction temperature after 3 h, from −78 oC to room temperature, conversion was improved 
significantly (79%); however, the reaction produced a 9:1 mixture of meso- (212) and chiral- (213) 
bisaldols, respectively (entry 4). Diminished diastereoselectivities are presumably due to lower 
stereoselectivity at room temperature. After increasing stoichiometry of c-Hex2BCl to 4 
equivalents, conversion was dramatically improved to 93% with 9:1 mixture of bisaldols (entry 
5). Further improvements in diastereoselectivities (dr >19:1) were obtained after aldol reaction 
was performed at lower temperature for longer time (−78 oC for 24 h, entry 6). 








































 products (mole fraction)b 
212 (213) 214 202aa 
1  3 0 oC, 1 h  
(0.14 M) 
−78 oC, 3 h 0.36 0.53 0.11 
2 3 0 oC, 1.5 h 
(0.14 M) 
−78 oC, 3 h 0.48 0.41 0.11 
3 3 0 oC, 3 h  
(0.18 M) 
−78 oC, 3 h 0.63 0.29 0.8 
4 3 0 oC, 3 h  
(0.18 M) 
−78 oC, 3 h, 
rt, 0.5 h 
0.71 (0.08) 0.11 0.10 
5 4 0 oC, 3 h  
(0.18 M) 
−78 oC, 3 h, 
rt, 0.5 h 
0.84 (0.09) 0.05 0.02 
6 4 0 oC, 3 h  
(0.18 M) 
−78 oC, 24 h 0.87 (0.04) 0.06 0.03 
a Reaction concentration with respect to 202aa. b From 1HNMR data of crude reaction mixture unless otherwise 
indicated. 
Using the above optimized reaction conditions, stereoselective enolization and aldol 
reactions of meso diketone 202aa with isobutyraldehyde and propanal gave meso bisaldols 212 
(85%; dr >19:1) and 216 (73%; dr >19:1), respectively (Scheme 2-15). These results confirmed 
that the meso (E,E)-bisenolate 215 was generated stereoselectively and the corresponding aldol 
reactions were highly diastereoselective (obtained 1 of 10 possible diastereomers exclusively) 
generating meso bisaldol adducts in excellent yields. 
 77 
 
Scheme 15: Stereoselective synthesis of meso bisenolate 215 and bisaldols 212 and 216 from 
meso diketone 202aa. 
 
2.5.2. Preparation of meso bis-anti-aldols from meso diketone 202ss 
To extend the scope of bisenolate and bisaldol chemistry, meso diketone 202ss (4,5-syn-
5,6-syn) was prepared from 178ss using the standard procedure (Scheme 2-16). A reaction of 
202ss with c-Hex2BCl and Et3N, followed by addition of isobutyraldehyde, under the identical 
conditions used for 202aa (Scheme 2-15) gave the unanticipated cyclized product 218 instead of 













c -Hex2BCl (4 equiv),
Et3N (4.8 equiv),
CH2Cl2, 0 oC, 3h




































Scheme 2-16: Cyclization of meso diketone 202ss to 218. 
Although monoenolate 219 can undergo further enolization to generate bisenolate, a 
competitive cyclization reaction (faster than enolization) is favored to give 218 (Scheme 2-16). 
Because cyclization occurs via an intramolecular reaction, the rate of cyclization does not depend 
on the reaction concentration; in contrast, enolization occurs via an intermolecular reaction, so the 
rate of enolization depends on reaction concentration, temperature and stoichiometry. Thus, by 
altering these reaction parameters, it should be possible to manipulate the difference in rates of 
enolization and cyclization. It was presumed that increasing reaction concentration would enhance 
the rate of bisenolate formation and decreasing the enolization temperature would slow down the 
undesired cyclization (reducing temperature might increase the difference in rates (△G‡) of 






c -Hex2BCl (4 equiv),
Et3N (4.8 equiv),
CH2Cl2, 0 oC, 3h
(enolization conc. 0.18 M)O
SiEt3
O O meso-bisaldol 217
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various concentrations and temperatures, followed by addition of isobutyraldehyde (Table 2-4). 
As anticipated, a significant amount of meso bisaldol 217 was observed when the enolization 
temperature was decreased from 0 oC to –42 oC confirming that (E,E)-bisenol borinate was formed 
under these reaction conditions (entry 2).xi Next, by increasing reaction concentration from 0.18M 
to 0.64M,xii the conversion to 217 was improved further (entry 3). Under optimized reaction 
conditions, treatment of 202ss with c-Hex2BCl and Et3N (at −78 oC, 0.64M), followed by addition 
of isobutyraldehyde furnished the anticipated 217 in high yield (82%) with excellent 
diastereoselectivity (dr >19:1) (entry 4).   
Table 2-4: Diastereoselective synthesis of meso bisaldol 217 from meso diketone 202ss. 
 
                                                        
xi Lowering temperature will slow cyclization because it will reduce the concentration of the conformer leading to 
cyclization; and may also “relatively” assist the enolization by favoring the necessary R2C=O-BL2Cl complex that 
leads to enolization. 
xii Most of the solvent (hexane) comes from the borane reagent and was removed under reduced pressure before 
proceeding to the enolization. 
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SiEt3



































products (mole fraction) b 
217 221 202ss 218 
1  0 oC, 0.18 M ------ ------ 0.03 0.97 
2 −42 oC, 0.18 M 0.41 0.15 0.02 0.42 
3 −42 oC, 0.64 M  0.86 0.02 0.02 0.1 
4 −78 oC, 0.64 M  0.91 0.05 0.04 ------ 
a Reaction concentration with respect to 202ss. b From 1H NMR data of crude reaction mixture unless otherwise 
indicated. 
 
In summary, stereoselective preparations of meso (E,E)-bisenol borinates were achieved 
from both meso diketones 202aa and 202ss, and the corresponding aldol reactions of these 
bisenolates were highly diastereoselective to give meso bis-anti-aldols. However, it is clear that 
syn-aldol adducts are required to prepare the target precursor 174 from the proposed SEGS aldol 
strategy. Towards that goal, research was focused on stereoselective synthesis of (Z,Z)-bisenolates 
in hope of generating the desired syn-aldol adducts with high diastereoselectivites. 
 
2.6. Preparation of Meso Bis-Syn-Aldol Adducts 
2.6.1. Preparation of meso bis-syn-aldols from 202aa 
Previous attempts to prepare the meso-(Z,Z)-bisenolate from the BOM protected ketone 
201aa confirmed the formation of bisenolates (Scheme 2-13); however, a mixture of adducts was 
obtained with poor diastereoselectivities. Alternatively, Et3Si protecting group on diketone 178aa 
was considered with hopes of improving the diastereoselectivities in bisaldol reactions. Although 
aldol additions of the (Z)-enol borinate of the related TES protected ketone 197aa to 
isobutyraldehyde gave low diastereoselectivities (dr 2:1, Table 2-2, entry 4), diketone 202aa was 
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chosen to attempt bisaldol reaction. Accordingly, 202aa was treated with 9-BBNOTf, Et3N, under 
conditions analogous to those used for 197aa, followed by addition of achiral aldehydes as shown 
in Scheme 2-17. Remarkably, under these conditions, meso bisaldols 223 (86%; dr >19:1) and 
224 (84%; dr >19:1) were obtained in excellent yields and diastereoselectivities. Formation of the 
meso-bis-syn-aldols 223 and 224 confirmed that the meso-(Z,Z)-bisenol borinate 222 was 
generated stereoselectively and the corresponding aldol reactions were highly diastereoselective. 
The much higher diastereoface selectivities observed for aldol additions to the meso-(Z,Z)-
bisenolates of 202aa compared with those to the known (Z)-enolate of 197aa suggest that the ketal 
group plays an important role. 
 
Scheme 2-17: Stereoselective synthesis of meso-(Z,Z)-bisenol borinate 222 and meso bisaldols 
223, 224 from meso diketone 202aa. 
In summary, all the obtained results from both meso diketones 202aa and 202ss confirmed 
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bisenol borinates with c-Hex2BCl and 9-BBNOTf respectively, and subsequent aldol reactions 
were highly diastereoselective to obtain meso bisaldols exclusively. However, all the above 
reactions were examined only with simple achiral aldehydes. Towards the synthesis of the putative 
precursor 174 and to develop the proposed SEGS bisaldol strategy, further bisaldol reactions were 
investigated with chiral aldehydes using the optimized conditions for bisenolate formation. 
 
2.7. Bisaldol Reactions with Chiral Aldehydes 
Aldol reactions of bisenolates of 202aa with racemic and enantiopure aldehydes are more 
complicated and can generate up to 36 and 32 possible diastereomers, respectively (Scheme 2-
18a). Thus, selective formation of the desired aldol adduct will be more challenging in such cases. 
Importantly, addition of (E)-enol borinates of ethyl ketones to chiral aldehydes (±)-109 and (±)-
159 are known42 to proceed with  high Felkin diastereoface selectivity in the Ward group (Scheme 
2-18b).66 These reactions are not only diastereoselective, but also proceed with high mutual kinetic 
enantioselection (MKE); i.e., each enantiomer of ketone (±)-197aa preferentially reacts with one 
enantiomer of racemic aldehydes (±)-109 or (±)-159. 
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Scheme 2-18: a) Possible diastereomers from aldol reactions of 202aa with chiral aldehydes; b) 
Diastereoselectivities from the known aldol reactions of 197aa (via (E)-enol 





















































a) possible diastereomers from aldol reactions of 202aa with chiral aldehydes









2.7.1. Reactions of (E,E)-bisenol borinates of 202aa and 202ss with chiral aldehydes 
Under optimized conditions, reactions of meso-(E,E)-bisenol borinate of 202aa with chiral 
aldehydes (±)-109 and (±)-159 furnished the meso bisaldols 230 and 232, respectively, in good 
yields and with excellent diastereoselectivities (Scheme 2-19). These results confirmed that 
additions of (E)-enol borinates of 215 to the aldehydes (±)-109 and (±)-159 proceeded with high 
Felkin diastereoface selectivities as was anticipated according to the known results from Scheme 
2-18. Similarly, under optimized conditions, reaction of meso-(E,E)-bisenol borinate of 202ss 
with chiral aldehydes (±)-109 and (±)-159 furnished the anticipated meso bisaldols 236 and 237, 







































c -Hex2BCl (4 equiv),
Et3N (4.8 equiv),
CH2Cl2, 0 oC, 3h
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Scheme 2-20: Reactions of meso-(E,E)-bisenol borinate of 202ss with chiral aldehydes (±)-109 
and (±)-159. 
Formation of meso bisaldols 230, 232, 236 and 237 with excellent diastereoselectivities 
and mutual kinetic enantioselections (MKEs) confirmed that these reactions are highly 
enantiotopic group selective (EGS) (Schemes 2-19 & 2-20). The two enolates in meso bisenolates 
215 and 235 have an enantiotopic relationship and each enolate will have two diastereotopic faces; 
each enantiotopic enolate (in 215, 235) must preferentially react with the matched enantiomer 
(kinetic preference) of racemic aldehydes (±)-109, (±)-159 to provide the meso bisaldols 230, 232, 
236 and 237. The selective formation of these meso bisaldols (with high MKE) demonstrates that 
with the proper choice of protecting group and enolate type, it should be possible to achieve 
enantioselective desymmetrization (or internal EGS) by reaction with an enantiopure aldehyde to 
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2.7.2. Enantioselective desymmetrization 
Enantioselective desymmetrization68 of meso bifunctional compounds is a powerful 
strategy to obtain enantioenriched products in asymmetric synthesis.74 Because high diastereo- 
and enantiotopic group selectivities were observed in reactions of meso (E,E)-bisenol borinates of 
202aa and 202ss with racemic aldehyde (±)-109 (Schemes 2-19 & 2-20), it was predicted that the 
corresponding enantiopure aldehyde (−)-10965 would preferentially react with one enolate 
(matched) of 202aa via enantioselective desymmetrization (internal EGS) (Scheme 2-21). 
However, for efficient enantioselective desymmetrization of the meso bisenolate, the amount of 
enantiopure aldehyde needs to be carefully controlled (e.g., one equivalent) to maximize 
conversion and to avoid further reactions (i.e., mismatched reactions) with the enolate in 238. This 
normally straightforward requirement is complicated by the stoichiometry of the boron reagent. 
Only two equivalents of borane reagent are needed to prepare bisenolates of meso-1,5-diketones; 
however, four equivalents of borane reagent were required to obtain bisenolates efficiently under 
optimized conditions. Thus, the excess (2 equiv) of borane reagent in the reaction mixture could 
potentially react with and consume the enantioenriched aldehyde (−)-109. To overcome this 
problem, the stoichiometry of aldehyde could be increased to 3 equivalents; however, the relative 
rates of the reactions of the aldehyde with enolate and borylating agent are unknown. This 
approach might be effective if the rate of borylation of the aldehyde is much faster than aldol; 
however, this process would not be practical if only because of the ‘expense’ of the enantiopure 
aldehyde. Given these difficulties, other possible alternatives for consuming the excess borane 
reagent before addition of aldehyde were considered. The method to consume excess reagent 
should be selective and should not interfere with any of the other components (e.g., enolates, 
aldolates, aldehyde) in the reaction mixture. 
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Scheme 2-21: Proposed enantioselective desymmetrization of meso bisenolate 215 with 
enantiopure aldehyde (−)-109. 
Cragg et al. described a method to prepare aminoboranes from reaction of 
arylchloroboranes with tert-butylamine.91 It was found that the reactivity of aminoboranes is much 
lower than that of arylchloroboranes. Encouraged by this research, it was anticipated that tert-
butylamine could react with and consume excess boron reagent in the proposed aldol reactions. 
To test this approach and to determine the effect of tert-butylamine (if any) in aldol reactions, 
meso (E,E)-bisenol borinate of 202aa was prepared under the optimized conditions and was 
treated with tert-butylamine followed by addition of isobutyraldehyde (excess) (Scheme 2-22). 
Aldol reactions with and without tert-butylamine produced the known meso bisaldol 212 with 


















202aa meso (E,E)-bisenol 
borinate 215
c -Hex2BCl (4 equiv),
Et3N (4.8 equiv),
CH2Cl2, 0 oC, 3h















Scheme 2-22: Aldol reaction of 202aa with isobutyraldehyde in presence and in absence of tert-
butylamine. 
Secondly, to determine if tert-butylamine could prevent borylation of the aldehyde, aldol 
reactions of meso 202aa with (±)-109 (2 equiv) were examined with different amounts of tert-
butylamine (Table 2-5). Increasing the amount of tert-butylamine from 0-3 equiv (with respect to 
ketone), improved conversion to aldol adducts accordingly (entries 1-4). These results suggest 
that the tert-butylamine reacted with excess borane reagent presumably to form the corresponding 
aminoborane, which apparently has no impact on enolate, aldehyde, or aldols; as a result, aldol 
conversion was improved.  
Table 2-5: Effect of tert-butylamine in aldol reactions with excess borane reagent c-Hex2BCl. 







1. standard (E,E)-bisenol 
    borinate conditions
2. isobutyraldehyde, 
    −78 oC, 24h. 212
1. standard (E,E)-bisenol 
    borinate conditions,





c -Hex2BCl (4 equiv), Et3N 
(4.8 equiv), CH2Cl2, 0 oC, 3h
(enolization conc. 0.18 M)
then, tert-BuNH2, 30 min.,

















entry tert-butylamine  
(equiv to 202aa) 
(±)-109 (equiv) conversion to 
aldols (%)a 
1  0 2 69 
2 1 2 76 
3 2 2 81 
4 3 2 86 
5 4 2 88 
6 0 4 96 
a Determined from 1H NMR data of crude reaction unless otherwise indicated. 
The above results (from Table 2-5) suggest that tert-butylamine is a suitable additive to 
consume excess borane reagent before addition of enantiopure aldehyde to meso bisenolate for 
enantioselective desymmetrization reactions. The known and readily available enantioenriched 
aldehyde (−)-10965 was considered for enantiotopic group selective aldol reactions. 
2.7.2.1. Preparation of enantioenriched aldehyde (−)-109 
The Ward group has previously reported the preparation of enantioenriched aldehyde (−)-
109 via oxidation of the corresponding alcohol (−)-239 using the Dess-Martin periodinane (DMP) 
(Scheme 2-23).65 This method is advantageous because the pure aldehyde is obtained after a 
simple aqueous work up in >90% yield and with negligible change in enantiopurity compared to 
the starting alcohol. However, the aldehyde (−)-109 is known to racemize on standing and long-
term storage is not prudent. The amount of aldehyde to be used in EGS aldol reaction is crucial 
and must be carefully controlled. A possible solution to control the amount of (−)-109 would be 
to oxidize a known amount of the stable alcohol (−)-239 and then directly use the resulting 
aldehyde product in the enantioselective desymmetrization reaction. However, this approach must 
be robust and give reproducible yields.65 Over multiple experiments, it was observed that the DMP 
oxidation of (−)-239 was very sensitive to the reaction time and the quality of DMP. 
Overoxidation (i.e., sulfide oxidation to the corresponding sulfoxide or sulfone) was observed 
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when the reaction time exceeded 10 minutes. Although overoxidation was negligible at shorter 
reaction times, the oxidation of (−)-239 was incomplete under these conditions. Running the 
reaction until the disappearance of (−)-239 (TLC monitoring, ca. 15 min) resulted in variable 
amounts of overoxidation products. Although the byproducts were removed by the aqueous work 
up, the yield of (−)-109 varied from 88-97%.  
Based on the supposition that sulfide oxidation by DMP might be catalyzed by the acetic 
acid byproduct from the alcohol oxidation,92,93 MgO was introduced as an insoluble base that 
might trap the acetic acid. After optimization of these conditions, the alcohol (−)-239 was oxidized 
to (−)-109 in reproducibly high yields (95% to 97%) over multiple experiments on various 
scales.xiii  
 
Scheme 2-23: An improved preparative method of aldehyde (−)-109 from alcohol (−)-239. 
2.7.2.2. Enantioselective desymmetrization of meso-(E,E)-bisenol borinate 215 
A reaction of meso-(E,E)-bisenol borinate 215 with tert-butylamine at 0 oC, followed by 
addition of one equivalent of enantioenriched aldehyde (−)-109 xiv  at −78 oC, furnished the 
                                                        
xiii Quality of DMP is very important to obtain reproducible results; freshly prepared and recrystallized DMP was 
used for these oxidations. 





















enantioenriched monoaldol adduct (+)-231, albeit in moderate yields (69%) (Scheme 2-24). 
Enantioselective desymmetrization yields were improved (81%) by increasing aldol reaction 
temperature to −42 oC. The adduct (+)-231 has 1,6′-syn-1,2-anti-2,4-syn relative configuration as 
expected from the previously described aldol reactions with racemic aldehydes. Although the 
enantiopurity of (−)-109 was 92% ee (assumed from 92% ee of the precursor alcohol (−)-239; 
Scheme 2-23), the monoaldol (+)-231 was generated with enhanced enantiopurity (ee >98%, by 
HPLC). This amplification of the product ee is an advantage of enantioselective desymmetrization 
reactions and results from consumption of the minor aldehyde enantiomer (+)-109 by preferential 
reaction (i.e., kinetic preference, matched) with enolate 238 generating the known meso bisaldol 
230. 
In summary, enantioselective desymmetrization of a simple meso diketone 202aa with 
enantioenriched aldehyde (−)-109 produced the aldol adduct (+)-231 with high enantio- and 
diastereoselectivity. Extrapolating from this result, it should be possible to obtain even more 
complex enantioenriched bisaldol adducts if the intermediate aldolate-enolate 238 can selectively 
react with different aldehydes (chiral or achiral) in a second aldol reaction. 
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Scheme 2-24: Enantioselective desymmetrization of meso-(E,E)-bisenol borinate 215 with 
enantioenriched (92% ee) aldehyde (−)-109. 
 
2.7.3. One-pot sequential enantiotopic group selective (SEGS) bisaldol reactions of meso-
(E,E)-bisenol borinate 215 
Towards developing a one-pot SEGS bisaldol strategy, the initial plan was to test stability 
and reactivity of the intermediate enolate 238 (Scheme 2-24) by trapping it with a simple achiral 
aldehyde (e.g., isobutyraldehyde) in the second aldol reaction. To that end, the aldolate-enolate 
238, generated as described above, was treated with isobutyraldehyde resulting in the formation 
of enantioenriched bisaldol product (−)-240 (32 possible diastereomers) in good yields with high 















c -Hex2BCl (4 equiv),
Et3N (4.8 equiv),
CH2Cl2, 0 oC, 3h
(enolization conc. 0.18 M)
tert-BuNH2, 30 min., then, 























Scheme 2-25: One-pot enantioselective bisaldol reaction of meso-(E,E)-bisenol borinate 215 
with (−)-109 and isobutyraldehyde. 
The Ward group has done extensive research to design stereoselective aldol reactions that 
proceed with kinetic resolution (KR); several polypropionates have been synthesized by 
exploiting racemic reactants with enantiopure reactants using this strategy. Adapting this strategy, 
it should be possible to achieve kinetic resolution (external EGS) by trapping the enantiopure 
intermediate 238 (>98% ee) with a racemic aldehyde in a second aldol reaction. For an efficient 
kinetic resolution, the two enantiomers of the racemic aldehyde must react with enantiomerically 
pure enolate with substantially different rate constants to produce an aldol product with high 
diastereoselectivity. 
In order to achieve kinetic resolution with high enantioselectivity a suitable racemic 
aldehyde must be used for aldol reaction with intermediate 238. Because the aldehyde (±)-159 is 

















c -Hex2BCl (4 equiv),
Et3N (4.8 equiv),
CH2Cl2, 0 oC, 3h
(enolization conc. 0.18 M)
tert-BuNH2, 30 min., 
then, (−)-109 (1 equiv, 




















(MKE), it was a logical candidate for this reaction. Accordingly, the aldolate-enolate 238, 
generated as described previously, was treated with racemic aldehyde (±)-159 to afford the 
enantioenriched bisaldol product (+)-241 (64 possible diastereomers) in good yields and with 
excellent diastereo- and enantioselectivities (dr >19:1; ee >98%, HPLC) (Scheme 2-26). 
 
Scheme 2-26: One-pot SEGS bisaldol reactions of meso-(E,E)-bisenol borinate 215 with (−)-109 
and (±)-159. 
In an analogous manner, addition of aldehyde (±)-159 to the aldolate-enolate 242, prepared 
from meso diketone 202ss as previously described, afforded enantioenriched bisaldol product (−)-
243 (64 possible diastereomers) in good yield and with excellent diastereo- and 

















c -Hex2BCl (4 equiv),
Et3N (4.8 equiv),
CH2Cl2, 0 oC, 3h
(enolization conc. 0.18 M)
tert-BuNH2, 30 min., 
then, (−)-109 (1 equiv, 




























Scheme 2-27: One-pot SEGS bisaldol reaction of meso-(E,E)-bisenol borinate 220 with (−)-109 
and (±)-159. 
In summary, meso diketones 202aa and 202ss underwent sequential directed aldol 
reactions first with enantioenriched aldehyde (−)-109 via enantioselective desymmetrization 
(internal EGS) and then with racemic aldehyde (±)-159 via kinetic resolution (external EGS) to 
give the enantioenriched bisaldol adducts (+)-241 and (−)-243, respectively, and sets the absolute 
configurations of eight stereocenters (C2 to C11) in a one-pot process (Schemes 2-26 & 2-27). 
This powerful SEGS bisaldol strategy demonstrates that simple meso diketones can be converted 
to a variety of complex enantiopure bisaldol products that are potential intermediates in 
polypropionate syntheses. The next objective was to apply this developed SEGS bisaldol strategy 
to the total synthesis of dolabriferol C (17). However, so far this strategy was applied to meso-
(E,E)-bisenol borinate to obtain anti-aldol products. To achieve the synthetic target 174 (Scheme 
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borinate, 220
c -Hex2BCl (4 equiv),
Et3N (4.8 equiv),
CH2Cl2, 0 oC, 3h
(enolization conc. 0.18 M)
tert-BuNH2, 30 min., 
then, (−)-109 (1 equiv, 
























strategy was further explored with meso-(Z,Z)-bisenolates to obtain syn-bisaldol products 
selectively. 
 
2.7.4. Reactions of meso-(Z,Z)-bisenol borinate 222 with chiral aldehydes 
The reaction of meso-(Z,Z)-bisenol borinate 222 with (±)-109 under the previously 
established conditions produced the meso bisaldol adduct 244 in excellent yield (80%) and with 
high diastereoselectivity (dr >19:1) (Scheme 2-28). However, under the identical conditions, 
reaction of 222 with (±)-159 produced a 1:1 mixture of meso bisaldol 245 and chiral bisaldol (±)-
246. Both 245 and (±)-246 have 3,4-syn-4,6-syn-8,10-syn-10,11-syn-11,12-syn relative 
configurations, with the meso 245 having 2,3-syn and the chiral (±)-246 having 2,3-anti relative 
configurations, respectively. This result proves that the mutual kinetic enantioselection (MKE) in 
reaction of (Z)-enol borinate 222 with (±)-159 is considerably lower than in reaction with (±)-109. 
Additions of (Z)-enolates to chiral 2-methyl aldehydes are known to proceed with lower Felkin 
(2,3-syn) diastereoselectivity compared to similar additions of (E)-enolates.94,95 It is also known 
in the Ward group that addition of (Z)-enolates of several ketones related to (±)-159 produced a 
mixture of aldols with both 2,3-syn (Felkin) and 2,3-anti (non-Felkin) relative configurations.66 
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Scheme 2-28: Reactions of meso-(Z,Z)-bisenol borinate 222 with chiral aldehydes. 
2.7.4.1. Effect of tert-butylamine on aldol reactions of meso-(Z,Z)-bisenol borinate 222 
Reactions of meso-(Z,Z)-bisenol borinate 222 with racemic aldehyde (±)-109 in presence 
of tert-butylamine at various temperatures were investigated, and the results are presented in the 
Table 2-6. With exception of the control experiment (with no additive, entry 1), poor conversions 
were observed in experiments with tert-butylamine (entries 2-5). In contrast to the previously 
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temperature did not improve conversion (Table 2-6, entries 4-6). The cyclized product 248xv was 
observed in presence of tert-butylamine at 0 oC.  
Table 2-6: Effect of tert-butylamine on bisaldol reactions of meso-(Z,Z)-bisenol borinate 222. 
 




products (mole fraction)a 
 244 247 202aa 248 
1  none 4 0.94 0.03 0.03 ------- 
2 −78 oC, 1 h 4 0.44 0.43 0.13 ------- 
3 −78 oC, 1 h 2 0.36 0.44 0.2 ------- 
4 −42 oC, 1 h 2 0.3 0.44 0.25 ------- 
5 0 oC, 1 h 2 0.23 0.18 0.24 0.36 
6 none, 0 oC, 1 h 4 0.96 0.2 0.2 ------- 
a Determined from 1H NMR data of crude reaction unless otherwise indicated. 
The stability of the meso-(Z,Z)-bisenol borinate 222 at higher temperature was tested by 
warming the reaction mixture to 0 oC for 1 h before addition of aldehyde (Table 2-6, entry 6). The 
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Et2O, −78 oC, 4h
(enolization conc. 0.09 M)
L2 = 9-BBN
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result of this reaction was quite similar to the standard reaction with aldehyde (±)-109 (entry 1) 
confirming the stability of meso-(Z,Z)-bisenol borinate 222 at 0 oC was not the reason for poor 
conversion or cyclization. From the above observations, it was concluded that the poor 
conversions were due to reaction of tert-butylamine with the meso-(Z,Z)-bisenol borinate 222. 
Thus, tert-butylamine was not effective in consuming excess 9-BBNOTf. 
2.7.4.2. A suitable additive to consume 9-BBNOTf 
As an alternative, 2,4-dimethyl-3-pentanone (249) was selected to react with and consume 
the excess 9-BBNOTf by formation of the corresponding enol borinate (Table 2-7). Initial 
experiments aimed to establish conditions to prepare the enolate from ketone 249 with 9-BBNOTf 
and test the reactivity of the generated enolate in aldol reactions. Accordingly, a reaction of ketone 
249 with 9-BBNOTf and Et3N at −78 oC, followed by addition of isobutyraldehyde gave no aldol 
adduct suggesting either no enolate was generated at −78 oC, or no aldol reaction occurred. 
However, an otherwise identical experiment where the enolization temperature was increased to 
0 oC produced the expected aldol product 25196 in reasonable yield (64%) (entry 2). Thereafter, 
aldol conversion with respect to 9-BBNOTf was examined with various stoichiometries of ketone 
249. Increasing the amount of ketone 249 improved aldol conversion significantly (entries 3-6). 
The obtained results from this optimization study suggested that the reaction of ketone 249 (4 
equiv) with 9-BBNOTf (1 equiv) at 0 oC for 1 h is a suitable condition to generate the enolate 250 
in over 95% yield (entry 6). On the other hand, using optimized enolization conditions, aldol 
reaction at −78 oC produced only 18% of the adduct 251 suggesting the enolate 250 is much less 
reactive (at −78 oC) to couple with isobutyraldehyde compare to the meso-(Z,Z)-bisenol borinate 
222 (entry 8). A large difference in reactivity is required for preferential reaction of meso-(Z,Z)-
bisenol borinate 222 with aldehyde to occur in presence of enolborinate 250. 
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Table 2-7: Enolization and aldol conditions for 2,4-dimethyl-3-pentanone (249). 
 




aldol conditions conversion 
(%)a 
1  1 −78 oC, 1 h −78 oC, 1 h, then  
0 oC, 0.5 h 
--------- 
2 1 0 oC, 1 h −78 oC, 1 h, then  
0 oC, 0.5 h 
64 
3 2 0 oC, 1 h 0 oC, 0.5 h 90 
4 2 0 oC, 1.5 h 0 oC, 0.5 h 93 
5 3 0 oC, 1 h 0 oC, 0.5 h 95 
6 4 0 oC, 1 h 0 oC, 0.5 h 97 
7 4 0 oC, 1 h −78 oC, 3 h 18 
a Conversion measured from 1H NMR data of crude reaction. 
The above investigation confirms that excess 9-BBNOTf must be consumed at 0 oC. 
Although the previous study confirmed the stability of meso-(Z,Z)-bisenol borinate 222 at 0 oC 
(Table 2-6, entry 6), it was not clear how this enolate behaves at 0 oC in presence of ketone 249. 
The stability of meso-(Z,Z)-bisenol borinate 222 was tested by warming the enolization reaction 
to 0 oC for 1 h in presence of  249, followed by addition of isobutyraldehyde at −78 oC using 
standard conditions to produce the known bisaldol 223 in excellent yield (Table 2-8, entry 1). 
From these results, ketone 249 was identified as a promising additive to consume excess 9-











−78 oC or 0 oC
Et2O, −78 oC/0 oC, 1h L2 = 9-BBN
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aldol conditions conversion 
(%)a 
1  8 −78 oC, 4 h, then 0 
oC 1 h with 249 
−78 oC, 3 h 96 
2 none −78 oC, 4 h, then 0 
oC 1 h 
−78 oC, 3 h 97 
3 none −78 oC, 4 h −78 oC, 3 h 96 
a Conversion measured from 1H NMR data of crude reaction. 
Although excellent conversions were obtained from reactions of bisenolate 222 with 
isobutyraldehyde in presence of 249, the aldehyde was used in excess (10 equiv) to drive the aldol 
reaction (Table 2-8). However, in enantioselective desymmetrization the amount of enantiopure 
aldehyde must be limited to one equivalent (with respect to diketone 202aa) to avoid undesired 
reactions. Reducing the amount of aldehyde to one equivalent would decrease the rate of aldol 
reaction at lower temperatures. Thus, the conversion of aldehyde in reactions of bisenolate 222 
with a limited amount of (±)-109 (2 equiv) was determined in presence of ketone 249 (Table 2-
9).  
A reaction of bisenolate 222 with aldehyde (±)-109 in presence of ketone 249 under the 
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249, 0 oC, 1 h
then, iPrCHO (excess),
−78 oC, 3 h
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(62%) in low yield (Table 2-9, entry 2). Increasing the aldol reaction temperature to 0 oC, 
improved conversion to 244 (78%) (entry 5). However, higher temperatures (0 oC) are not 
convenient for enantioselective desymmetrization because controlling undesired reactions and 
stereoselectivities might be challenging. To overcome this issue, increasing the reaction 
concentration while maintaining a lower temperature was considered. Accordingly, the reaction 
concentration (with respect to ketone 202aa) was increased from 0.07 M to 0.15 M by removing 
the solvent from 9-BBNOTfxvi followed by enolization and aldol reactions at −78 oC gave 244 
(76% conversion) (entry 6). Under optimized conditions, increasing aldol reaction temperature 
from −78 oC to −42 oC at 0.15 M concentration, improved conversion to 244 (88%) (entry 7). On 
the other hand, aldol reaction in absence of 249 led to poor conversion (entry 4) confirming the 
9-BBNOTf must be consumed before addition of aldehyde.  
Table 2-9: Aldol reaction of diketone 202aa with 2 equiv of (±)-109 in presence of ketone 249. 
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entry  ketone 249 
conditions 








244 247 202aa 
1 0 oC, 0.5 h −78 oC, 3 h 0.55 0.38 0.07 74 
2 0 oC, 1 h −78 oC, 3 h 0.62 0.29 0.09 77 
3 0 oC, 1.5 h −78 oC, 3 h 0.67 0.26 0.06 80 
4 none −78 oC, 3 h 0.13 0.57 0.3 42 
5 0 oC, 1 h −78 oC, 3 
h, 0 oC, 0.5 
h 
0.78 0.18 0.04 87 
6a 0 oC, 1 h −78 oC, 3 h 0.76 0.19 0.05 86 
7a 0 oC, 1 h −42 oC, 3 h 0.88 0.06 0.06 93 
a enolization and aldol reactions performed at 0.32 M and 0.15 M concentrations (with respect to ketone 202aa), 
respectively. 
 
2.7.4.3. Enantioselective desymmetrization of meso-(Z,Z)-bisenol borinate 222 with aldehyde 
(−)-109 
Having established conditions to consume excess 9-BBNOTf, enantiotopic group selective 
aldol reactions with meso-(Z,Z)-bisenol borinate 222 were explored. Gratifyingly, 
enantioselective desymmetrization of 222 with aldehyde (−)-109 afforded enantioenriched 
monoaldol 247 in good yield with excellent diastereo- and enantioselectivities (76%; dr >19:1; ee 
>98%) (Scheme 2-29). 
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Scheme 2-29: Enantioselective desymmetrization of meso-(Z,Z)-bisenol borinate 222 with 
enantioenriched aldehyde (−)-247. 
In summary, three meso bisenolates (215, 220 and 222) were prepared stereoselectively 
from two different meso diketones (202aa, 202ss) and were used in sequential aldol reactions with 
chiral and achiral aldehydes to obtain bisaldol adducts with high enantio- and 
diastereoselectivities. The established enantioselective desymmetrization of meso bisenolates and 
the one-pot SEGS bisaldol strategy allows access to various enantioenriched monoaldol and 
bisaldol adducts, respectively, in a very robust way. Application of these strategies in synthesis of 
polypropionate natural products is an opportunity to demonstrate their scope and advantages. 
 
2.8. Total Synthesis of Dolabriferol C 
As indicated, the main objective of this research was to test whether the putative 
contiguous precursor 174 could be transformed to dolabriferol C (17) via a spontaneous retro-
Claisen rearrangement (Scheme 2-30). Towards this objective, the initial synthetic target was the 
putative contiguous precursor 174 that can be synthesized from the established one-pot SEGS 
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(enolization conc. 0.32 M)
249, 0 oC, 1 h, then, 
(−)-109 (1 equiv, 















Scheme 2-30: Proposed synthesis of dolabriferol C (17) via the SEGS bisaldol strategy. 
 
2.8.1. Enantioselective desymmetrization of meso-(Z,Z)-bisenol borinate 222 with ‘eastern’ 
aldehyde (+)-128 
Towards the synthesis of the putative precursor 174, enantioselective desymmetrization of 
meso-(Z,Z)-bisenol borinate 222 with aldehyde (+)-12817, under the previously optimized 
conditions, produced the anticipated monoaldol 253, albeit in low yield (33%) (Table 2-10, entry 
1). Due to poor solubility of the aldehyde (+)-128 in diethyl ether (in contrast to the aldehyde (−)-
109), additional solvent was required to make a solution for addition to the bisenolate (reaction 
concentration was 0.08 M with respect to diketone 202aa). The poor conversion was presumably 
due to the lower rate of aldol reaction with lower concentration and (or) precipitation of the 
aldehyde (+)-128 in diethylether at −42 oC. To improve conversion, the reaction was investigated 
under various conditions (Table 2-10). Gratifyingly, the aldehyde (+)-128 is highly soluble in 
THF and addition of a THF solution of (+)-128 to the bisenolate (reaction concentration was 
0.16M with respect to 202aa) at −42 oC markedly improved the yield (69%) of 253 (entry 2); 







































however, undesired homo-bisaldol 254xvii was observed in significant amounts (10%). A slight 
improvement in ratio of 253 to 254 (from 7:1 to 10:1) was observed when the reaction was 
performed at −78 oC (entry 3). 
Because, the aldol conversion improved significantly in THF, the enolization solvent was 
switched from Et2O to THF; surprisingly, only starting ketone 202aa was recovered (Table 2-10, 
entry 4; presumably an irreversible reaction of 9-BBNOTf with THF occurred). Next, keeping the 
aldol temperature at −78 oC and using a slight excess of (+)-128 (1.2 equivalents) improved the 
aldol conversion to 87% with an 8:1 mixture of 253 and 254, respectively (entry 5). Under 
optimized conditions, reaction of 222 with 1.1 equivalents of (+)-128 at −78 oC, for 16 h improved 
the conversion to 88% with a 10:1 mixture of 253 (72% isolated yield) and 254, respectively 
(entry 6).  
Table 2-10: Enantioselective desymmetrization of meso (Z,Z)-bisenol borinate 222 with 
‘eastern’ aldehyde (+)-128. 
 
                                                        























Et2O, -78 oC, 4h
(enolization conc. 0.32M)
149, 0 oC, 1 h, then,




























products (mole fraction) 
254 253 202aa 
1  1 −42 oC, 3 h, 
Et2O 
-------- 0.33 0.67 
2 1 −42 oC, 3 h, 
THF 
0.1 0.69 0.21 
3 1 −78 oC, 3 h, 
THF 
0.06 0.6 0.34 
4b 1 −78 oC, 3 h, 
THF 
------- ------- 1 
5 1.2 −78 oC, 3 h, 
THF 
0.08 0.7 0.22 
6 1.1 −78 oC, 16 h, 
THF 
0.08 0.8c 0.12 
aThe solvent refers to the solution of aldehyde added to the bisenolate; reaction concentrations (with respect to 202aa) 
were 0.08 M (Et2O) and 0.16 M (THF). bEnolization performed in THF. c72% isolated yield. 
 
2.8.2. An improved synthesis of dolabriferol 
The monoaldol 253 (Table 2-10) is a potential intermediate for the synthesis of dolabriferol 
(15). Thus, an improved synthesis of 15 from 253 was proposed by adapting and streamlining the 
previous synthetic route.17 A reaction of monoaldol 253 with Raney-Ni in EtOH gave the desired 
255 in moderate yield (58%) and surprisingly, 256 was also obtained in a significant amount 
(19%) (Scheme 2-31). Compound 256 is a possible advanced intermediate for synthesis of the 
putative precursor 32; however, selective oxidation at C9 would be more challenging as two 
additional free hydroxy groups (at C-11 and C-13) are present in 256.  
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Scheme 2-31: Hydrogenolysis of 253 with Raney Ni. 
To avoid the challenging chemoselective oxidation of 256 (Scheme 2-31), reordering of 
synthetic sequence was considered. Accordingly, IBX mediated oxidation of 253 furnished the 
desired trione 257 in excellent yield (98%) (Scheme 2-32). As anticipated, under optimized 
reaction conditions, treatment of 257 with Raney-Ni resulted in both desulfurization and 
benzylidene acetal hydrogenolysis to produce the desired 258 (76%) predominantly in one 
hemiacetal form (13➔9) as a 3:1 mixture of C-8 epimers. TASF mediated silyl ether deprotection 
of 258 gave the known contiguous precursor 32 in good yield (80%) as a 2:1 mixture of C-8 
epimers. The spectral data for the contiguous precursor 32 fully matched those previously reported 
by Ward et al.17 Treating 32 with neutral alumina according to the known reaction conditions 
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Scheme 2-32: Synthesis of dolabriferol (15) from monoaldol 253. 
In summary, total synthesis of dolabriferol (15) was achieved via enantioselective 
desymmetrization (or internal EGS aldol reaction) of meso diketone 202aa with aldehyde (+)-
128. This improved synthesis was accomplished in 5 steps with 34% overall yield from the known 
aldehyde (+)-128.xviii. 
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2.8.3. One-pot SEGS bisaldol reactions of meso-(Z,Z)-bisenol borinate 222 with aldehydes 
(+)-128 and (±)-159 
Towards the synthesis of dolabriferol C (17), a one-pot SEGS bisaldol reaction was 
initiated to construct the full carbon skeleton for the putative precursor 174 as proposed in Scheme 
2-30. The aldolate-enolate 259, generated as described previously (Table 2-10), was treated with 
racemic aldehyde (±)-159 (kinetic resolution) to afford a 2.2:1:1 mixture of enantioenriched 
bisaldols 252sss (10S), 252ssa (10R) and homo-bisaldols 245 or 254, respectively (Scheme 2-33). 
As expected, addition of the (Z)-enol borinate 222 to aldehyde (±)-159 proceeded with lower 
Felkin (2,3-syn) diastereoselectivity (see Scheme 2-28) compared to the corresponding (E)-enol 
borinate 215 (see Scheme 2-19). However, the minor bisaldol 252ssa has the desired carbon 
skeleton and stereochemical arrangement (9,10-anti; C10 with ‘R’ configuration) for synthesis of 
the putative precursor 174. The desired 10R absolute configuration and improved 
diastereoselectivity in preparation of the adduct 252ssa should result by addition of the (R)-159 
to the (Z)-enol borinate 222. Because no literature method was available to prepare enantiopure 
aldehyde (R)-159;xix an enantioselective synthesis of (R)-159 was considered. 
                                                        
xix Recently, Leighton et al. reported preparation of the aldehyde (R)-159 in 53% yield with 81% ee.97 
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Scheme 2-33: One-pot SEGS bisaldol reactions of 202aa with (+)-128 and (±)-159. 
 
2.8.4. Preparation of enantiopure acyclic aldehyde (+)-(R)-159 
Synthesis of enantiopure aldehyde (+)-(R)-15997 was initiated with L-proline catalyzed 
enantioselective self-aldol reaction of propanal using MacMillan’s procedure31 (Scheme 2-34). 
According to the MacMillan’s method, aldol adducts 260a (anti) and 260s (syn) were obtained in 
4:1 ratio, respectively. Although the structure of 260a is proven (2S,3S absolute configuration), 
the absolute configuration of the minor (syn) diastereomer 260s was unknown.31,98 The absolute 
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have the same configuration at C2 then they can be converted into (+)-(R)-159 without separation 
(note that the C3 stereocenter is lost in that process). However, if the diastereomers have different 
configurations at C2, then they must be separated before proceeding to (R)-(+)-159.  
Using MacMillan’s procedure, L-proline catalyzed enantioselective aldol reaction of 
propanal gave no pure aldol adduct, but a complex mixture of oligomers was observed. To prevent 
oligomerization in the aldol reaction, Cordova et al. converted the aldol adducts to the 
corresponding diols with NaBH4 before isolation.99 Using Cordova’s procedure, one-pot aldol and 
reduction of propanal gave the diols 261100–108 as a 4:1 mixture of anti and syn diastereomers, 
respectively, in 46% yield (Scheme 2-34). The enantiopurity of the diol mixture (each >98% ee) 
was determined by HPLC after conversion to the corresponding monobenzoyl esters 261a.105–107 
The so obtained 261a with high enantioenrichement (each >98% ee) suggesting that the 4:1 
mixture of 260a and 260s diastereomers, respectively was enantiomerically pure. Selective 
silylation of the primary alcohol in diol 261 generated the TBS protected alcohol 262103,109 that 
upon DMP oxidation produced the known ketone 263104,110,111 ([α]D –36, c 1.2, CHCl3; lit.112 (for 
the S enantiomer) [α]D +43.70, c 1.0, CHCl3) in excellent yield (85% over two steps). The spectral 
data and optical rotation values of 263 was closely matched (with opposite sign) with those of the 




Scheme 2-34: Towards the synthesis of enantiopure aldehyde (+)-(R)-159. 
Ketal protection of the ketone, TBS removal and oxidation of the resulting primary alcohol 
are required to convert (R)-263 to the desired aldehyde (+)-(R)-159. Accordingly, a reaction of 
ketone (R)-263 with ethylene glycol under standard ketalization conditions (p-TsOH ･H2O, 
benzene, Dean-Stark reflux) produced mixture of desired ketal products 267 and 268 along with 
undesired ketal and elimination products (264, 265 and 266) (Scheme 2-35).xx An alternative 
ketalization method104 using TMSCl did not improve the result. 
                                                        






























Scheme 2-35: Ketal protection of 263 towards the synthesis of (+)-(R)-159. 
Noyori et al. converted various ketones to the corresponding ketals under aprotic 
conditions using 1,2-bis(trimethylsiloxy)ethane and catalytic amount of TMSOTf at lower 
temperature (e.g., −78 oC).113 Encouraged by this method, ketalization of 263 was examined using 
Noyori method (Table 2-11). Only 6% conversion to the desired ketal product 267 was observed 
under Noyori conditions (−78 oC, 4 h) (entry 1). Although increasing reaction temperature 
doubled the conversion (12%), undesired alkene 265 obtained as the major product (51%) (entry 
2). Increasing reaction temperature (−78 oC to 0 oC), improved the yield of 267 significantly (52%) 
but formation of the undesired 265 was not completely suppressed (entries 3 and 4).  
 




























entry ketalization conditions products (% yield)a 
267 265 
1  −78 oC, 4 h 6 ------- 
2 −78 oC, 5 min, then rt, 4 h 12 51 
3 −78 oC, 5 min, then 0 oC, 4 h 52 16 
4 −78 oC, 5 min, then 0 oC, 4 h, rt, 
30 min. 
44 23 
aDetermined from 1H NMR data using trichloroethylene as an internal standard, unless otherwise indicated. 
 
The undesired elimination reaction was presumably catalyzed by small amounts of triflic 
acid that was generated from TMSOTf in the reaction mixture. To remove the triflic acid (TfOH), 
bis(trimethylsilyl)acetamide (BSA) was introduced in the reaction mixture as a silylating agent to 
convert TfOH to TMSOTf. Addition of one equivalent of BSA to the ketalization reaction did not 
give any product; most likely BSA silylated the ketone 263 to the corresponding silyl enol ether 
(Table 2-12, entry 1). Decreasing the amount of BSA (10 mol%) drastically improved yields 
(>90%) (entries 2 and 3). Under the modified Noyori conditions (at −20 oC, 2 h), ketone 263 was 
successfully converted to the desired ketal 267 in excellent yield (96%) (entry 3).  
 
















ketalization conditions products (% yield)a 
 267 265 
1b 1 −42 oC, 4 h, −20 oC, 30 
min 
------- ------- 
2 0.1 −42 oC, 4 h, −20 oC, 30 
min 
93 ------- 
3 0.1 −20 oC, 2 h 96 ------- 
aDetermined from 1H NMR data using trichloroethylene as an internal standard, unless otherwise indicated. 
b>90% of ketone 263 was recovered in reaction with 1 equivalent of BSA. 
 
Removal of the TBS group in 267 with 10% aqueous hydrofluoric acid in acetonitrile led 
to elimination and ketal deprotected products (Scheme 2-36). Alternatively, treating 267 with 
HFᐧEt3N cleanly produced the desired alcohol (R)-268 in excellent yield (93%). In further 
improvements, both Noyori ketalization and TBS deprotection of ketone 263 were achieved in a 
one-pot process to give (R)-268 in excellent yield (88%). The enantiopurity of (R)-268 (97% ee) 
was determined by HPLC after conversion to the corresponding benzoate ester 269. Alcohol (R)-
268 was successfully oxidized to the desired aldehyde (R)-159 in good yield (91%) using DMP. 
It is noteworthy that only two chromatographic purifications were required to prepare enantiopure 
aldehyde (R)-159 starting from commercially available propanal.xxi Aldehyde (R)-159 was not 
stable and racemized upon storage. Consequently, (R)-268 was treated with DMP and, following 
an aqueous work up, the resulting aldehyde (R)-159 was used without purification in one-pot 
stereoselective bisaldol reactions. 
                                                        
xxi ketone 263 and alcohol 268 were purified. 
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Scheme 2-36: Preparation of enantiopure aldehyde (+)-(R)-159. 
 
2.8.5. One-pot stereoselective bisaldol reactions of meso-(Z,Z)-bisenol borinate 222 with 
aldehydes (+)-128 and (R)-(+)-159 
Under optimized conditions, an aldol reaction of freshly prepared aldehyde (R)-(+)-159 
with the intermediate aldolate-enolate 259, generated as described previously, gave a 21:3:1 
mixture of bisaldol adducts 252ssa, 252ass (tentative), and 252sss, respectively, in 63% yield 
(Scheme 2-37). Although the minor adduct 252ass (from a mismatched reaction of 259 with (+)-
(R)-159) was not fully characterized, careful analysis of 1D and 2D NMR spectral data of the 
mixture suggested the adduct 252ass has 6,8-anti-8,9-syn-9,10-syn relative configuration. The 
presence of 252sss arises from reaction of 259 with (S)-enantiomer of aldehyde 159 suggesting 



































(ca. 24:1, R:S) during its preparation. The above 21:3:1 mixture was carried forward in the 
synthesis of precursor 174 without any further purification. A small sample of the mixture was 
fractionated twice by PTLC to obtain pure (ca. 95%) 252ssa. Overall, by replacing the racemic 
159 with enantioenriched (+)-(R)-159 in reaction with the enolate 259, the yield of 252ssa was 
improved (63% of 21:3:1 mixture; i.e., ca. 53% of 252ssa) in this one-pot stereoselective bisaldol 
reaction. 
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(enolization conc. 0.32M)
249, 0 oC, 1 h, then, 

















2.8.6. Synthesis of the putative contiguous precursor 174 
The bisaldol 252ssa (Scheme 2-37) has the desired carbon skeleton and stereochemical 
configuration for the synthesis of putative precursor 174. The adduct 252ssa was subjected to 
FeCl3ᐧ6H2O in acetone to remove the ketal group at C2′′ (Scheme 2-38). Both ketal (at C2′′) and 
Et3Si group (at C5) were removed under these conditions to give undesired trione-triol 270, which 
presented a significant challenge for selective oxidation at C1. Before attempting selective 
oxidation at C1, it was advisable to assess the relative reactivity of three hydroxy groups at C9, 
C5 and C1. Toward that end, silylation of the trione-triol 270 was considered in hope to recover 
the 252ssa after desilylation of the corresponding undesired silylated products. If the C1-OH was 
more reactive than other two OH’s, then 270 would be suitable for selective oxidation at C1; 
however, if the C5-OH and C9-OH groups were more reactive than the C1-OH, then it might be 
possible to silylate the C5-OH and C9-OH groups before proceeding to oxidation of the C1-OH.  
Accordingly, reaction of trione-triol 270 with one equivalent of Et3SiCl and imidazole 
gave the silylated products 271a (34%) and 271b (13%) along with recovered 270 (44%), 
suggesting the C5-OH is the most reactive among three hydroxy groups (Scheme 2-38). Using 
two equivalents of Et3SiCl, produced 1.8:1.6:1.1:1 mixture of Et3Si protected products 271e, 
271d, 271c and 271a, respectively.xxii The bis-Et3Si protected product 271d (at C5 and C9) (29%) 
is the desired compound for oxidation at C1. The trione-triol 270 was regenerated after treating 
all the undesired mixture of Et3Si protected products 271e, 271c and 271a with FeCl3·6H2O. 
Although successful, this silyl protection-deprotection cycle was a laborious process to obtain 
271d in reasonable yield (e.g., >70%) from 270. Thus, an alternative route that included a selective 
oxidation at C1 of bisaldol 252ssa was considered. 
                                                        
xxii Structures of all the silylated products were tentatively assigned by NMR data. 
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Scheme 2-38: Ketal and Et3Si- deprotections of 252ssa; selective silylation of trione-triol 270. 
Oxidation of 252ssa with IBX in DMSO (Table 2-13, entry 1) generated a mixture of 
trione and tetrone products, suggesting that oxidation of the hydroxy groups at C1 and C9 was not 
selective under these conditions. Interestingly, DMP oxidation of 252ssa gave the desired product 
272 in low yield (33%) (entry 2). The three acetoxy groups on iodine makes DMP sterically 
bulkier than IBX. Based on this result, it was hypothesized that if the chemoselectivity of 
oxidation of 252ssa was improved with DMP compared to IBX, then increasing the steric 
bulkiness on DMP could improve selectivity further. Dess-Martin reported addition of a small 
amount of alcohols or water improved reactivity of DMP by replacing one of the acetoxy groups 
with an electron donating group (e.g., -OH, -OR).84 Thus, DMP was treated with tert-butanol to 
generate bulkier and more reactive oxidant than DMP,84,114 before addition of 252ssa. As hoped, 
under these conditions a chemoselective oxidation of the C1-OH group in 252ssa proceeded to 
give the desired trione 272 (76% by 1H NMR; 68% isolated yield) as a 1:2:5 mixture of enol and 












































271a; R, R′′ = H; R′ = Et3Si
271b; R, R′ = H; R′′ = Et3Si
271c; R = H; R′, R′′ = Et3Si
271d; R′′ = H; R, R′ = Et3Si
271e; R, R′, R′′ = Et3Si
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Table 2-13: Chemoselective oxidation of 252ssa. 
 
entry oxidation conditions products (mole fractions)a 
 272 273 274 252ssa 
1 IBX, DMSO, 16 h 0.14 0.1 0.23 0.53 
2 DMPb, pyridine, 
CH2Cl2, 0 oC, 20 min 
0.33 0.05 0.11 0.51 
3 DMPb, pyridine, 
CH2Cl2, t-BuOH, 0 oC, 20 min 
0.39 ------ 0.06 0.55 
4 DMPc, pyridine, 
CH2Cl2, t-BuOH, 0 oC, 60 min 
0.76d ------ 0.18 0.06 
aDetermined from 1H NMR spectra, unless otherwise indicated. b1.2 equivalents of DMP was used. c1.5 equivalents 
of DMP was used. d68% isolated yield. 
The remaining steps to obtain the putative precursor 174 were deprotections of 272. 

























































elimination product 279xxiii (Scheme 2-39). The enone 276 presumably resulted from FeCl3ᐧ6H2O 
catalyzed hemiacetal formation (C5-OH➔C1-carbonyl) from tetrone 275, followed by 
dehydration. After considerable experimentation, addition of FeCl3ᐧ6H2O at 0 oC and quenching 
the reaction with saturated NaHCO3 solution, suppressed the undesired elimination reaction and 
produced the desired product 275 in excellent yield (91%) as a 1:1:2 mixture of enol and two keto 
tautomers, respectively. 
 
Scheme 2-39: Ketal and Et3Si- deprotections of trione 272 with FeCl3ᐧ6H2O. 
The remaining steps for the synthesis of putative precursor 174 from 275 were removal of 
the benzylidene protecting group and desulfurization (Scheme 2-40). A reaction of 275 with 
Raney-Ni under hydrogen atmosphere (previously established conditions desulfurization and 
benzylidene hydrogenolysis) gave a complex mixture with low mass recovery. An alternative bis-
silyl protected derivative 277 was prepared in excellent yield (98%) and was subjected to the 
identical hydrogenation conditions (Raney Ni, H2) to give the desired product 278 (71%) as a 2:1 
mixture of hemiacetals (epimeric at C12). Final Et3Si-deprotections from 278 with TAS-F 
                                                        
xxiii Structure was assigned tentatively based on NMR data. 





























produced the putative precursor 174 in good yield (74%). The precursor 174 predominantly 
existed as 3.5:1 mixture of hemiacetals in C6D6 solution.  
 
Scheme 2-40: Synthesis of putative precursor 174 from tetrone 275. 
 
2.8.7. Regioselective retro-Claisen rearrangement of the putative precursor 174 to 
dolabriferol C 
Having the putative precursor 174a in hand, the main objective of this research (i.e., retro-
Claisen rearrangement of 174 to dolabriferol C) and the final transformation in this synthesis was 
tested (Scheme 2-41). Based on previous results from the dolabriferol synthesis,17 it was known 
that DBU induced retro-Claisen rearrangement of the putative precursor 32 occurred non-
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TAS-F
DMF, 74%
17 ➔ 13 
hemiacetal
17 ➔ 13 
hemiacetal
174a (3.5:1, hemiacetals) 278a, 278b 
(2:1, hemiacetals, epimeric at C-12)
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precursor 32 to dolabriferol via a highly regioselective retro-Claisen rearrangement. Thus, 
following these known conditions, a solution of the precursor 174a in benzene was applied to a 
column of neutral alumina, and after 20 minutes was eluted with ethyl acetate to afford 
dolabriferol C (17) in good yield (75%). The spectroscopic data (MS, 1H and 13C NMR) for the 
synthetic dolabriferol C ([α]D –38 (c 0.5, CHCl3) fully matched with those reported by Rodriguez 
et al ([α]D –45.2 (c 0.7, CHCl3) (Tables 2-14 and 2-15).8 This highly regioselective rearrangement 
clearly demonstrates that the putative contiguous precursor 174 can undergo retro-Claisen 
rearrangement under mild conditions during isolation to give the non-contiguous natural product, 
dolabriferol C (17). 
 
Scheme 2-41: Regioselective retro-Claisen rearrangement of the putative precursor 174 to 















































174a (3.5:1, 17➔13 hemiacetal)
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(J’s in Hz) 
5.24 dd (2.5, 2.5) HC-21 5.24 dd (2.8, 2.6) 
4.19 ddd (5, 7, 7) HC-6 4.19 dt (7, 5.2) 
4.06 d (11.5) HOC-12 4.04 br d (11.4) 
4.00 d (1.5) HOC-18 3.97 br s 
3.68 dd (2, 10.5) HC-24 3.68 dd (2.3, 10.6) 
3.64 ddd (3, 10, 11.5) HC-12 3.64 ddd (3.0, 10.0, 
11.4) 
3.25 d (7) HOC-6 3.25 br d (7.0) 
3.05 dq (10, 7) HC-10 3.05 dq (10.0, 6.9) 
2.88 dq (5, 7) HC-7 2.88 dq (6.9, 5.2) 
2.85 dq (7, 7) HC-4 2.85 dq (7.3, 5.2) 
2.77 dq (3, 7) HC-13 2.78 dq (7.2, 3.0) 
2.60-
2.50 
m H2C-2 2.55 m 
1.92 ddq (1.5, 2.5, 7) HC-19 1.92 dq (7.1, 2.8) 





1.76 (HC-22) ddd (10.6, 6.9, 
2.6) 
1.72 (HC-16) m 
1.37 d (7) H3C-14 1.37 d (7.2) 
1.10 d (7) H3C-8, H3C-5 1.10 (H3C-8) d (6.9) 
1.09 (H3C-5) d (7.3) 
1.06 d (7) H3C-20 1.06 d (7.1) 
1.01 ap d (7) H3C-26 1.01 d (6.8) 
1.00 t (7) H3C-1 1.00 t (7.3) 
0.97 t (7) H3C-17 0.97 t (7.4) 
0.84 d (7) H3C-27   
0.78 d (7) H3C-23 0.78 d (6.9) 
 
 127 
Table 2-15: 13C NMR (CDCl3) comparison of synthetic and natural dolabriferol C (17) 
synthetic assignment natural 
δC (125 MHz) δC (125 MHz) 
218.3 C-3 218.2 
216.6 C-9 216.6 
173.8 C-15 173.8 
98.4 C-18 98.4 
76.8 C-12 76.8 
76.6 C-21 76.6 
72.4 C-24 72.4 
72.0 C-6 72 
50.4 C-7 50.3 
49.8 C-10 49.8 
47.0 C-4 47 
43.2 C-13 43.2 
39.2 C-19 39.2 
36.7 C-22 36.7 
36.6 C-2 36.6 
32.7 C-16 32.8 
27.9 C-25 27.9 
20.2 C-26 20.2 
16.3 C-14 16.3 
14.4 C-11 14.3 
14.3 C-5 14.2 
14.0 C-27 14 
13.1 C-20 13.1 
12.9 C-23 12.9 
9.3 C-8 9.3 
7.3 C-1 7.3 
7.2 C-17 7.2 
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2.9. Structure Determination 
 
This structure determination section is divided into five main parts: 1) assignment by X-
ray crystallography; 2) assignment by chemical correlation (e.g., desulfurization) to the known 
compounds; 3) assignment by NMR analysis of derivatives (e.g., reduction and acetonide 
formation); 4) assignment based on comparison of NMR data with a database; v) assignment by 
analogy. 
 
2.9.1. Assignment by X-ray crystallography 
Meso bisaldol 230: 
The structure of meso bisaldol 230 was confirmed unambiguously by X-ray 
















Figure 2-1: Ellipsoid plot of 230. 
 
Meso bisaldol 237: 
The structure of meso bisaldol 237 was confirmed unambiguously by X-ray 
















Figure2-2: Ellipsoid plot of 237. 
 
Monoaldol 253: 




















Figure 2-3: Ellipsoid plot of 253. 
 
2.9.2. Assignment by correlation to known compounds 
Meso bisaldol 232: 
The structure of 10 was established by its correlation to the known 230 via desulfurization 
(Figure 2-4). 
 





























Meso bisaldol 236: 
The structure of 236 was established by its correlation to the known 237 via desulfurization 
(Figure 2-5). 
 
Figure 2-5: Desulfurization of 236 to the known 237. 
 
Meso bisaldol 241: 
The structure of 241 was established by its correlation to the known 232 via desulfurization 
(Figure 2-6). 
 
Figure 2-6: Desulfurization of 241 to the known 232. 
 
Meso bisaldol 243: 
























































Figure 2-7: Desulfurization of 243 to the known 237. 
 
2.9.3. Assignment via NMR analysis of derivatives 
General procedure for assignment of NMR spectra of bisacetonides 280a and 282a: 
Analysis of the 1H and 13C NMR data for acetonides 280a and 282a allowed assignment 
of each 1H and 13C signal and enabled assignment of the relative configurations of 280a and 282a 
and thus, of the precursor bisaldols 212 and 223. No attempt was made to distinguish between 
diastereotopic protons or carbons. 
Two-dimensional HH COSY data allowed assignment of all the hydrogens in the spin 
system spanning from (H3C)2CH-HC6′′′ to HC4(H3C)2. The COSY correlation of the HO- proton 
to HC-3 allowed the correct alignment of this otherwise symmetrical spin system. The attached 
carbons were assigned by analysis of a two-dimensional 1JCH correlation spectrum (e.g., gHSQC). 
The quaternary carbons C2′ and C2′′′ are easily distinguished by their chemical shifts (ca. 110 
ppm) and were assigned by reference to the appropriate 3JCH correlations (i.e., 3JC2′′′-HC6′′′, 3JC2′′′-
HC4′′′, 3JC2′-HC6′ and 3JC2′-HC4′) observed in the HMBC spectrum as shown in Figure 2-8. The methyl 
groups attached to C2′ and C2′′ were identified based on 2JH-C correlations in the HMBC spectrum. 



























Figure 2-8: Key HMBC correlations (H➝C) in chiral bis-acetonides 280a and 282a. 
The 1,3-relative configuration of acetonides of syn- and anti-1,3 diols can be readily 
determined using 13C chemical shifts of acetal carbon (e.g., C2′ of 1b) and acetal methyl groups.115 
In general, the acetal carbon (C2′) of the ‘syn-1,3 acetonides’ appears at <99.5 ppm (98-99.5 ppm) 
and the acetal methyls are near 19 and 30 ppm (Δ𝞭C = >9 ppm); while the ‘anti-1,3 acetonides’ 
have the acetal carbon (C2′) at >100.5 ppm (100.5-102 ppm) and the acetal methyls at around 23 
and 25 ppm (Δ𝞭C = <5 ppm).  
 
Assignment of the relative configuration of Meso bisaldol 212: 
The bisaldol 212 is symmetric (Cs) as indicated by the presence of 12 signals in the 13C 
NMR spectrum (Figure 2-9). Hydroxy-directed 1,3-syn selective reduction of 212 afforded the 
meso tetrol 279 (70% isolated yield) that upon treatment with 2,2-dimethoxypropane and p-
toluenesulfonic acid in acetone, was converted to a separable mixture of acetonides 280a (33%), 
280b (21%) and 280c (25%). The number of carbon resonances in the respective 13C NMR spectra 
indicated that 280b and 280c are symmetric and 280a is asymmetric. Analysis of the NMR data 
for 280a (derived from a meso tetrol) allowed assignment of its relative configuration thereby 
establishing the relative configuration of the precursor 212.  












Figure 2-9: Structure determination of 212 via conversion to the acetonide 280a. 
The C4′′′-C6′′′ and C4′-C6′ relative configurations of the bis-acetonide 280a were assigned 
based on the 13C NMR chemical shifts of C2′ (97.6 ppm à 4′,6′-syn), C2′′′ (98.0 ppm à 4′′′,6′′′-
syn), the C2′-Me’s (19.1 ppm and 30.0 ppm à 4′,6′-syn) and the C2′′′-Me’s (19.6 ppm and 30.5 



























meso bis-acetonide (280b) (21%)
O OH O OO
OMeMeO
Et2BOMe, NaBH4
THF, MeOH (4:1), 
−78 oC




12 !C (∴ Cs symmetric) 12 !C (∴ Cs symmetric)
!C2′ = 97.6 and Me’s at C2′ 
@ !C 19.1 and 30 (∴ 4′,6′-syn)
13 !C (∴ Cs symmetric)
6′′′ 4′′′ 6′
4′
3JH6′′′-5′′′  = 10.5 Hz (∴ 5′′′,6′′′-trans)
3JH4′′′-5′′′  = 10.5 Hz (∴ 4′′′,5′′′-trans)
3JH6′-5′  = 10.5 Hz (∴ 5′,6′-trans)
3JH4′-5′  = 10.5 Hz (∴ 4′,5′-trans)
!C2′′ = 98 and Me’s at C2′′ 















meso bis-acetonide (280c) (35 %)
15 !C (∴ Cs symmetric)
OH
R  =
PPTS = pyridinium p-toluenesulfonate
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C5′-C4′ of bis-acetonide 280a were assigned based on the 1H NMR coupling constants: 3JH5′′′-H6′′′ 
(10.5 Hz), 3JH4′′′-H5′′′ (10.5 Hz), 3JH5′-H6′ (10.5 Hz) and 3JH4′-H5′ (10.5 Hz). These large J-values 
clearly indicate that the coupled hydrogens are in trans diaxial relationships (i.e., anti-relation) 
establishing a 5′′′,6′′′-anti-4′′′,5′′′-anti-5′,6′-anti-4′,5′-anti relative configuration. Because 279 is 
meso (as are 280b and 280c) the C3-C6′′′, C2-C5′′′, C4′-C4′′′, and C5′-C1′′ relative configurations 
in 280a must be syn. Thus, the relative configurations of 280a is 2,3-anti-2,4′-anti-4′,5′-anti-5′,6′-
anti-6′,1′′-anti-1′′,4′′′-anti-4′′′,5′′′-anti-5′′′,6′′′-anti and that of 212 is 3,4-anti-4,6-syn-6,7-anti-7,8-
anti-8,10-syn-10,11-anti. 
 
Assignment of the relative configuration of Meso bisaldol 223: 
The bisaldol 223 is symmetric (Cs) as indicated by the presence of 12 resonances in the 13C 
NMR spectrum (Figure 2-10). Hydroxy-directed 1,3-syn selective reduction of 223 afforded the 
meso tetrol 281 (89% isolated yield) that, upon treatment with 2,2-dimethoxypropane and p-
toluenesulfonic acid in acetone, was converted to a separable mixture of acetonides 282a (38%), 
282b (40%) and 282c (9%). The numbers of carbon resonances in the respective 13C NMR spectra 
indicated that the 282b, 282c are symmetric (Cs) and 282a is asymmetric. Analysis of the NMR 
data for 282a (derived from a meso tetraol) allowed assignment of its relative configuration thereby 
establishing the relative configuration of the precursor 223.   
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Figure 2-10: Structure determination of 223 via conversion to the acetonide 282a. 
The C4′′′-C6′′′ and at C4′-C6′ relative configurations of bis-acetonide 282a were assigned 
based on the 13C NMR chemical shifts of C2′ (100.6 ppm à 4′,6′-anti), C2′′′ (99.0 ppm à 
4′′′,6′′′-syn), the C2′-Me’s (23.6 ppm and 25.8 ppm à 4′,6′-anti), and the C2′′′-Me’s (19.8 ppm 
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meso bis-acetonide (282c) (9%)
O OH O OO
12 !C (∴ Cs symmetric) 12 !C (∴ Cs symmetric)
OMeMeO PPTS acetone 
87%
Et2BOMe, NaBH4
THF, MeOH (4:1), 
−78 oC
89% (dr > 19:1)




!C2′ = 100.6 and Me’s at C2′ 
@ !C = 23.6 and 25.8 (∴ 4′,6′-anti)
!C2′′′ = 99 and Me’s at C2′′′ 
@ !C = 19.8 and 30.3 (∴ 4′′′,6′′′-syn)
4′′′
3JH6′′′-5′′′  = 2 Hz (∴ 5′′′,6′′′-cis)
3JH4′′′-5′′′  = 2 Hz (∴ 4′′′,5′′′-cis)
3JH6′-5′  = 6.5 Hz (∴ 5′,6′-trans)
















25 !C (∴ asymmetric)
13 !C (∴ Cs symmetric) 15 !C (∴ Cs symmetric)
PPTS = pyridinium p-toluenesulfonate
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C6′-C5′ and C5′-C4′ of bis-acetonide 282a were assigned based on the 1H NMR coupling 
constants of 3JH5′′′-H6′′′ (2 Hz), 3JH4′′′-H5′′′ (2 Hz), 3JH5′-H6′ (6.5 Hz) and 3JH4′-H5′ (3.5 Hz). These J-
values suggest a 5′′′,6′′′-syn-4′′′,5′′′-syn-5′,6′-anti-4′,5′-syn relative configuration. Because 281 is 
meso (as are 282b and 282c) the C3-C6′′′, C2-C5′′′, C4′-C4′′′, and C5′-C1′′ relative 
configurations in 282a must be syn. Thus, the relative configuration of 282a is 2,3-syn-2,4′-syn-
4′,5′-syn-5′,6′-anti-6′,1′′-anti-1′′,4′′′-syn-4′′′,5′′′-syn-5′′′,6′′′-syn and that of 223 is 3,4-syn-4,6-syn-
6,7-anti-7,8-anti-8,10-syn-10,11-syn. 
 
2.9.4. Assignment based on comparison of NMR data with a database 
In addition to the confirmed structures established in the previous sections, a large number 
of aldol adducts with the general structure GS1 have been established in previous work within the 
Ward group (Figure 2-11).42,66 The NMR data for these adducts of known structure generates a 
database that reveals consistent correlations of certain NMR data with the underlying relative 
configurations. Thus, comparison of the NMR data of an ‘unknown’ isomer with the database can 
provide evidence for the assignment of the relative configuration of the ‘unknown’. 
 







X = H,H or S
R = H or propionate units
GS1
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Mono aldol 231: 
Procedure for assignment of NMR spectra: 
The 1H NMR spectra of 231 can be divided in to six distinct ‘spin systems’ via analysis of 
the two-dimensional HH COSY spectrum (Figure 2-13). The Et3Si, H2C8-H3C9, and H2C2′-H2C3′ 
proton spin systems are unique and were readily assigned in the COSY spectrum; the 13C chemical 
shifts of attached carbon atoms were identified based on the relevant 1JCH correlations observed in 
the HSQC spectrum. No attempt was made to distinguish between diastereotopic protons or 
carbons in these spin systems.  
The proton signal for HC-1 was readily identified by the 3JHH correlation to the OH proton 
and two adjacent methine groups (i.e., HC-6′ and HC-2) (Figure 2-13). By analysis of the HH 
COSY spectrum and using the assigned HC-1 as an ‘anchor’ all the hydrogens in the spin system 
(i.e, HC-7′, HC-6′, HC-1, HC-2 and H3CC-2) were assigned. With the aid of these assigned 
protons, the chemical shifts of the attached carbons were assigned by analysis of a two-dimensional 
1JCH correlation spectrum (e.g., gHSQC). Among the carbonyl carbons, C3 is readily distinguished 
by 2JCH and 3JCH correlations (e.g., HMBC) to the HC-2 and CH3C-2, respectively (Figure 2-12). 
The HC-4 and CH3C-4 were assigned by 2JCH and 3JCH correlations to C3, respectively, observed 
in the HMBC spectrum. By analysis of the HH COSY spectrum and using the assigned HC-4 as 
an ‘anchor’ all the hydrogens in the spin system (i.e., H3CC-4, HC-5, HC-6 and H3CC-6) were 
assigned. Although the assignment of C7 can be inferred after the assignment of the other carbonyl 
C3, the 2JC7-HC6 and 3JC7-CH3C6 correlations observed in the HMBC spectrum is additional evidence 
to support this assignment. Among the methylene protons, H2C-8 is unique and was assigned using 
chemical shift and multiplicity; this assignment was further supported by 2JC7-HC8 and 3JC7-HC9 
correlations, observed in the HMBC spectrum. The methylene carbon C-9′ was assigned based on 
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3JC9-HC7′ correlation, observed in the HMBC spectrum. The H2C-9′ protons were assigned by 
analysis of 1JCH correlation spectrum (gHSQC) and also based on a long-range W-coupling (4JH9′-
7′; 1 Hz) with the assigned HC-7′; thus H2C-10′ was assigned by 3JH9′-H10′ correlation observed in 
the COSY spectrum. The quaternary carbon C5′ is unique and was readily distinguished in the 13C 
NMR spectrum on the basis of the chemical shift (𝞭C C5′ = 110.4) 
 
Figure 2-12: Key HMBC correlations (H➝C) in monoaldol 231. 
Assignment of the relative configuration of 231: 
NMR analysis of the known3 four diastereomers of 283 revealed consistent trends that 
allowed assignment of the relative configurations in 231 (Figure 2-13 & Table 2-16). The 6′,1-syn 
diastereomers (i.e., 283as and 283ss) consistently had lower 3JH6′-H1 (2-3 Hz) and 13C chemical 
shifts for C7′ (𝞭C 26-26.9) and higher 3JH1-H2 (7.5-9 Hz) values compared to those of the 6′,1-anti 
diastereomers (283aa and 283sa). Similarly, the 1,2-anti diastereomers (283as and 283aa) 
consistently had higher 13C chemical shifts for C1 (𝞭C 71.8-74.6) and CH3C-2 (𝞭C 13.9-14.2) 
compared to those of the 1,2-syn diastereomers (283ss and 283sa). The diastereomer 283sa can be 
easily distinguishable by its characteristic lower 13C chemical shift for CH3C-2 (𝞭C 8.1) compared 
















The 1H and 13C NMR data of the known meso bisaldol 230 closely matches those of 283as 
suggesting the trends from database are consistent and are applicable to the assignment of the 
relative configurations in similar structures (Figure 2-13 & Table 2-16). The mono aldol 231 was 
obtained from an incomplete reaction of (E,E)-bisenol borinate 215 with aldehyde 109 suggesting 
the adduct 231 has the same relative configuration as 230 (arising from complete reaction of 215 
with 109). The 1H and 13C NMR data for 231 were compared with those of the known adducts 230 
and 283as to assign the relative configurations in 231. The coupling constants 3JH6′-H1 (1 Hz; 6′,1-
syn), 3JH1-H2 (9.5 Hz; 1,2-anti), the 13C chemical shifts of C7′ (𝞭C 25.8; 6′,1-syn), CH3C-2 (𝞭C 14.1; 
1,2-anti) and the 1H chemical shift of H3CC-2 (𝞭H 0.96; 6′,1-syn) for 231 are consistent with those 
of the known adducts 230 and 283as suggesting the relative configuration of 231 is 1,2-anti-6′,1-
syn.  The C2-C4 relative configuration in 231 was assumed as 2,4-syn by analogy to the known 
adduct 230 as both the aldols (231 and 230) are obtained from reaction of (E,E)-bis enolborinate 
215 with aldehyde 109. The relative configurations of C4-C5 and C5-C6 should be unchanged 
from the starting diketone 202aa and were already confirmed as 4,5-anti-5,6-anti from the X-ray 





Figure 2-13: Assignment of the relative configuration of 231 by NMR comparison with the 
known compounds. 







𝞭C C-6′ 𝞭C C-7′ 𝞭C C-1 𝞭C C-2 𝞭C 
CH3C-2  
283aa 7 4.5 1.21 46.5 30.0 74.6 49.4 14.2 
283ss 3 7.5 1.19 47.3 26.9 69.4 49.7 13.3 
283sa 8.5 2 1.10 46.2 29.4 70.9 48.0 8.1 
283as 2 9 0.97 46.3 26.0 71.8 47.9 13.9 
230 <1 9.5 0.96 46.6 25.8 71.7 47.2  14.1  












3JH6′-H1 = <1 Hz 
!C C7′ = 25.8 ppm 
!C C1 = 71.9 ppm
from the same (E,E)-bis enolborinate
(∴ 2,4-syn by analogy)
3JH1-H2 = 9.5 Hz





!H H3CC-2= 0.96 ppm 


























































Mono aldol 233: 
The 1H NMR spectra of 233 can be divided in to six distinct ‘spin systems’ via analysis of 
the two-dimensional HH COSY spectrum (Figure 2-15). The Et3Si, H2C10-H3C11, and H2CC2′- 
H3CCC2′ proton spin systems are unique and were readily assigned in the COSY spectrum; the 
13C chemical shifts of the attached carbon atoms were identified based on the relevant 1JCH 
correlations observed in the HSQC spectrum. No attempt was made to distinguish between 
diastereotopic protons or carbons in these spin systems. 
The proton signal for HC-3 was readily identified by the 3JHH correlation to the OH proton 
and two adjacent methine groups (i.e., HC-2 and HC-4) (Figure 2-15). By analysis of the HH 
COSY spectrum and using the assigned HC-3 as an ‘anchor’ all the hydrogens in the spin system 
(i.e, HC-1, HC-2, HC-4 and H3CC-4) were assigned. With the aid of these assigned protons, the 
chemical shifts of the attached carbons were assigned by analysis of a two-dimensional 1JCH 
correlation spectrum (e.g., gHSQC). Among the carbonyl carbons, C5 is readily distinguished by 
2JC5-HC4 and 3JC5-H3CC4 correlations observed in the HMBC spectrum (Figure 2-14). The HC-6 and 
CH3C-6 were assigned by 2JC5-HC6 and 3JC5-H3CC6 correlations, respectively, observed in the HMBC 
spectrum. By analysis of the HH COSY spectrum and using the assigned HC-6 as an ‘anchor’ all 
the hydrogens in the spin system (i.e., H3CC-6, HC-7, HC-8 and H3CC-8) were assigned. Although 
the assignment of C9 can be inferred after the assignment of the other carbonyl C5, the 2JC9-HC8 
and 3JC9-CH3C8 correlations observed in HMBC spectrum is additional evidence to support this 
assignment. The quaternary carbon C2′ is unique and was readily distinguished in 13C NMR 
spectrum on the basis of the chemical shift (𝞭C C2′ = 114.7). Among the methylene protons, H2C-
10 was assigned by 2JC9-HC10 and 3JC9-HC11 correlations; H2CC2′ was assigned by 2JC2′-H2CC2′ and 




Figure 2-14: Key HMBC correlations (H➝C) in monoaldol 233. 
Assignment of the relative configuration of 233: 
NMR analysis of the known42 four diastereomers of 130 revealed consistent trends that 
allowed assignment of the relative configurations in 233 (Figure 2-15 & Table 2-17). The 2,3-syn 
diastereomers (i.e., 130as and 130ss) consistently had lower 3JH2-H3 (1 Hz), 1H chemical shift of 
H3CC-4 (𝞭H 0.94-1.24), 13C chemical shift of C1 (𝞭C 6.9-7.4), C2 (𝞭C 38.5-39.9)  and higher 3JH3-
H4 (9-9.5 Hz), 13C chemical shift of CH2C-2′ (𝞭C 28.1-28.2), CH3CC-2′ (𝞭C 8.2-8.3)  values 
compared to those of the 2,3-anti diastereomers (130aa and 130sa). Similarly, the 3,4-anti 
diastereomers (130aa and 130as) consistently had higher 13C chemical shift of C3 (𝞭C 73.4-76.1) 
compared to those of the 3,4-syn diastereomers (130ss and 130sa). The diastereomer 130sa can be 
easily distinguishable by its characteristic lower 13C chemical shift of CH3C-2 (𝞭C 8.0) compared 
to the other three diastereomers (𝞭C 13.7-14.9). 
The 1H and the 13C NMR data of the known meso bisaldol 232 closely matches those of 
130as suggesting the trends from database are consistent and are applicable to the assignment of 
the relative configurations in similar structures (Figure 2-15 & Table 2-17). The mono aldol 233 
was obtained from an incomplete reaction of (E,E)-bis enolborinate 215 with aldehyde 159 
suggesting the adduct 233 has the same C4-C6 relative configuration as 232 (arising from complete 
reaction of 215 with 159). The coupling constants 3JH2-H3 (<1 Hz; 2,3-syn) and 3JH3-H4 (10 Hz; 3,4-
anti), the 13C chemical shifts of C1 (𝞭C 6.6; 2,3-syn), C2 (𝞭C 38.4; 2,3-syn), CH2C-2′ (𝞭C 28.3; 2,3-














are consistent with those of the known adducts 232 and 130as suggesting the relative configuration 
of 233 is 2,3-syn-3,4-anti. The C4-C6 relative configuration in 233 was assumed as 4,6-syn by 
analogy to the known adduct 232 as both the aldols (232 and 233) are obtained from reaction of 
(E,E)-bis enolborinate 215 with aldehyde 159. The relative configurations of C6-C7 and C7-C8 
should be unchanged from the starting diketone 202aa and were already confirmed as 6,7-anti-
7,8-anti from the known structure of 232. Thus, the relative configuration of 233 was assigned as 
2,3-syn-3,4-anti-4,6-syn-6,7-anti-7,8-anti.   
 
Figure 2-15: Assignment of the relative configuration of 233 by NMR comparison with the 
known compounds. 









3JH2-H3 = <1 Hz (∴ 2,3-syn)
3JH3-H4 = 10 Hz (∴ 3,4-anti)
!C C1 = 6.6 ppm
!C C2 = 38.4 ppm 
!C C3 = 73.3 ppm
(∴ 2,3-syn)
!C CH3C-4 = 13.8 ppm
!C CH2C-2′ = 28.3 ppm






from the same (E,E)-bis enolborinate




































































130aa 8.5 3.5 1.24 13.1 42.0 76.1 49.7 14.5 26.0 7.1 
130ss 1 9 1.21 7.4 39.9 71.6 50.2 14.9 28.1 8.2 
130sa 9.5 2.5 1.06 12.8 41.4 73.0 49.1 8.0 25.7 7.0 
130as <1 9.5 0.94 6.9 38.5 73.4 48.7 13.7 28.2 8.3 
232 <1 9.5 0.91 6.7 38.8 73.1 48.0  13.8  28.2 8.2 
233 <1 10 0.91 6.6 38.4 73.3 47.1 13.8 28.3 8.3 
 
 
Mono aldol 214: 
Procedure for assignment of NMR spectra: 
The 1H NMR spectra of 214 can be divided in to four distinct ‘spin systems’ from analysis 
of its two-dimensional HH COSY NMR spectrum (Figure 2-17). The Et3Si and H2C10-H3C11 
proton spin systems are unique and were readily assigned in the COSY spectrum; the 13C chemical 
shifts of attached carbon atoms were identified based on the relevant 1JCH correlations observed in 
the HSQC spectrum. No attempt was made to distinguish between diastereotopic protons or 
carbons in these spin systems. 
The proton signal for HC-3 is readily differentiated by the 3JHH correlation to the OH group 
and two adjacent methine groups (i.e., HC-2 and HC-4) (Figure 2-17). By analysis of the HH 
COSY spectrum and using the assigned HC-3 as an ‘anchor’ all the hydrogens in the spin system 
(i.e, HC-1, HC-1′, HC-2, HC-4 and H3CC-4) were assigned. With the aid of these assigned protons, 
the attached carbons were assigned by analysis of the two-dimensional 1JCH correlation spectrum 
(gHSQC). Among the carbonyl carbons, C5 is readily distinguishable by 2JC5-HC4 and 3JC5-CH3C4 
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correlations observed in the HMBC spectrum (Figure 2-16). The HC-6 and H3CC-6 were assigned 
from 2JC5-HC6 and 3JC5-CH3C6 correlations, respectively, observed in the HMBC spectrum. By 
analysis of the HH COSY spectrum and using the assigned HC-6 as an ‘anchor’ all the hydrogens 
in the spin system (i.e, H3CC-6, HC-7, HC-8 and H3CC-8) were assigned. Although the assignment 
of C9 can be inferred after the assignment of the other carbonyl at C5, the 2JC9-HC8 and 3JC9-CH3C8 
correlations observed in HMBC spectrum is additional evidence to support this assignment. The 
methylene protons H2C-10 are unique and were assigned using 1H chemical shift and multiplicity 
and this assignment was further supported by 2JC9-HC10 correlations observed in the HMBC 
spectrum. 
 
Figure 2-16: Key HMBC correlations (H➝C) in monoaldol 214. 
Assignment of the relative configuration of 214: 
NMR analysis of the known42 13 diastereomers of 200 revealed consistent trends that 
allowed assignment of relative configurations in 214 (Figure 2-17, Table 2-18). Comparison of the 
coupling constants (3JH2-H3, 3JH3-H4), 13C chemical shifts (𝞭C CH3C-4), differences in 13C chemical 
shifts (Δ𝞭C (C1, C1′), Δ𝞭C (C2, C4) and Δ𝞭C (C3, CH3C-4)] values between 13 diastereomers of 
200, 212 and 214 allowed assignment of the relative configuration at C3-C4 and C4-C6 in 214. 
The 3,4-anti diastereomers (200aa and 200sa) consistently had lower 3JH2-H3 (3.9-5 Hz), Δ𝞭C [C3, 
CH3C-4] (63.6-64.6 ppm) and higher 3JH3-H4 (7-7.9 Hz), Δ𝞭C [C1, C1′] (4.2-5.3 ppm), Δ𝞭C [C2, 
C4] (17.8-19.7 ppm), 𝞭C CH3C-4 (14.3 ppm) values compared to those of the 3,4-syn diastereomers 












the 13C NMR data of the 4,6-syn diastereomers with those of the corresponding 4,6-anti 
diastereomers (i.e., ss vs. as and sa vs. aa). The 4,6-syn diastereomers consistently had higher Δ𝞭C 
[C1, C1′], Δ𝞭C [C2, C4] and lower Δ𝞭C (C3, CH3C-4) values compared to those of the 
corresponding 4,6-anti diastereomers (Table 2-18). 
The 1H and 13C NMR data of the known meso bisaldol 212 closely matches those of 200as 
suggesting the trends from data base are consistent and are applicable to the assignment of the 
relative configurations of similar structures (Table 2-18). The mono aldol 214 was obtained from 
an incomplete reaction of (E,E)-bis enolborinate 215 with iPrCHO suggesting the adduct 214 has 
same C4-C6 relative configuration as meso bisaldol 212 (arising from complete reaction of 215 
with iPrCHO) (Figure 2-17). The 1H and 13C NMR data for 214 were compared with those of the 
known adducts 212 and 200sa. The coupling constants 3JH2-H3 (3.5 Hz) and 3JH3-H4 (8 Hz), the 13C 
chemical shift of CH3C-4 (𝞭C 14.0) and the difference in 13C chemical shifts (Δ𝞭C [C1, C1′] = 5.7; 
Δ𝞭C [C2, C4] = 19.5; Δ𝞭C [C3, CH3C-4] = 64.3) for 214 are consistent with the observed trends 
from the database and with those of the known adducts 212 and 200sa suggesting the relative 
configuration of 214 is 3,4-anti-4,6-syn (Table 2-18). The relative configurations of C6-C7 and 
C7-C8 should be unchanged from the starting diketone 202aa and were already confirmed as 6,7-





Figure 2-17: Assignment of the relative configuration of 214 by NMR comparison with the 
known compounds. 
Table 2-18: Comparison of the selected NMR data of 214 with those of the known 212 and 200. 
adduct 3JH2-H3 (Hz) 3JH3-H4 (Hz) Δ𝞭C 
(C1,C1′) 




200as 8.8 1.9 0.6 15.8 68.2 8.5 
200ss 9.4 1.4 1.0 16.7 67.1 9.0 
200aa 5 7 4.2 17.8 64.6 14.3 
200sa 3.9 7.9 5.3 19.7 63.6 14.3 
212 3.5 7 5.6 19.3 64.0 14.2 














3JH2-H3 = 3.5 Hz
3JH3-H4 = 8 Hz
!C CH3C-4 = 14.0 ppm 
Δ!C C1, C1′ = 5.7 ppm
Δ!C C2, C4 = 19.5 ppm 





















































The adduct 217 is Cs-symmetric as indicated by the presence of 12 resonances in the 13C 
NMR spectrum (Figure 2-18). NMR spectra of 217 was assigned by following the identical 
procedure used for 214. 
Assignment of the relative configuration of 217: 
Similar to the assignment of 214, comparison of the coupling constants (3JH2-H3, 3JH3-H4), 
13C chemical shifts (𝞭C CH3C-4), difference in 13C chemical shifts (Δ𝞭C [C1, C1′, Δ𝞭C [C2, C4] 
and Δ𝞭C [C3, CH3C-4]) values between the known 13 diastereomers of 200, 212 and 217 allowed 
assignment of the relative configuration at C3-C4 and C4-C6 in 217 (for detailed discussion, refer 
to the assignment of 214) (Figure 2-17). The bisaldol 217 was obtained from the identical reaction 
conditions (i.e., from (E,E)-bis enolborinate 215 with iPrCHO) as 212, suggesting the adduct 217 
has same C4-C6 relative configuration as 212. The coupling constants 3JH2-H3 (4.0 Hz) and 3JH3-H4 
(7.0 Hz), the 13C chemical shift of CH3C-4 (𝞭C 14.5), and the difference in the 13C chemical shifts 
(Δ𝞭C [C1, C1′] = 5.0; Δ𝞭C [C2, C4] = 18.7; Δ𝞭C [C3, CH3C-4] = 64.0) for 217 are consistent with 
the observed trends from the database and with those of the known adducts 212 and 200sa 
suggesting the relative configuration of 217 is 3,4-anti-4,6-syn (Table 2-19). The relative 
configurations of C6-C7 and C7-C8 should be unchanged from the starting diketone 202ss and 
were already confirmed as 6,7-syn-7,8-syn from the known 237. Because 217 is meso, the C3-C11, 
C4-C10 and C6-C8 relative configurations in 217 must be syn. Thus, the relative configuration of 




Figure 2-18: Assignment of the relative configuration of 217 by NMR comparison with the 
known compounds. 
Table 2-19: Comparison of the selected NMR data of 217 with those of the known 212 and 200. 
adduct 3JH2-H3 (Hz) 3JH3-H4 (Hz) Δ𝞭C 
(C1,C1′) 




200as 8.8 1.9 0.6 15.8 68.2 8.5 
200ss 9.4 1.4 1.0 16.7 67.1 9.0 
200aa 5 7 4.2 17.8 64.6 14.3 
200sa 3.9 7.9 5.3 19.7 63.6 14.3 
212 3.5 7 5.6 19.3 64.0 14.2 
217 4.0 7 5.0 18.7 64.0 14.5 
 
Chiral-bisaldol 213: 
The bisaldol 213 is asymmetric as indicated by the presence of 21 resonances in the 13C 










3JH2-H3 = 4 Hz
3JH3-H4 = 7 Hz
!C CH3C-4 = 14.5 ppm 
Δ!C C1, C1′ = 5.0 ppm
Δ!C C2, C4 = 18.7 ppm 
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analysis of its two-dimensional HH COSY NMR spectrum. The Et3Si proton spin system is unique 
and was readily assigned in the COSY spectrum; the 13C chemical shifts of attached carbon atoms 
were identified based on the relevant 1JCH correlations observed in the HSQC spectrum. No attempt 
was made to distinguish between diastereotopic protons or carbons in this spin system. 
 
Figure 2-19: Key HMBC correlations (H➝C) in bisaldol 213. 
Comparison of the NMR data for the known 13 diastereomers of 200, 212 and 213 allowed 
assignment of the structure of 213 (Figure 2-20). To simplify the assignment, each spin system 
was analyzed and compared individually with the known compounds. The carbinol proton signals 
for “spin systems” ‘A’ and ‘B’ (i.e., HC-3 and HC-11) are readily differentiated by the 3JHH 
correlations to the OH protons and two adjacent methine groups (i.e., HC-2, HC-4 and HC-10, 
HC-12). By analysis of the HH COSY spectrum and using the assigned HC-3 and HC-11 as 
‘anchors’ all the hydrogens in the spin systems A and B (i.e, HC-1, HC-1′, HC-2, HC-4, H3CC-4 
and H3CC-10, HC-10, HC-12, HC-13′, HC-13) were assigned. The coupling constants 3JH2-H3 (3.5 
Hz) and 3JH3-H4 (7 Hz), the 13C chemical shift of CH3C-4 (𝞭C 14.2), and the differences in the 13C 
chemical shifts (Δ𝞭C [C1, C1′] = 5.6; Δ𝞭C [C2, C4] = 19.4; Δ𝞭C [C3, CH3C-4] = 63.9) for the “spin 
system-A” of 213 closely match those of the known adducts 212 and 200sa suggesting that the 
relative configuration of the “spin system-A” in 213 is 3,4-anti-4,6-syn (Table 2-20). Similarly, 
the coupling constants 3JH11-H12 (9.5 Hz) and 3JH10-H11 (1.5 Hz), the 13C chemical shift of CH3C-10 
(𝞭C 9.2), and the differences in 13C chemical shifts (Δ𝞭C [C13, C13′] = 1.0; Δ𝞭C [C10, C12] = 
















adducts 223 and 200ss suggesting the relative configuration of the “spin system-B” in 213 is 8,10-
syn-10,11-syn (Table 2-21). By analysis of the HMBC spectrum, the 2JC5-HC4, 3JC5-CH3C4, 2JC9-HC10 
and 3JC9-CH3C10 correlations allowed assignment of the carbonyls at C5 and C9. Knowing the 
chemical shifts for C5 and C9, the HC-6, H3CC-6 and HC-8, H3CC-8 protons were assigned from 
the 2JC5-HC6, 3JC5-CH3C6 and the 2JC9-HC8, 3JC9-CH3C8 correlations, respectively, observed in the HMBC 
spectrum (Figure 2-19). By analysis of the HH COSY spectrum and using the assigned HC-6 and 
HC-8 as ‘anchors’ all the hydrogens in the spin system (i.e, H3CC-6, HC-7 and H3CC-8) were 
assigned. The relative configurations at C6-C7 and C7-C8 should be unchanged from the starting 
diketone 202aa and were already confirmed as 6,7-anti-7,8-anti from the known 212. Thus, the 





Figure 2-20: Structure assignment of 213 by NMR comparison with the known compounds. 
Table 2-20: Comparison of the selected NMR data of “spin system-A” in 213 with those of the 
known 212 and 200. 







200as 8.8 1.9 0.6 15.8 68.2 8.5 
200ss 9.4 1.4 1.0 16.7 67.1 9.0 
200aa 5 7 4.2 17.8 64.6 14.3 
200sa 3.9 7.9 5.3 19.7 63.6 14.3 
212 3.5 7 5.6 19.3 64.0 14.2 
213 3.5 7 5.6 19.4 63.9 14.2 
 
21 !C (∴ asymmetric)
3JH11-H12 = 9.5 Hz
3JH10-H11 = 1.5 Hz
Δ"C C13, C13′ = 1.0 ppm
Δ"C C10, C12 = 16.7 ppm 
Δ"C C11, CH3C-10 = 66.7 ppm
"C CH3C-10 = 9.2 ppm
(∴ 8,10-syn
10,11-syn)










3JH2-H3 = 3.5 Hz
3JH3-H4 = 7 Hz
Δ"C C1, C1′ = 5.6 ppm
Δ"C C2, C4 = 19.4 ppm 
Δ"C C3, CH3C-4 = 63.9 ppm
"C CH3C-4 = 14.2 ppm
(∴ 3,4-anti
4,6-syn)
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Table 2-21: Comparison of the selected NMR data of “spin system-B” in 213 with those of the 
known 223 and 200. 












200as 8.8 1.9 0.6 15.8 68.2 8.5 
200aa 5 7 4.2 17.8 64.6 14.3 
200sa 3.9 7.9 5.3 19.7 63.6 14.3 
200ss 9.4 1.4 1.0 16.7 67.1 9.0 
223 9.5 1.5 1.0 16.7 66.7 9.2 
213 (9.5) (1.5) (1.0) (16.7) (66.7) (9.2) 
 
Meso-bisaldol 209: 
The adduct 209 is Cs-symmetric as indicated by the presence of 12 resonances in the 13C 
NMR spectrum (Figure 2-21). NMR spectra of 209 was assigned by following the identical 
procedure used for 214. 
Assignment of the relative configuration of 209: 
Similar to the assignment of 214 and 217, comparison of the coupling constants (3JH2-H3, 
3JH3-H4), 13C chemical shifts (𝞭C CH3C-4), difference in 13C chemical shifts (Δ𝞭C [C1, C1′, Δ𝞭C 
[C2, C4] and Δ𝞭C [C3, CH3C-4]) values between the known 16 diastereomers of 199, 212 and 209 
allowed assignment of the relative configuration at C3-C4 and C4-C6 in 209 (for detailed 
discussion, refer to the assignment of 214) (Figure 2-21). The bisaldol 209 was obtained from 
similar reaction conditions as 212 (i.e., from (E,E)-bis enolborinate 215 with iPrCHO), suggesting 
the adduct 209 has same C4-C6 relative configuration as 212. The coupling constants 3JH2-H3 (4.0 
Hz) and 3JH3-H4 (7.5 Hz), the 13C chemical shift of CH3C-4 (𝞭C 14.4), and the difference in the 13C 
chemical shifts (Δ𝞭C [C1, C1′] = 5.0; Δ𝞭C [C2, C4] = 19.4; Δ𝞭C [C3, CH3C-4] = 63.9) for 209 are 
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consistent with the observed trends from the database and with those of the known adducts 212 
and 199sa suggesting the relative configuration of 209 is 3,4-anti-4,6-syn (Table 2-22). The 
relative configurations of C6-C7 and C7-C8 should be unchanged from the starting diketone 202aa 
and were already confirmed as 6,7-anti-7,8-anti from the known 212. Because 209 is meso, the 
C3-C11, C4-C10 and C6-C8 relative configurations in 209 must be syn. Thus, the relative 
configuration of 209 was assigned as 3,4-anti-4,6-syn-6,7-anti-7,8-anti-8,10-syn-10,11-anti. 
 
















3JH2-H3 = 4 Hz
3JH3-H4 = 7.5 Hz
!C CH3C-4 = 14.4 ppm 
Δ!C C1, C1′ = 5.0 ppm
Δ!C C2, C4 = 19.4 ppm 
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Table 2-22: Comparison of the selected NMR data of 209 with those of the known 212 and 199. 







199as 8.9 2.1 0.53 16.3 68.3 8.5 
199ss 9.4 1.4 1.0 17.0 67.3 8.6 
199aa 4.7 6.9 4.6 18.3 64.5 14.0 
199sa 3.5 8.4 5.6 20.7 63.0 14.2 
212 3.5 7 5.6 19.3 64.0 14.2 
209 4.0 7.5 5.0 19.4 63.9 14.4 
 
Chiral bisaldol 210: 
The bisaldol 210 is asymmetric as indicated by the presence of 21 resonances in the 13C 
NMR spectrum. The 1H NMR spectra of 210 can be divided in to four distinct ‘spin systems’ from 
analysis of its two-dimensional HH COSY NMR spectrum. The BOM-proton spin system is 
unique and was readily assigned in the COSY spectrum; the 13C chemical shifts of attached carbon 
atoms were identified based on the relevant 1JCH correlations observed in the HSQC spectrum. No 
attempt was made to distinguish between diastereotopic protons or carbons in this spin system. 
Comparison of the NMR data for the known 16 diastereomers of 199, 212 and 210 allowed 
assignment of the structure of 219 (Figure 2-22). To simplify the assignment, each spin system 
was analyzed and compared individually with the known compounds. The carbinol proton signals 
for “spin systems” ‘A’ and ‘B’ (i.e., HC-3 and HC-11) are readily differentiated by the 3JHH 
correlations to the OH protons and two adjacent methine groups (i.e., HC-2, HC-4 and HC-10, 
HC-12). By analysis of the HH COSY spectrum and using the assigned HC-3 and HC-11 as 
‘anchors’ all the hydrogens in the spin systems A and B (i.e, HC-1, HC-1′, HC-2, HC-4, H3CC-4 
and H3CC-10, HC-10, HC-12, HC-13′, HC-13) were assigned. The coupling constants 3JH2-H3 (4 
Hz) and 3JH3-H4 (5 Hz), the 13C chemical shift of CH3C-4 (𝞭C 14.4), and the differences in the 13C 
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chemical shifts (Δ𝞭C [C1, C1′] = 5.1; Δ𝞭C [C2, C4] = 19.4; Δ𝞭C [C3, CH3C-4] = 64.0) for the “spin 
system-A” of 210 closely match those of the known adducts 212, 199sa and 209 suggesting that 
the relative configuration of the “spin system-A” in 210 is 3,4-anti-4,6-syn (Table 2-23). Similarly, 
the coupling constants 3JH11-H12 (4 Hz) and 3JH10-H11 (4.5 Hz), the 13C chemical shift of CH3C-10 
(𝞭C 14.1), and the differences in 13C chemical shifts (Δ𝞭C [C13, C13′] = 4.9; Δ𝞭C [C10, C12] = 
18.0; Δ𝞭C [C11, CH3C-10] = 64.6) for “spin system-B” of 210 closely match those of the known 
adduct 199aa suggesting the relative configuration of the “spin system-B” in 210 is 8,10-syn-
10,11-syn (Table 2-24). By analysis of the HH COSY spectrum and using the assigned HC-6 and 
HC-8 as ‘anchors’ all the hydrogens in the spin system (i.e, H3CC-6, HC-7 and H3CC-8) were 
assigned. The relative configurations at C6-C7 and C7-C8 should be unchanged from the starting 
diketone 202aa and were already confirmed as 6,7-anti-7,8-anti from the known 212. Thus, the 












21 !C (∴ asymmetric)
3JH11-H12 = 4 Hz
3JH10-H11 = 4.5 Hz
Δ"C C13, C13′ = 4.9 ppm
Δ"C C10, C12 = 18.0 ppm 
Δ"C C11, CH3C-10 = 64.6 ppm
"C CH3C-10 = 14.1 ppm
(∴ 8,10-anti
10,11-anti)










3JH2-H3 = 4 Hz
3JH3-H4 = 5 Hz
Δ"C C1, C1′ = 5.1 ppm
Δ"C C2, C4 = 19.4 ppm 
Δ"C C3, CH3C-4 = 64.0 ppm
"C CH3C-4 = 14.4 ppm
(∴ 3,4-anti
4,6-syn)
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Table 2-23: Comparison of the selected NMR data of “spin system-A” in 210 with those of the 
known 212 and 199. 







199as 8.9 2.1 0.53 16.3 68.3 8.5 
199ss 9.4 1.4 1.0 17.0 67.3 8.6 
199aa 4.7 6.9 4.6 18.3 64.5 14.0 
199sa 3.5 8.4 5.6 20.7 63.0 14.2 
212 3.5 7 5.6 19.3 64.0 14.2 
209 4.0 7.5 5.0 19.4 63.9 14.4 
210 4.0 5.0 5.1 19.4 64.0 14.4 
 
Table 2-24: Comparison of the selected NMR data of “spin system-B” in 210 with those of the 
known 199. 







199as 8.9 2.1 0.53 16.3 68.3 8.5 
199ss 9.4 1.4 1.0 17.0 67.3 8.6 
199sa 3.5 8.4 5.6 20.7 63.0 14.2 
199aa 4.7 6.9 4.6 18.3 64.5 14.0 




The bisaldol 20 is asymmetric as indicated by the presence of 25 resonances in the 13C 
NMR spectrum. The 1H NMR spectra of 240 can be divided in to four distinct ‘spin systems’ from 
analysis of its two-dimensional HH COSY NMR spectrum. The Et3Si and H2C2′-H2C3′ proton 
spin systems are unique and were readily assigned in the COSY spectrum; the 13C chemical shifts 
of attached carbon atoms were identified based on the relevant 1JCH correlations observed in the 
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HSQC spectrum. No attempt was made to distinguish between diastereotopic protons or carbons 
in this spin system. 
 
Figure 2-23: Key HMBC correlations (H➝C) in bisaldol 240. 
Comparison of the NMR data of the database (diastereomers of 200 and 283), 212, 230 and 
240 allowed assignment of the structure of 240 (Figure 2-24, Tables 2-25 and 2-26). To simplify 
the assignment, each spin system was analyzed and compared individually with the known 
compounds. The carbinol proton signals for “spin systems” ‘A’ and ‘B’ (i.e., HC-1 and HC-9) are 
readily differentiated by the 3JHH correlations to the OH protons and two adjacent methine groups 
(i.e., HC-2, HC-6′ and HC-8, HC-10). By analysis of the HH COSY spectrum and using the 
assigned HC-1 and HC-9 as ‘anchors’ all the hydrogens in the spin systems A and B (i.e, HC-6′, 
HC-7′, HC-2, H3CC-2 and HC-8, HC-10, H3CC-8, HC-11, HC-11′) were assigned. The coupling 
constants 3JH6′-H1 (<1 Hz) and 3JH1-H2 (9.5 Hz), the 13C chemical shifts of C6′ (𝞭C = 46.4 ppm), , 
C7′ (𝞭C = 25.8 ppm), C1 (𝞭C = 71.7 ppm), C2 (𝞭C = 46.6 ppm), CH3C-2 (𝞭C = 14.3 ppm), the 1H 
chemical shift of CH3C-2 (𝞭H = 0.96 ppm) for the “spin system-A” of 240 closely match those of 
the known adducts 230 and 283as suggesting that the relative configuration of the “spin system-
A” in 240 is 1,6′-syn-1,2-anti (Table 2-25). Similarly, the coupling constants 3JH9-H10 (3.0 Hz) and 
3JH8-H9 (8.5 Hz), the 13C chemical shift of CH3C-8 (C 13.6), and the differences in the 13C chemical 
shifts (Δ𝞭C [C11, C11′] = 5.95; Δ𝞭C [C8, C10] = 20.4; Δ𝞭C [C9, CH3C-8] = 64.8) for the “spin 














relative configuration of the “spin system-B” in 240 is 6,8-syn-8,9-anti (Table 2-26). By analysis 
of the HMBC spectrum, the 2JC3-HC2, 3JC3-CH3C2, 2JC7-HC8 and 3JC7-CH3C8 correlations allowed 
assignment of the carbonyls at C3 and C7 (Figure 2-23). Knowing the chemical shifts for C3 and 
C7, the HC-4, H3CC-4 and HC-6, H3CC-6 were assigned from the 2JC3-HC4, 3JC3-CH3C4 and the 2JC7-
HC6, 3JC7-CH3C6 correlations, respectively, observed in the HMBC spectrum. By analysis of the HH 
COSY spectrum and using the assigned HC-4 and HC-6 as ‘anchors’ all the hydrogens in the spin 
system (i.e, H3CC-4, HC-5 and H3CC-6) were assigned. The methylene carbon C-9′ was assigned 
based on 3JC9-HC7′ correlation, observed in the HMBC spectrum. The H2C-9′ protons were assigned 
by analysis of 1JCH correlation spectrum (gHSQC); thus H2C-10′ was assigned by 3JH9′-H10′ 
correlation observed in the COSY spectrum. The quaternary carbon C5′ is unique and was readily 
distinguished in the 13C NMR spectrum on the basis of the chemical shift (𝞭C C5′ = 110.3). The 
relative configuration at C2-C4 was assigned as 2,4-syn based on analogy. The relative 
configurations at C4-C5 and C5-C6 should be unchanged from the starting diketone 215 and were 
already confirmed as 4,5-anti-5,6-anti from the known 212 and 230. Thus, the relative 









for the “spin system-B”
3JH9-H10 = 3 Hz
3JH8-H9 = 8.5 Hz
!C CH3C-8 = 13.6 ppm 
Δ!C C11, C11′ = 5.95 ppm
Δ!C C8, C10 = 20.4 ppm
Δ!C C9, CH3C-8 = 64.8 ppm
(∴ 6,8-syn
8,9-anti)
for the “spin system-A”
3JH6′-H1 = <1 Hz 
3JH1-H2 = 9.5 Hz
!H CH3C-2 = 0.96 ppm
!C C6′ = 46.4 ppm 
!C C7′ = 25.8 ppm
!C C1 = 71.7 ppm 
!C C2 = 46.6 ppm















from the same E,E-bis enolborinate
(∴ 2,4-syn and 6,8-syn)





































































































Table 2-25: Comparison of the selected NMR data of “spin system-A” in 240 with those of the 







𝞭C C-6′ 𝞭C C-7′ 𝞭C C-1 𝞭C C-2 𝞭C 
CH3C-2  
283aa 7 4.5 1.21 46.5 30.0 74.6 49.4 14.2 
283ss 3 7.5 1.19 47.3 26.9 69.4 49.7 13.3 
283sa 8.5 2 1.10 46.2 29.4 70.9 48.0 8.1 
283as 2 9 0.97 46.3 26.0 71.8 47.9 13.9 
230 <1 9.5 0.96 46.6 25.8 71.7 47.2  14.1  
240 <1 9.5 0.96 46.4 25.8 71.7 46.6 14.3 
 
Table 2-26: Comparison of the selected NMR data of “spin system-B” in 240 with those of the 
known 212 and 200. 












200as 8.8 1.9 0.6 15.8 68.2 8.5 
200ss 9.4 1.4 1.0 16.7 67.1 9.0 
200aa 5 7 4.2 17.8 64.6 14.3 
200sa 3.9 7.9 5.3 19.7 63.6 14.3 
212 3.5 7 5.6 19.3 64.0 14.2 
240 (3.0)  (8.5)  (5.95) (20.4) (64.8) (13.6) 
 
Meso bisaldol 244: 
The bisaldol 244 is Cs-symmetric as indicated by the presence of only 16 resonances in the 
13C NMR spectrum (Figure 2-25). NMR spectra of 244 was assigned by following the identical 





Assignment of the relative configuration of 244: 
Similar to the assignment of 231, comparison of the coupling constants 3JH6′-H1, 3JH1-H2, 13C 
chemical shifts of C1, CH3C-2 and 1H chemical shifts of H3CC-2 values of the known adducts 
(283) and 244 allowed assignment of the relative configuration at C6′-C1 and C1-C2 in 244 (for 
the detailed discussion, refer to the assignment of 231) (Figure 2-25, Table 2-27). The coupling 
constants 3JH6′-H1 (3.5 Hz) and 3JH1-H2 (4.5 Hz), the 13C chemical shifts of C1 (𝞭C 67.9), CH3C-2 
(𝞭C 11.5), C6′ (𝞭C 46.8) and the 1H chemical shift of H3CC-2 (𝞭H 1.18) for 244 are consistent with 
those of the known adducts 283ss suggesting the relative configuration of 244 is 1,2-syn-6′,1-syn 
(Table 2-27). The C2-C4 relative configuration is assumed as ‘2,4-syn’ by analogy to the known 
adduct 223 as both the aldols (223 and 244) are obtained from (Z,Z)-bis enolborinate 222 reaction 
conditions. The relative configurations of C4-C5 and C5-C6 should be unchanged from the starting 
diketone 212 and were already confirmed as 4,5-anti-5,6-anti from the known structure of 223. 
Because 244 is meso, the C6′-C6′′, C1-C9, C2-C8 and C4-C6 relative configurations in 244 must 





Figure 2-25: Assignment of the relative configuration of 244 by NMR comparison with the 
known compounds. 







𝞭C C-6′ 𝞭C C-7′ 𝞭C C-1 𝞭C C-2 𝞭C 
CH3C-2  
283aa 7 4.5 1.21 46.5 30.0 74.6 49.4 14.2 
283sa 8.5 2 1.10 46.2 29.4 70.9 48.0 8.1 
283as 2 9 0.97 46.3 26.0 71.8 47.9 13.9 
283ss 3 7.5 1.19 47.3 26.9 69.4 49.7 13.3 
244 3.5 4.5 1.18 46.8 28.1 67.9 49.0 11.5 
 
Monoaldol 247: 












16 !C (∴ Cs symmetric)
from the same (Z,Z)-bis enolborinate
(∴ 2,4-syn)
3JH6′-H1 = 3.5 Hz
"C C1 = 67.9 ppm
"C CH3C-2 = 11.5 ppm
"H H3CC-2= 1.18 ppm
"C C6′ = 46.8 ppm
"C C1 = 67.9 ppm
"C C7′ = 28.1 ppm
















































Figure 2-26: Key HMBC correlations (H➝C) in monoaldol 247. 
Assignment of the relative configuration of 247: 
NMR analysis of the known3 four diastereomers of 283 revealed consistent trends that 
allowed assignment of the relative configuration of 247 (Figure 2-27 & Table 2-28). The 6′,1-syn 
diastereomers (i.e., 283as and 283ss) consistently had lower 3JH6′-H1 (2-3 Hz) and 13C chemical 
shifts for C7′ (𝞭C 26-26.9) and higher 3JH1-H2 (7.5-9 Hz) values compared to those of the 6′,1-anti 
diastereomers (283aa and 283sa). Similarly, the 1,2-anti diastereomers (283as and 283aa) 
consistently had higher 13C chemical shifts for C1 (𝞭C 71.8-74.6) and CH3C-2 (𝞭C 13.9-14.2) 
compared to those of the 1,2-syn diastereomers (283ss and 283sa). The diastereomer 283sa can be 
easily distinguishable by its characteristic lower 13C chemical shift for CH3C-2 (𝞭C 8.1) compared 
to the other three diastereomers (𝞭C 13.3-14.2). 
The 1H and 13C NMR data of the meso-bisaldol 244 closely matches those of 283ss 
suggesting the trends from database are consistent and are applicable to the assignment of the 
relative configurations in similar structures (Figure 2-27 & Table 2-28). The mono aldol 247 was 
obtained from an incomplete reaction of (Z,Z)-bis enolborinate 222 with aldehyde 109 suggesting 
the adduct 247 has the same relative configuration as 244 (arising from complete reaction of 222 
with 109). The 1H and 13C NMR data for 247 were compared with those of the known adducts 244 
and 283ss to assign the relative configuration of 247. The coupling constants 3JH6′-H1 (5 Hz; 6′,1-
syn), 3JH1-H2 (4.5 Hz; 1,2-anti), the 13C chemical shifts of C7′ (𝞭C 28; 6′,1-syn), CH3C-2 (𝞭C 11.9; 
















of the known adducts 244 and 283ss suggesting the relative configuration of 247 is 1,2-syn-6′,1-
syn.  The C2-C4 relative configuration in 247 was assumed as 2,4-syn by analogy to the known 
adduct 244 as both the aldols (244 and 247) are obtained from reaction of (Z,Z)-bis enolborinate 
222 with aldehyde 109. The relative configurations of C4-C5 and C5-C6 should be unchanged 
from the starting diketone 202aa and were already confirmed as 4,5-anti-5,6-anti from the X-ray 














3JH6′-H1 = 5 Hz 
!C C1 = 68.1 ppm
!H H3CC-2= 1.17 ppm 
!C C6′ = 46.8 ppm
!C C1 = 68.1 ppm
!C C7′ = 28 ppm
from the same (Z,Z)-bis enolborinate
(∴ 2,4-syn by analogy)
3JH1-H2 = 4.5 Hz





































































𝞭C C-6′ 𝞭C C-7′ 𝞭C C-1 𝞭C C-2 𝞭C 
CH3C-2  
283aa 7 4.5 1.21 46.5 30.0 74.6 49.4 14.2 
283sa 8.5 2 1.10 46.2 29.4 70.9 48.0 8.1 
283as 2 9 0.97 46.3 26.0 71.8 47.9 13.9 
283ss 3 7.5 1.19 47.3 26.9 69.4 49.7 13.3 
244 3.5 4.5 1.18 46.8 28.1 67.9 49.0 11.5 




Meso bisaldol 245: 
The adduct 245 is Cs-symmetric as indicated by the presence of 16 resonances in the 13C 
NMR spectrum (Figure 2-28). NMR spectra of 245 was assigned by following the identical 
procedure used for 233. 
Assignment of the relative configuration of 245: 
Similar to the assignment of 233, comparison of the coupling constants 3JH2-H3, 3JH3-H4, 13C 
chemical shifts of C1, C2, C3, CH3C-2′, CH3CC-2′ and 1H chemical shifts of H3CC-4 values for 
the known adducts 130 and 245 allowed assignment of the relative configuration at C2-C3 and 
C3-C4 in 245 (for the detailed discussion, refer to the assignment of 233) (Figure 2-28, Table 2-
29). The coupling constants 3JH2-H3 (3 Hz), 3JH3-H4 (7 Hz), 13C chemical shifts of C1 (𝞭C 9.0), C2 
(𝞭C 40.4), C3 (𝞭C 70.5), CH3C-4 (𝞭C 13.6), CH2C-2′ (𝞭C 27.5) and CH3CC-2′ (𝞭C 7.9) and 1H 
chemical shifts of H3CC-4 (𝞭H 1.23) are consistent with those of the known adduct 130ss 
suggesting the C2-C3 and C3-C4 relative configurations are 2,3-syn-3,4-syn. The C4-C6 relative 
configuration in 245 was assumed as 4,6-syn by analogy to the known adduct 223 as both the 
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aldols (223 and 245) were obtained from (Z,Z)-bis enolborinate 222 reaction conditions. The 
relative configurations at C6-C7 and C7-C8 should be unchanged from the starting diketone 202aa 
and were already confirmed as 6,7-anti-7,8-anti from the known structure of 223. Because 245 is 
meso, the C2-C12, C3-C11, C4-C10 and C6-C8 relative configurations in 245 must be syn. Thus, 
the relative configuration of 245 was assigned as 2,3-syn-3,4-syn-4,6-syn-6,7-anti-7,8-anti-8,10-
syn-10,11-syn-11,12-syn. 
 





3JH2-H3 = 3 Hz (∴ 2,3-syn)
3JH3-H4 = 7 Hz (∴ 3,4-syn)
!C C1 = 9.0 ppm
!C C2 = 40.4 ppm 
!C C3 = 70.5 ppm
(∴ 2,3-syn)
!C C4 = 49.9 ppm
!C CH3C-4 = 13.6 ppm
!C CH2C-2′ = 27.5 ppm














16 "C (∴ Cs symmetric)



































































130aa 8.5 3.5 1.24 13.1 42.0 76.1 49.7 14.5 26.0 7.1 
130sa 9.5 2.5 1.06 12.8 41.4 73.0 49.1 8.0 25.7 7.0 
130as <1 9.5 0.94 6.9 38.5 73.4 48.7 13.7 28.2 8.3 
130ss 1 9 1.21 7.4 39.9 71.6 50.2 14.9 28.1 8.2 
245 3 7 1.23 9.0 40.4 70.5 49.9 13.6 27.5 7.9 
 
A complementary correlation between 244 and 245 was obtained via desulfurization confirming 
both 244 and 245 have the same relative configuration (Figure 2-29). 
 
Figure 2-29: Desulfurization of 244 to 245. 
 
Chiral-bisaldol 234: 
The bisaldol 234 is asymmetric as indicated by the presence of 29 resonances in the 13C 
NMR spectrum (Figure 2-31). The 1H NMR spectra of 234 can be divided in to eight distinct ‘spin 
systems’ from analysis of its two-dimensional HH COSY NMR spectrum. The Et3Si proton spin 
system is unique and was readily assigned in the COSY spectrum; the 13C chemical shifts of 
attached carbon atoms were identified based on the relevant 1JCH correlations observed in the 
HSQC spectrum. No attempt was made to distinguish between diastereotopic protons or carbons 




























Figure 2-30: Key HMBC correlations (H➝C) in bisaldol 234. 
Comparison of the NMR data for the known 130, 232, 245 and 234 allowed assignment of 
the structure of 234 (Figure 2-31, Tables 2-30 and 2-31). To simplify the assignment, each spin 
system was analyzed and compared individually with the known compounds. The carbinol proton 
signals for “spin systems” ‘A’ and ‘B’ (i.e., HC-3 and HC-11) are readily differentiated by the 
3JHH correlations to the OH protons and two adjacent methine groups (i.e., HC-2, HC-4 and HC-
10, HC-12). By analysis of the HH COSY spectrum and using the assigned HC-3 and HC-11 as 
‘anchors’ all the hydrogens in the spin systems A and B (i.e, HC-1, HC-2, HC-4, H3CC-4 and 
H3CC-10, HC-10, HC-12, HC-13) were assigned. The coupling constants 3JH2-H3 (<1 Hz) and 3JH3-
H4 (10 Hz), the 13C chemical shifts of C1 (𝞭C 6.6), C2 (𝞭C 38.7), C3 (𝞭C 72.9), C4 (𝞭C 48.4), CH3C-
4 (𝞭C 13.8), CH2C-2′ (𝞭C 28.2), CH3CC-2′ (𝞭C 8.3) and the 1H chemical shift of CH3C-4 (𝞭H 0.93) 
for the “spin system-A” of 234 closely match those of the known adducts 232 and 130as suggesting 
that the relative configuration of the “spin system-A” in 234 is 2,3-syn-3,4-anti-4,6-syn (Table 2-
30). Similarly, the coupling constants 3JH11-H12 (3.0 Hz) and 3JH10-H11 (7.0 Hz), the 13C chemical 
shifts of C13 (𝞭C 9.0), C12 (𝞭C 40.6), C11 (𝞭C 70.6), C10 (𝞭C 49.8), CH3C-10 (𝞭C 13.5), CH2C-
2′′ (𝞭C 27.6), CH3CC-2′′ (𝞭C 7.9) and the 1H chemical shift of CH3C-10 (𝞭H 1.22) for “spin system-
B” of 234 closely match those of the known adducts 245 and 130ss suggesting the relative 
configuration of the “spin system-B” in 234 is 8,10-syn-10,11-syn-11,12-syn (Table 2-31). By 
analysis of the HMBC spectrum, the 2JC5-HC4, 3JC5-CH3C4, 2JC9-HC10 and 3JC9-CH3C10 correlations 














C5 and C9, the HC-6, H3CC-6 and HC-8, H3CC-8 were assigned from the 2JC5-HC6, 3JC5-CH3C6 and 
the 2JC9-HC8, 3JC9-CH3C8 correlations, respectively, observed in the HMBC spectrum. By analysis of 
the HH COSY spectrum and using the assigned HC-6 and HC-8 as ‘anchors’ all the hydrogens in 
the spin system (i.e, H3CC-6, HC-7 and H3CC-8) were assigned. The quaternary carbons C2′ and 
C2′′ are unique and were readily distinguished in the 13C NMR spectrum on the basis of the 
chemical shifts (𝞭C 114.7, 114.5) and were assigned by the 3JC2′-HC1 and the 3JC2′′-HC13 correlations, 
observed in the HMBC spectrum. The HC-4′/HC-5′ and HC-4′′/HC-5′′ protons are unique and 
were assigned by the 3JC2′-HC4′/5′ and the 3JC2′′-HC4′′/5′′ correlations, observed in the HMBC spectrum. 
The ethyl protons CH3CH2-C2′ and CH3CH2-C2′′ were assigned from the 2JC2′-H2CC2′, 3JC2′-H3CCC2′ 
and 2JC2′′-H2CC2′′, 3JC2′′-H3CCC2′′ correlations, respectively, observed in the HMBC spectrum. The 
relative configurations at C6-C7 and C7-C8 should be unchanged from the starting diketone 202aa 
and were already confirmed as 6,7-anti-7,8-anti from the known 232. Thus, the relative 





Figure 2-31: Structure assignment of 234 by NMR comparison with the known compounds. 
 
for the “spin system-A”
3JH2-H3 = <1 Hz (∴ 2,3-syn)
3JH3-H4 = 10 Hz (∴ 3,4-anti)
!H CH3C-4 = 0.93 ppm
!C C1 = 6.6 ppm
!C C2 = 38.7 ppm 
!C C3 = 72.9 ppm
!C CH2C-2′ = 28.2 ppm
!C CH3CC-2′ = 8.3 ppm
(∴ 2,3-syn)
!C C4 = 48.4 ppm
!C CH3C-4 = 13.8 ppm
(∴ 3,4-anti
and 2,3-syn)
for the “spin system-B”
3JH11-H12 = 3 Hz 
3JH10-H11 = 7 Hz
!H CH3C-10 = 1.22 ppm
!C C10 = 49.8 ppm
!C CH3C-10 = 13.5 ppm
!C C13 = 9.0 ppm
!C C12 = 40.6 ppm 
!C C11 = 70.6 ppm
!C CH2C-2′′ = 27.6 ppm
!C CH3CC-2′′ = 7.9 ppm
(∴ 10,11-syn 
11,12-syn)
29 "C (∴ asymmetric)



































































Table 2-30: Comparison of the selected NMR data of “spin system-A” in 234 with those of the 

























130aa 8.5 3.5 1.24 13.1 42.0 76.1 49.7 14.5 26.0 7.1 
130sa 9.5 2.5 1.06 12.8 41.4 73.0 49.1 8.0 25.7 7.0 
130ss 1 9 1.21 7.4 39.9 71.6 50.2 14.9 28.1 8.2 
130as <1 9.5 0.94 6.9 38.5 73.4 48.7 13.7 28.2 8.3 
232 <1 9.5 0.91 6.7 38.8 73.1 48.0  13.8  28.2 8.2 
234 <1 10 0.93 6.6 38.7 72.9 48.4 13.8 28.2 8.3 
 
Table 2-31: Comparison of the selected NMR data of “spin system-B” in 234 with those of the 

























130aa 8.5 3.5 1.24 13.1 42.0 76.1 49.7 14.5 26.0 7.1 
130sa 9.5 2.5 1.06 12.8 41.4 73.0 49.1 8.0 25.7 7.0 
130as <1 9.5 0.94 6.9 38.5 73.4 48.7 13.7 28.2 8.3 
130ss 1 9 1.21 7.4 39.9 71.6 50.2 14.9 28.1 8.2 
245 3 7 1.23 9.0 40.4 70.5 49.9 13.6 27.5 7.9 
234  3 7 1.22  9.0 40.6 70.6 49.8 13.5 27.6 7.9 
 
Chiral-bisaldol 246: 
The bisaldol 246 is asymmetric as indicated by the presence of 29 resonances in the 13C 
NMR spectrum. The 1H NMR spectra of 246 can be divided in to eight distinct ‘spin systems’ 
from analysis of its two-dimensional HH COSY NMR spectrum. The Et3Si proton spin system is 
unique and was readily assigned in the COSY spectrum; the 13C chemical shifts of attached carbon 
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atoms were identified based on the relevant 1JCH correlations observed in the HSQC spectrum. No 
attempt was made to distinguish between diastereotopic protons or carbons in this spin system. 
 
Figure 2-32: Key HMBC correlations (H➝C) in bisaldol 246. 
Comparison of the NMR data between the known 130, 245 and 246 allowed assignment of 
the structure of 246 (Figure 2-33). To simplify the assignment, each spin system was analyzed and 
compared individually with the known compounds. The carbinol proton signals for “spin systems” 
‘A’ and ‘B’ (i.e., HC-3 and HC-11) are readily differentiated by the 3JHH correlation to the OH 
protons and two adjacent methine groups (i.e., HC-2, HC-4 and HC-10, HC-12). By analysis of 
the HH COSY spectrum and using the assigned HC-3 and HC-11 as ‘anchors’ all the hydrogens 
in the spin systems A and B (i.e, HC-1, HC-2, HC-4, H3CC-4 and H3CC-10, HC-10, HC-12, HC-
13) were assigned. The coupling constants 3JH2-H3 (9.5 Hz) and 3JH3-H4 (<1 Hz), the 13C chemical 
shifts of C1 (𝞭C 12.8), C2 (𝞭C 41.5), C3 (𝞭C 72.1), C4 (𝞭C 49.2), CH3C-4 (𝞭C 8.1; ‘key signal’), 
CH2C-2′ (𝞭C 25.9), CH3CC-2′ (𝞭C 7.0) and the 1H chemical shift of CH3C-4 (𝞭H 1.15) for the “spin 
system-A” of 246 closely match those of the known adduct 130sa suggesting that the relative 
configuration of the “spin system-A” in 246 is 2,3-anti-3,4-syn-4,6-syn (Table 2-32). Similarly, 
the coupling constant 3JH10-H11 (7.0 Hz), the 13C chemical shifts of C13 (𝞭C 8.7), C12 (𝞭C 40.1), 
C11 (𝞭C 70.8), C10 (𝞭C 48.5), CH3C-10 (𝞭C 14.4), CH2C-2′′ (𝞭C 27.6), CH3CC-2′′ (𝞭C 7.9) and the 
1H chemical shift of CH3C-10 (𝞭H 1.22) for “spin system-B” of 246 closely match those of the 
known adducts 245 and 130ss suggesting the relative configuration of the “spin system-B” in 246 














3JC5-CH3C4, 2JC9-HC10 and 3JC9-CH3C10 correlations allowed assignment of the carbonyls at C5 and C9 
(Figure 2-32). Knowing the chemical shifts for C5 and C9, the HC-6, H3CC-6 and HC-8, H3CC-8 
protons were assigned from the 2JC5-HC6, 3JC5-CH3C6 and the 2JC9-HC8, 3JC9-CH3C8 correlations, 
respectively, observed in the HMBC spectrum. By analysis of the HH COSY spectrum and using 
the assigned HC-6 and HC-8 as ‘anchors’ all the hydrogens in the spin system (i.e, H3CC-6, HC-
7 and H3CC-8) were assigned. The quaternary carbons C2′ and C2′′ are unique and were readily 
distinguished in the 13C NMR spectrum on the basis of the chemical shifts (𝞭C 114.9, 114.5) and 
were assigned by the 3JC2′-HC1 and the 3JC2′′-HC13 correlations, observed in the HMBC spectrum. The 
HC-4′/HC-5′ and HC-4′′/HC-5′′ protons are unique and were assigned by the 3JC2′-HC4′/5′ and the 
3JC2′′-H4C′′/5′′ correlations, observed in the HMBC spectrum. The ethyl protons H2CC-2′-H3CCC-2′ 
and H2CC-2′′- H3CCC-2′′ were assigned by 2JC2′-H2CC2′, 3JC2′-H3CCC2′ and 2JC2′′-H2CC2′′, 3JC2′′-H3CCC2′′ 
correlations, respectively, observed in the HMBC spectrum. The relative configurations at C6-C7 
and C7-C8 should be unchanged from the starting diketone 202aa and were already confirmed as 

















for the “spin system-A”
3JH2-H3 = 9.5 Hz (∴ 2,3-anti)
3JH3-H4 = <1 Hz (∴ 3,4-syn)
!H CH3C-4 = 1.15 ppm
!C C1 = 12.8 ppm
!C C2 = 41.5 ppm 
!C C3 = 72.1 ppm
!C CH2C-2′ = 25.9 ppm
!C CH3CC-2′ = 7.0 ppm
(∴ 2,3-anti)
!C C4 = 49.2 ppm
!C CH3C-4 = 8.1 ppm
(∴ 3,4-syn 
2,3-anti)
3JH10-H11 = 7 Hz
!H CH3C-10 = 1.22 ppm
!C C10 = 48.5 ppm
!C CH3C-10 = 14.4 ppm
!C C13 = 8.7 ppm
!C C12 = 40.7 ppm 
!C C11 = 70.8 ppm
!C CH2C-2′′ = 27.6 ppm
!C CH3CC-2′′ = 7.9 ppm
(∴ 10,11-syn 
11,12-syn)
29 "C (∴ asymmetric)
from the same (Z,Z)-bis enolborinate conditions (∴ 4,6-syn and 8,10-syn)












































Table 2-32: Comparison of the selected NMR data of “spin system-A” in 246 with those of the 

























130ss 1 9 1.21 7.4 39.9 71.6 50.2 14.9 28.1 8.2 
130as <1 9.5 0.94 6.9 38.5 73.4 48.7 13.7 28.2 8.3 
130aa 8.5 3.5 1.24 13.1 42.0 76.1 49.7 14.5 26.0 7.1 
130sa 9.5 2.5 1.06 12.8 41.4 73.0 49.1 8.0 25.7 7.0 
245 3 7 1.23 9.0 40.4 70.5 49.9 13.6 27.5 7.9 
246 9.5 <1 1.15 12.8  41.5 72.1 49.2 8.1 25.9  7.0 
 
Table 2-33: Comparison of the selected NMR data of “spin system-B” in 246 with those of the 
known 245 and 130. 


































130aa 3.5 1.24 13.1 42.0 76.1 49.7 14.5 26.0 7.1 
130sa 2.5 1.06 12.8 41.4 73.0 49.1 8.0 25.7 7.0 
130as 9.5 0.94 6.9 38.5 73.4 48.7 13.7 28.2 8.3 
130ss 9 1.21 7.4 39.9 71.6 50.2 14.9 28.1 8.2 
245 7 1.23 9.0 40.4 70.5 49.9 13.6 27.5 7.9 
246 (7) (1.22) (8.7) (40.1) (70.8) (48.5) (14.4) (27.6) (7.9) 
 
Chiral bisaldol 252ssa: 
Procedure for assignment of NMR spectra: 
The bisaldol 252ssa is asymmetric as indicated by the presence of 36 resonances in the 13C 
NMR spectrum (Figure 2-35). The 1H NMR spectra of 252ssa can be divided in to eight distinct 
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‘spin systems’ from analysis of its two-dimensional HH COSY NMR spectrum. The Et3Si, HC-
4′′-HC-5′′, HC-2′ and -Ph proton spin systems are unique and were readily assigned in the COSY 
spectrum and by chemical shifts; the 13C chemical shifts of attached carbon atoms were identified 
based on the relevant 1JCH correlations observed in the HSQC spectrum. No attempt was made to 
distinguish between diastereotopic protons or carbons in these spin systems. 
 
Figure 2-34: Key HMBC correlations (H➝C) in bisaldol 252ssa. 
The C4-C5, C5-C6, C6-C8, C8-C9 and C9-C10 relative configurations in 252ssa were 
unambiguously confirmed by achieving the total synthesis of dolabriferol C (relative configuration 
of dolabriferol C known as 4,5-anti-5,6-anti-6,8-syn-8,9-syn-9,10-anti) from 252ssa (Figure 2-35). 
The stereocenter at C1 and the absolute configuration at C2 were lost due to oxidation of the 
hydroxy group at C1 to the keto group in the process of the synthesis of dolabriferol C; as a result, 
the C1-C8′, C1-C2 and C2-C4 relative configurations cannot be established from dolabriferol C. 
However, comparison of the NMR data between the known 130, 253, 234 and 252ssa allowed 
assignment of the structure of 252ssa (Figure 2-35). To simplify the assignment, each spin system 
was analyzed and compared individually with the known compounds. The carbinol proton signals 
for “spin systems” ‘A’ and ‘B’ (i.e., HC-1 and HC-9) are readily differentiated by the 3JHH 
correlation to the OH protons and two adjacent methine groups (i.e., HC-8′, HC-2 and HC-8, HC-
10). By analysis of the HH COSY spectrum and using the assigned HC-1 and HC-9 as ‘anchors’ 
all the hydrogens in the spin systems A and B (i.e, HC-8, H3CC-8, HC-10, HC-11 and HC-2, 



















coupling constants 3JH8-H9 (<1 Hz) and 3JH9-H10 (10 Hz), the 13C chemical shifts of C11 (𝞭C 12.8), 
C10 (𝞭C 41.4), C9 (𝞭C 72.3), C8 (𝞭C 48.1), CH3C-8 (𝞭C 8.35; ‘key signal’), CH2C-2′′ (𝞭C 25.95), 
CH3CC-2′′ (𝞭C 7.1) and the 1H chemical shift of CH3C-8 (𝞭H 1.11) for the “spin system-A” of 
252ssa closely match those of the known adducts 130sa and 234 suggesting that the relative 
configuration of the “spin system-A” in 252ssa is 6,8-syn-8,9-syn-9,10-anti (Table 2-34). The 
bisaldol 252ssa was obtained from a complete reaction of (Z,Z)-bis enolborinate 222 with 
aldehydes 128 and 159 suggesting the “spin system-B” in 252ssa has the same relative 
configuration as 253 (arising from an incomplete reaction of 222 with 128). The coupling constants 
3JH1-H2 (3.0 Hz) and 3JH1-H8′ (5.5 Hz), the 13C chemical shifts of C1 (𝞭C 69.9), C2 (𝞭C 49.6), CH3C-
2 (𝞭C 11.1), C8′ (𝞭C 46.3), C7′ (𝞭C 28.5) for “spin system-B” of 252ssa closely match those of the 
known adduct 253 suggesting the relative configuration of the “spin system-B” in 252ssa is 1,2-
syn-1,8′-syn-2,4-syn (Table 2-35). By analysis of the HMBC spectrum, the 2JC3-HC2, 3JC3-CH3C2, 
2JC7-HC8 and 3JC7-CH3C8 correlations allowed assignment of the carbonyls at C3 and C7 (Figure 2-
34). Knowing the chemical shifts of C3 and C7, the HC-4, H3CC-4 and HC-6, H3CC-6 were 
assigned from the 2JC3-HC4, 3JC3-CH3C4 and the 2JC7-HC6, 3JC7-CH3C6 correlations, respectively, 
observed in the HMBC spectrum. By analysis of the HH COSY spectrum and using the assigned 
HC-4 and HC-6 as ‘anchors’ all the hydrogens in the spin system (i.e, H3CC-4, HC-5 and H3CC-
6) were assigned. The H2CC-2′′-H3CCC-2′′ proton spin system was assigned by 2JC2′′-H2CC2′′, 3JC2′′-
H3CCC2′′ correlations, observed in the HMBC spectrum. The relative configurations at C4-C5 and 
C5-C6 should be unchanged from the starting diketone 202aa and were already confirmed as 4,5-






















for the “spin system-B”
3JH1-H2 = 3 Hz (∴ 1,2-syn)
3JH1-H8′ = 5.5 Hz (∴ 1,8′-syn)
!C C-1 = 69.9 ppm
!C C-2 = 49.6 ppm 
!C CH3C-2 = 11.1 ppm
!C C-8′ = 46.3 ppm
!C C-7′ = 28.5 ppm
(∴1,2-syn
1,8′-syn)
for the “spin system-A”
3JH9-H10 = 9.5 Hz (∴ 9,10-anti)
3JH8-H9 = <1 Hz (∴ 8,9-syn)
!H CH3C-8 = 8.35 ppm
!C C11 = 12.8 ppm
!C C10 = 41.4 ppm 
!C C9 = 72.3 ppm
!C CH2C-2′′ = 25.95 ppm
!C CH3CC-2′′ = 7.1 ppm
(∴ 9,10-anti)
!C C8 = 49.2 ppm




36 "C (∴ asymmetric)


































































Table 2-34: Comparison of the selected NMR data of “spin system-A” in 252ssa with those of 









































130aa 8.5 3.5 1.24 13.1 42.0 76.1 49.7 14.5 26.0 7.1 
130as <1 9.5 0.94 6.9 38.5 73.4 48.7 13.7 28.2 8.3 
130ss 1 9 1.21 7.4 39.9 71.6 50.2 14.9 28.1 8.2 
130sa 9.5 2.5 1.06 12.8 41.4 73.0 49.1 8.0 25.7 7.0 
234 9.5 <1 1.15 12.8 41.5 72.1 49.2 8.1 25.9 7.0 
252ssa (10) (<1) (1.11) (12.8) (41.4) (72.3) (48.1) (8.35) (25.95) (7.1) 
 
Table 2-35: Comparison of the selected NMR data of “spin system-B” in 252ssa with those of 





𝞭C C-1 𝞭C C-2 𝞭C CH3C-2 𝞭C C-8′ 𝞭C C-7′ 
253 3.5 5.5 70.1 50.1 10.9 46.2 28.6 
252ssa 3 5.5 69.9 49.6 11.1 46.3 28.5 
 
Chiral bisaldol 252sss: 
The bisaldol 252sss is asymmetric as indicated by the presence of 36 resonances in the 13C 
NMR spectrum (Figure 2-37). NMR spectra of 252sss was assigned by following the identical 
procedure used for 252ssa. 
 



















Assignment of the relative configuration of 252sss: 
The coupling constants 3JH8-H9 (8 Hz) and 3JH9-H10 (2.5 Hz), the 13C chemical shifts of C11 
(𝞭C 12.8), C10 (𝞭C 39.94), C9 (𝞭C 70.9), C8 (𝞭C 48.5), CH3C-8 (𝞭C 14.7), CH2C-2′′ (𝞭C 27.7), 
CH3CC-2′′ (𝞭C 7.9) and the 1H chemical shift of CH3C-8 (𝞭H 1.21) for the “spin system-A” of 
252sss closely match those of the known adducts 130ss and 245 suggesting that the relative 
configuration of the “spin system-A” in 252sss is 6,8-syn-8,9-syn-9,10-syn (Figure 2-37, Table 2-
36). The bisaldol 252sss was obtained from a complete reaction of (Z,Z)-bis enolborinate 222 with 
aldehydes 128 and 159 suggesting the “spin system-B” in 252sss has the same relative 
configuration as 253 (arising from an incomplete reaction of 222 with 128). The coupling constants 
3JH1-H2 (3.0 Hz) and 3JH1-H8′ (6.0 Hz), the 13C chemical shifts of C1 (𝞭C 70.3), C2 (𝞭C 50.9), CH3C-
2 (𝞭C 10.4), C8′ (𝞭C 46.0), C7′ (𝞭C 28.9) for “spin system-B” of 252sss closely match those of the 
known adduct 253 suggesting the relative configuration of the “spin system-B” in 252sss is 1,2-
syn-1,8′-syn-2,4-syn (Table 2-37). The relative configurations at C4-C5 and C5-C6 should be 
unchanged from the starting diketone 202aa and were already confirmed as 4,5-anti-5,6-anti from 























for the “spin system-A”
3JH9-H10 = 2.5 Hz (∴ 9,10-syn
3JH8-H9 = 8 Hz (∴ 8,9-syn 9,10-syn)
!H CH3C-8 = 14.7 ppm
!C C11 = 8.5 ppm
!C C10 = 39.9 ppm 
!C C9 = 70.9 ppm
!C CH2C-2′′ = 27.7 ppm
!C CH3CC-2′′ = 7.9 ppm
(∴ 9,10-syn)
!C C8 = 48.5 ppm
!C CH3C-8 = 14.7 ppm
(∴ 8,9-syn
9,10-syn)
for the “spin system-B”
3JH1-H2 = 3 Hz (∴ 1,2-syn)
3JH1-H8′ = 6 Hz (∴ 1,8′-syn)
!C C-1 = 70.3 ppm
!C C-2 = 50.9 ppm 
!C CH3C-2 = 10.4 ppm
!C C-8′ = 46.0 ppm
!C C-7′ = 28.9 ppm
(∴1,2-syn
1,8′-syn)
from the same (Z,Z)-bis enolborinate conditions (∴ 2,4-syn and 6,8-syn)



























































Table 2-36: Comparison of the selected NMR data of “spin system-A” in 252sss with those of 









































130aa 8.5 3.5 1.24 13.1 42.0 76.1 49.7 14.5 26.0 7.1 
130sa 9.5 2.5 1.06 12.8 41.4 73.0 49.1 8.0 25.7 7.0 
130as <1 9.5 0.94 6.9 38.5 73.4 48.7 13.7 28.2 8.3 
130ss 1 9 1.21 7.4 39.9 71.6 50.2 14.9 28.1 8.2 
245 3 7 1.23 9.0 40.4 70.5 49.9 13.6 27.5 7.9 
252sss (2.5) (8) (1.21) (12.8) (39.94) (70.9) (48.5) (14.7) (27.7) (7.9) 
 
Table 2-37: Comparison of the selected NMR data of “spin system-B” in 252sss with those of 















253 3.5 5.5 70.1 50.1 10.9 46.2 28.6 
252sss 3 6 70.3 50.9 10.4 46.0 28.9 
 
2.9.5. Assignment by analogy 
 
Meso bisaldol 216: 
Procedure for assignment of NMR spectra: 
The bisaldol 216 is Cs-symmetric as indicated by the presence of 11 resonances in the 13C 
NMR spectrum (Figure 2-38). The 1H NMR spectra of 216 can be divided in to three distinct ‘spin 
systems’ from analysis of its two-dimensional HH COSY NMR spectrum. The Et3Si, H2C2-
H3C1/H2C12-H3C13 proton spin systems and C5/C9 carbonyls are unique and were readily 
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assigned in the COSY and 13C NMR spectrum, respectively; the 13C chemical shifts of attached 
carbon atoms were identified based on the relevant 1JCH correlations observed in the HSQC 
spectrum. No attempt was made to distinguish between diastereotopic protons or carbons in these 
spin systems. 
The proton signals for HC-3 and HC-11 are readily differentiated by the 3JHH correlation 
to the OH protons and two adjacent groups (i.e., H2C-2, HC-4 and H2C-12, HC-10) (Figure 2-38, 
Table 2-38). By analysis of the HH COSY spectrum and using the assigned HC-3 and HC-11 as 
‘anchors’ all the hydrogens in the spin system (i.e., HC-1, HC-2, HC-4, H3CC-4 and HC-10, 
H3CC-10, HC-12, HC-13) were assigned. With the aid of these assigned protons, the attached 
carbons were assigned by analysis of the two-dimensional 1JCH correlation spectrum (gHSQC). 
Among the methine protons in the remaining spin system, the HC-7 has unique 1H chemical shift 
(𝞭H 4.59) and multiplicity (t) that allowed assignment of all the protons in the spin system (i.e., 
HC-6, H3CC-6, HC-7, HC-8 and H3CC-8) by 3JHH correlations observed in the HH COSY 
spectrum.  
Assignment of the relative configuration of 216: 
The relative configurations of 216 was determined by analogy to the known 212 and by 
comparing 1H and 13C NMR data of 216 with those of the known 212 and 200 (Figure 2-38, Table 
2-38). Based on the established structures so far, it is clear that both (E,E) and (Z,Z)-bis 
enolborinates 215 and 222, respectively, followed a trend and produced adducts with a common 
relative configuration (i.e., 4,6-syn or 8,10-syn) under identical conditions. Similarly, (E,E)-215 
produced adducts with 3,4-anti relative configurations, while (Z,Z)-222 produced adducts with 
3,4-syn relative configurations irrespective of type of aldehydes. Based on this trend and analogy, 
the relative configuration of 216 was assumed as 3,4-anti-4,6-syn-8,10-syn-10,11-anti. This 
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assignment was further supported by comparing 1H and 13C NMR data of 216 with those of the 
known 212 and 200. The coupling constant 3JH3-H4 (J = 7.5 Hz), the 13C chemical shift of CH3C-4 
(𝞭C 14.4) and the difference in 13C chemical shifts (Δ𝞭C [C3, CH3C-4] = 61.0) for 216 are 
consistent with the observed trend from the database and with those of the known adducts 212 and 
200sa suggesting the relative configuration of 216 is 3,4-anti-4,6-syn (Table 2-38). The relative 
configurations of C6-C7 and C7-C8 should be unchanged from the starting diketone 202aa and 
were already confirmed as 6,7-anti-7,8-anti from the known 212. Because 216 is meso, the C3-
C11, C4-C10 and C6-C8 relative configurations in 216 must be syn. Thus, the relative 
configuration of 216 was assigned as 3,4-anti-4,6-syn-6,7-anti-7,8-anti-8,10-syn-10,11-anti. 
 
Figure 2-38: Assignment of the relative configuration of 216 by NMR comparison with the 
known compounds. 









from the same (E,E)-bis enolborinate
(∴ 4,6-syn by analogy)
11 !C (∴ Cs symmetric)
3JH3-H4 = 7.5 Hz
"C CH3C-4 = 14.4 ppm (∴ 3,4-anti)
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adduct 3JH2-H3 (Hz) 3JH3-H4 (Hz) Δ𝞭C (C3,CH3C-4) 𝞭C CH3C-4 
200as 8.8 1.9 68.2 8.5 
200ss 9.4 1.4 67.1 9.0 
200aa 5 7 64.6 14.3 
200sa 3.9 7.9 63.6 14.3 
212 3.5 7 64.0 14.2 
216 αH=3.5; βH=7.5 7.5 61.0 14.4 
 
Mono aldol 216a: 
Procedure for assignment of NMR spectra: 
The 1H NMR spectra of 216a can be divided in to four distinct ‘spin systems’ from analysis 
of its two-dimensional HH COSY NMR spectrum (Figure 2-40). The Et3Si and H2C10-H3C11 
proton spin systems are unique and were readily assigned in the COSY spectrum; the 13C chemical 
shifts of attached carbon atoms were identified based on the relevant 1JCH correlations observed in 
the HSQC spectrum. No attempt was made to distinguish between diastereotopic protons or 
carbons in these spin systems.  
The proton signals for HC-3 is readily differentiated by the 3JHH correlation to the OH 
protons and two adjacent groups (i.e., H2C-2, HC-4) (Figure 2-40). By analysis of the HH COSY 
spectrum and using the assigned HC-3 as an ‘anchor’ all the hydrogens in the spin system (i.e, 
HC-1, HC-2, HC-4, H3CC-4) were assigned. With the aid of these assigned protons, the attached 
carbons were assigned by analysis of the two-dimensional 1JCH correlation spectrum (gHSQC). 
Among the carbonyl carbons, C5 is readily distinguishable by 2JC5-HC4 and 3JC5-CH3C4 correlations 
observed in the HMBC spectrum (Figure 2-39). The HC-6 and H3CC-6 were assigned from 2JC5-
HC6 and 3JC5-CH3C6 correlations, respectively, observed in the HMBC spectrum. By analysis of the 
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HH COSY spectrum and using the assigned HC-6 as an ‘anchor’ all the hydrogens in the spin 
system (i.e, H3CC-6, HC-7, HC-8 and H3CC-8) were assigned. Although the assignment of C9 can 
be inferred after the assignment of the other carbonyl C5, the 2JC9-HC8 and 3JC9-CH3C8 correlations 
observed in the HMBC spectrum is additional evidence to support this assignment. The methylene 
protons H2C-10 are unique and were assigned using 1H chemical shift and multiplicity; this 
assignment was further supported by 2JC9-HC10 correlations observed in the HMBC spectrum. 
 
Figure 2-39: Key HMBC correlations (H➝C) in mono aldol 216a. 
Assignment of the relative configuration of 216a: 
The mono aldol 216a was obtained from an incomplete reaction of (E,E)-bis enolborinate 
215 with propanal suggesting 216a has same relative configuration as meso bisaldol 216 (arising 
from complete reaction of 215 with propanal) (Figure 2-40, Table 2-39). Similar to 216, the relative 
configuration of 216a was determined by analogy to the known 212 and by comparing 1H and 13C 
NMR data of 216a with those of the known adducts 212 and 200. The coupling constant 3JH3-H4 (J 
= 7.5 Hz), 13C chemical shift of CH3C-4 (𝞭C 14.4) and the difference in 13C chemical shifts (Δ𝞭C 
[C3, CH3C-4] = 61.4) values of 216a are consistent with the observed trend from the database and 
with those of the known adducts 212 and 200sa suggesting the relative configuration of 216a is 
3,4-anti-4,6-syn (Table 2-39). The relative configurations of C6-C7 and C7-C8 should be 
unchanged from the starting diketone 202aa and were already confirmed as 6,7-anti-7,8-anti from 














Figure 2-40: Assignment of the relative configuration of 216a by NMR comparison with the 
known compounds. 
Table 2-39: Comparison of the selected NMR data of 216a with those of the known 212 and 
200. 
adduct 3JH2-H3 (Hz) 3JH3-H4 (Hz) Δ𝞭C (C3,CH3C-4) 𝞭C CH3C-4 
200as 8.8 1.9 68.2 8.5 
200ss 9.4 1.4 67.1 9.0 
200aa 5 7 64.6 14.3 
200sa 3.9 7.9 63.6 14.3 
212 3.5 7 64.0 14.2 














3JH3-H4 = 7.5 Hz
!C CH3C-4 = 14.2 ppm
Δ!C C3,CH3C-4 = 61.4 ppm
(∴ 3,4-anti)
from the same (E,E)-bis enolborinate
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Meso bisaldol 224: 
The bisaldol 224 is Cs-symmetric as indicated by the presence of 11 resonances in the 13C 
NMR spectrum (Figure 2-41). NMR spectra of 224 was assigned by following the identical 
procedure used for 216.  
Similar to 216, the relative configuration of 224 was determined by analogy the known 223 
and by comparing 1H and 13C NMR data of 224 with those of the known adducts 223 and 200 
(Figure 2-41, Table 2-40). The coupling constant 3JH3-H4 (J = 2.0 Hz), 13C chemical shift of CH3C-
4 (𝞭C 9.4) and the difference in 13C chemical shifts (Δ𝞭C [C3, CH3C-4] = 62.6) for 224 are 
consistent with the observed trend from the database and with those of the known adducts 223 and 
200ss suggesting the relative configuration of 224 is 3,4-syn-4,6-syn. The relative configurations 
of C6-C7 and C7-C8 should be unchanged from the starting diketone 202aa and were already 
confirmed as 6,7-anti-7,8-anti from the known 223. Because 224 is meso the C3-C11, C4-C10 and 
C6-C8 relative configurations in 224 must be syn. Thus, the relative configuration of 224 was 




Figure 2-41: Assignment of the relative configuration of 224 by NMR comparison with the 
known compounds. 
Table 2-40: Comparison of the selected NMR data of 224 with those of the known 223 and 200. 
adduct 3JH2-H3 (Hz) 3JH3-H4 (Hz) Δ𝞭C (C3,CH3C-4) 𝞭C CH3C-4 
200aa 5.0 7.0 64.6 14.3 
200sa 3.9 7.9 63.6 14.3 
200as 8.8 1.9 68.2 8.5 
200ss 9.4 1.4 67.1 9.0 
223 9.5 1.5 66.7 9.2 






11 !C (∴ Cs symmetric)
3JH3-H4 = 2.0 Hz
"C CH3C-4 = 9.4 ppm
(∴ 3,4-syn)
from the same (Z,Z)-bis enolborinate




























































The bisaldol 216b is asymmetric as indicated by the presence of 19 resonances in the 13C 
NMR spectrum (Figure 2-43). NMR spectra of 216b was assigned by following the identical 
procedure used for 213. 
 
Figure 2-42: Key HMBC correlations (H➝C) in bisaldol 216b. 
Comparison of the NMR data between the known 13 diastereomers of 200, 212, 216, 224 
and 216b allowed assignment of the structure of 216b (Figure 2-43, Tables 2-41 and 2-42). The 
coupling constant 3JH3-H4 (7.5 Hz), the 13C chemical shift of CH3C-4 (𝞭C 14.4), and the differences 
in the 13C chemical shifts (Δ𝞭C [C3, CH3C-4] = 61.0) for the “spin system-A” of 216b closely 
match those of the known adducts 200sa, 212 and 216 suggesting that the relative configuration 
of the “spin system-A” in 216b is 3,4-anti-4,6-syn (Table 2-41). Similarly, the coupling constants 
3JH10-H11 (2.0 Hz), the 13C chemical shift of CH3C-10 (𝞭C 9.5), and the differences in 13C chemical 
shifts (Δ𝞭C [C11, CH3C-10] = 62.5) for “spin system-B” of 216b closely match those of the known 
adducts 200ss, 223 and 224 suggesting the relative configuration of the “spin system-B” in 216b 
is 8,10-syn-10,11-syn (Table 2-42). The relative configurations at C6-C7 and C7-C8 should be 
unchanged from the starting diketone 202aa and were already confirmed as 6,7-anti-7,8-anti from 
























for the “spin system-A”
3JH3-H4 = 7.5 Hz
!C CH3C-4 = 14.4 ppm
Δ!C C3, CH3C-4 = 61.0 ppm
(∴ 3,4-anti
4,6-syn)
3JH10-H11 = 2 Hz
!C CH3C-10 = 9.5 ppm
Δ!C C11, CH3C-10 = 62.5 ppm
(∴ 10,11-syn
8,10-syn)
for the “spin system-B”
from the same (E,E)-bis enolborinate
(∴ 4,6-syn and 8,10-syn)
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Table 2-41: Comparison of the selected NMR data of the “spin system-A” in 216b with those of 
the known 200, 212, and 216. 
adduct 3JH2-H3 (Hz) 3JH3-H4 (Hz) Δ𝞭C (C3,CH3C-4) 𝞭C CH3C-4 
200ss 9.4 1.4 67.1 9.0 
200as 8.8 1.9 68.2 8.5 
200aa 5 7 64.6 14.3 
200sa 3.9 7.9 63.6 14.3 
212 3.5 7 64.0 14.2 
216 αH=3.5; βH=7.5  7.5 61.0 14.4 
216b αH=3.0; βH=7.5  7.5 61.0 14.4 
 
Table 2-42: Comparison of the selected NMR data of the “spin system-B” in 216b with those of 
the known 200, 223, and 224. 
adduct 3JH2-H3 (Hz) 3JH3-H4 (Hz) Δ𝞭C (C3,CH3C-4) 𝞭C CH3C-4 
200aa 5.0 7.0 64.6 14.3 
200as 8.8 1.9 68.2 8.5 
200sa 3.9 7.9 63.6 14.3 
200ss 9.4 1.4 67.1 9.0 
223 9.5 1.5 66.7 9.2 
224 αH=5.0; βH=7.5  2.0 62.6 9.4 
216b αH=6.5; βH=7.5 
(3JH11-H12) 







3. SUMMARY AND CONCLUSIONS 
 
Although several research groups attempted synthesis of non-contiguous natural products 
via esterification approach or retro-Claisen rearrangement approach, only the Ward group 
accomplished syntheses of complex natural products baconipyrone A, baconipyrone C, 
dolabriferol and dolabriferol C from their putative contiguous precursors. Regioselective retro-
Claisen rearrangements of the precursors to these natural products under mild conditions (on 
exposure to neutral alumina) provide the first experimental evidence that support the proposed 
hypothesis on the origin of the so-called non-contiguous natural products and suggests these 
products are isolation artifacts. 
For the highly convergent total synthesis of 174, the putative contiguous precursor of 
dolabriferol C, a powerful sequential enantiotopic group selective (SEGS) bisaldol strategy was 
established. For the first time, stereoselective syntheses of meso bisenolates (E,E and Z,Z) 215, 
222 and 220 were achieved from meso diketones 202aa and 202ss, respectively and were 
successfully used in stereoselective aldol reactions. Several mono and bisaldols (meso, racemic 
and enantioenriched) were prepared by establishing internal and external EGS aldol reactions 
using meso diketones 202aa and 202ss. SEGS bisaldol reaction of meso diketones 202aa and 202ss 
with aldehyde (−)-109 (via enantioselective desymmetrization) and then with aldehyde (±)-159 
(via kinetic resolution) generated the enantioenriched bisaldols (+)-241 and (−)-243, respectively, 
and sets the absolute configuration of eight stereocenters in a one-pot process. This remarkable 
process is the first example where eight stereocenters (absolute configurations) were generated 
from a coupling of meso, racemic and enantioenriched reactants in a one-pot process. Using this 
strategy, the desired bisaldol 252ssa that has the full carbon skeleton of the precursor 174 was 
prepared. An alternative stereoselective bisaldol reaction of diketone 202aa with enantioenriched 
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aldehydes (−)-109 and (+)-159 gave the desired bisaldol 252ssa with improved yield and 
diastereoselectivity. This strategy allowed access to the natural products dolabriferol (15) and 
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4.1. General Methods 
Anhydrous solvents were distilled under argon atmosphere as follows:  tetrahydrofuran 
(THF) from benzophenone sodium ketyl; CH2Cl2 from CaH2; MeOH from Mg(OMe)2; acetonitrile 
(CH3CN) from CaH2 and stored over 4 Å molecular sieves; DMSO from CaH2 under reduced 
pressure; DMF over P2O5 and stored over 4 Å molecular sieves.  All experiments involving air- 
and/or moisture-sensitive compounds were conducted in an oven dried round-bottom flask capped 
with a rubber septum and attached via a needle and connecting tubing to a mercury bubbler under 
argon atmosphere.  Low temperature baths were ice/water (0 °C), CO2(s)/acetonitrile (−42 °C) and 
CO2(s)/acetone (−78 °C). Concentration refers to removal of volatiles at water aspirator pressure 
on a rotary evaporator. Evacuation at ca. 0.1 torr with a vacuum pump generally followed rotary 
evaporation.  
Preparative TLC was carried out on glass plates (20x20 cm) pre-coated (0.25 mm) with 
silica gel 60 F254.  Materials were detected by visualization under an ultraviolet lamp (254 nm) 
and/or by treating a 1 cm vertical strip removed from the plate with a solution of phosphomolybdic 
acid (PMA) solution [PMA (40 g), Ce(SO4)2 (10 g) and H2SO4 (50 mL) and diluted to 1 L with 
water] followed by charring on a hot plate.  Flash column chromatography (FCC) was performed 
according to Still et al.116 with Merck Silica Gel 60 (40-63 mm). All mixed solvent eluents are 
reported as v/v solutions. Unless otherwise noted, all reported compounds were homogeneous by 
thin layer chromatography (TLC) and by 1H NMR spectroscopy.  
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4.2. Spectral Data 
High resolution mass spectra (HRMS) were obtained on a JEOL AccuTOF 4G GCv Mass 
spectrometer using field desorption (FD) ionization or a QSTAR XL MS/MS Mass spectrometer 
using electrospray ionization (ESI) method; only partial data are reported. Alternatively, HRMS 
was obtained on a LC-MS/MS time-of-flight high resolution spectrometer with electrospray 
ionization (ESI) from methanol solution. Infrared spectra were recorded on a Bio-Rad FTS-40 
Fourier transform interferometer using a diffuse reflectance cell (DRIFT); only diagnostic and/or 
intense peaks are reported.  
The NMR solvent CDCl3 was passed through small plug of basic alumina prior to use. 
Unless otherwise noted, NMR spectra were measured in CDCl3 or C6D6 solution at 500 MHz for 
1H and 125 MHz for 13C. Signals due to the solvent (13C NMR) or residual protonated solvent (1H 
NMR) served as the internal standard: CDCl3 (7.26 δH, 77.23 δC); C6D6 (7.16 δH, 128.39 δC). 
The 1H NMR chemical shifts and coupling constants were determined assuming first-order 
behavior. Multiplicity is indicated by one or more of the following: s (singlet), d (doublet), t 
(triplet), q (quartet), m (multiplet), br (broad), ap (apparent); the list of couplings constants (J) 
corresponds to the order of the multiplicity assignment. Coupling constants are reported to the 
nearest 0.5 Hz (consistent with the digital resolution of ca. 0.2 Hz/pt). The NMR assignments were 
made on the basis of chemical shifts, coupling constants (J) and multiplicity and were confirmed, 
where necessary, by homonuclear decoupling and/or two-dimensional correlation experiments 
(gCOSY, gHSQC, gHMBC).117 The multiplicity of 13C NMR signals refers to the number of H's 
attached (i.e., s = C, d = CH, t = CH2, q = CH3) and was determined by gHSQC. 
 Specific rotations ([α]D) are the average of five determinations at ambient temperature on 
a Rudolph Digipol 781 polarimeter using a 1 mL, 10 dm cell; the units are 10-1 deg cm2 g-1 and 
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the concentrations (c) are reported in g/100 mL. The values reported are rounded to reflect the 
accuracy of the measured concentrations (the major source of error). HPLC analyses were carried 
out using a normal phase Agilent Technologies 1200 series liquid chromatograph using chiralpak® 
IB column or chiralpak® IC column (column size: 150 x 2.1 mm (L x I.D.); particle size: 5 um), 
eluted with 1% or 2% isopropanol in hexanes. 
 
4.3. Materials 
The following compounds and reagents were prepared as described previously: 
109,78 110,45 (+)-128,17 130aa,42 130ss,42 159,42 W-2 Raney® nickel,118 IBX,119 DMP (from 
IBX),120 benzyl cyanoformate,83 c-Hex2BCl.121 n-Butylithium and t-Butylithium were titrated 
using diphenyl acetic acid as the titrant and indicator. Et3N, i-Pr2NEt and i-Pr2NH were distilled 
from CaH2 under argon and stored over KOH. All other reagents were commercially available and, 
unless otherwise noted, were used as received. 
 
4.4. Experimental Procedures and Characterization Data 
4.4.1. Compounds synthesized from methodology project 
 
AA-TES-(E,E)-bisborinate (215) 
General procedure for aldol reactions of 202aa via its (2E,7E)-dien-3,7-yl 
bis(dicyclohexylborinate). c-Hex2BCl (1.0 M in hexane; 4 equiv) was added via syringe to a 







After 3 h, the mixture was cooled to –78 °C and the aldehyde was added. After the indicated aldol 
reaction time and temperature, the reaction was quenched by sequential addition of phosphate 
buffer (pH 7; 6 mL/mmol of boron), MeOH (6 mL/mmol of boron), and 30% aq H2O2 (3 mL/mmol 
of boron) with vigorous stirring. The reaction vessel was transferred to an ice bath and after 
vigorous stirring for 15 min, the mixture was diluted with water and extracted with CH2Cl2. The 
combined organic layers were dried over Na2SO4 and concentrated to give the crude product that 
was analyzed by 1H NMR and then fractionated. 
 
AA-TES-(Z,Z)-bisborinate (222) 
General procedure for aldol reactions of 202aa via its (2Z,7Z)-2,7-dien-3,7-diyl bis(9-
borabicyclo[3.3.1]nonan-9-ylborinate). 9-BBNOTf (0.5 M in hexane; 0.50 mL, 0.25 mmol) was 
added via syringe to a stirred solution of 202aa (20 mg, 0.064 mmol) and Et3N (0.044 mL, 31 mg, 
0.31 mmol) in Et2O (0.2 mL) at –78 °C under argon. After 4 h, aldehyde (4-10 equiv) was added. 
After 3 h, the reaction was quenched by sequential addition of phosphate buffer (pH 7; 0.5 mL), 
30% aq H2O2 (0.5 mL), and MeOH (0.5 mL) with vigorous stirring. The reaction vessel was 
transferred to an ice bath and after vigorous stirring for 15 min, the mixture was diluted with water 
and extracted with CH2Cl2. The combined organic layers were dried over Na2SO4 and concentrated 












General procedure for aldol reactions of 202ss via its (2E,7E)-dien-3,7-yl 
bis(dicyclohexylborinate). c-Hex2BCl (1.0 M in hexane; 4 equiv) was added via syringe to a clean 
dry Schlenk tube containing a magnetic stir bar, and the hexane was removed under reduced 
pressure. A solution of Et3N (5 equiv) and 202ss (20 mg, 0.064 mmol) in CH2Cl2 (0.10 mL) was 
added via syringe to the neat borane reagent with stirring at –78 °C under argon. After 3 h, the 
aldehyde was added. After the indicated aldol reaction time and temperature, the reaction was 
quenched by sequential addition of phosphate buffer (pH 7; 6 mL/mmol of boron), MeOH (6 
mL/mmol of boron), and 30% aq H2O2 (3 mL/mmol of boron) with vigorous stirring. The reaction 
vessel was transferred to an ice bath and after vigorous stirring for 15 min, the mixture was diluted 
with water and extracted with CH2Cl2. The combined organic layers were dried over Na2SO4 and 




A solution of (–)-(S)-23965 ([α]D = –25 (c 1.0, CHCl3); er >50:1 (HPLC); 10-15 mg, 0.052-0.079 
mmol) in water-saturated CH2Cl2 (0.1 M) was added to a stirring suspension of MgO (10 equiv) 
and Dess-Martin periodinane (DMP) (1.5 equiv) in water-saturated CH2Cl2 (0.15 M in DMP). 
After 10 min, Et2O (ca. 2× the volume of CH2Cl2) was added and a white precipitate formed. A 
solution made up of saturated NaHCO3 (0.8 mL) and Na2S2O3 (0.2 g) diluted to 2 mL with water 
was added to the stirring reaction mixture resulting in two layers. The aqueous phase was extracted 












title compound as pale yellow oil (>95%) that was immediately used in the aldol reaction. An 
analogous reaction of (±)-239 (32 mg, 0.17 mmol) gave a (±)-109 (31 mg, 97%) whose 1H NMR 




Anhydrous FeCl3 (147 mg, 0.91 mmol) was added to a stirring solution of 130aa (1.1 g, 
4.5 mmol) in acetone (40 mL). After 30 min, most of the acetone was removed under reduced 
pressure and the remaining mixture was taken up in CH2Cl2 and transferred to a separatory funnel. 
The mixture was washed sequentially with saturated aq NaHCO3 and brine, dried over Na2SO4, 
and concentrated to give the title compound (870 mg, 97%). 
colorless oil, TLC Rf = 0.3 (30% ethyl acetate in hexane). 
IR (DRIFT) vmax 3487, 1710, 1698 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 3.65 (1H, dt, J = 9, 6 Hz, HC-5), 3.60 (1H, d, J = 9 Hz, HO), 2.70 
(2H, dq, J = 6, 7 Hz, HC-4 & HC-6), 2.52 (2H, dq, J = 18.5, 7.5 Hz, HC-2 & HC-8), 2.43 (2H, dq, 
J = 18.5, 7.5 Hz, HC-2 & HC-8), 1.09 (6H, d, J = 7 Hz, H3CC-4 & H3CC-6), 0.98 (6H, t, J = 7.5 
Hz, H3C-1 & H3C-9). 
13C NMR (125 MHz, CDCl3) δ 216.2 (s ×2, C-3 & C-7), 77.0 (d, C-5), 48.4 (d ×2, C-4 & C-6), 











FeCl3 (25 mg, 0.15 mmol) was added to a stirring solution of 130ss (180 mg, 0.74 mmol) 
in acetone (8 mL). After 30 min, the reaction mixture was concentrated under reduced pressure 
and the residue was taken up in CH2Cl2 and then washed sequentially with saturated aq NaHCO3 
and brine, dried over Na2SO4 and concentrated to give the title compound as colorless oil (143 mg, 
97%). 
pale yellow liquid, TLC Rf = 0.40 (35% ethyl acetate in hexane). 
IR (DRIFT) vmax 3509, 1702 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.10 (1H, dt, J = 2.5, 5.5 Hz, HC-5), 3.14 (1H, d, J = 2.5 Hz, HO), 
2.66 (2H, dq, J = 5.5, 7 Hz, HC-4 & HC-6), 2.55 (2H, dq, J = 18, 7 Hz, HC-2 & HC-8), 2.43 (2H, 
dq, J = 18, 7 Hz, HC-2 & HC-8), 1.16 (6H, d, J = 7 Hz, H3CC-4 & H3CC-6), 1.04 (6H, t, J = 7 Hz, 
H3C-1 & H3C-9). 
13C NMR (125 MHz, CDCl3) δ 215.7 (s ×2, C-3 & C-7), 71.4 (d, C-5), 48.0 (d ×2, C-4 & C-6), 
35.3 (t ×2, C-2 & C-8), 12.3 (q ×2, H3CC-4 & H3CC-6), 7.8 (q ×2, C-1 & C-9). 










PhCH2OCH2Cl (BOM-Cl) (ca. 80% (w/w), mainly contaminated with BnCl and Bn2O; 145 
mg, ca. 0.74 mmol of BOM-Cl) was added to a stirring solution of 178aa (126 mg, 0.63 mmol) 
and iPr2EtN (0.28 mL, 204 mg, 1.6 mmol) in DMF (3 mL) at room temperature under argon. After 
20 h, iPr2EtN and PhCH2OCH2Cl (same amounts as above) were added. After 5 h (reaction 
complete by TLC analysis), the reaction was quenched by addition of methanol (1.5 mL). After 1 
h, the mixture was diluted with ethyl acetate and washed sequentially with saturated aq NH4Cl, 
water and brine, dried over Na2SO4, concentrated, and fractionated by FCC (15% ethyl acetate in 
hexane) to give the title compound (173 mg, 86%). 
colorless oil, TLC Rf = 0.3 (15% ethyl acetate in hexane). 
IR (DRIFT) vmax 1711 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 7.36-7.26 (5H, m, Ph), 4.70 (2H, s, H2CO2), 4.53 (2H, s, H2CPh), 
4.22 (1H, t, J = 6.5 Hz, HC-5), 2.91 (2H, dq, J = 6.5, 7 Hz, HC-4 & HC-6), 2.52 (4H, ap q, J = 7 
Hz, H2C-2 & H2C-8), 1.03 (6H, t, J = 7 Hz, H3C-1 & H3C-9), 1.02 (6H, d, J = 7 Hz, H3CC-4 & 
H3CC-6). 
13C NMR (125 MHz, CDCl3) δ 213.1 (s ×2, C-3 & C-7), 137.7 (s, Ph), 128.6 (d ×2, Ph), 128.98 
(d ×2, Ph), 127.96 (d, Ph), 95.6 (t, OCH2O), 81.5 (d, C-5), 70.3 (t, CH2Ph), 48.8 (d ×2, C-4 & C-
6), 35.9 (d ×2, C-2 & C-8), 12.2 (q ×2, CH3C-4 & CH3C-6), 7.8 (q ×2, C-1 & C-9). 










Imidazole (196 mg, 2.87 mmol) and Et3SiCl (0.41 ml, 371 mg, 2.46 mmol) were 
sequentially added to a stirring solution of 178aa (410 mg, 2.05 mmol) at room temperature. After 
45 min, the reaction mixture was diluted with Et2O and washed sequentially with aq citric acid 
(0.2 M) and brine, dried over Na2SO4, concentrated, and fractionated by FCC (5% ethyl acetate in 
hexane) gave the title compound (612 mg, 95%). 
colorless oil, TLC Rf = 0.5 (5% ethyl acetate in hexane). 
IR (DRIFT) vmax 1715 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.32 (1H, t, J = 6 Hz, HC-5), 2.68 (2H, dq, J = 6, 7 Hz, HC-4 & 
HC-6), 2.49 (4H, ap q, J = 7 Hz, HC-2 & HC-8), 1.02 (6H, t, J = 7 Hz, H3C-1 & H3C-9), 0.98 (6H, 
d, J = 7 Hz, H3CC-4 & H3CC-6), 0.92 (9H, t, J = 8 Hz, H3CCSi ×3), 0.57 (6H, q, J = 8 Hz, H2CSi 
×3). 
13C NMR (125 MHz, CDCl3) δ 213.3 (s ×2, C-3 & C-7), 75.7 (d, C-5), 50.9 (d ×2, C-4 & C-6), 
36.1 (d ×2, C-2 & C-8), 12.4 (q ×2, CH3C-4 & CH3C-6), 7.7 (q ×2, C-1 & C-9), 7.1 (q ×3, CH3CSi), 
5.2 (t ×3, CH2Si). 










Imidazole (92 mg, 1.4 mmol) and Et3SiCl (0.19 mL, 170 mg, 0.75 mmol) were sequentially 
added to a stirring solution of 178ss (150 mg, 0.75 mmol) in DMF (2.0 mL) at 0 °C under argon. 
The ice bath was removed and the mixture was allowed to warm to ambient temperature. After 3 
h, the mixture was diluted with ethyl acetate and washed sequentially with saturated aq NH4Cl and 
brine, dried over Na2SO4, concentrated, and fractionated by FCC (5% ethyl acetate in hexane) to 
afford the titled compound (229 mg, 97%). 
colorless liquid, TLC Rf = 0.32 (5% ethyl acetate in hexane). 
IR (DRIFT) vmax 1709 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.31 (1H, t, J = 5.5 Hz, HC-5), 2.63 (2H, dq, J = 5.5, 7 Hz, HC-4 
& HC-6), 2.56 (2H, dq, J = 18, 7 Hz, HC-2 & HC-8), 2.46 (2H, dq, J = 18, 7 Hz, HC-2 & HC-8), 
1.024 (6H, t, J = 7 Hz, H3C-1 & H3C-9), 1.017 (6H, d, J = 7 Hz, H3CC-4 & H3CC-6), 0.95 (9H, t, 
J = 8 Hz, H3CCSi ×3), 0.60 (6H, q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 213.8 (s ×2, C-5 & C-7), 73.7 (d, C-5), 50.6 (d ×2, C-4 & C-6), 
35.8 (t ×2, C-2 & C-8), 13.0 (q ×2, CH3C-4 & CH3C-6), 7.8 (q ×2, C-1 & C-9), 7.2 (q ×3, CH3CSi), 
5.4 (t ×3, CH2Si). 











c-Hex2BCl (1.0 M in hexane; 0.19 mL, 0.19 mmol) was added to a stirring solution of 
201aa (20 mg, 0.063 mmol) and Et3N (0.032 mL, 0.14 g, 0.23 mmol) in CH2Cl2 (0.2 mL) at –42 
°C under argon. After 3 h, the mixture was cooled to –78 °C and iPrCHO (0.57 mL, 45 mg, 0.63 
mmol) was added. After 3 h, the reaction was quenched by sequential addition of phosphate buffer 
(pH 7; 0.3 mL), MeOH (0.5 mL), and 30% aq H2O2 (0.3 mL) with vigorous stirring. The reaction 
vessel was transferred to an ice bath and after vigorous stirring for 15 min, the mixture was diluted 
with water and extracted with CH2Cl2. The combined organic layers were dried over Na2SO4 and 
concentrated to give the crude product whose 1H NMR spectrum indicated the presence of a 1.8:1 
mixture of 209 and 210, respectively. Fractionation of the crude product by FCC (20% ethyl 
acetate in hexane) gave 210 (9.5 mg; ca. 85% pure) and the title compound (16 mg, 55%). 
colorless viscous oil, TLC Rf = 0.35 (20% ethyl acetate in hexane). 
IR (DRIFT) vmax 3501, 1707 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 7.34-7.27 (5H, m, Ph), 4.75 (2H, s, H2CO2), 4.57 (2H, s, H2CPh), 
4.34 (1H, t, J = 6 Hz, HC-7), 3.48 (2H, ddd, J = 4, 5.5, 8 Hz, HC-3 & HC-11), 3.22 (2H, dq, J = 
6, 7 Hz, HC-6, HC-8), 2.93 (2H, dq, J = 8, 7 Hz, HC-4 & HC-10), 2.63 (2H, d, J = 5.5 Hz, HO 










1.02 (6H, d, J = 7 Hz, H3CC-4 & H3CC-10), 0.96 (6H, d, J = 7 Hz, H3C-1 & H3C-13), 0.89 (6H, 
d, J = 7 Hz, H3C-1' & H3C-13'). 
13C NMR (125 MHz, CDCl3) δ 217.7 (s ×2, C-5 & C-9), 137.6 (s, Ph), 128.7 (d ×2, Ph), 128.1 (d 
×2, Ph), 128.0 (d, Ph), 96.2 (t, OCH2O), 81.5 (d, C-7), 78.3 (d ×2, C-3 & C-11), 70.5 (t, CH2Ph), 
49.3 (d ×2, C-4 & C-10), 49.0 (d ×2, C-6 & C-8), 29.9 (d ×2, C-2 & C-12), 20.3 (q ×2, CH3-1 & 
CH3-13), 15.3 (q ×2, CH3-1' & CH3-13'), 14.4 (q ×2, CH3C-4 & CH3C-10), 12.2 (q ×2, CH3C-6 & 
CH3C-8). 
HRMS m/z calcd for C27H44O6+Na+ 487.3030, found 487.3009 (ESI). 
 
  210 
(3R,4R,6S,7R,8R,10R,11R)-7-((Benzyloxy)methoxy)-3,11-dihydroxy-2,4,6,8,10,12-
hexamethyltridecane-5,9-dione (210) 
For procedure, see the preparation of 209. 
colorless viscous oil, TLC Rf = 0.3 (20% ethyl acetate in hexane). 
IR (DRIFT) vmax 3553, 1707 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 7.34-7.28 (5H, m, Ph), 4.75 (1H, d, J = 7 Hz, HCO2), 4.73 (1H, d, 
J = 7 Hz, HCO2), 4.58 (1H, d, J = 11.5 Hz, CHPh), 4.55 (1H, d, J = 11.5 Hz, CHPh), 4.30 (1H, 
dd, J = 6, 6.5 Hz, HC-7), 3.49 (1H, ddd, J = 4, 5.5, 8 Hz, HC-3), 3.45 (1H, ddd, J = 4, 7, 7.5 Hz, 









8, 7 Hz, HC-4), 2.93 (1H, dq, J = 7.5, 7 Hz, HC-10), 2.67 (1H, d, J = 5.5 Hz, HOC-3), 2.25 (1H, 
d, J = 7 Hz, HOC-11), 1.77 (1H, dqq, J = 4, 7, 7 Hz, HC-12), 1.72 (1H, dqq, J = 4, 7, 7 Hz, HC-
2), 1.07 (3H, d, J = 7 Hz, H3CC-8), 1.06 (3H, d, J = 7 Hz, H3CC-4), 1.04 (3H, d, J = 7 Hz, H3CC-
6), 1.02 (3H, d, J = 7 Hz, H3CC-10), 0.97 (3H, d, J = 7 Hz, H3C-13), 0.93 (3H, d, J = 7 Hz, H3C-
1), 0.90 (3H, d, J = 7 Hz, H3C-13), 0.84 (3H, d, J = 7 Hz, H3C-1) (* assignments may be reversed). 
13C NMR (125 MHz, CDCl3) δ 217.9 (s, C-5), 217.1 (s, C-9), 137.7 (s, Ph), 128.7 (d ×2, Ph), 
128.1 (d ×2, Ph), 128.0 (d, Ph), 95.9 (t, OCH2O), 80.6 (d, C-7), 78.7 (d, C-11), 78.4 (d, C-3), 70.5 
(d, CH2Ph), 50.2 (d, C-8*), 49.3 (d, C-4), 48.9 (d, C-6*), 48.2 (d, C-10), 30.2 (d, C-12), 29.9 (d, 
C-2), 20.3 (q, C-1'), 20.2 (q, C-13), 15.3 (q, C-13'), 15.2 (q, C-1), 14.4 (q, CH3C-4), 14.1 (q, CH3C-
10), 12.6 (q, CH3C-6), 11.6 (q, CH3C-8) (* assignments may be reversed). 





iPrCHO (0.175 mL, 138 mg, 1.9 mmol) was added via syringe to a stirring solution of the 
(E,E)-215, prepared from 202aa (60 mg, 0.19 mmol) according to the general procedure, at –78 
°C under Ar. After 24 h, the reaction was quenched and processed as described in the general 
procedure to give the crude product whose 1H NMR spectrum suggested the presence of a 85:7:5:3 










(20% ethyl acetate in hexane) gave 213 (3.5 mg, 4%), 214 (4.5 mg, 6%), and the title compound 
(71 mg, 81%). 
colorless viscous oil, TLC Rf = 0.3 (15% ethyl acetate in hexane). 
IR (DRIFT) vmax 3470, 1716 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.64 (1H, t, J = 6 Hz, HC-7), 3.48 (2H, ddd, J = 3.5, 5, 8 Hz, HC-
3 & C-11), 3.03 (2H, dq, J = 6, 7 Hz, HC-6 & HC-8), 2.90 (2H, dq, J = 8, 7 Hz, HC-4 & HC-10), 
2.75 (2H, d, J = 5 Hz, HO ×2), 1.77 (2H, dqq, J = 3.5, 6.5, 7 Hz, HC-2 & HC-12), 1.01 (12H, ap 
d, J = 7 Hz, H3CC-4 & H3CC-6, H3CC-8 & H3CC-10), 0.98 (6H, d, J = 6.5 Hz, H3C-1 & H3C-13), 
0.96 (9H, t, J = 8 Hz, H3CCCSi ×3), 0.89 (6H, d, J = 7 Hz, H3C-1' & H3C-13'), 0.63 (6H, q, J = 8 
Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 217.3 (s ×2, C-5 & C-9), 78.2 (d ×2, C-3 & C-11), 74.0 (d , C-7), 
51.3 (d ×2, C-6 & C-8), 48.9 (d ×2, C-4 & C-10), 29.7 (d ×2, C-2 & C-12), 20.3 (q ×2, C-1 & C-
13), 14.8 (q ×2, C-1' & C-13'), 14.2 (q ×2, CH3C-4 & CH3C-10), 11.6 (q ×2, CH3C-6 & CH3C-8), 
7.0 (q ×3, CH2Si), 5.1 (t ×3, CH3CSI). 
HRMS m/z calcd for C25H50O5Si+Na+ 481.3305, found 481.3319 (ESI). 
 











iPrCHO (0.116 mL, 92 mg, 1.3 mmol) was added via syringe to a stirring solution of the 
(E,E)-215, prepared from 202aa (40 mg, 0.13 mmol) according to the general procedure, at –78 
°C under Ar. After 3 h, the reaction vessel was removed from the cool bath. After 30 min, the 
reaction vessel was transferred to an ice bath and the reaction was quenched and processed as 
described in the general procedure. Fractionation of the crude product by FCC (20% ethyl acetate 
in hexane) gave 212 (45 mg, 77%) and the title compound (5 mg, 9%). 
colorless viscous oil, TLC Rf = 0.3 (20% ethyl acetate in hexane). 
IR (DRIFT) vmax 3517, 1699 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.48 (1H, t, J = 6 Hz, HC-7), 3.50 (1H, ddd, J = 3.5, 5, 8 Hz, HC-
3), 3.50 (1H, ddd, J = 1.5, 2, 9 Hz, HC-11), 3.23 (1H, d, J = 2 Hz, HOC-11), 3.03 (1H, dq, J = 6, 
7 Hz, HC-6), 3.00 (1H, dq, J = 6, 7 Hz, HC-8), 2.90 (1H, dq, J = 8, 7 Hz, HC-4), 2.88 (1H, dq, J 
= 1.5, 7.5 Hz, HC-10), 2.62 (1H, d, J = 5 Hz, HOC-3), 1.78 (1H, dqq, J = 3.5, 7, 7 Hz, HC-2), 1.67 
(1H, dqq, J = 9, 7, 7 Hz, HC-12), 1.13 (3H, d, J = 7.5 Hz, H3CC-10), 1.04 (3H, d, J = 7 Hz, H3C-
13), 1.02 (3H, d, J = 7 Hz, H3CC-4), 1.01 (6H, br d, J = 7 Hz, H3CC-6 & H3CC-8), 0.99 (3H, d, J 
= 7 Hz, H3C-1), 0.96 (9H, t, J = 8 Hz, H3CCSi ×3), 0.90 (3H, d, J = 7 Hz, H3C-1'), 0.84 (3H, d, J 
= 7 Hz, H3C-13'), 0.62 (6H, ap q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 218.6 (s, C-9), 217.2 (s, C-5), 78.1 (d, C-3), 75.9 (d, C-11), 75.0 
(d, C-7), 51.1 (d, C-6), 49.5 (d, C-8), 49.1 (d, C-4), 47.2 (d, C-10), 30.5 (d, C-12), 29.7 (d, C-2), 
20.3 (q, C-1), 19.9 (q, C-13), 18.9 (q, C-13'), 14.8 (q, C-1'), 14.2 (q, CH3C-4), 12.1 (q, CH3C-8), 
11.9 (q, CH3C-6), 9.2 (q, CH3C-10), 7.1 (q ×3, CH3CSi), 5.2 (t ×3, CH2Si). 




   214 
(4S,5R,6R,8S,9S)-rel-9-Hydroxy-4,6,8,10-tetramethyl-5-((triethylsilyl)oxy)undecane-3,7-
dione (214) 
For preparation, see the preparation of 212. Characterization data. 
colorless viscous oil, TLC Rf = 0.5 (15% ethyl acetate in hexane). 
IR (DRIFT) vmax 3544, 1714 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.49 (1H, dd, J = 6, 6 Hz, HC-5), 3.48 (1H, ddd, J = 3.5, 4.5, 8 Hz, 
HC-9), 3.00 (1H, dq, J = 6, 7 Hz, HC-6), 2.87 (1H, dq, J = 8, 7 Hz, HC-8), 2.76 (1H, dq, J = 6, 7 
Hz, HC-4), 2.75 (1H, d, J = 4.5 Hz, HO), 2.57-2.45 (2H, m, H2C-2), 1.78 (1H, dqq, J = 3.5, 7, 7 
Hz, HC-10), 1.05 (3H, d, J = 7 Hz, CH3C-4), 1.04 (3H, t, J = 7.5 Hz, H3C-1), 1.01 (3H, d, J = 7 
Hz, H3CC-8), 0.99 (3H, d, J = 7 Hz, H3C-11), 0.95 (3H, d, J = 7 Hz, H3CC-6), 0.95 (9H, t, J = 8 
Hz, H3CCSi ×3), 0.90 (3H, d, J = 7 Hz, H3C-11'), 0.62 (6H, ap q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 218.0 (s, C-7), 212.6 (s, C-3), 78.3 (d, C-9), 75.2 (d, C-5), 51.4 (d, 
C-4), 50.8 (d, C-6), 49.2 (d, C-8), 35.8 (t, C-2), 29.7 (d, C-10), 20.4 (q, C-11), 14.7 (q, C-11'), 14.0 
(q, CH3C-8), 12.5 (q, CH3C-6), 11.4 (q, CH3C-4), 7.8 (q, C-1), 7.1 (q ×3, CH3CSi), 5.1 (t ×3, 
CH2Si). 












EtCHO (0.140 mL, 111 mg, 1.9 mmol) was added via syringe to a stirring solution of the 
(E,E)-215, prepared from 202aa (60 mg, 0.19 mmol) according to the general procedure, at –78 
°C under Ar. After 24 h, the reaction was quenched and processed as described in the general 
procedure to give the crude product whose 1H NMR spectrum suggested the presence of a 
82:5:3:4:1 mixture of 216, 216b, 10-epi-216b, 216a, and 202aa, respectively. Fractionation of the 
crude product by FCC (20% ethyl acetate in hexane) gave a 1.6:1 mixture of  216b, 10-epi-216b 
(5 mg, 6%), 216a (5 mg, 7%), and the title compound (60 mg, 73%). 
colorless viscous oil, TLC Rf = 0.3 (20% ethyl acetate in hexane). 
IR (DRIFT) vmax 3459, 1710 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.59 (1H, t, J = 6 Hz, HC-7), 3.58 (2H, dddd, J = 3, 5, 7.5, 7.5 Hz, 
HC-3 & HC-11), 3.02 (2H, dq, J = 6, 7 Hz, HC-6 & HC-8), 2.93 (2H, d, J = 5 Hz, HO ×2), 2.79 
(2H, dq, J = 7.5, 7 Hz, HC-4 & HC-10), 1.60 (2H, ddq, J = 3,14, 7.5 Hz, HC-2 & HC-12), 1.41 
(2H, ddq, J = 7.5,14, 7.5 Hz, HC-2 & HC-12), 1.06 (6H, d, J = 7 Hz, H3CC-4 & H3CC-10), 1.01 
(6H, d, J = 7 Hz, H3CC-6 & H3CC-8), 0.98 (6H, t, J = 7.5 Hz, H3C-1 & H3C-13), 0.96 (9H, t, J = 
8 Hz, H3CCSi ×3), 0.64 (6H, q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 217.0 (s ×2, C-5 & C-9), 75.4 (d ×2, C-3 & C-11), 74.3 (d , C-7), 
51.1 (d ×2, C-6 & C-8), 50.9 (d ×2, C-4 & C-10), 27.4 (t ×2, C-2 & C-12), 14.4 (q ×2, CH3C-4 & 
OOH HOO O
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CH3C-10), 11.7 (q ×2, CH3C-6 & CH3C-8), 9.8 (q ×2, C-1 & C-11), 7.0 (q ×3, CH3CSi), 5.1 (t ×3, 
CH2Si). 





For preparation, see the preparation of 216.  
colorless oil, TLC Rf = 0.3 (15 % ethyl acetate in hexane). 
IR (DRIFT) vmax 3523, 1713 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.48 (1H, dd, J = 6, 6 Hz, HC-5), 3.58 (1H, dddd, J = 3, 4.5 8, 8 
Hz, HC-9), 3.00 (1H, dq, J = 6, 7.0 Hz, HC-6), 2.94 (1H, d, J = 4.5 Hz, HO), 2.78 (1H, dq, J = 8, 
7 Hz, HC-8), 2.75 (1H, dq, J = 6, 7 Hz, HC-4), 2.58-2.45 (2H, m, H2C-2), 1.61 (1H, ddq, J = 3, 
14, 7.5 Hz, HC-10), 1.42 (1H, ddq, J = 8, 14, 7.5 Hz, HC-10), 1.05 (3H, d, J = 7 Hz, H3CC-8), 
1.04 (3H, d, J = 7 Hz, H3CC-4), 1.04 (3H, t, J = 7.5 Hz, H3C-1), 0.98 (3H, t, J = 7.5 Hz, H3C-11), 









13C NMR (125 MHz, CDCl3) δ 217.8 (s, C-7), 212.6 (s, C-3), 75.6 (d, C-9), 75.2 (d, C-5), 51.4 (d, 
C-4), 51.0 (d, C-8), 50.7 (d, C-6), 35.8 (t, C-2), 27.4 (t, C-10), 14.2 (q, CH3C-8), 12.5 (q, CH3C-
6), 11.4 (q, CH3C-4), 9.7 (q, C-11), 7.8 (q, C-1), 7.0 (q ×3, CH3CSi), 5.1 (t ×3, CH2Si). 





EtCHO (0.091 mL, 74 mg, 1.3 mmol) was added via syringe to a stirring solution of the 
(E,E)-215, prepared from 202aa (40 mg, 0.13 mmol) according to the general procedure, at –78 
°C under Ar. After 3 h, the reaction vessel was removed from the cool bath. After 30 min, the 
reaction vessel was transferred to an ice bath and the reaction was quenched and processed as 
described in the general procedure. Fractionation of the crude product by FCC (20% ethyl acetate 
in hexane) gave 216 (27 mg, 49%) and the title compound as a 3:1 mixture with 10-epi-216b 
(tentatively identified) (7 mg, 13%). 
colorless viscous oil, TLC Rf = 0.3 (20% ethyl acetate in hexane). 
IR (DRIFT) vmax 3472, 1701 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.47 (1H, dd, J = 6, 6.5 Hz, HC-7), 3.86 (1H, ddd, J = 6.5, 7, 8 Hz, 
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6, 7 Hz, HC-6 or HC-8), 2.99 (1H, dq, J = 6, 7 Hz, HC-8 or HC-6), 2.85-2.75 (2H, m, HOC-3 & 
HC-4), 2.72 (1H, br q, J = 7 Hz, HC-10), 1.68-1.50 (2H, m, HC-2 & HC-12), 1.48-1.30 (2H, m, 
HC-2 & HC-12), 1.13 (3H, d, J = 7 Hz, H3CC-10), 1.07 (3H, d, J = 7 Hz, H3CC-4), 1.00 (6H, br 
d, J = 7 Hz, H3CC-6 & H3CC-8), 0.98 (3H, t, J = 7 Hz, H3C-1), 0.97 (3H, t, J = 7 Hz, H3C-13), 
0.96 (9H, t, J = 8 Hz, H3CCSi ×3), 0.67-0.58 (6H, m, H2CSi ×3), δ (for minor isomer; partial data) 
4.54 (1H, dd, J = 5.5, 6.5 Hz, HC-7), 2.47 (1H, d, J = 6 Hz, HO). 
13C NMR (125 MHz, CDCl3) δ 218.3 (s, C-9), 217.0 (s, C-5), 75.4 (d, C-3), 75.0 (d, C-7), 72.0 (d, 
C-11), 51.0 (d, C-4 or C-6), 50.8 (d, C-6 or C-4), 49.5 (d, C-8 or C-10), 49.3 (d, C-10 or C-8), 27.4 
(t, C-2), 26.7 (t, C-12), 14.4 (q, CH3C-4), 12.0 (q, CH3C-8 or CH3C-6), 11.7 (q, CH3C-6 or CH3C-
8), 10.7 (q, C-13), 9.8 (q, C-1), 9.5 (q, CH3C-10), 7.0 (q ×3, CH3CSi), 5.2 (t ×3, CH2Si), δ (for 
minor isomer) 217.5, 216.5, 75.5, 75.4, 73.7, 52.0, 50.9, 50.8, 49.9, 27.7, 27.4, 14.4, 14.0, 12.0, 
11.3, 9.9, 9.8, 7.0, 5.2. 





iPrCHO (0.060 mL, 47 mg, 0.64 mmol) was added via syringe to a stirring solution of the 
(E,E)-220 prepared from 202ss (20 mg, 0.064 mmol) according to the general procedure, at –78 










procedure to give the crude product whose 1H NMR spectrum suggested the presence of a 85:7:5:3 
mixture of 217, 221, 11-epi-217 (tentatively identified), and 202aa, respectively. Fractionation of 
the crude product by FCC (20% ethyl acetate in hexane) gave the title compound (24 mg, 82%). 
colorless viscous oil, TLC Rf = 0.4 (15% ethyl acetate in hexane). 
IR (DRIFT) vmax 3487, 1704 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.37 (1H, t, J = 5.5 Hz, HC-7), 3.49 (2H, ddd, J = 4, 6, 8 Hz, HC-
3 & HC-11), 2.91 (2H, dq, J = 8, 7 Hz, HC-4 & HC-10), 2.86 (2H, dq, J = 5.5, 7 Hz, HC-6 & HC-
8), 2.51 (2H, d, J = 6 Hz, HO ×2), 1.75 (2H, dqq, J = 4, 7, 7 Hz, HC-2 & HC-12), 1.10 (6H, d, J = 
7 Hz, H3CC-6 & H3CC-8), 1.03 (6H, d, J = 7 Hz, H3CC-4 & H3CC-10), 0.97 (6H, d, J = 7 Hz, 
H3C-1 & H3C-13), 0.96 (9H, t, J = 8 Hz, H3CCSi ×3), 0.89 (6H, d, J = 7 Hz, H3C-1', H3C-13'), 
0.65 (6H, q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 218.8 (s ×2, C-5 & C-9), 78.5 (d ×2, C-3 & C-11), 72.0 (d, C-7), 
51.5 (d ×2, C-6 & C-8), 48.7 (d ×2, C-4 & C-10), 30.0 (d ×2, C-2 & C-12), 20.3 (q ×2, C-1 & C-
13), 15.2 (q ×2, C-1' & C-13'), 14.5 (q ×2, CH3C-4 & CH3C-10), 12.9 (q ×2, CH3C-6 & CH3C-8), 
7.3 (q ×3, CH3CSi), 5.4 (t ×3, CH2Si). 










c-Hex2BCl (1M in hexane; 0.25 mL, 0.25 mmol) was added via syringe to a stirring 
solution of 202ss (20 mg, 0.064 mmol) and triethylamine (0.043 mL, 31 mg, 0.31 mmol) in CH2Cl2 
(0.1 mL) at 0 °C under argon. After 3 h, the mixture was cooled to –78 °C and a solution of iPrCHO 
(0.60 mL, 47 mg, 0.64 mmol) was added via syringe. After 3 h, the reaction was quenched with 
sequential addition of phosphate buffer (pH 7, 0.5 mL), 30% aq H2O2 (0.5 mL), and MeOH (0.5 
mL) with vigorous stirring. The reaction vessel was transferred to an ice bath, and after vigorous 
stirring for 20 min, the mixture was diluted with sat. NaHCO3 solution and extracted with CH2Cl2. 
The combined organic layers were washed with brine, dried over Na2SO4, concentrated, and 
fractionated by FCC (15% ethyl acetate in hexane) to give the title compound as a single 
diastereomer (19 mg, 95%). 
white waxy solid, TLC Rf = 0.3 (15% ethyl acetate in hexane). 
IR (DRIFT) vmax 3518, 1699 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 3.49 (1H, t, J = 9.5 Hz, HC-5), 2.64 (1H, dq, J = 9.5, 6.5 Hz, HC-
6), 2.49 (1H, q, J = 7.5 Hz, HC-2), 1.96 (1H, dq, J = 9.5, 7 Hz, HC-4), 1.72 (1H, dq, J = 15, 7.5 
Hz, HC-1'), 1.48 (1H, dq, J = 15, 7.5 Hz, HC-1'), 1.34 (1H, s, OH), 1.12 (3H, d, J = 7.5 Hz, H3CC-
2), 1.10 (3H, d, J = 6.5 Hz, H3CC-6), 1.06 (3H, d, J = 6.5 Hz, H3CC-4), 0.98 (9H, t, J = 8 Hz, 
H3CCSi ×3), 0.85 (3H, t, J = 7.5 Hz, H3C-2'), 0.67 (6H, q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 213.8 (s, C-1), 79.5 (d, C-5), 77.1 (d, C-3), 52.8 (d, C-2), 49.1 (d, 
C-6), 42.7 (d, C-4), 29.2 (t, C-1'), 14.7 (q, H3CC-2), 11.8 (q, H3CC-6), 11.0 (q, H3CC-4), 7.3 (q 
×3, H3CCSi), 6.5 (q, C-2'), 5.9 (t ×3, H2CSi). 







Reaction of the (Z,Z)-222, prepared from 202aa (20 mg, 0.064 mmol), with i-PrCHO 
(0.058 mL, 46 mg, 0.64 mmol) according to the general procedure gave a crude product whose 1H 
NMR spectrum suggested the presence of a 50:1.5:1 mixture of 223, monoaldol, and 202aa, 
respectively. Fractionation of the crude product by FCC (20% ethyl acetate in hexane) gave the 
title compound (25 mg, 86%). 
colorless viscous oil, TLC Rf = 0.3 (15% ethylacetate in hexanes). 
IR (DRIFT) vmax 3513, 1699 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.35 (1H, t, J = 6 Hz, HC-7), 3.50 (2H, ddd, J = 1.5. 2, 9.5 Hz, HC-
3 & HC-11), 3.21 (2H, d, J = 2 Hz, HO ×2), 2.97 (2H, dq, J = 6, 7 Hz, HC-6 & HC-8), 2.87 (2H, 
dq, J = 1.5, 7.5 Hz, HC-4 & HC-10), 1.66 (2H, dqq, J = 9.5, 6.5, 7 Hz, HC-2 & HC-12), 1.13 (6H, 
d, J = 7.5 Hz, H3CC-4 & H3CC-10), 1.04 (6H, d, J = 6.5 Hz, H3C-1 & H3C-13), 0.99 (6H, d, J = 7 
Hz, H3CC-6 & H3CC-8), 0.95 (9H, t, J = 8 Hz, H3CCSi ×3), 0.84 (6H, d, J = 7 Hz, H3C-1' & H3C-
13'), 0.59 (6H, q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 218.5 (s ×2, C-5 & C-9), 75.9 (d ×2, C-3 & C-11), 75.8 (d, C-7), 
49.5 (d ×2, C-6 & C-8), 47.1 (d ×2, C-4 & C-10), 30.4 (d ×2, C-2 & C-12), 19.9 (q ×2, C-1 & C-
13), 18.9 (q ×2, C-1' & C-13'), 12.0 (q ×2, CH3C-6 & CH3C-8), 9.2 (q ×2, CH3C-4 & CH3C-10), 















Reaction of the (Z,Z)-222, prepared from 202aa (20 mg, 0.064 mmol), with propanal (0.046 
mL, 38 mg, 0.64 mmol) according to the general procedure gave a crude product whose 1H NMR 
spectrum suggested the presence of a 25:1.3:1 mixture of 224, monoaldol, and 202aa, respectively. 
Fractionation of the crude product by FCC (20% ethyl acetate in hexane) gave the title compound 
(23 mg, 84%). 
colorless viscous oil, TLC Rf = 0.3 (20% ethyl acetate in hexane). 
IR (DRIFT)  vmax 3487, 1699 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.35 (1H, t, J = 6 Hz, HC-7), 3.85 (2H, dddd, J = 2, 2, 5.5, 8 Hz, 
HC-3 & HC-11), 3.08 (2H, d, J = 2 Hz, HO), 2.95 (2H, dq, J = 6, 7 Hz, HC-6 & HC-8), 2.70 (2H, 
dq, J = 2, 7.5 Hz, HC-4 & HC-10), 1.56 (2H, ddq, J = 8, 14, 7.5 Hz, HC-2 & HC-12), 1.34 (2H, 
ddq, J = 5.5, 14, 7.5 Hz, HC-2 & HC-12), 1.12 (6H, d, J = 7.5 Hz, H3CC-4 & H3CC-10), 0.97 (6H, 
d, J = 7 Hz, H3CC-6 & H3CC-8), 0.94 (6H, t, J = 7.5 Hz, H3C-1 & H3C-13), 0.94 (9H, t, J = 8 Hz, 
H3CCSi ×3), 0.58 (6H, q, J = 8 Hz, H2CSi ×3). 
OOH HOO O
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13C NMR (125 MHz, CDCl3) δ 218.3 (s ×2, C-5 & C-9), 75.6 (d, C-7), 72.0 (d ×2, C-3 & C-11), 
49.4 (d ×2, C-6 & C-8), 49.2 (d ×2, C-4 & C-10), 26.7 (t ×2, C-2 & C-12), 11.8 (q ×2, CH3C-6 & 
CH3C-8), 10.7 (q ×2, C-1 & C-13), 9.4 (q ×2, CH3C-4 & CH3C-10), 7.0 (q ×3, CH3CSi), 5.2 (t ×3, 
CH2Si). 






A solution of (±)-109 (96 mg, 0.51 mmol) in CH2Cl2 (0.20 mL) was added via syringe to 
a stirring solution of the (E,E)-215, prepared from 202aa (40 mg, 0.13 mmol) according to the 
general procedure, at –78 °C under Ar. After 24 h, the reaction was quenched and processed as 
described in the general procedure to give the crude product whose 1H NMR spectrum suggested 
the presence of a 82:12:3:3 mixture of 230, 231, 230a (tentative), and 235, respectively. 
Fractionation of the crude product by FCC (40% ethyl acetate in hexane) gave recovered (±)-109 
(37 mg, 38%), 231 (4.5 mg, 6%), and the title compound (69 mg, 79%). 
colorless viscous oil, TLC Rf = 0.3 (40% ethyl acetate in hexane). 
IR (DRIFT) vmax 3525, 2879 cm
-1. 
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1H NMR (500 MHz, CDCl3) δ 4.48 (1H, t, J = 6 Hz, HC-5), 4.23 (2H, br d, J = 9.5 Hz, HC-1 & 
HC-9), 4.08-3.9 (8H, m, H2CO ×4), 3.08 (2H, dd, J = 12, 13.5 Hz, HC-7' & HC-7''), 3.03 (2H, s, 
HO ×2), 2.93-2.85 (6H, m, HC-2 & HC-4 & HC-6, HC-8 & HC-9' & HC-9''), 2.64 (2H, br d, J = 
14 Hz, HC-1'), 2.56 (2H, br d, J = 13.5 Hz, HC-7' & HC-7''), 2.50 (2H, br d, J = 14 Hz, HC-9' & 
HC-9''), 2.12 (2H, br d, J = 14 Hz, HC-10' & HC-10''), 2.02 (2H, br d, J = 11.5 Hz, HC-6' & HC-
6''), 1.72 (2H, dd, J = 3, 12.5, 14 Hz, HC-10' & HC-10''), 1.07 (6H, d, J = 7 Hz, H3CC-4 & H3CC-
6), 0.96 (6H, d, J = 7 Hz, H3CC-2 & H3CC-8), 0.94 (9H, t, J = 8 Hz, H3CCSi ×3), 0.63 (6H, q, J 
= 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 216.2 (s ×2, C-3 & C-7), 110.3 (s ×2, C-5' & C-5''), 73.9 (d , C-
5), 71.7 (d ×2, C-1 & C-9), 64.9 (t ×2, C-2' & C-2''), 64.4 (t ×2, C-3' & C-3''), 51.7 (d ×2, C-4 & 
C-6), 47.2 (d ×2, C-2 & C-8), 46.6 (d ×2, C-6' & C-6''), 36.9 (t ×2, C-10' & C-10''), 26.7 (t ×2, C-
9' & C-9''), 25.8 (t ×2, C-7' & C-7''), 14.1 (q ×2, CH3C-2 & CH3C-8), 12.3 (q ×2, CH3C-4 & CH3C-
6), 7.2 (q ×3, CH3CSi), 5.3 (t ×3, CH2Si). 





A solution of (±)-109 (11 mg, 0.059 mmol) in CH2Cl2 (0.080 mL) was added via syringe 













general procedure, at –78 °C under Ar. After 3 h, the reaction vessel was removed from the cooling 
bath. After 30 min, the reaction vessel was transferred to an ice bath and the reaction was quenched 
and processed as described in the general procedure. Fractionation of the crude product by FCC 
(20% ethyl acetate in hexane) to give recovered 202aa (4 mg, 19%), 230 (10 mg, 50%), and a 
fraction containing (±)-231; fractionation of the latter by PTLC (20% ethyl acetate in toluene) gave 
the title compound (13 mg, 44%). 
colorless viscous oil, TLC Rf = 0.3 (20% ethyl acetate in hexane). 
IR (DRIFT) vmax 3526, 1715 cm
-1.	 
1H NMR (500 MHz, CDCl3) δ 4.35 (1H, dd, J = 4, 8 Hz, HC-5), 4.27 (1H, ddd, J = 1, 1.5, 9.5 Hz, 
HC-1), 4.09-3.90 (4H, m, H2C-2' & H2C-3'), 3.07 (1H, dd, J = 12, 14 Hz, HC-7'), 3.01 (1H, d, J = 
1.5 Hz, HO), 2.95 (1H, dq, J = 9.5, 7 Hz, HC-2), 2.83 (1H, dt, J = 2.5, 13, 13 Hz, HC-9'), 2.78 
(1H, dq, J = 4, 7 Hz, HC-4), 2.75 (1H, dq, J = 8, 7 Hz, HC-6), 2.57 (1H, ddd, J = 2, 3.5, 14 Hz, 
HC-7'), 2.55-2.39 (2H, m, HC-8 & HC-9'), 2.43 (1H, dq, J = 18.5, 7 Hz, HC-8), 2.14 (1H, ddd, J 
= 2.5, 4, 13.5 Hz, HC-10'), 2.03 (1H, ddd, J = 1, 3.5, 12 Hz, HC-6'), 1.72 (1H, dt, J = 4, 13, 13.5 
Hz, HC-10'), 1.14 (3H, d, J = 7 Hz, H3CC-4), 1.01 (3H, t, J = 7 Hz, H3C-9), 0.96 (6H, br d, J = 7 
Hz, H3CC-2 & H3CC-6), 0.93 (9H, t, J = 8 Hz, H3CCSi ×3), 0.59 (6H, ap q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 216.2 (s, C-3), 213.9 (s, C-7), 110.4 (s, C-5'), 75.1 (d, C-5), 71.9 
(d, C-1), 64.9 (t, C-2'), 64.4 (t, C-3'), 51.7 (d, C-4), 50.6 (d, C-6), 46.46 (d, C-2 or C-6'), 46.42 (d, 
C-2 or C-6'), 36.7 (t, C-10'), 36.5 (t, C-8), 26.7 (t, C-9'), 25.8 (t, C-7'), 14.1 (q, CH3C-2), 13.4 (q, 
CH3C-6), 12.0 (q, CH3C-4), 7.6 (q, C-9), 7.1 (q ×3, CH3CSi), 5.2 (t ×3, CH2Si). 







t-BuNH2 (0.020 mL, 14 mg, 0.19 mmol) was added via syringe to a stirring solution of the 
(E,E)-215, prepared from 202aa (20 mg, 0.064 mmol) according to the general procedure, at 0 °C 
under Ar. After 30 min, the mixture was cooled to –50 °C and a solution of (–)-(S)-109, prepared 
from (–)-(S)-139 (92% ee; 11 mg, 0.058 mmol) as described above, in CH2Cl2 (0.10 mL) was 
added via syringe. After 3 h, the reaction was quenched and processed as described in the general 
procedure to give the crude product whose 1H NMR spectrum suggested the presence of a 
87:10:2:1 mixture of (+)-231, 202aa, 230a, and (–)-(S)-109, respectively. Fractionation of the 
crude product by FCC (20% ethyl acetate in hexane) gave recovered 202aa (1.5 mg, 8%), and the 
title compound (26 mg, 81%) ([a]D +71 (c 1.0, CHCl3); er > 50:1 by HPLC). 1H and 13C NMR 
data closely matched those reported above for (±)-231. 


























From 230. A suspension of Raney nickel (W2; 0.3 mL settled volume) in EtOH (1 mL) 
was added to 230 (21 mg, 0.030 mmol), and the mixture was heated under reflux with vigorous 
stirring. After 2.5 h (reaction was complete by TLC analysis), the mixture was decanted, and the 
solid was suspended in EtOH (2 mL) and heated under reflux with vigorous stirring for several 
min. This washing procedure was repeated with ethyl acetate, and acetone. The combined organic 
layers were filtered through Celite® and concentrated to get the crude product. The crude was 
dissolved in 30% ethyl acetate in hexane and passed through a short plug of silica gel washing 
with 30% ethyl acetate in hexane. The combined filtrate and washings were concentrated to give 
the title compound (18 mg, 94%); spectral data were consistent with those reported below. From 
(±)-241. A suspension of Raney Ni (W2; 0.3 mL settled volume) in EtOH (0.8 mL) was added to 
(±)-241 (17 mg, 0.026 mmol) and the mixture was heated under reflux with vigorous stirring. After 
3 h (reaction was complete by TLC analysis), the mixture was processed as described above to 
give the title compound (15 mg, 92%); spectral data were consistent with those reported below. 
From 202aa. A solution of (±)-159 (121 mg, 0.76 mmol) in CH2Cl2 (0.30 mL) was added via 
syringe to a stirring solution of the (E,E)-215, prepared from 202aa (60 mg, 0.19 mmol) according 
to the general procedure, at –78 °C under Ar. After 24 h, the reaction was quenched and processed 
as described in the general procedure to give the crude product whose 1H NMR spectrum suggested 
the presence of a 81:11:3:5 mixture of 232, 233, 234, and 202aa, respectively. Fractionation of the 
crude product by FCC (20% ethyl acetate in hexane) gave 233 (8 mg, 9%), a 2.3:1 mixture of 234 
and 232, respectively (6 mg, 5%), and the title compound (93 mg, 77%). 
colorless viscous oil, TLC Rf = 0.3 (20% ethyl acetate in hexane). 




1H NMR (500 MHz, CDCl3) δ 4.57 (1H, t, J = 5.5 Hz, HC-7), 4.03 (2H, br d, J = 9.5 Hz, HC-3 & 
HC-9), 3.97-3.94 (8H, m, H2CO ×4), 3.07 (2H, br s, HO ×2), 2.95-2.84 (4H, m, HC-4 & HC-6), 
1.96 (2H, br q, J = 7 Hz, HC-2 & HC-12), 1.78-1.64 (4H, m, H2CC-2' & H2CC-2''), 1.07 (6H, d, J 
= 7 Hz, H3CC-6 & H3CC-8), 0.95 (9H, t, J = 8 Hz, H3CCSi ×3), 0.94 (6H, d, J = 7 Hz, H3C-1 & 
H3C-13), 0.91 (6H, d, J = 7 Hz, H3CC-4 & H3CC-10), 0.87 (6H, t, J = 7.5 Hz, H3CCC-2' & H3CCC-
2''), 0.66 (6H, q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 216.6 (s ×2, C-5 & C-9), 114.7 (s ×2, C-2' & C-2''), 73.9 (d, C-7), 
73.1 (d ×2, C-3 & C-11), 65.8 (t ×2, C-4' & C-4''), 64.9 (t ×2, C-5', & C-5''), 51.8 (d ×2, C-6 & C-
8), 48.0 (d ×2, C-4 & C-10), 38.8 (d ×2, C-2 & C-12), 28.2 (t ×2, CH2C-2' & CH2C-2''), 13.8 (q 
×2, CH3C-4 & CH3C-10), 12.1 (q ×2, CH3C-6 & CH3C-8), 8.2 (q ×2, CH3CC-2' & CH3CC-2''), 
7.2 (q ×3, CH3CSi), 6.6 (q ×2, C-1 & C-13), 5.3 (t ×3, CH2Si). 
HRMS m/z calcd for C33H62O9Si+Na+ 653.4055, found 653.4029 (ESI). 
 
   233 
(4R,5S,6S,8R,9S,10R)-rel-10-(2-ethyl-1,3-dioxolan-2-yl)-9-hydroxy-4,6,8-trimethyl-5-
((triethylsilyl)oxy)undecane-3,7-dione (233) 
For preparation, see the preparation of 232. 
colorless viscous oil, TLC Rf = 0.4 (20% ethyl acetate in hexane). 












1H NMR (500 MHz, CDCl3) δ 4.37 (1H, dd, J = 4, 8 Hz, HC-5), 4.07 (1H, br d, J = 10 Hz, HC-
9), 4.0-3.93 (4H, m, H2C-4' & H2C-5'), 3.05 (1H, d, J = 1 Hz, HO), 2.93 (1H, dq, J = 10, 7 Hz, 
HC-8), 2.80 (1H, dq, J = 4, 7 Hz, HC-6), 2.77 (1H, dq, J = 8, 7 Hz, HC-4), 2.53 (1H, dq, J = 18.5, 
7 Hz, HC-2), 2.44 (1H, dq, J = 18.5, 7 Hz, HC-2), 1.98 (1H, br q, J = 7 Hz, HC-10), 1.77-1.65 
(2H, m, H2CC-2'), 1.16 (3H, d, J = 7 Hz, H3CC-6), 1.01 (3H, t, J = 7 Hz, H3C-1), 0.97 (3H, d, J = 
7 Hz, H3CC-4), 0.95 (3H, d, J = 7 Hz, H3C-11), 0.94 (9H, t, J = 8 Hz, H3CCSi ×3), 0.91 (3H, d, J 
= 7 Hz, H3CC-8), 0.88 (3H, t, J = 7.5 Hz, H3CCC-2'), 0.61 (6H, ap q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 216.5 (s, C-7), 213.9 (s, C-3), 114.7 (s, C-2'), 75.1 (d, C-5), 73.3 
(d, C-9), 65.8 (t, C-4'), 64.9 (t, C-5'), 51.8 (d, C-6), 50.6 (d, C-4), 47.1 (d, C-8), 38.4 (d, C-10), 
36.4 (t, C-2), 28.3 (t, CH2C-2'), 13.8 (q, CH3C-8), 13.3 (q, CH3C-4), 12.0 (q, CH3C-6), 8.3 (q, 
CH3CC-2'), 7.6 (q, C-1), 7.1 (q ×3, CH3CSi), 6.6 (q, C-11), 5.2 (t ×3, CH2Si). 
HRMS m/z calcd for C25H48O6Si+Na+ 495.3112, found 495.3108 (ESI). 
 
  234 
(2R,3S,4R,6S,7S,8R,10S,11S,12R)-rel-2,12-Bis(2-ethyl-1,3-dioxolan-2-yl)-3,11-dihydroxy-
4,6,8,10-tetramethyl-7-((triethylsilyl)oxy)tridecane-5,9-dione (234) 
Fractionation of a 2.3:1 mixture of 234 and 232, respectively (6 mg) (see preparation of 
232), by PTLC (20% Et2O in hexane) gave the title compound as an ca. 7:1 mixture with 10-epi-
234 (tentatively identified) (3 mg, 2.5% from 202aa). 
colorless viscous oil, TLC Rf = 0.3 (20% ethyl acetate in hexane). 
O
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 231 
IR (DRIFT) vmax 3532, 1711 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.51 (1H, dd, J = 5.5, 5.5 Hz, HC-7), 4.11 (1H, ddd, J = 1, 3, 7 Hz, 
HC-11), 4.06 (1H, br d, J = 10 Hz, HC-3), 4.00-3.94 (8H, m, H2CO ×4), 3.16 (1H, d, J = 1 Hz, 
HOC-11), 3.07 (1H, d, J = 1.5 Hz, HOC-3), 2.98-2.89 (3H, m, HC-6 & HC-8 & HC-10), 2.86 (1H, 
dq, J = 10, 7 Hz, HC-4), 1.97 (1H, br q, J = 7 Hz, HC-2), 1.88 (1H, dq, J = 3, 7 Hz, HC-12), 1.77-
1.62 (4H, m, H2CC-2' & H2CC-2''), 1.22 (3H, d, J = 7 Hz, H3CC-10), 1.04 (6H, br d, J = 7 Hz, 
H3CC-6 & H3CC-8), 0.99 (3H, d, J = 7 Hz, H3C-13), 0.96 (9H, t, J = 8 Hz, H3CCSi ×3), 0.95 (3H, 
d, J = 7 Hz, H3C-1), 0.92 (3H, d, J = 7 Hz, H3CC-4), 0.88 (3H, t, J = 7.5 Hz, H3CCC-2'), 0.86 (3H, 
t, J = 7.5 Hz, H3CCC-2''), 0.63 (6H, ap q, J = 8 Hz, H2CSi ×3). 
13C NMR δ 216.2 (s, C-9 or C-5), 216.0 (s, C-5 or C-9), 114.7 (s, C-2' or C-2''), 114.6 (s, C-2 or 
C-2'), 73.9 (d, C-7), 72.9 (d, C-3), 70.6 (d, C-11), 65.8 (t, CH2O), 65.5 (t, CH2O), 65.1 (t, CH2O), 
64.9 (t, CH2O), 51.5 (d, C-6), 50.0 (d, C-8 or C-10), 49.8 (d, C-10 or C-8), 48.5 (d, C-4), 40.6 (d, 
C-12), 38.7 (d, C-2), 28.2 (t, CH2C-2'), 27.6 (t, CH2C-2''), 13.8 (q, CH3C-4), 13.5 (q, CH3C-10), 
12.2 (q, CH3C-6 or CH3C-8), 12.0 (q, CH3C-6 or CH3C-8), 9.0 (q, C-13), 8.3 (q, CH3CC-2'), 7.9 
(q, CH3CC-2''), 7.2 (q ×3, CH3CSi), 6.6 (q, C-1), 5.3 (t ×3, CH2Si), minor, 216.7, 215.2, 114.8, 
73.7, 73.2, 73.0, 65.7, 64.9, 53.4, 51.0, 48.4, 47.9, 38.8, 38.4, 28.3, 28.2, 13.8, 13.2, 12.3, 10.7, 
8.4, 8.2, 7.2, 6.73, 6.68, 5.3. 
HRMS m/z calcd for C33H62O9Si+Na+ 653.4055, found 653.4054 (ESI). 
 
 236 S S
OOH HOO OOO OO
SiEt3

















A solution of (±)-109 (48 mg, 0.26 mmol) in CH2Cl2 (0.10 mL) was added via syringe to 
a stirring solution of the (E,E)-220, prepared from 202ss (20 mg, 0.064 mmol) according to the 
general procedure, at –78 °C under Ar. After 24 h, the reaction was quenched and processed as 
described in the general procedure to give the crude product whose 1H NMR spectrum suggested 
the presence of a 82:12:3:3 mixture of 236, monoaldol, 5-epi-235 (tentative), and 202ss, 
respectively. Fractionation of the crude product by FCC (30% ethyl acetate in hexane) gave 
recovered (±)-109 (15 mg, 31%), 236 δ (4.5 mg, 6%), and the title compound (37 mg, 84%). 
colorless viscous oil, TLC Rf = 0.3 (40% ethyl acetate in hexane). 
IR (DRIFT) vmax 3520, 1709 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.24 (2H, br d, J = 9.5 Hz, HC-1 & HC-9), 4.07-3.9 (8H, m, CH2O 
×4), 3.04 (2H, dd, J = 12, 14 Hz, HC-7' & HC-7), 2.95 (2H, d, J = 2.5 Hz, HO ×2), 2.93 (2H, dq, 
J = 9, 7 Hz, HC-2 & HC-8), 2.86-2.78 (4H, m, HC-4 & HC-6 & HC-9' & HC-9''), 2.62 (2H, ddd, 
J = 2, 3.5, 14 Hz, HC-7' & HC-7''), 2.51 (2H, dddd, J = 2, 3.5, 4, 13.5 Hz, HC-9' & HC-9''), 2.14 
(2H, ddd, J = 2.5, 4, 13.5 Hz, HC-10' & HC-10''), 2.00 (2H, br d, J = 12 Hz, HC-6' & HC-6''), 1.72 
(2H, ddd, J = 3.5, 13, 13.5 Hz, HC-10' & HC-10''), 1.09 (6H, d, J = 7 Hz, H3CC-4 & H3CC-6), 
0.95 (6H, d, J = 7 Hz, H3CC-2 & H3CC-8), 0.93 (9H, t, J = 8 Hz, H3CCSi ×3), 0.63 (6H, q, J = 8 
Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 216.8 (s ×2, C-3 & C-7), 110.3 (s ×2, C-5' & C-5''), 71.9 (d ×2, C-
1 & C-9), 70.8 (d, C-5), 64.9 (t ×2, C-2' & C-2''), 64.4 (t ×2, C-3' & C-3''), 51.7 (d ×2, C-4 & C-
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6), 47.0 (d ×2, C-2 & C-8), 46.5 (d ×2, C-6' & C-6''), 36.7 (t ×2, C-10' & C-10''), 26.7 (t ×2, C-9' 
& C-9''), 26.0 (t ×2, C-7' & C-7''), 14.2 (q ×2, CH3C-2 & HC3C-8), 12.2 (q ×2, CH3C-4 & CH3C-
6), 7.3 (q ×3, CH3CSi), 5.5 (t ×3, CH2Si). 





From 236. A suspension of Raney nickel (W2; 0.2 mL settled volume) in EtOH (1 mL) 
was added to 236 (13.5 mg, 0.020 mmol), and the mixture was heated under reflux with vigorous 
stirring. After 3 h (reaction was complete by TLC analysis), the mixture was decanted, and the 
solid was suspended in EtOH (2 mL) and heated under reflux with vigorous stirring for several 
min and then decanted. This washing procedure was repeated with ethyl acetate, and acetone (×2). 
The combined organic layers were filtered through Celite®, concentrated to get the crude product. 
The crude was dissolved in 30% ethyl acetate in hexanes, passed through a short silica gel pad and 
the combined organic layers were concentrated to give the title compound (11.6 mg, 94%). 
Spectral data were consistent with those reported below. From 202ss. A solution of (±)-159 (48 
mg, 0.26 mmol) in CH2Cl2 (0.10 mL) was added via syringe to a stirring solution of the (E,E)-220, 
prepared from 202aa (20 mg, 0.064 mmol) according to the general procedure, at –78 °C under 
Ar. After 24 h, the reaction was quenched and processed as described in the general procedure to 












give the crude product whose 1H NMR spectrum suggested the presence of a 100:4:3:5 mixture of 
237, monoaldol 7-epi-234, and 202ss, respectively. Fractionation of the crude product by FCC 
(20% ethyl acetate in hexane) gave the title compound (31 mg, 78%). 
colorless viscous oil, TLC Rf = 0.5 (30% ethyl acetate in hexane). 
IR (DRIFT) vmax 3530, 1710 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.48 (1H, t, J = 5 Hz, HC-7), 4.05 (2H, dd, J = 1, 9.5 Hz, HC-3 & 
HC-11), 3.99-3.92 (8H, m, H2CO ×4), 2.97 (2H, br s, HO ×2), 2.92-2.85 (4H, m, HC-4 & HC-10 
& HC-6 & HC-8), 1.94 (2H, dq, J = 1, 7 Hz, HC-2, HC-12), 1.76-1.63 (4H, m, H2CC-2' & H2CC-
2''), 1.09 (6H, d, J = 7 Hz, H3CC-6 & H3CC-8), 0.93 (6H, d, J = 7 Hz, H3C-1 & H3C-13), 0.92 
(9H, t, J = 8 Hz, H3CCSi ×3), 0.89 (6H, d, J = 7 Hz, H3CC-4 & H3CC-10), 0.86 (6H, t, J = 7.5 Hz, 
H3CCC-2' & H3CCC-2''), 0.63 (6H, q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 217.2 (s ×2, C-5 & C-9), 114.7 (s ×2, C-2' & C-2''), 73.2 (d ×2, C-
3 & C-11), 70.9 (d, C-7), 65.7 (t ×2, C-4' & C-4''), 64.9 (t ×2, C-5' & C-5''), 51.7 (d ×2, C-6 & C-
8), 47.7 (d ×2, C-4 & C-10), 38.6 (d ×2, C-2 & C-12), 28.2 (t ×2, CH2C-2' & CH2C-2''), 14.0 (q 
×2, CH3C-4 & CH3C-10), 12.1 (q ×2, CH3C-6 & CH3C-8), 8.3 (q ×2, CH3CC-2' & CH3CC-2''), 
7.3 (q ×3, CH3CSi), 6.7 (q ×2, C-1 & C-13), 5.4 (t ×3, CH2Si). 


















t-BuNH2 (0.020 mL, 14 mg, 0.19 mmol) was added via syringe to a stirring solution of the (E,E)-
215, prepared from 202aa (20 mg, 0.064 mmol) according to the general procedure, at 0 °C under 
Ar. After 30 min, the mixture was cooled to –42 °C and a solution of (–)-(S)-109, prepared from 
(–)-(S)-139 (92% ee; 11 mg, 0.058 mmol) as described above, in CH2Cl2 (0.10 mL) was added via 
syringe. After 3 h, iPrCHO (0.060 mL, 46 mg, 0.64 mmol) was added via syringe. After 3 h, 
reaction was quenched and processed as described in the general procedure to give the crude 
product whose 1H NMR spectrum suggested the presence of a 50:7:5:4 mixture of (–)-240, 212, 
231, and 202aa, respectively. Fractionation of the crude product by PTLC (20% ethyl acetate in 
hexane; 3 developments) gave the title compound (26 mg, 71%); [α]D –41 (c 1.0, CHCl3) 
(enantiomers not separable by HPLC; er assumed to be >50:1 based on the results for (+)-231 and 
(+)-241). 
colorless viscous oil, TLC Rf = 0.3 (20% ethyl acetate in hexane). 
IR (DRIFT) vmax 3519, 1712 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.67 (1H, dd, J = 3.5, 8.5 Hz, HC-5), 4.29 (1H, br d, J = 9.5 Hz, 
HC-1), 4.09-3.91 (4H, m, H2C-2' & H2C-3'), 3.43 (1H, dd, J = 3, 8.5 Hz, HC-9), 3.13-3.06 (3H, 
m, HO & HC-6 & HC-7'), 3.02 (1H, br s, HO), 2.98 (1H, dq, J = 9.5, 7 Hz, HC-2), 2.87-2.80 (3H, 
m, HC-4 & HC-8 & HC-9'), 2.57 (1H, ddd, J = 2, 3, 14 Hz, HC-7'), 2.51 (1H, ap dq, J = 3, 3, 3.5, 
13.5 Hz, HC-9'), 2.15 (1H, ddd, J = 3, 3.5, 14 Hz, HC-10'), 2.02 (1H, br dd, J = 2, 12 Hz, HC-6'), 
1.78 (1H, dqq, J = 3, 7, 7 Hz, HC-10), 1.72 (1H, ddd, J = 3.5, 13, 13.5 Hz, HC-10'), 1.17 (3H, d, 
J = 7 Hz, H3CC-4), 0.99 (3H, d, J = 7 Hz, H3C-11), 0.98 (3H, d, J = 7 Hz, H3CC-8), 0.96 (3H, d, 
 
 236 
J = 7 Hz, H3CC-2), 0.95 (9H, t, J = 8 Hz, H3CCSi ×3), 0.88 (6H, ap d, J = 6.5 Hz, H3C-11' & 
H3CC-6, ), 0.63 (6H, q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 218.5 (s, C-7), 215.0 (s, C-3), 110.3 (s, C-5'), 78.4 (d, C-9), 73.7 
(d, C-5), 71.5 (d, C-1), 64.9 (t, C-2'), 64.3 (t, C-3'), 52.5 (d, C-4), 51.0 (d, C-6), 49.9 (d, C-8), 46.6 
(d, C-2), 46.4 (d, C-6'), 36.6 (t, C-10'), 29.5 (d, C-10), 26.7 (t, C-9'), 25.8 (t, C-7'), 20.4 (q, C-11), 
14.4 (q, C-11), 14.3 (q, CH3C-2), 13.6 (q, CH3C-8), 13.0 (q, CH3C-6), 10.4 (q, CH3C-4), 7.1 (q 
×3, HC3CSi), 5.1 (t ×3, CH2Si). 






A solution of (±)-109 (11 mg, 0.059 mmol) in CH2Cl2 (0.10 mL) was added via syringe to 
a stirring solution of the (E,E)-215, prepared from 202aa (21 mg, 0.067 mmol) according to the 
general procedure, at –78 °C under Ar. After 6 h, a solution of (±)-159 (43 mg, 0.27 mmol) in 
CH2Cl2 (0.10 mL) was added After 14 h, the reaction was quenched and processed as described in 
the general procedure to give the crude product whose 1H NMR spectrum suggested the presence 
of an ca. 3:1.5:1:1:1:1:1 mixture of (±)-241, 231, 232, 230, 233, and 202aa, respectively. 

















231 and 232, respectively (8 mg), 230 (3.5 mg, 8.5%), 233 (4 mg; ca. 80% pure), 202aa (2 mg, 
10%), and the title compound (14.5 mg, 33%). 
colorless viscous oil, TLC Rf = 0.4 (40% ethyl acetate in hexane). 
IR (DRIFT)  vmax 3524, 1712 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.53 (1H, ap t, J = 5.5 Hz, HC-5), 4.24 (1H, br d, J = 9.5 Hz, HC-
1), 4.09-3.90 (8H, m, H2CO ×4), 4.05-4.02 (1H, m, HC-9), 3.07 (1H, dd, J = 12, 14 Hz, HC-7'), 
3.06 (1H, d, J = 1 Hz, HOC-9), 3.05 (1H, d, J = 1.5 Hz, HOC-1), 2.94-2.81 (4H, m, HC-2 & HC-
4 & HC-6 & HC-8), 2.84 (1H, ddd, J = 2.5, 13, 13.5 Hz, HC-9'), 2.58 (1H, ddd, J = 2.5, 3, 14 Hz, 
HC-7'), 2.50 (1H, dddd, J = 2.5, 3.5, 4, 13.5 Hz, HC-9'), 2.13 (1H, ddd, J = 2.5, 4, 13.5 Hz, HC-
10'), 2.02 (1H, ddd, J = 1, 3, 12 Hz, HC-6'), 1.96 (1H, dq, J = 1, 7 Hz, HC-10), 1.77-1.60 (3H, m, 
HC-10' & H2CC-2''), 1.077 (3H, d, J = 7 Hz, H3CC-4 or H3CC-6), 1.074 (3H, d, J = 7 Hz, H3CC-
4 or H3CC-6), 0.97 (3H, d, J = 7 Hz, H3CC-2), 0.95 (9H, t, J = 8 Hz, H3CCSi ×3), 0.94 (3H, d, J 
= 7 Hz, H3C-11), 0.91 (3H, d, J = 7 Hz, H3CC-8), 0.87 (3H, t, J = 7.5 Hz, H3CCC-2''), 0.65 (6H, 
ap q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 216.5 (s, C-7), 216.3 (s, C-3), 114.7 (s, C-2''), 110.3 (s, C-5'), 73.9 
(d, C-5), 73.1 (d, C-9), 71.7 (d, C-1), 65.8 (t, CH2O), 64.9 (t ×2, CH2O), 64.5 (t, CH2O), 51.8 (d, 
C-6 or C-4), 51.7 (d, C-4 or C-6), 48.0 (d, C-8), 47.3 (d, C-2), 46.6 (d, C-6'), 38.7 (d, C-10), 36.9 
(t, C-10'), 28.2 (t, H2CC-2''), 26.7 (t, C-9'), 25.9 (t, C-7'), 14.1 (q, CH3C-2), 13.8 (q, CH3C-8), 12.3 
(q, CH3C-4 or CH3C-6), 12.2 (q, CH3C-6 or CH3C-4), 8.3 (q, CH3CC-2''), 7.2 (q ×3, CH3CSi), 6.6 
(q, C-10), 5.3 (q ×3, CH2Si). 








t-BuNH2 (0.020 mL, 14 mg, 0.19 mmol) was added via syringe to a stirring solution of the 
(E,E)-215, prepared from 202aa (20 mg, 0.064 mmol) according to the general procedure, at 0 °C 
under Ar. After 30 min, the mixture was cooled to –50 °C and a solution of (–)-(S)-109, prepared 
from (–)-(S)-139 (92% ee; 11 mg, 0.058 mmol) as described above, in CH2Cl2 (0.10 mL) was 
added via syringe. After 3 h, a solution of (±)-159 (30 mg, 0.19 mmol) CH2Cl2 (0.10 mL) was 
added via syringe. After 3 h, reaction was quenched and processed as described in the general 
procedure to give the crude product whose 1H NMR spectrum suggested the presence of a 
78:10:7:3:2 mixture of (+)-241, 231, 232, 233, and 202aa, respectively. Fractionation of the crude 
product by FCC (20% ethyl acetate in hexane) gave the title compound (29 mg, 70%); [a]D +6.2 
(c 1.0, CHCl3) (er > 50:1 by HPLC). 1H and 13C NMR data closely matched those reported above 
for (±)-241. 
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t-BuNH2 (0.020 mL, 14 mg, 0.19 mmol) was added via syringe to a stirring solution of the 
(E,E)-220, prepared from 202ss (20 mg, 0.064 mmol) according to the general procedure, at –78 
°C under Ar. The reaction vessel was transferred to an ice-bath and stirring continued for 30 min. 
The mixture was cooled to –42 °C and a solution of (±)-109 (13 mg, 0.070 mmol) in CH2Cl2 (0.10 
mL) was added via syringe with stirring. After 3 h, a solution of (±)-159 (30 mg, 0.19 mmol) 
CH2Cl2 (0.10 mL) was added via syringe. After 3 h, reaction was quenched and processed as 
described in the general procedure to give the crude product whose 1H NMR spectrum suggested 
the presence of a 50:19:6:15:10 mixture of 243, 236, 237, monoaldol, and 202aa, respectively. 
Fractionation of the crude product by FCC (30% ethyl acetate in hexane) gave the title compound 
(19 mg, 46%). 
colorless viscous oil, TLC Rf = 0.3 (30% ethyl acetate in hexane). 
IR (DRIFT) vmax 3525, 1710 cm
-1.  
1H NMR (500 MHz, CDCl3) δ 4.48 (1H, dd, J = 4.5, 6 Hz, HC-5), 4.25 (1H, br d, J = 9.5 Hz, HC-
1), 4.07-3.90 (8H, m, H2CO ×4), 4.03 (1H, d, J = 10 Hz, HC-9), 3.05 (1H, dd, J = 12, 14 Hz, HC-
7'), 2.98 (2H, br s, HO), 2.96 (1H, dq, J = 9.5, 7 Hz, HC-2), 2.90-2.79 (4H, m, HC-4 & HC-6 & 
HC-8 & HC-9'), 2.63 (1H, ddd, J = 2, 3, 14 Hz, HC-7'), 2.50 (1H, dddd, J = 2, 3.5, 4, 13.5 Hz, HC-
S
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9'), 2.12 (1H, ddd, J = 2.5, 4, 13.5 Hz, HC-10'), 2.00 (1H, ddd, J = 1.5, 3, 12 Hz, HC-6'), 1.95 (1H, 
br q, J = 7 Hz, HC-10), 1.75-1.66 (3H, m, HC-10' & H2C-2''), 1.10 (3H, d, J = 7 Hz, H3CC-6), 
1.08 (3H, d, J = 7 Hz, H3CC-4), 0.95 (3H, d, J = 7 Hz, H3CC-2), 0.94 (3H, d, J = 7 Hz, H3C-11), 
0.93 (9H, t, J = 8 Hz, H3CCSi ×3), 0.89 (3H, d, J = 7 Hz, H3CC-8), 0.87 (3H, t, J = 7.5 Hz, H3CCC-
2''), 0.63 (6H, q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 217.3 (s, C-7), 216.8 (s, C-3), 114.7 (s, C-2''), 110.3 (s, C-5'), 73.5 
(d, C-9), 71.7 (d, C-1), 70.8 (d, C-5), 65.8 (t, CH2O), 65.0 (t, CH2O), 64.9 (t, CH2O), 64.4 (t, 
CH2O), 52.1 (d, C-6), 51.4 (d, C-4), 47.8 (d, C-8), 46.7 (d, C-2), 46.6 (d, C-6'), 38.5 (d, C-10), 
36.7 (t, C-10'), 28.3 (t, CH2C-2''), 26.7 (t, C-9'), 26.1 (t, C-7'), 14.3 (q, CH3C-2), 13.9 (q, CH3C-
8), 12.7 (q, CH3C-6), 11.5 (q, CH3C-4), 8.3 (q, CH3CC-2''), 7.4 (q ×3, CH3CSi), 6.6 (q, C-11), 5.5 
(t ×3, CH2Si). 






Following the same procedure described for the preparation of (±)-243 but using (–)-(S)-
109 (prepared from (–)-(S)-139 (92% ee; 12 mg, 0.063 mmol) as described above) instead of (±)-
109 gave a crude product whose 1H NMR spectrum suggested the presence of a 70:12:8:10 mixture 
S
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of (–)-243, 232, and 202aa, respectively. Fractionation of the crude product by FCC (30% ethyl 
acetate in hexane) gave 232 (5 mg, 12%) and the title compound (29 mg, 70%); [a]D –15 (c 0.60, 
CHCl3) (er > 40:1 by HPLC). 1H and 13C NMR data closely matched those reported above for (±)-
243. 






Reaction of the (Z,Z)-222, prepared from 202aa (20 mg, 0.064 mmol), with a solution of 
(±)-109 (50 mg, 0.26 mmol) in Et2O (0.1 mL) according to the general procedure gave a crude 
product whose 1H NMR spectrum suggested the presence of a 33:2:1 mixture of 244, 247, and 
202aa, respectively. Fractionation of the crude product by FCC (30% ethyl acetate in hexane) 
afforded (±)-109 (18 mg, 36%) and the title compound (34 mg, 78%). 
colorless viscous oil, TLC Rf = 0.3 (35% ethylacetate in hexanes). 
IR (DRIFT) vmax 3513, 1696 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.44 (1H, t, J = 6 Hz, HC-5), 4.37 (2H, ddd, J = 1.5, 4, 6 Hz, HC-
1, HC-9), 4.04-3.94 (8H, m, H2CO ×4), 3.23 (2H, d, J = 2 Hz, HO ×2), 3.1 (2H, dq, J = 4, 7 Hz, 
S S
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HC-2 & HC-8), 2.97-2.87 (6H, m, HC-4 & HC-6 & H2C-7' & H2C-7''), 2.70 (2H, ddd, J = 3, 9.5, 
13.5 Hz, HC-9'), 2.63 (2H, br ddd, J = 3.5, 6.5, 13,5 Hz, HC-9''), 2.03 (2H, ddd, J = 3.5, 6.5, 13.5 
Hz, HC-10'), 1.98 (2H, ddd, J = 3.5, 6, 8.5 Hz, HC-6' & HC-6''), 1.71 (2H, ddd, J = 3.5, 9.5, 13.5 
Hz, HC-10''), 1.19 (6H, d, J = 7 Hz, H3CC-2 & H3CC-8), 0.98 (6H, d, J = 7 Hz, H3CC-4 & H3CC-
6), 0.95 (9H, t, J = 8 Hz, H3CCSi ×3), 0.62 (6H, q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 217.1 (s ×2, C-3 & C-7), 109.5 (s ×2, C-5' & C-5''), 74.4 (d, C-5), 
67.9 (d ×2, C-1 & C-9), 64.6 (t ×2, C-2' & C-2''), 64.3 (t ×2, C-3' & C-3''), 49.6 (d ×2, C-4 & C-
6), 49.0 (d ×2, C-2 & C-8), 46.8 (d ×2, C-6' & C-6''), 35.3 (t ×2, C-10' & C-10''), 28.1 (t ×2, C-7' 
& C-7''), 26.7 (t ×2, C-9' & C-9''), 11.7 (q ×2, CH3C-4 & CH3C-6), 11.5 (q ×2, CH3C-2 & CH3C-
8), 7.1 (q ×3, CH3CSi), 5.1 (t ×3, CH2Si). 





From 202aa. Reaction of the (Z,Z)-222, prepared from 202aa (20 mg, 0.064 mmol), with 
a solution of (±)-159 (43 mg, 0.26 mmol) in Et2O (0.1 mL) according to the general procedure 
gave a crude product whose 1H NMR spectrum suggested the presence of a 9:9:1 mixture of a 245, 
246, and an unidentified product (possibly a mono aldol), respectively. Fractionation of the crude 
product by FCC (30% ethyl acetate in hexane) gave an inseparable 1:1 mixture the title compound 












and 245 (29 mg, 73%). The NMR signals for 246 in the 1:1 mixture could be readily assigned 
because a pure sample of 245 was available (see below). From 244. A suspension of Raney nickel 
(W2; 0.1 mL settled volume) in EtOH (2 mL) was added to 244 (15 mg, 0.022 mmol), and the 
mixture was heated under reflux with vigorous stirring under a H2 atmosphere (balloon). After 2 
h (reaction was complete by TLC analysis), the mixture was decanted, and the solid was suspended 
in EtOH (2 mL) and heated under reflux with vigorous stirring for several min. This washing 
procedure was repeated with ethyl acetate, and acetone. The combined organic layers were filtered 
through Celite® and concentrated to get the crude product. The crude was dissolved in 30% ethyl 
acetate in hexane and passed through a short plug of silica gel washing with 30% ethyl acetate in 
hexane. The combined filtrate and washings were concentrated to give the title compound (13 mg, 
92%).. 
colorless viscous oil, TLC Rf = 0.3 (30% ethyl acetate in hexane). 
IR (DRIFT) vmax 3524, 1703 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.41 (1H, t, J = 5.5 Hz, HC-7), 4.11 (2H, dd, J = 2.5, 7 Hz, HC-3, 
HC-11), 4.02-3.93 (8H, m, H2CO ×4 ), 3.17 (2H, br s, HO ×2), 2.93 (2H, dq, J = 5.5, 7 Hz, HC-6 
& HC-8), 2.90 (2H, dq, J = 7, 7 Hz, HC-4 & HC-10), 1.87 (2H, dq, J = 3, 7 Hz, HC-2 & HC-12), 
1.75-1.60 (4H, m, H2CC-2' & H2CC-2''), 1.23 (6H, d, J = 7 Hz, H3CC-4 & H3CC-10), 0.99 (6H, 
br d, J = 7 Hz, H3C-1 & H3C-13, H3CC-6 & H3CC-8), 0.95 (9H, t, J = 8 Hz, H3CCSi ×3), 0.86 
(6H, t, J = 7.5 Hz, H3CCC-2' & H3CCC-2''), 0.61 (6H, q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 215.8 (s, C-5 & C-9), 114.5 (s, C-2' & C-2''), 73.9 (d, C-7), 70.4 
(d, C-3 & C-11), 65.4 (t, C-4' & C-4''), 65.1 (t, C-5' & C-5''), 49.9 (d, C-4, & C-10), 49.8 (d, C-6 
& C-8), 40.5 (d, C-2 & 12), 27.5 (t, CH2C-2' & CH2C-2''), 13.5 (q, CH3C-4 & CH3C-10), 12.0 (q, 
 
 244 
CH3C-6 & CH3C-8), 9.0 (q, C-1 & C-13), 7.8 (q, CH3CC-2' & CH3CC-2''), 7.1 (q ×3, CH3CSi), 
5.2 (t ×3, CH2Si). 
HRMS m/z calcd for C33H62O9Si+Na+ 653.4055, found 653.4064 (ESI). 
 
   246 
(2S,3R,4R,6S,7S,8R,10S,11S,12S)-rel-2,12-Bis(2-ethyl-1,3-dioxolan-2-yl)-3,11-dihydroxy-
4,6,8,10-tetramethyl-7-((triethylsilyl)oxy)tridecane-5,9-dione (246) 
NMR data from a 1:1 mixture with 245 (see preparation of 245). 
colorless viscous oil, TLC Rf = 0.3 (30% ethyl acetate in hexane). 
IR (DRIFT) vmax 3514, 1702 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 4.38 (1H, dd, J = 3, 8.5 Hz, HC-7), 4.12-4.09 (2H, m, HOC-11, 
HC-3), 4.06 (1H, br d, J = 9.5 Hz, HC-11), 4.03-3.92 (8H, m, H2CO ×4), 3.50 (1H, d, J = 0.5 Hz, 
HOC-3), 3.08 (1H, dq, J = 8, 7 Hz, HC-8), 3.03 (1H, dq, J = 7, 7 Hz, HC-4), 2.95-2.87 (1H, m, 
HC-6), 2.48 (1H, br q, J = 7 Hz, HC-10), 1.91-1.84 (1H, m, HC-2), 1.81 (1H, dq, J = 4, 7 Hz, HC-
12), 1.76-1.60 (4H, m, H2CC-2', H2CC-2''), 1.22 (3H, d, J = 7 Hz, H3CC-4), 1.15 (3H, d, J = 7 Hz, 
H3CC-10), 1.12 (3H, d, J = 7 Hz, H3CC-6), 0.98 (3H, d, J = 7 Hz, H3C-1), 0.93 (9H, t, J = 8 Hz, 
H3CCSi ×3), 0.88 (3H, t, J = 7.5 Hz, H3CC-2''), 0.87 (3H, d, J = 7 Hz, H3C-13), 0.86 (3H, d, J = 7 
Hz, H3CC-8), 0.86 (3H, t, J = 7.5 Hz, H3CC-2'), 0.59 (6H, ap q, J = 8 Hz, H2CSi ×3). 
O
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 245 
13C NMR (125 MHz, CDCl3) δ 215.72 (s, C-5 or C-9), 215.65 (s, C-9 or C-5), 114.9 (s, C-2''), 
114.5 (s, C-2'), 74.8 (d, C-7), 72.1 (d, C-11), 70.8 (d, C-3), 65.47 (t, C-4''), 65.44 (t, C-4'), 65.06 
(t, C-5'), 65.04 (t, C-5''), 51.0 (d, C-6), 49.2 (d, C-10), 48.5 (d, C-4), 47.0 (d, C-8), 41.5 (d, C-12), 
40.1 (d, C-2), 27.6 (t, CH2C-2'), 25.9 (t, CH2C-2''), 14.4 (q, CH3C-4), 13.4 (q, CH3C-8), 12.8 (q, 
C-13), 10.8 (q, CH3C-6), 8.7 (q, C-1), 8.1 (q, CH3C-10), 7.9 (q, CH3CC-2'), 7.1 (q ×3, CH3CSi), 
7.0 (q, CH3CC-2''), 5.2 (t ×3, CH2Si). 





2,4-Dimethyl-3-pentanone (0.072 ml, 58.5 mg, 0.51 mmol) was added was added via syringe to a 
stirring solution of the (Z,Z)-222, prepared from 202aa (20 mg, 0.064 mmol) according to the 
general procedure, at 0 °C under Ar. After 1 h, the mixture was cooled to –78 °C and a solution of 
(–)-(S)-109, prepared from (–)-(S)-139 (92% ee; 12 mg, 0.064 mmol) as described above, in Et2O 
(0.20 mL) was added via syringe. After 3 h, the reaction was quenched and processed as described 
in the general procedure to give the crude product whose 1H NMR spectrum suggested the presence 
of a 81:14:5 mixture of (+)-247, 202aa, and 6ʹ-epi-244 (tentative), respectively. Fractionation of 
the crude product by PTLC (30% ethyl acetate in hexane) gave the title compound (24 mg, 76%); 
[α]D +14 (c 1.1, CHCl3). 
S
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colorless viscous oil, TLC Rf = 0.4 (30% ethyl acetate in hexane). 
IR (DRIFT) vmax 3515, 1714 cm
-1.	  
1H NMR (500 MHz, CDCl3) δ 4.35 (1H, dd, J = 4.5, 7.5 Hz, HC-5), 4.33 (1H, br t, J = 5 Hz, HC-
1), 4.07-3.93 (4H, m, H2C-2', H2C-3'), 3.29 (1H, br s, HO), 3.16 (1H, dq, J = 4.5, 7 Hz, HC-2), 
2.94 (1H, dd, J = 9, 14 Hz, HC-7'), 2.90-2.83 (2H, m, HC-7', HC-4), 2.75 (1H, dq, J = 7.5, 7 Hz, 
HC-6), 2.70 (1H, ddd, J = 3, 10, 13.5 Hz, HC-9'), 2.64-2.58 (1H, m, HC-9'), 2.53-2.44 (2H, m, 
H2C-8), 2.04 (1H, ddd, J = 3, 6.5, 13.5 Hz, HC-10'), 1.97 (1H, ddd, J = 3.5, 5.5, 9 Hz, HC-6'), 1.70 
(1H, ddd, J = 3.5, 10, 13.5 Hz, HC-10'), 1.17 (3H, d, J = 7 Hz, H3CC-2), 1.03 (3H, d, J = 7 Hz, 
H3CC-4), 1.01 (3H, d, J = 7 Hz, H3C-9), 0.93 (9H, t, J = 8 Hz, H3CCSi ×3), 0.90 (3H, d, J = 7 Hz, 
H3CC-6), 0.59 (6H, ap q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 217.4 (s, C-3), 213.4 (s, C-7), 109.5 (s, C-5'), 75.1 (d, C-5), 68.1 
(d, C-1), 64.6 (t, C-2'), 64.3 (t, C-3'), 50.3 (d, C-6), 50.2 (d, C-4), 48.1 (d, C-2), 46.8 (d, C-6'), 36.7 
(d, C-8), 35.3 (t, C-10'), 28.0 (t, C-7'), 26.7 (t, C-9'), 12.6 (q, H3CC-6), 11.9 (q, H3CC-2), 11.1 (q, 
H3CC-4), 7.6 (q, H3C-9), 7.1 (q ×3, H3CCSi), 5.1 (t ×3, H2CSi). 














Et2BOMe (25 µL, 22 mg, 0.22 mmol) was added to a stirring solution of 212 (30 mg, 0.072 
mmol) in THF (0.60 mL) at −78 °C under argon. The mixture was removed from the cooling bath, 
and the Et2BOMe slowly dissolved. After 1 h, the mixture was cooled to −78 °C, and MeOH (0.15 
mL) and NaBH4 (22 mg, 0.58 mmol) were added. After 2 h, the mixture was allowed to slowly 
warm to ambient temperature. After 12 h, hexane (0.2 mL), and aq phosphate buffer (pH 7; 1 mL) 
were added. The mixture was cooled to 0 °C and 30% aq H2O2 (1 mL) was added with vigorous 
stirring. After 1 h, the mixture was allowed to warm to ambient temperature. After 2 h, the mixture 
was diluted with dichloromethane and washed sequentially with saturated aq NaHCO3 and brine, 
dried over Na2SO4, concentrated, and fractionated by PTLC (30% ethyl acetate in hexanes) to 
afford the title compound (21 mg, 70%) as a single diastereomer. 
white amorphous solid, TLC Rf = 0.3 (30% ethyl acetate in hexane). 
IR (DRIFT) vmax 3370 cm
-1. 
1H NMR (500 MHz, C6D6) δ 4.40-4.25 (2H, br s, HO ×2), 4.31 (1H, t, J = 4 Hz, HC-7), 3.59 (2H, 
dd, J = 3.5, 8.5 Hz, HC-5 & HC-9), 3.52 (2H, dd, J = 3.5, 8 Hz, HC-3 & HC-11), 3.29-3.14 (2H, 
br s, HO ×2), 2.44 (2H, ddq, J = 4, 8.5, 7 Hz, HC-6 & HC-8), 1.92 (2H, ddq, J = 3.5, 3.5, 7 Hz, 
HC-4 & HC-10), 1.78 (2H, dqq, J = 3.5, 6.5, 6.5 Hz, HC-2 & HC-12), 1.14 (6H, d, J = 7 Hz, 
H3CC-6 & H3CC-8), 1.02 (9H, t, J = 8 Hz, H3CCSi ×3), 1.01 (6H, d, J = 6.5 Hz, H3C-1 & H3C-
13), 0.97 (6H, d, J = 6.5 Hz, H3C-1' & H3C-13'), 0.94 (6H, d, J = 7 Hz, H3CC-4 & H3CC-10), 0.67 
(6H, q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, C6D6) δ 81.0 (d ×2, C-5 & C-9), 80.3 (d ×2, C-3 & C-11), 80.1 (d, C-7), 
43.2 (d ×2, C-6 & C-8), 38.4 (d ×2, C-4 & C-10), 31.2 (d ×2, C-2 & C-12), 21.0 (q ×2, C-1 & C-
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13), 18.1 (q ×2, CH3C-4 & CH3C-10), 16.0 (q ×2, CH3C-6 & CH3C-8), 15.6 (q ×2, C-1' & C-13'), 
7.5 (q ×3, CH3CSi), 5.8 (q ×3, CH2Si). 
HRMS m/z calcd for C25H54O5Si+Na+ 485.3633, found 485.3629 (ESI). 
 
  280a 
(2S,3S)-rel-2-{(4S,5S,6S)-6-[(R)-1-((4R,5R,6R)-6-Isopropyl-2,2,5-trimethyl-1,3-dioxan-4-
yl)ethyl]-2,2,5-trimethyl-1,3-dioxan-4-yl}-4-methylpentan-3-ol (280a) 
2,2-dimethoxypropane (0.21 mL, 0.18 g, 1.7 mmol) was added to a stirring solution of 279 
(8 mg, 0.02 mmol) in acetone (0.3 mL) at room temperature. After 3 h, the reaction mixture was 
diluted with dichloromethane and washed sequentially with saturated aq NaHCO3 and brine, dried 
over Na2SO4, concentrated, and fractionated by PTLC (5% ethyl acetate in hexane) to give 280c 
(the meso bisacetonide of 279; 3.3 mg, 35%; 13C NMR (125 MHz, CDCl3) δ 97.6, 78.4, 76.1, 72.7, 
44.3, 35.5, 30.3, 28.1, 20.5, 19.7, 14.6, 12.7, 12.6, 7.3, 5.8) and 280b (the TES-deprotected 
derivative of 280c;1.3 mg, 21%; 13C NMR (125 MHz, CDCl3) δ 98.0, 79.8, 78.6, 77.6, 37.2, 34.0, 
30.4, 28.3, 20.4, 19.3, 17.9, 14.6, 12.3) along with the title compound (2 mg, 33%). 
colorless viscous oil, TLC Rf = 0.5 (5% ethyl acetate in hexane). 
IR (DRIFT) vmax 3550 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 3.56 (1H, dd, J = 3.5, 10.5 Hz, HC-6'), 3.52 (1H, dd, J = 3, 10 Hz, 
HC-4'''), 3.47 (1H, dd, J = 1.5, 10.5 Hz, HC-4'), 3.36 (1H, ddd, J = 3.5, 4, 7.5 Hz, HC-3), 3.28 (1H, 















dd, J = 2, 10 Hz, HC-6'''), 3.21 (1H, d, J = 4 Hz, HO), 2.02 (1H, ddq, J = 3, 3.5, 7.5 Hz, HC-1''), 
1.98 (1H, ddq, J = 10.5, 10.5, 6.5 Hz, HC-5'), 1.92 (1H, ddq, J = 1.5, 7.5, 7 Hz, HC-2), 1.89 (1H, 
dqq, J = 2, 7, 7 Hz, HCC-6'''), 1.81 (1H, dqq, J = 4.5, 6.5, 7 Hz, HC-4), 1.57 (1H, ddq, J = 10, 10, 
6.5 Hz, HC-5'''), 1.40 (3H, s, H3CC-2'), 1.361 (3H, s, H3CC-2' or H3CC-2'''), 1.360 (3H, s, H3CC-
2' or H3CC-2'''), 1.30 (3H, s, H3CC-2'''), 1.01 (3H, d, J = 7.5 Hz, H3C-2''), 0.99 (3H, d, J = 7 Hz, 
H3C-5), 0.98 (3H, d, J = 7 Hz, H3C-1), 0.93 (3H, d, J = 7 Hz, H3CCC-6'''), 0.91 (3H, d, J = 6.5 Hz, 
H3C-5), 0.84 (3H, d, J = 6.5 Hz, H3CC-5'), 0.83 (3H, d, J = 7 Hz, H3CCC-6'''), 0.74 (3H, d, J = 6.5 
Hz, H3CC-5'''). 
13C NMR (125 MHz, CDCl3) δ 98.0 (s, C-2'''), 97.6 (s, C-2'), 81.1 (d, C-4'), 79.8 (d, C-3), 78.3 (d, 
C-6'''), 75.9 (d, C-6'), 75.7 (d, C-4'''), 40.8 (d, C-1''), 36.5 (d, C-2), 34.8 (d, C-5'), 33.0 (d, C-5'''), 
31.0 (d, C-4), 30.5 (q, CH3C-2'), 30.3 (q, CH3C-2'''), 28.3 (d, CHC-6'''), 20.7 (q, C-5), 20.4 (q, 
H3CCC-6'''), 19.6 (q, H3CC-2'''), 19.1 (q, H3CC-2'), 18.8 (q, C-1), 16.1 (q, C-5), 14.6 (q, H3CCC-
6'''), 14.1 (q, C-2''), 13.4 (q, H3CC-5'), 12.5 (q, H3CC-5'''). 
HRMS m/z calcd for C25H48O5+Na+ 451.3394, found 451.3389 (ESI). 
 
  281 
(3R,4S,5R,6S,7s,8R,9S,10R,11S)-2,4,6,8,10,12-Hexamethyl-7-((triethylsilyl)oxy)tridecane-
3,5,9,11-tetraol (281) 
Et2BOMe (14 µL, 12 mg, 0.12 mmol) was added to a stirring solution of 223 (18 mg, 0.040 










and the Et2BOMe slowly dissolved. After 1 h, the mixture was cooled to −78 °C, and MeOH (0.1 
mL) and NaBH4 (12 mg, 0.31 mmol) were added. After 3 h, the mixture was allowed to slowly 
warm to ambient temperature. After 1 h, ethyl acetate (0.5 mL), and aq NaOH (0.1 M; 0.5 mL) 
were added. The mixture was cooled to 0 °C and 30% aq H2O2 (0.5 mL) was added with vigorous 
stirring. After 1 h, the mixture was allowed to warm to ambient temperature. After 3 h, the mixture 
was diluted with dichloromethane and washed sequentially with saturated aq NaHCO3 and brine, 
dried over Na2SO4, concentrated, and fractionated by PTLC (30% ethyl acetate in hexanes) to 
afford the title compound (16 mg, 89%) as a single diastereomer. 
colorless viscous oil, TLC Rf = 0.3 (40% ethyl acetate in hexane). 
IR (DRIFT) vmax 3393 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 3.94 (2H, dd, J = 2, 6.5 Hz, HC-5 & HC-9), 3.82 (1H, t, J = 4.5 
Hz, HC-7), 3.28 (2H, br s, HO ×2), 3.21 (2H, dd, J = 1, 9.5 Hz, HC-3 & HC-11), 2.18 (2H, br s, 
HO ×2), 2.0 (2H, ddq, J = 2, 4.5, 7 Hz, HC-6 & HC-8), 1.71 (2H, ddq, J = 2, 6.5, 7 Hz, HC-4 & 
HC-10), 1.69 (2H, dqq, J = 9.5, 6.5, 6.5 Hz, HC-2 & HC-12), 1.04 (6H, d, J = 7 Hz, H3CC-6 & 
H3CC-8), 1.01 (6H, d, J = 6.5 Hz, H3C-1 & H3C-13), 0.99 (9H, t, J = 8 Hz, H3CCSi ×3), 0.97 (6H, 
d, J = 7 Hz, H3CC-4 & H3CC-10), 0.83 (6H, d, J = 6.5 Hz, H3C-1' & H3C-13'), 0.69 (6H, q, J = 8 
Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 81.9 (d, C-7), 80.0 (d, C-3 & C-11), 75.0 (d, C-5 & C-9), 38.6 (d, 
C-4 & C-10), 38.4 (d, C-6 & C-8), 31.6 (d, C-2 & C-12), 20.1 (q, C-1 & C-13), 19.3 (q, C-1' & C-
13'), 11.4 (q, CH3C-6 & CH3C-8), 7.6 (q, CH3C-4 & CH3C-10), 7.2 (q ×3, CH3CSi), 5.4 (t ×3, 
CH2Si). 







For procedure, see the preparation of 282b. 
colorless viscous oil, TLC Rf = 0.3 (5% ethyl acetate in hexane). 
IR (DRIFT) vmax 3480 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 3.73 (1H, dd, J = 3.5, 10 Hz, HC-4'), 3.66 (1H, dd, J = 2, 8 Hz, 
HC-4'''), 3.27-3.23 (2H, m, HC-6', HC-6'''), 3.16 (1H, ddd, J = 1.5, 6.5, 8 Hz, HC-3), 2.01 (1H, 
ddq, J = 3.5, 6.5, 6.5 Hz, HC-5'), 1.87 (1H, ddq, J = 6, 8, 7 Hz, HC-1''), 1.83 (1H, ddq, J = 1.5, 10, 
6.5 Hz, HC-2), 1.73-1.63 (3H, m, HC-4, HC-5''', HC-1''''), 1.39 (3H, s, H3CC-2'''), 1.37 (3H, s, 
H3CC-2'''), 1.34 (3H, s, H3CC-2'), 1.30 (3H, s, H3CC-2'), 1.25-1.23 (1H, d, J = 6.5 Hz, HO), 1.03 
(3H, d, J = 6.5 Hz, H3C-5), 0.96 (3H, d, J = 7 Hz, H3C-2''), 0.93 (3H, d, J = 6.5 Hz, H3C-2''''), 0.91 
(3H, d, J = 6.5 Hz, H3C-1), 0.89 (3H, d, J = 6.5 Hz, H3CC-5'), 0.86 (3H, d, J = 7 Hz, H3CC-5'''), 
0.84 (3H, d, J = 6.5 Hz, H3C-5), 0.79 (3H, d, J = 6.5 Hz, H3C-2''''). 
13C NMR (125 MHz, CDCl3) δ 100.6 (s, C-2'), 99.0 (s, C-2'''), 80.0 (d, C-6'''), 77.0 (d, C-3), 76.4 
(d, C-6'), 75.4 (d, C-4'''), 71.8 (d, C-4'), 39.8 (d, C-1''), 34.5 (d, C-2), 34.3 (d, C-5'), 33.3 (d, C-5'''), 
32.2 (d, C-4), 30.3 (q, H3CC-2'''), 29.4 (d, C-1''''), 25.8 (q, H3CC-2'), 23.6 (q, H3CC-2'), 20.3 (q, 














C-5), 20.1 (q, C-2''''), 19.8 (q, H3CC-2'''), 19.0 (q, C-5), 17.6 (q, C-2''''), 13.8 (q, H3CC-5'), 11.2 (q, 
C-2''), 8.4 (q, C-1), 5.8 (q, H3CC-5'''). 





2,2-dimethoxypropane (0.21 mL, 0.18 g, 1.7 mmol) was added to a stirring solution of 
282b (12 mg, 0.026 mmol) in CH2Cl2 (0.2 mL) at room temperature. After 40 h, the reaction 
mixture was diluted with CH2Cl2 and washed sequentially with saturated aq NaHCO3 and brine, 
dried over Na2SO4, concentrated, and fractionated by PTLC (5% ethyl acetate in hexane) to give 
282c (1 mg, 9%), 282a (4.2 mg, 38%), and the title compound (5.5 mg, 40%). 
colorless viscous oil, TLC Rf = 0.7 (5% ethyl acetate in hexane). 
IR (DRIFT) vmax cm
-1. 
1H NMR (500 MHz, CDCl3) δ 3.80 (2H, dd, J = 2, 6.5 Hz, HC-4' & HC-4''), 3.54 (1H, t, J = 4 Hz, 
HC-3), 3.26 (2H, dd, J = 2, 9.5 Hz, HC-6' & HC-6''), 1.77 (2H, ddq, J = 4, 6.5, 7 Hz, HC-2 & HC-
4), 1.65 (2H, dqq, J = 9.5, 6.5, 6.5 Hz, HCC-6' & HCC-6''), 1.56 (2H, ddq, J = 2, 2, 7 Hz, HC-5' 
& HC-5''), 1.37 (12H, ap s, (H3C)2C-2' & (H3C)2CC-2''), 0.98 (9H, t, J = 8 Hz, H3CCSi ×3), 0.932 











d, J = 7 Hz, H3CC-5' & H3CC-5''), 0.79 (6H, d, J = 7 Hz, H3CCC-6' & H3CCC-6'), 0.63 (6H, q, J 
= 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 99.0 (s, C-2' & C-2''), 80.0 (d, C-6' & C-6''), 77.9 (d, C-3), 73.8 
(d, C-4' & C-4''), 39.8 (d, C-2 & C-4), 33.6 (d, C-5' & C-5''), 30.2 (q, H3CC-2' & H3CC-2''), 29.4 
(d, CHC-6' & CHC-6''), 20.1 (q, H3CCC-6' & H3CCC-6''), 19.9 (q, H3CC-2' & H3CC-2''), 17.6 (q, 
H3CCC-6' & H3CCC-6'), 13.8 (q, C-1 & C-5), 7.3 (q ×3, H3CCSi), 5.7 (q, H3CC-5' & H3CC-5''), 
5.5 (t ×3, H2CSi). 
HRMS m/z calcd for C31H62O5Si+Na+ 565.4264, found 565.4264 (ESI). 
 





9-BBNOTf (0.5 M in hexane; 5.3 mL, 2.6 mmol) was added via syringe to a clean dry 
Schlenk tube and the hexane was removed under reduced pressure. A solution of 202aa (207 mg, 
0.66 mmol) and Et3N (0.44 mL, 0.32 g, 3.2 mmol) in Et2O (2.0 mL) was added to the neat borane 
reagent at –78 °C under argon with stirring. After 4 h, the reaction mixture was warmed to 0 °C 

















BBN-OTf). After 1 h, the mixture was cooled to −78 °C and a solution of (+)-128 (223 mg, 0.73 
mmol) in THF (2 mL) was added via syringe. After 16 h, the reaction was quenched by sequential 
addition of phosphate buffer (pH 7; 4 mL), 30% aq H2O2 (4 mL), and MeOH (4 mL) with vigorous 
stirring. The reaction vessel was transferred to an ice bath and after vigorous stirring for 20 min, 
the mixture was diluted with water and extracted with CH2Cl2. The combined organic layers were 
dried over Na2SO4 and concentrated to give the crude product whose 1H NMR spectrum indicated 
the presence of a 9:1.3:1 mixture of 253, 202aa, and an unidentified adduct (presumably a 
bisaldol), respectively. Fractionation of the crude product by FCC (20% ethyl acetate in hexane) 
gave the title compound (294 mg, 72%); [α]D –42 (c 1.1, C6H6). 
colorless viscous oil, TLC Rf = 0.3 (20% ethyl acetate in hexane). 
IR (DRIFT) vmax 3509, 1710 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 7.47-7.43 (2H, m, Ph), 7.38-7.31 (3H, m, Ph), 5.53 (1H, s, HC-2'), 
4.36 (1H, dd, J = 5.5, 7 Hz, HC-5), 4.17 (1H, ddd, J = 3, 3.5, 6 Hz, HC-1), 3.50 (1H, ap t, J = 9.5 
Hz, HC-8'a), 3.39 (1H, dd, J = 2, 10 Hz, HC-4'), 3.06 (1H, dq, J = 3.5, 7 Hz, HC-2), 2.92 (1H, ddd, 
J = 2.5, 3, 14 Hz, HC-7'), 2.88 (1H, d, J = 3.5 Hz, HO), 2.80 (1H, dq, J = 7, 7 Hz, HC-4), 2.68 
(1H, dd, J = 11, 14 Hz, HC-7'), 2.65 (1H, dq, J = 5.5, 7 Hz, HC-6), 2.55-2.40 (3H, m, HC-5', H2C-
8), 2.31 (1H, dd, J = 12, 13 Hz, HC-5'), 2.11-2.02 (2H, m, HC-8', HC-4'a), 1.94 (1H, dqq, J = 2, 
7, 7 Hz, HC-1''), 1.16 (3H, d, J = 7 Hz, H3CC-2), 1.05 (3H, d, J = 7 Hz, H3CC-1''), 1.02 (3H, t, J 
= 7 Hz, H3C-9), 0.97 (3H, d, J = 7 Hz, H3CC-1''), 0.95 (3H, d, J = 7 Hz, H3CC-6), 0.91 (9H, t, J = 
8 Hz, H3CCSi ×3), 0.83 (3H, d, J = 7 Hz, H3CC-4), 0.55 (6H, q, J = 8 Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3) δ 218.0 (s, C-3), 212.4 (s, C-7), 138.9 (s, Ph), 128.8 (d, Ph), 128.3 
(d ×2, Ph), 126.3 (d ×2, Ph), 101.1 (d, C-2'), 84.0 (d, C-4'), 82.3 (d, C-8'a), 75.2 (d, C-5), 70.1 (d, 
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C-1), 51.6 (d, C-6), 50.1 (d, C-2), 49.0 (d, C-4), 46.2 (d, C-8'), 43.8 (d, C-4'a), 35.6 (t, C-8), 28.6 
(t, C-7'), 28.4 (d, C-1''), 27.5 (t, C-5'), 20.2 (q, CH3C-1''), 15.0 (q, CH3C-1''), 12.9 (q, CH3C-4), 
11.2 (q, CH3C-6), 10.9 (q, CH3C-2), 7.8 (q, C-9), 7.1 (q, CH3CSi ×3), 5.2 (t, CH2Si ×3). 





To a stirring solution of 253 (120 mg, 0.19 mmol) in DMSO (2 mL) was added IBX (82 
mg, 0.29 mmol). After 20 h, the mixture was diluted with saturated aq NaHCO3 and extracted with 
Et2O. The combined organic layers were washed with brine, dried over Na2SO4, concentrated, and 
fractionated by FCC (15% ethyl acetate in hexane) to afford the title compound as a 1:2:1 mixture 
of an enol and two keto tautomers, respectively (117 mg, 98%); [α]D +50 (c 1.0, C6H6).. 
colorless viscous oil, TLC Rf = 0.5 (15% ethyl acetate in hexane). 
IR (DRIFT) vmax 2959, 2878, 1716 cm
-1. 
1H NMR (500 MHz, C6D6) δ (* enol tautomer; † major keto tautomer; ‡ minor keto tautomer) 
17.80 (0.25H, s, *HO), 7.59-7.47 (2H, m, Ph), 7.28-7.02 (3H, m, Ph), 5.47 (0.25H, s, ‡HC-2'), 5.31 
(0.25H, s, *HC-2'), 5.29 (0.5H, s, †HC-2'), 4.43 (0.25H, dd, J = 4.5, 8 Hz, *HC-5), 4.37 (0.5H, ap 

















(0.25H, ap t, J = 10 Hz, ‡HC-8'a), 3.78 (0.25H, q, J = 7 Hz, ‡H3C-2), 3.64 (0.25H, ap t, J = 10 Hz, 
*HC-8'a), 3.60 (0.5H, ap t, J = 10 Hz, †HC-8'a), 3.35-3.20 (1H, m, H-8'), 3.07 (0.25H, dd, J = 11.5, 
13.5 Hz, ‡HC-7'), 3.04 (0.25H, dq, J = 7, 7 Hz, *HC-4), 3.02 (0.25H, dd, J = 2, 10 Hz, ‡HC-4'), 
2.99-2.89 (1.5H, m, †‡HC-7', *†HC-4'), 2.80 (0.25H, dd, J = 11.5, 13.5 Hz, *HC-7'), 2.71 (0.25H, 
dq, J = 4.5, 7 Hz, ‡HC-4), 2.68-2.55 (1.25H, m, J = 7 Hz, †HC-4, *†HC-6), 2.52 (0.25H, ddd, J = 
2.5, 2.5, 13.5 Hz, *HC-7'), 2.37-1.96 (4.25H, m, H2C-8, HC-4'a, HC-5', ‡HC-7'), 1.91-1.79 (1H, 
m, HC-5'), 1.72 (0.75H, s, *H3CC-2), 1.55-1.41 (1H,, J = m Hz, HC-1''), 1.30 (1.5H, d, J = 7 Hz, 
†H3CC-2), 1.20 (0.75H, d, J = 7 Hz, ‡H3CC-2), 1.05 (0.75H, d, J = 7 Hz, *H3CC-4), 1.04 (0.75H, 
d, J = 7 Hz, *H3CC-6), 1.03-0.93 (7.5H, m, H3C-9, H3CC-1'', †‡H3CC-6), 0.99 (2.25H, t, J = 8 Hz, 
*(H3CC)3Si or ‡(H3CC)3Si), 0.97 (4.5H, t, J = 8 Hz, †(H3CC)3Si), 0.91 (2.25H, t, J = 8 Hz, 
*(H3CC)3Si or ‡(H3CC)3Si), 0.89 (0.75H, d, J = 7 Hz, ‡H3CC-6), 0.87 (1.5H, ap d, J = 7 Hz, 
*‡H3CC-2''), 0.86 (1.5H, d, J = 7 Hz, †H3CC-2''), 0.85 (1.5H, d, J = 7 Hz, †H3CC-4), 0.80 (0.75H, 
d, J = 7 Hz, ‡H3CC-4), 0.69-0.50 (6H, m, (H2C)3Si). 
13C NMR (125 MHz, C6D6) δ (* enol tautomer; † major keto tautomer; ‡ minor keto tautomer) 
211.9 (s, ‡C-7), 211.26 (s, *C-7), 211.24 (s, †C-7), 210.8 (s, †C-3), 209.2 (s, ‡C-1 or ‡C-3), 209.1 
(s, ‡C-1 or ‡C-3), 208.3 (s, †C-1), 196.7 (s, *C-3), 193.1 (s, *C-1), 139.8 (s, *Ph or ‡Ph), 139.5 (s, 
†Ph), 139.4 (s, *Ph or ‡Ph), 129.4 (d, *Ph or ‡Ph), 129.2 (d, †Ph), 129.1 (d, *Ph or ‡Ph), 128.68 (d 
×2, †Ph), 128.67 (d ×2, *Ph or ‡Ph), 128.55 (d ×2, *Ph or ‡Ph), 127.2 (d ×2, *Ph or ‡Ph), 127.0 (d 
×2, *Ph or ‡Ph), 126.6 (d ×2, †Ph), 106.2 (s, *C-2), 102.1 (d, *C-2'), 101.6 (d, ‡C-2'), 101.2 (d, †C-
2'), 83.84 (d, ‡C-4'), 83.83 (d, †C-4'), 83.79 (d, *C-4'), 83.5 (d, †C-8'a), 82.6 (d, *C-8'a), 81.3 (d, 
‡C-8'a), 76.7 (d, ‡C-5), 76.2 (d, †C-5), 75.9 (d, *C-5), 62.1 (d, †C-2), 60.6 (d, ‡C-2), 56.1 (d, †C-8'), 
53.7 (d, ‡C-8'), 51.7 (d, †C-6), 51.14 (d, ‡C-6 or *C-6), 51.11 (d, ‡C-6 or *C-6), 50.5 (d, †C-4), 49.6 
(d, ‡C-4), 48.9 (d, *C-8'), 44.23 (d, *C-4), 44.15 (d, ‡C-4'a), 43.8 (d, †C-4'a), 43.7 (d, *C-4'a), 36.4 
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(t, ‡C-8 or *C-8), 36.1 (t, †C-8), 35.6 (t, ‡C-8 or *C-8), 31.0 (t, *C-7' or ‡C-7'), 30.9 (t, *C-7' or ‡C-
7'), 30.8 (t, †C-7'), 28.6 (d, ‡C-1'' or *C-1''), 28.5 (d ×2, †C-1'' & ‡C-1'' or *C-1''), 27.57 (t, *C-5' or 
‡C-5'), 27.54 (t, *C-5' or ‡C-5'), 27.51 (t, ‡C-5'), 20.37 (q, *CH3C-1'' or ‡CH3C-1''), 20.36 (q, 
*CH3C-1'' or ‡CH3C-1''), 20.34 (q, †CH3C-1''), 15.20 (q, *CH3C-1'' or ‡CH3C-1''), 15.17 (q, †CH3C-
1''), 15.16 (q, *CH3C-1'' or ‡CH3C-1''), 13.8 (q, *CH3C-6), 13.7 (q, †CH3C-4), 13.5 (q, *CH3C-4 
or ‡CH3C-6), 13.4 (q, *CH3C-4 or ‡CH3C-6), 13.2 (q, ‡CH3C-2), 12.5 (q, *CH3C-4), 12.41 (q, 
†CH3C-6), 12.37 (q, †CH3C-2), 12.3 (q, *CH3C-2), 8.2 (q, *C-9 or ‡C-9), 8.1 (q, †C-9), 8.0 (q, *C-
9 or ‡C-9), 7.7 (q ×2, †(CH3C)3Si and *(CH3C)3Si or ‡(CH3C)3Si), 7.6 (q, *(CH3C)3Si or 
‡(CH3C)3Si), 5.75 (t, †CH2Si), 5.72 (t, *(CH2)3Si or ‡(CH2)3Si), 5.70 (t, *(CH2)3Si or ‡(CH2)3Si). 





A suspension of Raney nickel (W2; 0.5 mL settled volume) in EtOH (5 mL) was added to 
257 (62 mg, 0.10 mmol), and the mixture was heated under reflux with vigorous stirring under H2 
atmosphere (balloon). After 2 h (reaction was complete by TLC analysis), the mixture was 
decanted, and the solid was suspended in EtOH (4 mL) and heated under reflux with vigorous 
stirring for several min. This washing procedure was repeated with ethyl acetate and with acetone. 
The combined organic layers were filtered through Celite®, concentrated and fractionated by FCC 
OO OHOHO



















(20% ethyl acetate in hexane) to give the title compound (38 mg, 76%) that was predominantly a 
3:1 mixture of two hemiacetal forms (HOC-13 à O=C-9; epimeric at C-8) in C6D6 solution; [α]D 
–48 (c 1.0, C6H6). 
colorless viscous oil, TLC Rf = 0.3 (20% ethyl acetate in hexane). 
IR (DRIFT) vmax 3407, 1705 cm
-1. 
1H NMR (500 MHz, C6D6) δ (* denotes signals for the minor hemiacetal) 5.43 (0.75H, s, HOC-
9), 5.03 (0.25H, s, *HOC-9), 4.66 (0.75H, dd, J = 6, 6.5 Hz, HC-5), 4.38 (0.25H, dd, J = 6, 6.5 Hz, 
*HC-5), 3.68 (0.25H, dd, J = 2.5, 10.5 Hz, *HC-13), 3.61 (0.75H, dq, J = 7, 7 Hz, HC-6), 3.56 
(0.75H, dq, J = 2, 10.5 Hz, HC-13), 3.22 (0.25H, dq, J = 7, 7 Hz, *HC-6), 3.20 (0.75H, q, J = 7 
Hz, HC-8), 3.15 (0.25H, br s, *HC-11), 3.12 (0.75H, br s, HC-11), 3.08 (0.25H, q, J = 7 Hz, *HC-
8), 2.73 (0.75H, dq, J = 6.5, 7 Hz, HC-4), 2.69 (0.25H, dq, J = 6, 7 Hz, *HC-4), 2.41-2.11 (3H, t, 
J = 8 Hz, H2C-2, *H2C-2, HOC-13, *HOC-13), 1.75-1.57 (1H, m, HC-14, *HC-14), 1.53 (0.25H, 
dq, J = 2.5, 7 Hz, *HC-10), 1.48 (0.75H, d, J = 7 Hz, *H3CC-8), 1.44 (0.75H, dq, J = 2.5, 7 Hz, 
HC-10), 1.30-1.21 (1H, m, HC-12, *HC-12), 1.23 (0.75H, d, J = 7 Hz, *H3CC-10), 1.20 (2.25H, 
d, J = 7 Hz, H3CC-6), 1.18 (2.25H, d, J = 7 Hz, H3CC-8), 1.14 (0.75H, d, J = 7 Hz, *H3CC-6), 
1.11 (3H, ap d, J = 7 Hz, H3C-15, *H3C-15), 1.08 (0.75H, d, J = 7 Hz, *H3CC-4), 1.06 (6.75H, t, 
J = 8 Hz, (H3CC)3Si), 1.04-0.98 (9.75H, m, H3C-1, *H3C-1, H3CC-4, H3CC-10, *(H3CC)3Si), 0.89 
(2.25H, d, J = 7 Hz, H3C-15), 0.87 (0.75H, d, J = 7 Hz, *H3C-15), 0.79-0.69 (4.5H, m, (H2C)3Si), 
0.70 (0.75H, d, J = 7 Hz, *H3CC-12), 0.69 (1.5H, ap q, J = 8 Hz, *(H2C)3Si), 0.62 (2.25H, d, J = 
7 Hz, H3CC-12). 
13C NMR (125 MHz, C6D6) δ (* denotes signals for the minor hemiacetal) 216.6 (s, *C-7), 212.3 
(s, C-7), 211.9 (s, C-3), 211.5 (s, *C-3), 101.8 (s, C-9), 101.5 (s, *C-9), 77.4 (d, *C-5), 77.1 (d, 
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*C-11), 77.0 (d, C-11), 76.4 (d, C-5), 72.7 (d, *C-13), 72.4 (d, C-13), 54.4 (d, *C-8), 52.7 (d, C-
6), 52.4 (d, C-8), 51.9 (d, *C-4), 51.2 (d, C-4), 47.9 (d, *C-6), 41.8 (d, *C-10), 39.1 (d, C-10), 38.2 
(d, *C-12), 37.8 (d, C-12), 36.6 (t, C-2), 36.0 (t, *C-2), 28.9 (d, C-14), 28.8 (d, *C-14), 21.1 (q, C-
15), 21.0 (q, *C-15), 15.2 (q, *C-15), 15.0 (q, *CH3C-6), 14.70 (q, C-15), 14.67 (q, *CH3C-10), 
13.8 (q ×2, CH3C-12, *CH3C-12), 13.7 (q, CH3C-10), 13.1 (q, *CH3C-4), 12.7 (q, CH3C-8), 12.3 
(q, CH3C-4), 11.9 (q, CH3C-6), 11.1 (q, *CH3C-8), 8.1 (q ×2, C-1, *C-1), 7.6 (q ×2, (CH3C)3Si 
*(CH3C)3Si), 5.81 (t, (CH2)3Si), 5.77 (t, *(CH2)3Si). 





Tris(dimethylamino)sulfonium Difluorotrimethylsilicate (TASF, 15 mg, 0.054 mmol) was 
added to a stirring solution of 258 (18 mg, 0.036 mmol) in DMF (0.2 ml). After 30 min, the reaction 
was quenched by sequential addition of saturated aq NaHCO3 and ethyl acetate. The organic layer 
was separated and the aqueous layer was extracted with ethyl acetate. The combined organic layers 
were washed with brine, dried over Na2SO4, concentrated, and fractionated first by FCC (40% 
ethyl acetate in hexane) and then by PTLC (40% ethyl acetate in hexane) gave the title compound 
(11 mg, 80%) that was predominantly a 1.8:1 mixture of two hemiacetal forms (HOC-13 à O=C-
9; epimeric at C-8) in C6D6 solution. Specific rotation and NMR data for 32 closely match those 
OOH OHOHO


















previously reported ([α]D –36 (c 1.1, C6H6), lit. –30 (c 0.5, C6H6); DdH ≤ 0.02 for H-C, ≤ 0.2 for 
H-O; DdC ≤ 0.2).17 
colorless oil, TLC Rf = 0.3 (40% ethyl acetate in hexane). 
1H NMR (500 MHz, C6D6) δ (* denotes signals for the minor hemiacetal) 5.57 (0.7H, s, HOC-9), 
5.08 (0.4H, s, *HOC-9), 3.85-3.70 (2H, m, HC-5, *HC-5, HOC-5, *HOC-5), 3.66 (0.4H, dd, J = 
2, 11 Hz, *HC-13), 3.58 (0.7H, dd, J = 2, 11 Hz, HC-13), 3.37 (0.7H, dq, J = 7, 7 Hz, HC-6), 3.15 
(0.4H, ddd, J = 2.5, 2.5, 7 Hz, *HC-11), 3.13-3.01 (2H, m, *HC-6, HC-8, *HC-8, HC-11), 2.54 
(0.4H, dq, J = 4.5, 7 Hz, *HC-4), 2.51 (0.7H, dq, J = 4.5, 7 Hz, HC-4), 2.37 (0.4H, d, J = 7 Hz, 
*HOC-11), 2.29 (0.7H, d, J = 7.5 Hz, HOC-11), 2.23 (0.4H, dq, J = 18.5, 7 Hz, *HC-2), 2.17-2.03 
(1.7H, m, *HC-2, H2C-2), 1.73-1.63 (1H, m, HC-14, *HC-14), 1.51 (0.4H, dq, J = 2.5, 7 Hz, HC-
10*), 1.36 (0.7H, dq, J = 2.5, 7 Hz, HC-10), 1.31 (0.4H, ddq, J = 2.5, 11, 7 Hz, *HC-12), 1.25 
(1.2H, d, J = 7 Hz, *H3CC-8), 1.21 (0.7H, ddq, J = 2.5, 11, 7 Hz, HC-12), 1.16 (1.2H, d, J = 7 Hz, 
*H3CC-10), 1.14 (2H, d, J = 7 Hz, H3CC-8), 1.111 (2H, d, J = 7 Hz, H3CC-6 or H3CC-15), 1.107 
(2H, d, J = 7 Hz, H3CC-6 or H3CC-15), 1.07 (1.2H, d, J = 7 Hz, *H3CC-15), 1.02 (1.2H, d, J = 7 
Hz, *H3CC-4), 1.00 (1.2H, d, J = 7 Hz, *H3CC-6), 0.98 (1.2H, t, J = 7 Hz, *H3C-1), 0.96 (4H, ap 
d, J = 7 Hz, H3CC-4, H3CC-10), 0.93 (2H, t, J = 7 Hz, H3C-1), 0.87 (2H, d, J = 7 Hz, H3C-15), 
0.85 (1.2H, d, J = 7 Hz, *H3C-15), 0.71 (1.2H, d, J = 7 Hz, *H3CC-12), 0.65 (2H, d, J = 7 Hz, 
H3CC-12). 
13C NMR (125 MHz, C6D6) δ (* denotes signals for the minor hemiacetal) 218.5* (s, C-7), 217.4 
(s, C-7), 215.6 (s, C-3), 215.2* (s, C-3), 102.4 (s, C-9), 101.8* (s, C-9), 78.8 (d, C-5), 78.0* (d, C-
5), 77.2* (d, C-11), 76.7 (d, C-11), 72.7* (d, C-13), 72.6 (d, C-13), 54.6* (d, C-8), 54.3 (d, C-8), 
49.6 (d, C-6), 49.0* (d, C-6), 48.31* (d, C-4), 48.29 (d, C-4), 41.5* (d, C-10), 39.1 (d, C-10), 38.2* 
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(d, C-12), 37.8 (d, C-12), 36.5 (t, C-2), 36.0* (t, C-2), 28.9 (d, C-14), 28.7* (d, C-14), 21.2 (q, C-
15), 21.0* (q, C-15), 15.4* (q, H3CC-6), 15.3 (q, H3CC-6), 15.15 (q, H3CC-4), 15.10* (q, H3CC-
4), 14.9* (q, H3CC-15), 14.84 (q, H3CC-15), 14.76* (q, H3CC-10), 14.0 (q, H3CC-12), 13.9* (q, 
H3CC-12), 13.7 (q, H3C-C10), 12.5 (q, H3CC-8), 11.8* (q, H3CC-8), 7.95* (q, C-1), 7.93 (q, C-1). 




Following the published procedure,17 a solution of 32 (5.6 mg, 0.015 mmol) in benzene 
(0.2 mL) was applied to a small column of neutral alumina (Brockmann I; ca. 5 cm in a Pasteur 
pipette). After 30 min, the column was eluted with ethyl acetate and the eluent was concentrated 
and fractionated by PTLC (40% ethyl acetate in hexane) to give dolabriferol (15) (4.4 mg, 79%). 
Specific rotation and NMR data for 15 closely match those previously reported ([α]D –27 (c 0.44, 
CHCl3), lit. –29.4 (c 0.7, CHCl3); DdH ≤ 0.01 for H-C, ≤ 0.03 for H-O; DdC ≤ 0.1).7 
white solid, TLC Rf = 0.5 (40% ethylacetate in hexanes). 
1H NMR (500 MHz, CDCl3) δ 5.25 (1H, dd, J = 2.5, 2.5 Hz), 3.76 (1H, ddd, J = 5, 8, 8 Hz), 3.62 
(1H, d, J = 8 Hz), 3.61 (1H, dd, J = 2, 10.5 Hz), 3.46 (1H, s), 2.78 (1H, dq, J = 7, 7 Hz), 2.74 (1H, 
dq, J = 5, 7 Hz), 2.58 (1H, dq, J = 18, 7 Hz), 2.46 (1H, dq, J = 18, 7 Hz), 1.91 (1H, dq, J = 3, 7 





















Hz), 1.59 (1H, dq, J = 14.5, 7.5 Hz), 1.33 (3H, d, J = 7 Hz), 1.15 (3H, d, J = 7 Hz), 1.04 (3H, t, J 
= 7 Hz), 1.01 (3H, d, J = 7 Hz), 1.00 (3H, d, J = 7 Hz), 0.91 (3H, t, J = 7.5 Hz), 0.83 (3H, d, J = 7 
Hz), 0.78 (3H, d, J = 7 Hz). 
13C NMR (125 MHz, CDCl3) δ 215.5, 173.9, 98.7, 77.1, 75.9, 72.5, 49.6, 43.9, 39.6, 36.6, 36.2, 
32.7, 28.2, 20.5, 15.8, 14.6, 14.2, 13.2, 13.0, 7.7, 7.5. 




Following the known procedures,31,99 propanal (4.80 g, 82.6 mmol) was added to a stirring 
suspension of L-proline (476 mg, 4.14 mmol) in dry dimethylformamide (36 mL) at 4 oC. After 
10 h, MeOH (6.7 mL, 5.3 g, 0.17 mol) and NaBH4 (6.2 g, 16 mmol) were added and the reaction 
mixture was allowed warmed to ambient temperature over 30 minutes. The mixture was cooled to 
0 oC, and reaction was quenched by slow addition of water (20 mL) and 30% H2O2 (18.5 mL, 
0.166 mol) with vigorous stirring. After 30 min, the mixture was diluted with water, and extracted 
with EtOAc. The combined organic layers were washed with brine, dried over Na2SO4, 
concentrated, and re-concentrated from toluene (several times) to obtain the crude diol (2.59 g) as 
a 4:1 mixture of 260a (anti), 260s (syn) diastereomers, that was used in the next step without 
further purification. A small sample of this mixture was converted to the corresponding mono 
benzoate ester 261a;106–108 HPLC analysis of 261a indicated >98% ee (for each diastereomer).  
TBSCl (2.91g, 19.3 mmol) and imidazole (1.77g, 26 mmol) were added to a stirring 




argon. After 2 h, the mixture was diluted with a 30% Et2O in hexane solution and washed 
sequentially with 0.2 M aq citric acid and brine, dried over Na2SO4, concentrated and 
reconcentrated from toluene (several times) to give the crude TBS alcohol 262 (4.32 g) that was 
used in the next step without further purification. 
A solution of the crude TBS alcohol 262 (4.32 g, 18.6 mmol) and pyridine (4.5 mL, 4.40 
g, 56 mmol) in wet CH2Cl2 (20 mL; saturated with water) was added to a stirring solution of DMP 
(12.1 g, 28.5 mmol) in wet CH2Cl2 (170 mL; saturated with water) under argon. After 10 min, the 
reaction was quenched by addition of a 1:1 mixture (v/v) of 10% aq Na2S2O3 and saturated aq 
NaHCO3. The organic layer was removed, and the aqueous layer was extracted with CH2Cl2. The 
combined organic layers were washed with water, dried over Na2SO4, concentrated, and 
fractionated by FCC (5% ethyl acetate in hexane) to give the title compound (4.2 g; 44% from 
propanal) as a colorless liquid. NMR data for (R)-263 closely matched those previously 




1,2-Bis(trimethylsiloxy)ethane (8.0 mL, 8.6 g, 32 mmol), bis(trimethylsilyl)acetamide 
(0.20 mL, 0.17 g, 0.82 mmol), and TMSOTf (0.42 mL, 0.52 g, 2.3 mmol) were sequentially added 
to a stirring solution of 263 (1.80 g, 7.82 mmol) in dry CH2Cl2 (13 mL) at –20 oC under argon. 
After 2 h, a solution of Et3N (3.3 mL, 2.4 g, 24 mmol) in CH2Cl2 (20 mL) and saturated aq NaHCO3 




water, dried over Na2SO4, and concentrated to give the crude product (8.7 g) that was used in the 
next step without further purification.  
Et3N (16.3 mL, 11.9 g, 120 mmol) and 7.7% aq HF (31 mL, 0.12 mol) were sequentially 
added to a stirring solution of the above crude product (8.7 g) in acetonitrile (26 mL) at 0 oC. The 
cooling bath was removed and stirring continued at room temperature for 3 h. The reaction mixture 
was cooled to 0 oC and saturated aq NaHCO3 was added. The mixture was diluted with EtOAc and 
the organic layer was separated and washed with brine, dried over Na2SO4, concentrated, and 
fractionated by FCC to give the title compound (1.08 g, 86% from 263) as a colorless oil ([α]25 
+38, c 1.3, CHCl3). NMR data for (R)-268 closely matched those previously reported.78 The 
enantiopurity of (R)-268 (97% ee) was determined by HPLC of the corresponding benzoate ester 
as described by Leighton et al.97 
 
    (+)-R-159 
(R)-2-(2-ethyl-1,3-dioxalane-2-yl)propanal (159) 
A solution of (R)-268 (342 mg, 2.14 mmol), pyridine (0.52 mL, 511 mg, 6.45 mmol) in 
water-saturated CH2Cl2 (10.0 mL) was added to a stirring suspension of Dess-Martin periodinane 
(DMP) (1.36 g, 3.21 mmol) in water-saturated CH2Cl2 (10.0 mL). After 10 min, Et2O (40 mL) was 
added and a white precipitate formed. A solution made up of saturated NaHCO3 (12.6 mL) and 
Na2S2O3 (3.3 g) diluted to 20 mL with water was added to the stirring reaction mixture resulting 
in two layers. The aqueous phase was extracted with Et2O and the combined organic layers were 
washed with H2O, brine, dried over Na2SO4 and concentrated to give the title compound (311 mg) 









As described above for the preparation of 253, the (Z,Z)-dienyl bis(9-
borabicyclo[3.3.1]nonan-9-ylborinate) of 202aa (221 mg, 0.71 mmol) was prepared by reaction 
with 9-BBNOTf (4 equiv) and Et3N (5 equiv) in Et2O at –78 °C for 4 h, followed by addition of 
2,4-dimethyl-3-pentanone (8 equiv) and reaction at 0 °C for 1 h (to quench the excess 9-BBN-
OTf). The stirring mixture was cooled to –78 °C and a solution of (+)-128 (238 mg, 0.78 mmol) 
in THF (2.0 mL) was added via syringe. After 16 h, a solution of (R)-(+)-159 (311 mg, 1.97 mmol) 
in Et2O (2 mL) was added. After 6 h, the reaction was quenched by sequential addition of 
phosphate buffer (pH 7, 4 ml), 30% aq H2O2 (4 ml), and MeOH (4 ml) with vigorous stirring. The 
reaction vessel was transferred to an ice bath, and after vigorous stirring for 20 min, the mixture 
was diluted with saturated aq NaHCO3 and extracted with CH2Cl2. The combined organic layers 
were dried over Na2SO4 and concentrated to give the crude product as pale yellow oil whose 1H 
NMR spectrum indicated the presence of a 4:1 mixture of 252ssa and homobisaldols (i.e., double 
addition of (+)-128 or (+)-159 to 222), respectively. Fractionation of the crude product by FCC 
(30% ethyl acetate in hexane) and then a second FCC (20% acetone in hexane) gave an ca. 84:12:4 




















A small sample of the mixture was fractioned twice by PTLC (20% Et2O in toluene, developed 
twice) to give the title compound (ca. 95% pure); [α]D +14 (c 0.4, CHCl3). 
pale yellow viscous oil, TLC Rf = 0.3 (30% ethyl acetate in hexane). 
IR (DRIFT) vmax 3540, 1711 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 7.47-7.44 (2H, m, Ph), 7.37-7.30 (3H, m, Ph), 5.54 (1H, s, HC-2'), 
4.39 (1H, dd, J = 6, 6 Hz, HC-5), 4.22 (1H, ddd, J = 3, 3, 5 Hz, HC-1), 4.18 (1H, s, HOC-9), 4.03 
(1H, br d, J = 10 Hz, HC-9), 4.02-3.95 (4H, m, H2CO ×2), 3.51 (1H, dd, J = 9.5, 9.5 Hz, HC-8'a), 
3.39 (1H, dd, J = 2, 10 Hz, HC-4'), 3.07 (1H, dq, J = 3, 7 Hz, HC-2), 2.98 (1H, d, J = 3 Hz, HOC-
1), 2.97 (1H, dq, J = 6, 7 Hz, HC-6), 2.92-2.88 (1H, m, HC-7'), 2.85 (1H, dq, J = 6, 7 Hz, HC-4), 
2.70 (1H, dd, J = 11, 14 Hz, HC-7'), 2.63-2.57 (1H, m, HC-8), 2.53-2.47 (1H, m, HC-5'), 2.31 (1H, 
dd, J = 12, 13.5 Hz, HC-5'), 2.11-2.03 (2H, m, HC-4'a, HC-8'), 1.94 (1H, dqq, J = 2, 7, 7 Hz, HC-
1''), 1.85 (1H, dq, J = 9.5, 7 Hz, HC-10), 1.83-1.69 (2H, m, H2CC-2'''), 1.17 (3H, d, J = 7 Hz, 
H3CC-2), 1.11 (3H, d, J = 7 Hz, H3CC-8), 1.05 (3H, d, J = 7 Hz, H3CC-1''), 0.97 (3H, d, J = 7 Hz, 
H3CC-1''), 0.94 (3H, d, J = 7 Hz, H3CC-6), 0.92-0.88 (9H, m, H3CC-4, H3C-11, H3CCC-2'''), 0.90 
(9H, t, J = 8 Hz, (H3CC)3Si), 0.54 (6H, ap q, J = 8 Hz, (H2C)3Si). 
13C NMR (125 MHz, CDCl3) δ 218.1 (s, C-3), 214.6 (s, C-7), 138.9 (s, Ph), 128.8 (d, Ph), 128.3 
(d ×2, Ph), 126.3 (d ×2, Ph), 114.8 (s, C-2'''), 101.1 (d, C-2'), 84.0 (d, C-4'), 82.1 (d, C-8'a), 74.9 
(d, C-5), 72.3 (d, C-9), 69.9 (d, C-1), 65.4 (t, CH2O), 65.1 (t, CH2O), 49.6 (d, C-2), 49.2 (d, C-4), 
48.4 (d, C-6), 48.1 (d, C-8), 46.3 (d, C-8'), 43.7 (d, C-4'a), 41.4 (d, C-10), 28.5 (t, C-7'), 28.4 (d, 
C-1''), 27.5 (t, C-5'), 26.0 (t, CH2C-2'''), 20.2 (q, CH3C-1''), 15.0 (q, CH3C-1''), 12.8 (q ×2, CH3C-
4 & C-11), 12.1 (q, CH3C-6), 11.1 (q, CH3C-2), 8.4 (q, CH3C-8), 7.2 (q, (CH3C)3Si), 7.1 (q, 
CH3CC-2'''), 5.2 (t, (CH2)3Si). 
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As described above for the preparation of 253, the (Z,Z)-dienyl bis(9-
borabicyclo[3.3.1]nonan-9-ylborinate) of 202aa (20 mg, 0.064 mmol) was prepared by reaction 
with 9-BBNOTf (4 equiv) and Et3N (5 equiv) in Et2O at –78 °C for 4 h, followed by addition of 
2,4-dimethyl-3-pentanone (8 equiv) and reaction at 0 °C for 1 h (to quench the excess 9-BBN-
OTf). The stirring mixture was cooled to –78 °C and a solution of (+)-128 (24 mg, 0.08 mmol) in 
THF (0.2 mL) was added via syringe. After 12 h, a solution of (±)-159 (31 mg, 0.19 mmol) in Et2O 
(0.2 mL) was added. After 6 h, the reaction was quenched by sequential addition of phosphate 
buffer (pH 7, 0.5 ml), 30% aq H2O2 (0.5 ml), and MeOH (0.5 ml) with vigorous stirring. The 
reaction vessel was transferred to an ice bath, and after vigorous stirring for 20 min, the reaction 
mixture was diluted with saturated aq NaHCO3 and extracted with CH2Cl2. The combined organic 
layers were dried over Na2SO4 and concentrated to give the crude product as pale yellow oil whose 
1H NMR spectrum indicated the presence of a 2.2:1:1 mixture of 252sss, 252ssa, and 
homobisaldols (i.e., double addition of (+)-128 or (±)-159 to 222), respectively. Fractionation of 




















hexane) gave a 1:1.1 mixture of 252sss and 252ssa (17 mg, 34%; 13C NMR signals of the major 
component match those of a authentic sample; see below), respectively, and the title compound as 
an 8:1 mixture with 252ssa (17 mg, ca. 90% pure, ca. 30%); [α]D +9.0 (c 1.4, CHCl3). 
colorless viscous oil, TLC Rf = 0.3 (30% ethyl acetate in hexane). 
IR (DRIFT) vmax 3536, 1712 cm
-1. 
1H NMR (500 MHz, CDCl3) δ 7.48-7.44 (2H, m, Ph), 7.37-7.32 (3H, m, Ph), 5.53 (1H, s, HC-2'), 
4.42 (1H, dd, J = 3, 8.5 Hz, HC-5), 4.17 (1H, dd, J = 3, 6 Hz, HC-1), 4.10 (1H, dd, J = 2.5, 8 Hz, 
HC-9), 4.02-3.93 (4H, m, H2CO ×2), 3.49 (1H, dd, J = 9 Hz, HC-8'a), 3.39 (1H, dd, J = 2, 10 Hz, 
HC-4'), 3.22 (1H, br s, HO), 3.07 (1H, dq, J = 3, 7 Hz, HC-2), 3.00 (1H, dq, J = 8, 7 Hz, HC-8), 
2.97 (1H, br d, J = 14 Hz, HC-7'), 2.85 (1H, dq, J = 8.5, 7 Hz, HC-4), 2.82 (1H, dq, J = 3, 7 Hz, 
HC-6), 2.64 (1H, dd, J = 11.5, 14 Hz, HC-7'), 2.50 (1H, br d, J = 13.5 Hz, HC-5'), 2.31 (1H, dd, J 
= 12, 13.5 Hz, HC-5'), 2.13-2.03 (2H, m, HC-8', HC-4'a), 1.95 (1H, dqq, J = 2, 7, 7 Hz, HC-1''), 
1.85 (1H, dq, J = 2.5, 7 Hz, HC-10), 1.72-1.64 (2H, m, H2CC-2'''), 1.21 (3H, d, J = 7 Hz, H3CC-
8), 1.14 (3H, d, J = 7 Hz, H3CC-2), 1.05 (3H, d, J = 7 Hz, H3CC-1''), 1.04 (3H, d, J = 7 Hz, H3CC-
6), 0.97 (6H, ap d, J = 7 Hz, H3CC-1'', H3C-11), 0.91 (9H, t, J = 8 Hz, (H3CC)3Si), 0.85 (3H, t, J 
= 7.5 Hz, H3CCC-2'''), 0.75 (3H, d, J = 7 Hz, H3CC-4), 0.55 (6H, ap q, J = 8 Hz, (H2C)3Si). 
13C NMR (125 MHz, CDCl3) δ 217.9 (s, C-3), 215.1 (s, C-7), 138.9 (s, Ph), 128.9 (d, Ph), 128.3 
(d ×2, Ph), 126.3 (d ×2, Ph), 114.5 (s, C-2'''), 101.1 (d, C-2'), 84.0 (d, C-4'), 82.5 (d, C-8'a), 73.7 
(d, C-5), 70.9 (d, C-9), 70.3 (d, C-1), 65.5 (t, CH2O), 65.0 (t, CH2O), 51.5 (d, C-6), 50.9 (d, C-2), 
48.54 (d, C-4), 48.47 (d, C-8), 46.0 (d, C-8'), 43.8 (d, C-4'a), 39.9 (d, C-10), 28.9 (t, C-7'), 28.5 (d, 
C-1''), 27.7 (t, CH2C-2'''), 27.6 (t, C-5'), 20.2 (q, CH3C-1''), 15.0 (q, CH3C-1''), 14.7 (q, CH3C-8), 
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13.5 (q, CH3C-4), 10.4 (q, CH3C-2), 9.8 (q, CH3C-6), 8.5 (q, C-11), 7.9 (q, CH3CC-2'''), 7.1 (q, 
(CH3C)3Si), 5.2 (t, (CH2)3Si). 






A solution of Dess-Martin periodinane (DMP; 133 mg, 0.31 mmol) and tert-butylalcohol 
(23 mg, 0.31 mmol) in CH2Cl2 (2 mL) was stirred for 10 min at room temperature and then cooled 
to 0 °C. A solution of the above 84:12:4 mixture of 252ssa, 252ass, and 252sss, respectively (162 
mg, 0.21 mmol), and pyridine (0.05 mL, 50 mg, 0.64 mmol) in CH2Cl2 (2 mL) was added to the 
above stirring solution. After 1 h, the reaction was quenched by sequential addition of Et2O (12 
mL) and a 1:1 mixture (v/v) of saturated aq NaHCO3 and 10% aq Na2S2O3 (12 mL) with vigorous 
stirring. The two layers were separated and the aqueous phase was extracted with Et2O. The 
combined organic layers were washed with brine, dried over Na2SO4 and concentrated to give the 
crude product, whose 1H NMR spectrum indicated the presence of a 12:3:1 mixture of 272, the 
corresponding tetrone (tentatively identified), and 252ssa, respectively. Fractionation of the crude 




















on 252ssa; 43% from (+)-128) that was a 1:2:5 mixture of enol and two keto tautomers, 
respectively, in C6D6 solution; [α]D +54 (c 1.0, C6H6). 
colorless viscous oil, TLC Rf = 0.3 (15% ethyl acetate in hexane). 
IR (DRIFT) vmax 3488, 1700 cm
-1. 
1H NMR (500 MHz, C6D6) δ (* enol tautomer; † major keto tautomer; ‡ minor keto tautomer) 
17.86 (0.15H, s, HO-enol), 7.60-7.48 (2H, m, Ph), 7.33-7.07 (3H, m, Ph), 5.45 (0.15H, s, *HC-2'), 
5.32 (0.25H, s, ‡HC-2'), 5.31 (0.6H, s, †HC-2'), 4.60 (0.6H, dd, J = 5.5, 6 Hz, †HC-5), 4.60-4.57 
(0.15H, m, *HC-5), 4.51 (0.25H, dd, J = 4.5, 8 Hz, ‡HC-5), 4.34-4.26 (2H, m, HOC-9, HC-9), 4.09 
(0.6H, q, J = 7 Hz, †HC-2), 3.88 (0.25H, q, J = 7 Hz, ‡HC-2), 3.67 (0.15H, ap t, J = 10 Hz, *HC-
8'a), 3.62 (0.25H, ap t, J = 10 Hz, ‡HC-8'a), 3.62 (0.6H, ap t, J = 10 Hz, †HC-8'a), 3.40-3.20 (6H, 
m, J = 7 Hz, H2CO ×2, HC-6, HC-8'), 3.10-2.77 (3.6H, m, HC-4, HC-4', †H2C-7', ‡HC-7', *HC-
7'), 2.72 (0.15H, br q, J = 7 Hz, *HC-8), 2.65 (0.6H, br q, †HC-8), 2.61-2.54 (0.5H, m, ‡HC-7', 
‡HC-8), 3.25 (0.15H, ddd, J = 2.5, 2.5, 13.5 Hz, *HC-7'), 2.15-2.81 (4H, m, HC-4'a, H2C-5', HC-
10), 1.80 (0.45H, s, *H3CC-2), 1.75-1.44 (3H, m, HC-1'', H2CC-2'''), 1.35 (1.8H, d, J = 7 Hz, 
†H3CC-2), 1.33 (0.75H, d, J = 7 Hz, ‡H3CC-8), 1.31 (1.8H, d, J = 7 Hz, †H3CC-8), 1.30 (0.45H, d, 
J = 7 Hz, *H3CC-8), 1.25 (0.75H, d, J = 7 Hz, ‡H3CC-2), 1.23 (0.45H, d, J = 7 Hz, *H3CC-6), 1.12 
(2.55H, ap d, J = 7 Hz, †H3CC-6, ‡H3CC-6), 1.07-0.92 (15H, m, H3CC-4, H3CC-1'', (H3CC)3Si), 
0.90-0.81 (9H, m, H3CC-10, H3CC-1'', H3CCC-2'''), 0.75-0.62 (6H, m, (H2C)3Si). 
13C NMR (125 MHz, C6D6) δ (* enol tautomer; † major keto tautomer; ‡ minor keto tautomer) 
215.0 (s, ‡C-7), 214.2 (s, *C-7), 213.7 (s, †C-7), 209.9 (s, †C-3), 209.24 (s, ‡C-1 or ‡C-3), 209.16 
(s, ‡C-1 or ‡C-3), 208.3 (s, †C-1), 196.4 (s, *C-3), 193.3 (s, *C-1), 139.7 (s, *Ph), 139.5 (s, †Ph), 
139.4 (s, ‡Ph), 129.3 (d, ‡Ph), 129.2 (d ×2, ‡Ph), 129.1 (d, *Ph), 128.9 (d, †Ph), 128.66 (d ×2, †Ph), 
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128.64 (d ×2, *Ph), 127.2 (d ×2, ‡Ph), 126.9 (d ×2, *Ph), 126.6 (d ×2, †Ph), 115.22 (d, ‡C-2'''), 
115.17 (t, †C-2'''), 115.13 (d, *C-2'''), 106.35 (s, *C-2), 102.0 (d, ‡C-2'), 101.4 (d, *C-2'), 101.3 (d, 
†C-2'), 83.9 (d ×2, †C-4' & ‡C-4'), 83.8 (d, *C-4'), 83.3 (d, †C-8'a), 82.6 (d, ‡C-8'a), 81.4 (d, *C-
8'a), 77.1 (d, ‡C-5), 76.1 (d, †C-5), 75.9 (d, *C-5), 73.42 (d, ‡C-9), 73.38 (d, *C-9), 73.2 (d, †C-9), 
65.4 (t, CH2O), 65.1 (t, CH2O), 62.2 (d, †C-2), 60.5 (d, ‡C-2), 55.8 (d, †C-8'), 53.6 (d, ‡C-8'), 51.0 
(d, †C-4), 50.1 (d, ‡C-4), 49.5 (d, ‡C-8), 49.2 (d, †C-8), 49.0 (d, *C-8 or *C-8'), 48.9 (d, *C-8 or 
*C-8'), 48.3 (d, †C-6), 47.9 (d, *C-6), 47.6 (d, ‡C-6), 44.6 (d, *C-4 or *C-4'a), 44.2 (d, *C-4 or *C-
4'a), 43.8 (d, †C-4'a), 43.7 (d, ‡C-4'a), 42.08 (d, *C-10), 42.05 (d, ‡C-10), 42.02 (d, †C-10), 31.1 (d, 
‡C-7'), 30.9 (d, †C-7'), 30.5 (d, *C-7'), 28.7 (d, *C-1''), 28.6 (d ×2, †C-1'' & ‡C-1''), 27.6 (d ×2, ‡C-
5' & *C-5'), 27.5 (d, †C-5'), 26.6 (d, *CH2C-2'''), 26.4 (d, †CH2C-2'''), 26.3 (d, ‡CH2C-2'''), 20.3 (q, 
CH3C-1''), 15.8 (q, CH3C-1''), 14.1 (q, ‡CH3C-6), 13.6 (q ×2, †CH3C-4 & *CH3C-4 or *CH3C-6), 
13.53 (q, *CH3C-4 or *CH3C-6), 13.46 (q ×2, ‡CH3C-2 & ‡CH3C-4), 13.3 (q, †CH3C-6), 13.0 (q 
×2, †CH3C-10 & ‡CH3C-10), 12.9 (q, *CH3C-10), 12.5 (q, †CH2C-2), 12.4 (q, *CH3C-2), 8.9 (q, 
*CH3C-8), 8.8 (q, †CH3C-8), 8.6 (q, ‡CH3C-8), 7.71 (q, ‡(CH3C)3Si), 7.69 (q, †(CH3C)3Si), 7.6 (q, 
*(CH3C)3Si), 7.55 (q, *CH3CC-2'''), 7.48 (q, †CH3CC-2'''), 7.43 (q, ‡CH3CC-2'''), 5.83 (t, 
†(H2C)3Si), 5.81 (t, ‡(H2C)3Si), 8.79 (t, *(H2C)3Si). 

























FeCl3·6H2O (4.7 mg, 0.018 mmol) was added to a stirring solution of 272 (68 mg, 0.088 
mmol) in acetone (2.5 mL) at 0 °C. The reaction vessel was removed from the ice bath and allowed 
to warm to ambient temperature with stirring. After 30 min, the reaction was quenched by 
sequential addition of saturated aq NaHCO3 and ethyl acetate. The organic layer was separated 
and the aqueous layer was extracted with ethyl acetate. The combined organic layers were washed 
with brine, dried over Na2SO4, concentrated, and fractionate by FCC (30% ethyl acetate in hexane) 
to give the title compound (49 mg, 91%) that was a 1:2:1 mixture of enol and two keto tautomers, 
respectively, in C6D6 solution; [α]D +59 (c 1.0, C6H6). 
colorless viscous oil, TLC Rf = 0.3 (30% ethyl acetate in hexane). 
IR (DRIFT) vmax 3483, 1712 cm
-1. 
1H NMR (500 MHz, C6D6) δ (for major keto tautomer) 7.41-7.37 (2H, m, Ph), 7.13-7.08 (2H, m, 
Ph), 7.07-7.02 (1H, m, Ph), 5.18 (1H, s, HC-2'), 4.45 (1H, dd, J = 4, 8 Hz, HC-9), 4.07-4.02 (1H, 
m, HO), 3.54-3.50 (1H, m, HC-5), 3.50 (1H, q, J = 7 Hz, HC-2), 3.43 (1H, dd, J = 9.5, 10 Hz, HC-
8'a), 3.36 (1H, dq, J = 10, 6.5 Hz, HC-6), 2.96 (1H, ddd, J = 3, 10, 11.5 Hz, HC-8'), 2.90 (1H, dd, 
J = 2, 9.5 Hz, HC-4'), 2.82 (1H, dq, J = 3, 7 Hz, HC-8), 2.78 (1H, dd, J = 11.5, 13.5 Hz, HC-7'), 
2.73 (1H, dq, J = 8, 7 Hz, HC-10), 2.48 (1H, dq, J = 18, 7 Hz, HC-12), 2.45-2.40 (1H, dq, J = 2.5, 
7.5 Hz, HC-4), 2.23 (1H, dq, J = 18, 7 Hz, HC-12), 2.11 (1H, br d, J = 13.5 Hz, HC-7'), 2.09-1.99 
(2H, m, HC-5', HC-4'a), 1.83 (1H, dd, J = 12.5, 14 Hz, HC-5'), 1.51-1.44 (1H, m, HC-1''), 1.16 
(3H, d, J = 7 Hz, H3CC-8), 1.07-1.02 (6H, m, H3C-13, H3CC-6), 0.91 (3H, d, J = 7 Hz, H3CC-1''), 
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0.90 (3H, d, J = 7 Hz, H3CC-1''), 0.88 (3H, d, J = 7 Hz, H3CC-2 ), 0.86 (3H, d, J = 7 Hz, H3CC-
10), 0.51 (3H, d, J = 7.5 Hz, H3CC-4), δ (for minor keto tautomer; partial data) 3.85 (1H, q, J = 7 
Hz, HC-2), 1.19 (3H, d, J = 7 Hz, H3CC-2), δ (for enol tautomer; partial data) 17.4 (1H, br s, enol 
HO), 1.52 (3H, s, H3CC-2). 
13C NMR (125 MHz, C6D6) δ (for major keto tautomer) 217.8 (s, C-7), 214.8 (s, C-11), 213.15 (s, 
C-3), 210.8 (s, C-1), 138.9 (s, Ph), 130.0 (d, Ph), 129.0 (d ×2, Ph), 127.3 (d ×2, Ph), 102.7 (d, C-
2'), 83.9 (d, C-8'a), 83.8 (d, C-4'), 79.1 (d, C-5), 73.7 (d, C-9), 60.2 (d, C-2), 54.8 (d, C-8'), 51.0 
(d, C-8), 49.0 (d, C-6), 48.0 (d, C-10), 46.4 (d, C-4), 43.7 (d, C-4'a), 36.7 (t, C-12 ), 30.3 (t, C-7'), 
28.5 (d, C-1''), 27.5 (t, C-5'), 20.2 (q, CH3C-1''), 15.3 (q, CH3C-6), 15.1 (q, CH3C-1''), 14.9 (q, 
CH3C-4), 14.3 (q, CH3C-10), 11.5 (q, CH3C-2), 9.7 (q, CH3C-8), 8.0 (q, C-13), δ (for minor keto 
tautomer; partial data), 213.11 (s, C-3), 208.1 (s, C-1), 61.9 (d, C-2), 56.1 (d, C-8'), 12.6 (q, CH3C-
2), δ (for enol tautomer; partial data) 200.6 (s, C-3), 192.5 (s, C-1), 106.6 (s, C-2), 48.7 (d, C-8'), 
39.5 (d, C-4), 12.2 (q, CH3C-2). 




























Imidazole (21 mg, 0.297 mmol) and Et3SiCl (0.034 ml, 30 mg, 0.199 mmol) were 
sequentially added to a stirring solution of 275 (41 mg, 0.066 mmol) in dry DMF (1 mL) at 0 °C. 
The reaction mixture was removed from the ice-bath and allowed to warm to ambient temperature 
with stirring. After 2 h (reaction was complete by TLC analysis), the mixture was diluted with 
Et2O and washed sequentially with aq citric acid (0.2 M) and brine, dried over Na2SO4, and 
concentrated to give the crude product. Fractionation of the crude product by FCC (10% ethyl 
acetate in hexane) gave the title compound (55 mg, 98%) that was an ca. 2:5:1 mixture of enol and 
two keto tautomers, respectively, in C6D6 solution; [α]D +18 (c 1.0, C6H6). 
colorless viscous oil, TLC Rf = 0.3 (10% ethyl acetate in hexane). 
IR (DRIFT) vmax 1720 cm
-1. 
1H NMR (500 MHz, C6D6) δ (for major keto tautomer) 7.50-7.46 (2H, m, Ph), 7.19-716 (2H, m, 
Ph), 7.09 (1H, br t, J = 7.5 Hz, Ph), 5.29 (1H, br s, HC-2'), 4.62 (1H, dd, J = 3, 7.5 Hz, HC-9), 4.49 
(1H, ap t, J = 6 Hz, HC-5), 4.02 (1H, q, J = 7 Hz, HC-2), 3.60 (1H, dd, J = 9.5, 10 Hz, HC-8'a), 
3.23 (1H, ddd, J = 3, 10, 11.5 Hz, HC-8'), 3.02 (1H, dd, J = 11.5, 14 Hz, HC-7'), 2.97-2.90 (3H, 
m, HC-6, HC-4', HC-7'), 2.77 (1H, dq, J = 3, 7 Hz, HC-8), 2.73 (1H, dq, J = 7, 6.5 Hz, HC-4), 
2.61 (1H, dq, J = 7.5, 7 Hz, HC-10), 2.4-2.15 (2H, m, HC-12), 2.08-1.98 (2H, m, HC-5', HC-4'a ), 
1.84 (1H, dd, J = 12.5, 13.5 Hz, HC-5'), 1.54-1.44 (1H, m, HC-1''), 1.32 (3H, d, J = 7 Hz, H3CC-
2), 1.17 (3H, d, J = 7 Hz, H3CC-8), 1.08-1.03 (15H, m, H3C-13, (H3CC)3Si, H3CC-6), 0.98 (9H, t, 
J = 8 Hz, (H3CC)3Si), 0.95 (3H, d, J = 7 Hz, H3CC-1''), 0.92 (3H, d, J = 6.5 Hz, H3CC-4), 0.91 
(3H, d, J = 7 Hz, H3CC-10), 0.85 (3H, d, J = 7 Hz, H3CC-1''), 0.80-0.74 (6H, m, (H2C)3Si), 0.71-
0.65 (6H, m, (H2C)3Si), δ (for minor keto tautomer; partial data) 5.31 (1H, br s, HC-2'), 3.76 (1H, 
q, J = 7 Hz, HC-2), 3.64 (1H, dd, J = 9.5, 10 Hz, HC-8'a), 1.19 (3H, d, J = 7 Hz, H3CC-2), δ (for 
enol tautomer; partial data) 17.78 (1H, br s, HO), 5.46 (1H, br s, HC-2'), 4.56 (1H, dd, J = 3.5, 7.5 
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Hz, HC-9), 4.54 (1H, dd, J = 3, 8 Hz, HC-5), 3.85 (1H, dd, J = 9.5, 10 Hz, HC-8'a), 1.76 (3H, s, 
H3CC-2). 
13C NMR (125 MHz, C6D6) δ (for major keto tautomer) 213.0 (s, C-7), 212.25 (s, C-11), 210.6 (s, 
C-3), 208.3 (s, C-1), 139.5 (s, Ph), 129.2 (d, Ph), 128.7 (d ×2, Ph), 126.6 (d ×2, Ph), 101.3 (d, C-
2'), 83.9 (d, C-4'), 83.5 (d, C-8'a), 76.3 (d, C-5), 73.54 (d, C-9), 62.2 (d, C-2), 56.1 (d, C-8'), 51.0 
(d, C-4 or C-10), 50.5 (d, C-4 or C-10), 49.8 (d, C-6), 48.53 (d, C-8), 43.9 (d, C-4'a), 37.1 (t, C-12 
), 30.8 (t, C-7'), 28.6 (d, C-1''), 27.5 (t, C-5'), 20.3 (q, CH3C-1''), 15.2 (q, CH3C-1''), 14.0 (q, CH3C-
4 or CH3C-10), 13.8 (q, CH3C-4 or CH3C-10), 12.6 (q, CH3C-6), 12.4 (q, CH3C-2), 11.6 (q, CH3C-
8), 8.0 (q, C-13), 7.8 (q, (CH3C)3Si), 7.7 (q, (CH3C)3Si), 6.0 (t, (CH2)3Si), 5.9 (t, (CH2)3Si), δ (for 
minor keto tautomer; partial data) 213.20 (s, C-7), 212.29 (s, C-11), 209.1 (s, C-3), 209.0 (s, C-1), 
102.1 (d, C-2'), 82.6 (d, C-8'a), 76.5 (d, C-5), 73.47 (d, C-9), 60.8 (d, C-2), δ (for enol tautomer; 
partial data) 213.22 (s, C-7), 212.15 (s, C-11), 196.7 (s, C-3), 193.2 (s, C-1), 106.1 (s, C-2), 101.6 
(d, C-2'), 81.3 (d, C-8'a), 76.0 (d, C-5), 74.0 (d, C-9), 12.3 (q, CH3C-2). 





A suspension of Raney nickel (W2; 0.3 mL settled volume) in EtOH (2 mL) was added to 































H2 atmosphere. After 2 h (reaction was complete by TLC analysis), the mixture was decanted, and 
the solid was suspended in EtOH (4 mL) and heated under reflux with vigorous stirring for several 
min. This washing procedure was repeated with ethyl acetate and acetone. The combined organic 
layers were filtered through Celite, and concentrated to obtain the crude product (12 mg) as a 2:1 
mixture of hemiacetal diastereomers (HOC-17 à O=C-13; epimeric at C-12) 278a and 278b, 
respectively, by 1H NMR in C6D6 solution. The crude product was fractionated by PTLC (15% 
ethyl acetate in hexane) to give 278b as a 6:1 mixture with 278a (6 mg, 23%) and 278a (13 mg, 
48%); [α]D –27 (c 1.0, C6H6). 
colorless viscous oil, TLC Rf = 0.5 (20% ethyl acetate in hexane). 
IR (DRIFT) vmax 3417, 1712 cm
-1. 
1H NMR (500 MHz, C6D6) δ 5.38 (1H, s, HOC-13), 4.76 (1H, dd, J = 5.5, 7 Hz, HC-9), 4.70 (1H, 
dd, J = 2.5, 8 Hz, HC-5), 3.67 (1H, dq, J = 5.5, 7 Hz, HC-10), 3.54 (1H, dd, J = 2, 10.5 Hz, HC-
17), 3.22 (1H, q, J = 7 Hz, HC-12), 3.15 (1H, dq, J = 7, 7 Hz, HC-8), 3.06 (1H, br s, HC-15), 3.72 
(1H, dq, J = 2.5, 7.5 Hz, HC-6), 2.61 (1H, dq, J = 8, 7 Hz, HC-4), 2.35 (1H, dq, J = 18.5, 7 Hz, 
HC-2), 2.22 (1H, dq, J = 18.5, 7 Hz, HC-2), 1.81 (1H, br d, J = 5 Hz, HOC-15), 1.65 (1H, dqq, J 
= 2, 7, 7 Hz, HC-18), 1.41 (1H, dq, J = 2.5, 7 Hz, HC-14), 1.28 (3H, d, J = 7 Hz, H3CC-10), 1.24-
1.19 (1H, m, HC-16), 1.18 (3H, d, J = 7 Hz, H3CC-12), 1.17 (3H, d, J = 7.5 Hz, H3CC-6), 1.13 
(3H, d, J = 7 Hz, H3CC-8), 1.12 (3H, d, J = 7 Hz, H3C-19), 1.10 (9H, t, J = 8 Hz, (H3CC)3Si), 1.06 
(9H, t, J = 8 Hz, (H3CC)3Si), 1.06 (3H, t, J = 7 Hz, H3C-1), 0.97 (3H, d, J = 7 Hz, H3CC-14), 0.888 
(3H, d, J = 7 Hz, H3CC-4), 0.886 (3H, d, J = 7 Hz, H3C-19), 0.81 (12H, ap q, J = 8 Hz, (H2C)3Si 
× 2), 0.58 (3H, d, J = 7 Hz, H3CC-16). 
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13C NMR (125 MHz, C6D6) δ 213.3 (s, C-7), 212.4 (s, C-3), 212.0 (s, C-11), 101.7 (s, C-13), 77.0 
(d, C-15), 76.4 (d, C-9), 73.5 (d, C-5), 72.4 (d, C-17), 52.8 (d, C-10), 52.1 (d, C-12), 50.8 (d, C-
4), 49.1 (d, C-6), 48.8 (d, C-8), 39.1 (d, C-14), 37.7 (d, C-16), 37.3 (t, C-2), 28.8 (d, C-18), 21.0 
(q, C-19), 14.7 (q, C-19), 14.2 (q, CH3C-4), 13.7 (q, CH3C-16), 13.6 (q, CH3C-14), 12.9 (q, CH3C-
8), 12.8 (q, CH3C-12), 12.0 (q, CH3C-10), 10.9 (q, CH3C-6), 8.0 (q, C-1), 7.8 (q, (CH3C)3Si), 7.7 
(q, (CH3C)3Si), 6.0 (t, (CH2)3Si), 5.9 (t, (CH2)3Si). 





A 6:1 mixture of diastereomers. For preparation, see 278a. 
colorless viscous oil, TLC Rf = 0.4 (20% ethyl acetate in hexane). 
[α]D –18 (c 0.6, C6H6). 
IR (DRIFT) vmax 1716 cm
-1. 
1H NMR (500 MHz, C6D6) δ (for the major diastereomer of the 6:1 mixture) 4.92 (1H, s, HOC-
13), 4.67 (1H, dd, J = 2.5, 8 Hz, HC-5), 4.57 (1H, dd, J = 5.5, 6.5 Hz, HC-9), 3.66 (1H, dd, J = 2, 
11 Hz, HC-17), 3.32 (1H, dq, J = 5.5, 7 Hz, HC-10), 3.13-3.07 (3H, m, HC-8, HC-12, HC-15), 































Hz, HC-2), 2.21 (1H, dq, J = 18.5, 7 Hz, HC-2), 1.93 (1H, d, J = 6 Hz, HOC-15), 1.69 (1H, dqq, 
J = 2.5, 7, 7 Hz, HC-18), 1.53 (1H, dq, J = 2.5, 7 Hz, HC-14), 1.50 (3H, d, J = 7 Hz, H3CC-12), 
1.28-1.22 (1H, m, HC-16), 1.228 (3H, d, J = 7 Hz, H3CC-8), 1.223 (3H, d, J = 7.5 Hz, H3CC-6), 
1.20 (6H, ap d, J = 7 Hz, H3CC-10, H3CC-14), 1.12 (3H, d, J = 7 Hz, H3C-19), 1.09 (3H, t, J = 7 
Hz, H3C-1), 1.07 (9H, t, J = 8 Hz, (H3CC)3Si), 1.06 (9H, t, J = 8 Hz, (H3CC)3Si), 0.90 (3H, d, J = 
7 Hz, H3CC-4), 0.87 (3H, d, J = 7 Hz, H3C-19), 0.84-0.72 (12H, m, (H2C)3Si × 2), 0.65 (3H, d, J 
= 7 Hz, H3CC-16). 
13C NMR (125 MHz, C6D6) δ (for the major diastereomer of the 6:1 mixture) 216.2 (s, C-11), 
213.0 (s, C-7), 212.3 (s, C-3), 101.4 (s, C-13), 77.1 (d, C-15), 77.0 (d, C-9), 73.6 (d, C-5), 72.3 (d, 
C-17), 54.6 (d, C-12), 51.0 (d, C-4), 49.9 (d, C-8), 48.3 (d, C-6), 47.9 (d, C-10), 41.5 (d, C-14), 
38.1 (d, C-16), 37.3 (t, C-2), 28.8 (d, C-18), 21.1 (q, C-19), 15.1 (q, CH3C-10), 15.0 (q, C-19), 
14.6 (q, CH3C-14), 14.1 (q, CH3C-4), 13.7 (q, CH3C-16), 13.0 (q, CH3C-8), 11.4 (q, CH3C-6), 11.0 
(q, CH3C-12), 8.0 (q, C-1), 7.8 (q, (CH3C)3Si), 7.6 (q, (CH3C)3Si), 6.0 (t, (CH2)3Si), 5.9 (t, 
(CH2)3Si). 





























To a stirring solution of 278 (a 2:1 mixture of C-12 epimers; 14 mg, 0.020 mmol) in DMF 
(0.2 ml) was added tris(dimethylamino)sulfonium difluorotrimethylsilicate (TASF; 22 mg, 0.08 
mmol). After 1 h, the reaction was quenched by the sequential addition of saturated aq NaHCO3 
and ethyl acetate. The organic layer was separated and the aqueous layer was extracted with ethyl 
acetate. The combined organic layers were washed with brine, dried over Na2SO4, and 
concentrated to give the crude product whose 1H NMR spectrum (C6D6) indicated the presence of 
a 1:1 mixture of hemiacetals. Fractionation of the crude product by FCC (40% ethyl acetate in 
hexane), followed by PTLC gave the title compound (7 mg, 74%) that was predominantly a 3.5:1 
mixture of hemiacetal diastereomers (HOC-17 à O=C-13; epimeric at C-12) by 1H NMR in C6D6 
solution; [α]D –25 (c 0.7, C6H6). 
colorless waxy solid, TLC Rf = 0.3 (40% ethylacetate in hexanes). 
IR (DRIFT) vmax 3394, 1708 cm
-1. 
1H NMR (500 MHz, C6D6) δ (for the major diastereomer) 5.83 (1H, s, HOC-13), 4.41 (1H, ddd, 
J = 3, 4.5, 8 Hz, HC-5), 4.02 (1H, br d, J = 9 Hz, HOC-9), 3.85 (1H, ddd, J = 4.5, 8.5, 9 Hz, HC-
9), 3.66 (1H, br d, J = 4.5 Hz, HOC-5), 3.61 (1H, dd, J = 2, 11 Hz, HC-17), 3.26 (1H, dq, J = 4.5, 
7 Hz, HC-10), 3.15-3.11 (1H, m, HC-15), 3.00 (1H, dq, J = 8.5, 7 Hz, HC-8), 2.96 (1H, q, J = 7 
Hz, HC-12), 2.71-2.65 (2H, m, HC-4, HC-6), 2.48 (1H, dq, J = 18.5, 7 Hz, HC-2), 2.45 (1H, br 
dd, J = 5.5 Hz, HOC-15), 2.20 (1H, dq, J = 18.5, 7 Hz, HC-2), 1.67 (1H, dqq, J = 2, 7, 7 Hz, HC-
18), 1.31 (1H, dq, J = 2.5, 7 Hz, HC-14), 1.23-1.18 (1H, m, HC-16), 1.15 (3H, d, J = 7 Hz, H3CC-
10), 1.12 (3H, d, J = 7 Hz, H3CC-6), 1.08 (3H, d, J = 7 Hz, H3C-19), 1.05 (3H, d, J = 7 Hz, H3CC-
12), 1.02 (3H, t, J = 7 Hz, H3C-1), 0.99 (3H, d, J = 7 Hz, H3CC-8), 0.94 (3H, d, J = 7 Hz, H3CC-
14), 0.86 (3H, d, J = 7 Hz, H3C-19), 0.84 (3H, d, J = 7 Hz, H3CC-4), 0.68 (3H, d, J = 7 Hz, H3CC-
16), δ (for the minor diastereomer; partial data) 5.53 (1H, s, HOC-13), 4.38 (1H, ddd, J = 4, 4, 8 
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Hz, HC-5), 3.97 (1H, br d, J = 6.5 Hz, HOC-9), 3.76 (1H, ddd, J = 4.5, 6.5, 8.5 Hz, HC-9), 3.70 
(1H, dd, J = 2, 11 Hz, HC-17), 3.24-3.21 (1H, m, HC-15), 3.07 (1H, q, J = 7 Hz, HC-12), 2.87 
(1H, br d, J = 6 Hz, HOC-15), 1.52 (1H, dq, J = 2.5, 7 Hz, HC-14), 1.21 (3H, d, J = 7 Hz, H3CC-
12). 
13C NMR (125 MHz, C6D6) δ (for the major diastereomer) 218.0 (s, C-11), 217.6 (s, C-7), 215.2 
(s, C-3), 102.6 (s, C-13), 79.3 (s, C-9), 76.7 (d, C-15), 73.6 (d, C-5), 72.7 (d, C-17), 52.9 (d, C-
12), 50.4 (d, C-6), 48.6 (d, C-8), 48.2 (d, C-10), 47.9 (d, C-4), 39.0 (d, C-14), 37.7 (d, C-16), 37.2 
(t, C-2), 28.8 (d, C-18), 21.1 (q, C-19), 15.3 (q, CH3C-10), 15.2 (q, H3CC-8), 14.7 (q, C-19), 14.2 
(q, CH3C-4), 13.9 (q, CH3C-16), 13.5 (q, CH3C-14), 12.7 (q, CH3C-12), 9.3 (q, CH3C-6), 8.0 (q, 
C-1), δ (for minor diastereomer; partial data) 219.9 (s, C-11), 216.9 (s, C-7), 214.6 (s, C-3), 102.1 
(s, C-13), 79.0 (d, C-9), 77.7 (d, C-15), 73.8 (d, C-5), 54.6 (d, C-12), 50.1 (d, C-6), 48.8 (d, C-8), 
40.7 (d, C-14), 37.9 (d, C-16), 28.7 (d, C-18), 12.1 (q, CH3C-12). 
HRMS m/z calcd for C27H48O8+Na+ 523.3241, found 523.3225. 
 
 17 
dolabriferol C (17) 
A solution of 174 (6 mg, 0.012 mmol) in benzene (0.2 mL) was applied to a small column 
of neutral alumina (Brockmann I; ca. 5 cm in a Pasteur pipette). After 20 min, the column was 
eluted with ethyl acetate and the eluent was concentrated and fractionated by PTLC (30% ethyl 





























White solid, TLC Rf = 0.3 (30% ethyl acetate in hexane). 
1H NMR (500 MHz, CDCl3) δ 5.24 (1H, dd, J = 2.5, 2.5 Hz, HC-21), 4.19 (1H, ddd, J = 5, 7, 7 
Hz, HC-6), 4.06 (1H, d, J = 11.5 Hz, HOC-12), 4.00 (1H, d, J = 1.5 Hz, HOC-18), 3.68 (1H, dd, J 
= 2, 10.5 Hz, HC-24), 3.64 (1H, ddd, J = 3, 10, 11.5 Hz, HC-12), 3.25 (1H, d, J = 7 Hz, HOC-6), 
3.05 (1H, dq, J = 10, 7 Hz, HC-10), 2.88 (1H, dq, J = 5, 7 Hz, HC-7), 2.85 (1H, dq, J = 7, 7 Hz, 
HC-4), 2.77 (1H, dq, J = 3, 7 Hz, HC-13), 2.60-2.50 (2H, m, H2C-2), 1.92 (1H, ddq, J = 1.5, 2.5, 
7 Hz, HC-19), 1.79 (1H, dqq, J = 2, 7, 7 Hz, HC-25), 1.78-1.65 (3H, m, HC-22, H2C-16), 1.37 
(3H, d, J = 7 Hz, H3C-14), 1.10 (6H, ap d, J = 7 Hz, H3C-8, H3C-5), 1.06 (3H, d, J = 7 Hz, H3C-
20), 1.01 (6H, ap d, J = 7 Hz, H3C-11, H3C-26), 1.00 (3H, t, J = 7 Hz, H3C-1), 0.97 (3H, t, J = 7 
Hz, H3C-17), 0.84 (3H, d, J = 7 Hz, H3C-27), 0.78 (3H, d, J = 7 Hz, H3C-23). 
13C NMR (125 MHz, CDCl3) δ 218.3 (s, C-3), 216.6 (s, C-9), 173.8 (s, C-15), 98.4 (s, C-18), 76.8 
(d, C-12), 76.6 (d, C-21), 72.4 (d, C-24), 72.0 (d, C-6), 50.4 (d, C-7), 49.8 (d, C-10), 47.0 (d, C-
4), 43.2 (d, C-13), 39.2 (d, C-19), 36.7 (d, C-22), 36.6 (d, C-2), 32.7 (t, C-16), 27.9 (d, C-25), 20.2 
(q, C-26), 16.3 (q, C-14), 14.4 (q, C-11), 14.3 (q, C-5), 14.0 (q, C-27), 13.1 (q, C-20), 12.9 (q, C-
23), 9.3 (q, C-8), 7.3 (q, C-1), 7.2 (q, C-17). 
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